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Abstract
Filamentous fungi are eukaryotic multicellular organisms, which are essential in our ecosystem for degra-
dation of organic matter. Additionally, ﬁlamentous fungi produce an arsenal of small, bioactive molecules,
secondary metabolites, which may be exploited for commercial purposes e.g. as pigments, fungicides, insecti-
cides, pharmaceuticals etc. In this study I have examined the possibilities for elucidating the biosyntheses of
fungal secondary metabolites, as well as identifying novel compounds, by application of genetic engineering
techniques. I have focused on three levels of genetic engineering in three diﬀerent ﬁlamentous fungi, all be-
longing to the genus Aspergillus: A. nidulans, A. niger, and A. aculeatus. A. nidulans is a well-characterized
eukaryotic model system for which many genetic tools have been developed. A. niger is a well-characterized
cell factory, however, as production strains have traditionally been constructed by random mutagenesis or
directed evolution approaches only few genetic tools are publicly available. A. aculeatus is an industrial
enzyme producer, which was only recently genome-sequenced. No genetic tools exist for this organism, and
only very little is known about its potential to produce secondary metabolites.
In this study I have examined parts of the secondary metabolism in all three fungi, using diﬀerent
approaches. For A. nidulans we have constructed an entire genome-wide polyketide synthase (PKS) deletion
library, which has linked the known compounds austinol and dehydroaustinol to the corresponding PKS and
we have identiﬁed a new group of orsellinic acid-derived compounds. Also, I have successfully over-expressed
individual A. nidulans transcription factors and phosphatases in an eﬀort to perturb regulation of secondary
metabolism and identify new compounds. Furthermore, A. nidulans was used as a host for examination of
secondary metabolism by heterologous expression of secondary metabolite genes from A. niger, A. aculeatus,
and A. terreus.
In A. niger I have investigated the products of all 37 putative PKSs by heterologous expression of the genes
in A. nidulans. This approach identiﬁed the products of three PKSs, which were subsequently examined in
detail in A. niger. One of the products was 6-methylsalicylic acid (6-MSA), which proved to be the precursor
to the meroterpenoid yanuthone D, a compound that was previously hypothesized to be of mixed terpenoid
and shikimic acid origin. Individual gene deletions in this gene cluster mapped the entire biosynthetic pathway
towards yanuthone D, meanwhile identifying six novel yanuthones, which were not previously described.
The other two products both turned out to be the yellow pigment YWA1, which has previously been
characterized from A. nidulans and A. fumigatus. YWA1 serves as the precursor to both naphtho-γ-pyrones
and black melanin (DHN-melanin), which is the pigment that provides the characteristic black color of A.
niger. Intriguingly, only one of these PKS genes (napA) is placed in a typical secondary metabolite gene
cluster, but this PKS gene appears to be silenced.
For investigation of secondary metabolism in fungi with no available genetic tools, I have applied two
diﬀerent approaches: heterologous expression of secondary metabolite genes in A. nidulans and/or plasmid-
based gene expression in the native fungus. Heterologous expression in A. nidulans was used for successful
reconstruction of the (+)-geodin pathway, by transfer of the entire (+)-geodin cluster from A. terreus. For
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A. aculeatus, I have used a combination of the two approaches: I heterologously expressed a putative 6-
MSA synthase from A. aculeatus in A. nidulans, verifying that the gene indeed encoded a 6-MSA synthase.
Next, a transcription factor embedded in the putative gene cluster, was over-expressed from a plasmid-based
expression platform, which was developed in this study. Expression of the transcription factor triggered
activation of a biosynthetic pathway, which appear to be involved in production of ﬁve novel compounds.
Feeding experiments with fully 13C labelled 6-MSA, produced in this study, conﬁrmed that 6-MSA was
incorporated into three of these compounds.
Based on these results, I conclude that the combination of diﬀerent interdisciplinary approaches is a very
powerful tool for investigating fungal secondary metabolism. The results of my studies also suggest that
continuing optimization of existing tools as well as development of new tools is equally important as mere
application of existing tools.
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Sammenfatning
Filamentøse svampe er eukaryote multicellulære organismer der er essentielle for vores økosystem ved ned-
brydning af dødt organisk materiale. Derudover er ﬁlamentøse svampe også i stand til at producere et arsenal
af små, bioaktive molekyler, kaldet sekundære metabolitter, som kan udnyttes til kommercielle formål fx som
pigmenter, svampegifte, insektgifte, lægemidler mv. Igennem dette studium har jeg undersøgt mulighederne
for at belyse biosyntesen af sekundære metabolitter såvel som at identiﬁcere nye stoﬀer, ved at benytte
forskellige genetiske værktøjer. Jeg har fokuseret på tre niveauer af genteknologi i tre forskellige ﬁlamen-
tøse svampe som alle hører til genus Aspergillus: A. nidulans, A. niger og A. aculeatus. A. nidulans er et
velkarakteriseret eukaryot modelsystem hvortil der er udviklet mange genetiske værktøjer. A. niger er en
velkarakteriseret cellefabrik, men da produktionsstammer traditionelt set er lavet ved tilfældig mutagenese
eller directed evolution er der kun få genetiske værktøjer oﬀentligt til rådighed. A. aculeatus er en industriel
enzymproducer som kun for nyligt er blevet genomsekventeret. Der eksisterer ingen genetiske værktøjer til
denne organisme og kun meget lidt er kendt omkring dens potentiale til at producere sekundære metabolitter.
I dette studium har jeg undersøgt dele af den sekundære metabolisme i alle tre svampe, ved hjælp af
forskellige fremgangsmåder. I A. nidulans har vi konstrueret et fuldgenom polyketidsyntase (PKS) gendele-
tionsbibliotek, som har koblet de kendte stoﬀer austinol og dehydroaustinol til deres respektive PKS og vi
har identiﬁceret en ny gruppe af orsellinsyre-deriverede stoﬀer. Jeg har også med success overudtrykt in-
dividuelle A. nidulans transkriptionsfaktorer og fosfataser i et forsøg på at pertubere reguleringen af den
sekundære metabolisme for at ﬁnde nye stoﬀer. Derudover har jeg brugt A. nidulans som værtsorganisme
i en undersøgelse af den sekundære metabolisme ved heterologt udtryk af sekundære metabolitgener fra A.
niger, A. aculeatus og A. terreus.
I A. niger har jeg undersøgt produkterne fra samtlige 37 PKSer ved heterologt udtryk i A. nidulans.
Ved hjælp af denne fremgangsmåde har jeg identiﬁceret produkterne fra tre PKSer, som efterfølgende er
undersøgt nærmere i A. niger. Et af produkterne var 6-methylsalicylsyre (6-MSA) som viste sig at være
byggesten for meroterpenoidet yanuthone D, et stof som tidligere var forudsagt til at stamme fra shikimisyre.
Individuelle deletioner i dette genkluster har kortlagt hele biosyntesevejen mod yanuthone D, og samtidig
har vi identiﬁceret seks nye yanuthoner, som ikke er beskrevet tidligere.
De to andre produkter viste sig begge at være YWA1, som tidligere er karakteriseret fra A. nidulans og
A. fumigatus. YWA1 er byggestenen for både naphtho-γ-pyroner og sort melanin (DHN-melanin) som er det
sorte pigment der giver A. niger sin karakteristiske sorte farve. Genetiske analyser har vist at et af disse
PKS gener, napA, er placeret i et typisk sekundær metabolitkluster men denne PKS ser ikke ud til at være
udtrykt.
For at undersøge den sekundære metabolisme i svampe, hvor der ikke ﬁndes nogen genetiske værktøjer,
har jeg brugt to forskellige fremgangsmåder: heterologt udtryk af sekundære metabolitgener i A. nidulans
og/eller plasmidbaseret genudtryk i den native svamp. Heterologt udtryk i A. nidulans er med success brugt
til at rekonstruere hele (+)-geodin biosyntesevejen ved at overføre hele (+)-geodin genklusteret fra A. terreus.
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I A. aculeatus har jeg anvendt en kombination af de to fremgangsmåder: jeg har udtrykt en formodet 6-
MSA syntase fra A. aculeatus i A. nidulans og bekræftet at genet var en 6-MSA syntase. Derefter har jeg
overudtrykt en transkriptionsfaktor fra genklusteret, via en plasmidbaseret platform der er blevet udviklet
som en del af dette projekt. Udtrykket af transkriptionsfaktoren aktiverede en ukendt biosyntesevej som
ser ud til at være ansvarlig for produktion af fem nye stoﬀer. Fødeforsøg med 13C-mærket 6-MSA, der blev
produceret som en del af dette projekt, bekræftede at 6-MSA inkorporeres i tre af de nye stoﬀer.
Baseret på disse resultater konkluderer jeg at kombinationen af interdisciplinære fremgangsmåder er et
meget stærkt værktøj når man undersøger sekundær metabolisme. Resultaterne fra mine studier viser også
at fortsat optimering af eksisterende værktøjer, samt udvikling af nye værktøjer, er mindst lige så vigtigt
som kun at udnytte de værktøjer der allerede er til rådighed.
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Chapter 1
Introduction
1.1 General introduction to thesis
Within ﬁlamentous fungi the genus Aspergillus is one of the most important in relation to humans: Aspergillus
fumigatus is a human pathogen, A. ﬂavus produces the carcinogenic aﬂatoxin, A. oryzae is widely used in
Asia for production of traditional foods, A. niger is an industrial workhorse used for production of organic
acids and enzymes, and A. nidulans is used as a model organism for eukaryotes.
As Aspergilli have such an impact on our lives, is it important that we possess the ability to study these
organisms, whether it be in the context of ﬁnding a cure for fatal Aspergillus infections (aspergillosis) or in the
context of producing compounds that are beneﬁcial to humans e.g. enzymes, pigments or pharmaceuticals.
During this study I have assessed the current available tools for performing genetic engineering in two very
diﬀerent Aspergilli: the model organism A. nidulans and the industrially important A. niger and tried to
optimize and expand the tools and methods in relation to implementation of a high-throughput (HTP) setting
for genetic engineering. I have successfully combined the development of new tools with implementation
thereof, in order to investigate secondary metabolism, primarily in the three Aspergilli; A. nidulans, A. niger
and A. aculeatus.
Figure 1.1 shows the connections between development of new tools, and the implementation thereof for
investigation of secondary metabolism.
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Figure 1.1: Overview of the connections between method development and implementation thereof. SM =
secondary metabolism.
In this thesis, I ﬁrst provide a short introduction to ﬁlamentous fungi, currently available genetic tools,
and secondary metabolism (Chapter 1). This introduction will provide a background for reading and assessing
all of the following chapters.
Following the introduction, I will very brieﬂy present the overall results of this study and discuss them in
the context of genetic approaches and fungal secondary metabolism in general (Chapter 2).
Subsequently, I brieﬂy present the novel genetic tools that I have developed in order to expand and improve
the current toolbox for genetic engineering in A. nidulans and A. niger, providing a basis for conducting both
HTP fungal strain construction and in-depth investigations of cell biology (Chapter 3). The tools presented
in this chapter have been applied for investigation of secondary metabolism throughout the study.
Then I ﬁrst present the results of A. nidulans studies (Chapters 4, 5, and 6). Chapter 4 describes con-
struction of a genome-wide polyketide synthase (PKS) deletion library for linking PKS genes to metabolites,
and Chapter 5 comprises a review that summarizes the current state of linking PKS genes to metabolites in
A. nidulans as per December 2012. Chapter 6 describes a HTP method for triggering metabolite produc-
tion in A. nidulans, combining novel genetic techniques for over-expression of A. nidulans phosphatases and
transcription factors.
Chapters 7, 8, 9, and 10 contain studies on A. niger : Chapter 7 contains a paper in which we describe
the development of a web-based computer program, PHUSER, which enables the non-experienced user to
6
ﬂexibly design PCR primers that are compatible with the uracil-excision (USERTM ) cloning system that has
been applied throughout this study. Chapter 8 describes heterologous expression of all PKS genes from A.
niger in A. nidulans, linking three polyketide compunds to their PKSs. Based on these results, Chapters 9
and 10 describe in-depth studies on naphtho-γ-pyrones and yanuthone D biosyntheses, in A. niger.
Lastly, I present reconstruction of the (+)-geodin pathway of A. terreus in A. nidulans (Chapter 11) and
activation of a biosynthetic pathway in A. aculeatus that resulted in identiﬁcation of ﬁve novel compounds
(Chapter 12). For each chapter, I have included a short introduction to the speciﬁc study, and for chapters
comprising manuscripts in preparation, I have also included a description of work that needs to be ﬁnished
before submitting the paper for publication. To avoid redundancy, a combined reference list for all chapters
is provided in the end, except for chapters that contain published manuscripts.
1.2 Filamentous fungi
Filamentous fungi, or mold fungi, constitute a huge group of multicellular eukaryotes that are essential for our
ecosystem, as they have a large role in biodegradation of organic matter. More than 100,000 fungal special are
known, and it is estimated that as much as 1,400,000 species exist [Petersen, 2003]. Because of their natural
ability to degrade organic material fungi are most commonly thought of as food spoilers, but they also have
several other qualities that make them interesting organisms to study. One of the characteristics that make
fungi stand out from other organisms is their ability to grow in very diverse environments: they are very
tolerant to changes in pH, they degrade and consume a wide range of substrates, and they can survive in very
harsh environments. Furthermore, many species possess the ability to form specialized structures, which can
survive in a dormant state for many years until environmental conditions are appropriate for propagation.
Importantly, ﬁlamentous fungi are capable of producing an arsenal of bioactive small organic compounds.
The possibilty of exploiting this ability to improve human life was indeed realized when Alexander Fleming
discovered that the ﬁlamentous fungus Penicillium notatum produced the antibacterial compound penicillin
[Fleming, 1942, 1943], which became one of the most important medicines of the 20th century. Since then,
many more compounds have been isolated from ﬁlamentous fungi, which possess bioactivities that can be
exploited to human advantage e.g. the cholesterol-lowering statins and the antimicrobial and immunosup-
pressive mycophenolic acid. In fact, 64 % of all approved drugs are natural products or natural product
mimics [Newman and Cragg, 2012].
1.2.1 Life cycle of Aspergilli
Filamentous fungi are multicellular organisms that form long tubular structures (ﬁlaments) called hyphae
(see Figure 1.2). In Aspergilli, the hypha is divided into compartments by septa, which are perforated walls
that allow for diﬀusion of nutrients, proteins, and even organelles. Thus the whole network of hyphae, the
mycelium, is considered one single organism.
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Figure 1.2: Filamentous growth of Aspergilli. The mycelium (A.) comprises a network of tubular ﬁlaments
called hyphae (B.). In Aspergilli, hyphae contain perforated septa which form compartments within the
hypha.
Aspergilli are able to propagate via diﬀerent lifecycles: asexually, parasexually, and sexually (see Figure
1.3). However, not all Aspergilli have a known sexual cycle. The asexual life cycle begins with a single
asexual spore called a conidium. If nutrients are available the conidium germinates to form the tadpole-like
germling which matures to form a hypha and eventually the entire mycelium. From the hypha, a stalk will
arise and form a structure called a conidiophore (see Figure 1.3). The conidiophore consists of a vesicle,
coated with metulae and phialides which are specialized cells for production of conidia. The conidia will
bud from the phialides in long chains, and the extremely hydrophobic conidia will be dispersed into the
surrounding environment by wind, water, or by passing animals. Each of those conidia are then able to form
a new mycelium if nutrition is available.
The parasexual life cycle allows the fungus to change ploidity and exchange nuclei. This means that
diﬀerent fungi of the same species can fuse their mycelia by a process called anastomosis, and propagate as
one organism. In this case the new fungus, the heterokaryon, would contain two diﬀerent and independent
nuclei. In some cases, nuclei of both heterokaryons and homokaryons will fuse to form a diploid. Diploid fungi
can propagate via the asexual cycle on equal terms as haploid fungi. Similarly, homokaryons, heterokaryons,
and diploids can enter the sexual cycle, which will not be described in the present thesis.
Knowledge of the fungal life cycle allows researchers to make use of the diﬀerent parts of the life cycle to
their advantage. Asexual propagation is desired for basic cultivation of fungi, whether it be in a Petri dish
or in a fermentor. For industrial purposes it it desirable to maintain asexual propagation for production of
a given compound or protein, whereas it may be desirable for the molecular biologist to exploit meiosis in
order to cross diﬀerent strains and make hybrids. However, the presence of diﬀerent life cycles can also be a
disadvantage when handling fungi in the laboratory, as one has to take care that a given strain has not fused
with other strains to form heterokaryons or changed ploidity.
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Figure 1.3: Asexual and parasexual life cycle of Aspergilli. The asexual life cycle (A.) begins with a
single conidium which germinates to form the hypha. From the hypha a conidiophore, comprising a vesicle
with metulae and phialides, will arise and conidia will bud from the conidiogenous phialides and form long
chains of hydrophobic conidia. The parasexual life cycle (B.) allows the fungus to interchange between
haploid and diploid stages, as well as existing as a heterokaryon: a haploid fungus containing two (or more)
diﬀerent, but intact, nuclei.
In this study I have chosen to investigate three very diﬀerent fungi, which all belong to the Aspergilli:
A. nidulans, which is a well-studied model organism for ﬁlamentous fungi, A. niger, which is an important
industrial work-horse, and A. aculeatus, which is an industrial enzyme producer, which was only recently
genome-sequenced by the DOE Joint Genome Institute (Figure 1.4).
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Figure 1.4: Aspergilli used in this study.
A. nidulans is a ﬁlamentous fungus, which is considered an important model organism for ﬁlamentous
fungi. A. nidulans was genetically characterized by Guido Pontecorvo in the 1950s, and due to his pioneering
work within classic genetics A. nidulans is now a well-studied model organism for eukaryotes [Pontecorvo
et al., 1953, Morris and Enos, 1992]. As a consequence of this, several tools for genetic engineering in A.
nidulans exist, and for this reason this fungus is often the ﬁrst choice for development of new methods and
techniques for ﬁlamentous fungi. The details of the tools are described in Section 1.3.1.
As many tools exist for genetic engineering in A. nidulans, the polyketome (complete set of polyketides)
was explored by diﬀerent approaches: genome-wide PKS deletion, over-expression of genes, and site-directed
mutagenesis. Furthermore, A. nidulans was used for heterologous expression of genes from organisms where
little or no genetic tools exist(ed).
A. niger is a very important fungus for production of organic acids and enzymes. For that reason, A.
niger has been studied extensively with respect to behavior in liquid cultures. Traditionally, fermentation
organisms have been optimized for better morphology and productivity via random mutagenesis and random
gene insertions, respectively, and for that reason not many genetic techniques are (publicly) available. More-
over, A. niger does not have a known sexual cycle, which makes it diﬃcult to introduce or remove genetic
alterations by sexual crossing, as it is possible in A. nidulans.
A. niger is known to produce a wide array of secondary metabolites, including the harmful fumonisins
[Frisvad et al., 2007]. As only few genetic tools are available for this organism, I have explored the polyke-
tome of A. niger using a combination of heterologous expression in A. nidulans and gene deletions in A. niger.
A. aculeatus is a recently genome-sequenced fungus, belonging to the group of black Aspergilli. A.
aculeatus is a natural plant pathogen why it is able to produce enzymes for degradation of plant material
e.g. cellulases and hemicellulases. As these enzymes are of great value for production of second generation
bioethanol this fungus is used in industrial fermentations. Interestingly, only little research has been con-
ducted to elucidate its potential of producing secondary metabolites. Exploring the secondary metabolism is
possible by traditional mycologial tools; cultivation on diﬀerent media followed by metabolite proﬁle analysis
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by HPLC and/or LC-MS, however, as no tools exist for genetic engineering in A. aculeatus it is diﬃcult to
link genes to metabolites and explore silenced biosynthetic pathways.
Although the annotated genome of A. aculeatus has been available for more than two years1, there are
no reports on genome mining for identiﬁcation of genes that are involved in secondary metabolism. In this
study I have used A. aculeatus as a model for AMA1-based (non-integrative) gene expression, and shown that
AMA1-based plasmids are maintained in A. aculeatus, that the A. nidulans PgpdA promoter controls gene
expression in A. aculeatus, and that constitutive expression of a transcription factor activates a biosynthetic
pathway whose products have not before been reported (Chapter 12).
1http://genome.jgi-psf.org/Aspac1/Aspac1.info.html
11
1.3 Genetic engineering
Genetic engineering is a term that covers all genetic maniputations in a given organism e.g. gene deletion,
gene disruption, gene insertion (random or site-speciﬁc), promoter exchange, silencing by RNAi, GFP-tagging
etc. As the ﬁeld of genetic engineering is so broad, it is not possible to apply one single method that will
work for all possible disciplines. For instance, what might be a powerful method for gene deletion, may not
be applicable for GFP-tagging. Therefore it is important to have a large available toolbox with a broad range
of tools to choose from (Figure 1.5).
Figure 1.5: The toolbox for genetic engineering. Elements in bold have been primary foci of this study.
Such a toolbox should contain very basic elements such as promoters, terminators, and selection markers.
Furthermore, it should contain a system for generation of transformation substrates, whether it be PCR-
based or clonal. Last, but maybe most important, the toolbox should contain a transformation system for
the organism in which the genetic engineering will be carried out. In this section I will briﬂy introduce the
tools that are currently present in the A. nidulans and A. niger toolboxes. Subsequently, I will introduce the
main vector construction approach used throughout this study: uracil excision (UE) cloning, and the present
gene expression platform for A. nidulans.
1.3.1 Tools for genetic engineering in Aspergillus nidulans
During the past 30 years many attempts have been carried out in order to establish a platform for genetic
engineering in Aspergilli, primarily A. nidulans, which was genetically well-established in the 1980s due to the
preceding work of Pontecorvo. It was during the 1980s that most of the currently used genetic markers were
described and characterized: argB, pyrG, argB, trpC, riboB, amdS, and hph [Buxton et al., 1985, Ballance
et al., 1983, Yelton et al., 1984, Oakley et al., 1987, Tilburn et al., 1983, Cullen et al., 1987]. This decade also
provided the two most widely used promoters in A. nidulans: the alcohol-inducible PalcA and the constitutive
PgpdA [Lockington et al., 1985, Punt et al., 1990, 1991]. Recently, the repertoire of promoters was expanded
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by the sucrose-inducible PsucA [Zuccaro et al., 2008, Roth and Dersch, 2010] and the doxycycline-sensitive
tunable inducible O7 promoter, known as the TetON/OFF system [Meyer et al., 2011]. In this study I have
primarily used the PgpdA promoter, as a strong and constitutively active promoter is an advantage both
for testing new tools, and for expression of non-lethal biosynthetic genes. Additionally, I have used the O7
promoter for tunable over-expression ofA. nidulans phosphatases and transcription factors (Chapter 6).
One of the very important tools that exists for A. nidulans is the use of color markers. The wild-type A.
nidulans produces green conidia, however, the pathway for producing the green melanin pigment consists of
two individual steps: synthesis of the yellow pigment YWA1 by the WA PKS (encoded by wA) [Watanabe
et al., 1999] and polymerization of YWA1 by the laccase YA (encoded by yA) into green melanin (see Figure
1.6). Deletion of the yA gene results in a yellow strain and deletion of wA, which is epistatic to yA, results
in a white strain. Hence, use of these color markers can help indentify diploid strains, heterokaryons, gene
targeting eﬃciencies and what not. In this study I have used the color markers for verifying expression from
the newly developed AMA1 expression platform (Section 3.1.4), and for development of a background-free
transformation system for gene expression (Section 3.1.5).
Figure 1.6: The pathway towards green melanin in A. nidulans. The WA PKS synthesizes yellow pigment
YWA1, which is polymerized into green melanin by the YA laccase.
The annotated genome sequence of A. nidulans was released in 2005 [Galagan et al., 2005], and the
availability of this sequence allowed for semi-large scale gene deletions e.g. the genome-wide phosphatase
deletion study (27 genes) [Son and Osmani, 2009], the PKS deletion study (32 strains) [Nielsen et al., 2011],
and the recent kinase deletion study (127 strains) [De Souza et al., 2013].
A very important tool, that made these semi-HTP strain constructions possible was the deletion of
nkuA, a KU70 homologue, resulting in >90 % gene targeting eﬃciencies [Nayak et al., 2006, Nielsen et al.,
2008]. NkuA is responsible for non-homologous end-joining (NHEJ), which is the most common DNA double
strand break repair mechanism in A. nidulans [Nielsen et al., 2006]. This mechanism is also employed for
random integration of transformation substrates, why screening for targeted integration events can be quite
cumbersome in an nkuA+ strain.
In this study I have focused on assessing and improving tools for A. nidulans that are important for HTP
genetic engineering: eﬃcient cloning vectors (section 3.1.5) and eﬃcient transformation systems (section
3.1.2). For future work, it is important not just to apply eﬃcient methods for cloning and transformation,
but also to have a wide available selection of genetic elements: promoters, terminators, markers, integration
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sites etc. I have tried to expand the pool of available constitutively expressed A. nidulans promoters by
analyzing expression data and testing selected promoters using a qualitative β-galactosidase assay, resulting
in ﬁve novel strong promoters, of which one is a short bidirectional promoter (section 3.1.1). Lastly, I have
expanded the repertoire of integration sites with ﬁve new sites that provide varying expression levels, making
a total of eight available deﬁned integration sites for A. nidulans, including the yA locus [Chiang et al., 2013]
(section 3.1.2).
1.3.2 Tools for genetic engineering in Aspergillus niger
In the beginning of my PhD studies, I worked with a genetically wild-type fermentation strain of A. niger,
ATCC1015, as this was the strain used in the fermentation activities at our research center and it was
genome sequenced by the DOE Joint Genome Institute [Andersen et al., 2011]. As my collaboration with the
analytical chemists at the research center expanded, I included several other strains of A. niger which had
been isolated in various ecological environments. During my studies I engaged in a collaboration with Paciﬁc
Northwest National Laboratory (PNNL, Richland, WA, USA), which also had ongoing genetic activities with
A. niger. They had prepared a derivative of ATCC1015, KB1001, which was pyrG− and kusA::pyrG [Chiang
et al., 2011]. The kusA gene is the homologue of nkuA in A. nidulans, why deletion of kusA allows for highly
eﬃcient gene targeting in A. niger (>80 % compared to 7 % in the wild-type) [Meyer et al., 2007]. The
kusA::pyrG cassette in KB1001 is a transient construction, so pyrG can be looped out and restore kusA to
wild-type after genetic alterations have been made, as reported for A. nidulans [Nielsen et al., 2008]. I have
used this strain for preparation of A. niger mutants, unless otherwise stated.
A disadvantage of using this strain is that the pyrG marker is used for making the kusA disruption
and thus it cannot be used as a selection (and counter-selection) marker for iterative transformation steps.
However, the ability to restore KusA after transformation is highly valued, as this protein is also involved in
telomere maintenance [Fisher and Zakian, 2005, Palmer et al., 2010], which is crucial to the integrity of the
strain. As the strain does not have any other auxotrophies, it is necessary to use dominant markers conferring
resistance to e.g. hygromycin B or phleomycin which is a toxic and mutagenic substance. Furthermore, it is
not possible to loop out the markers after transformation, why these markers can be used only once. The
hygromycin prophatase (hph) from E. coli confers resistance to hygromycin B, to which A. niger is naturally
sensitive [Punt et al., 1987], and this setup has been successfully implemented for A. niger KB1001 at PNNL.
Therefore, I have used this marker for gene targeting in A. niger throughout my studies.
1.4 Uracil excision cloning
Over time, many diﬀerent approaches for substrate generation have emerged, enabling construction of vir-
tually any nucleic acid sequence one may wish. Basically, three options are available: PCR-based substrate
generation, traditional cloning, or a combination of the two. Each method has advantages and disadvantages,
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and thus the choice depends on what type of construct one wishes to make, and how many. In table 1.1 I
have listed the methods that I believe are presently most commonly used, stating what I believe are their
advantages and disadvantages. Generally, the use of PCR will always be mutagenic to some extent, but it
allows for a ﬂexibility in vector design that is absolutely essential in our time.
Based on the assessment of currently available methods for substrate generation, I have chosen to use
the uracil excision (UE) cloning methods for generation of substrates for genetic engineering throughout this
study. I have listed two types of UE cloning: PCR-based [Geu-Flores et al., 2007] and combined cassette/PCR
[Nour-Eldin et al., 2006]. The PCR-based approach is solely based on fusion of PCR fragments for vector
construction i.e. E. coli origin of replication and E. coli selection markers are also present as PCR fragments.
The combined cassette/PCR approach uses a cassette, which contains recognition sites for a restriction
endonuclease and a nicking enzyme. When digested, the cassette is opened and long single-stranded overhangs
allow for fusion with PCR fragments. Thus several PCR fragments can be fused and inserted into the cassette
in a single reaction. This will be described in detail below.
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Method Advantages Disadvantages
(Fusion)PCR
Flexible
Fast (<1 day)
Seamless fusion
Independent of restriction enzymes
Ineﬃcient
Not robust
Mutagenic
Traditional cloning Not mutagenic
Ineﬃcient
Inﬂexible
Leaves scars
Screening laborious
Combined PCR/cloning Flexible
Ineﬃcient
Leaves scars
Mutagenic
Screening laborious
In-Fusion R©
Flexible
Seamless fusion of multiple fragments
Independent of restriction enzymes
Low eﬃciency for multiple
fragments
Mutagenic
Gibson Assembly R©
Flexible
Seamless fusion of multiple fragments
Independent of restriction enzymes
Low eﬃciency for multiple
fragments
Mutagenic
Expensive reagents
GatewayTM
Robust
Eﬃcient
Suitable for HTP
Inﬂexible
Leaves large scars
Expensive reagents
Uracil excision, PCR
Very ﬂexible
Robust
Eﬃcient (for <5 fragments)
Seamless fusion of >10 fragments
Independent of restriction enzymes
Mutagenic
Expensive primers
Uracil excision, combined
cassette/PCR
Flexible
Robust
Eﬃcient (for <5 fragments)
Seamless fusion of >10 fragments
Suitable for HTP
Mutagenic
Expensive primers
Table 1.1: Assessment of current methods for substrate generation. Gibson Assembly R©Master Mix and
USERTM Reagent are products of New England Biolabs (MA, USA), GatewayTM is a product of Life
Technologies (former Invitrogen), and the In-Fusion R©Cloning System is a product of Clontech Laboratories,
Inc.
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UE cloning is also known as USERTM cloning, developed by New England Biolabs (Ipswich, MA, USA).
Basically, the principle of UE cloning is to integrate a uracil into the PCR fragment, which will then be
excised to form a long single-stranded overhang on the PCR fragment (see Figure 1.7). This single-stranded
overhang will anneal to a complementary overhang and be ligated by the native ligase of the E. coli host
after transformation.
Thus three reagents are needed in order to perform UE cloning: primers with uracil bases incorporated,
a polymerase which does not stall at uracil bases, and the USERTM reagent containing enzymes for excision
of the uracil base. Uracil-containing primers are available from most nucleotide suppliers, although at a
higher price (≈20-100%) than ordinary PCR primers. However, the appertaining polymerase, PfuX7, is
freely available as an E. coli strain expressing the His-tagged polymerase [Nørholm, 2010], and the USERTM
reagent is available from New England Biolabs at a very reasonable price (≈ $ 1/reaction, July 2013). In
comparison, the price for Gibson Assembly R©reagent is ≈ $ 15/reaction (New England Biolabs, July 2013).
The USER enzyme is a mixture of Uracil DNA glycosylase (UDG) and DNA glycosylase-lyase Endonu-
clease VIII (DGLE). UDG catalyzes cleavage of the glycosidic bond between the (deoxy)ribose and the uracil
of the uridine in a RNA (or DNA) molecule [Lindahl et al., 1977, Lindahl, 1982]. This reaction excises the
uracil base, but leaves the phosphodiester backbone intact (Figure 1.7). Subsequently, the DGLE breaks the
phosphodiester backbone at the 3' and 5' ends of the abasic site so the deoxyribose is released [Melamede
et al., 1994, Jiang et al., 1997]. The strength of the hydrogen bonds between the bases in the tail is not
suﬃcient for keeping the two strands together, and thus the remaining bases of the tail will release from the
double strand, generating a single-stranded overhang.
Figure 1.7: Generation of single-stranded overhangs by uracil base excision. The UDG cleaves the glycosidic
bond between the deoxyribose and the uracil, releasing the uracil without disrupting the backbone. Subse-
quently the DGLE cleaves the backbone while releasing the deoxyribose. Hydrogen bonds in the short tail
are too weak to keep the strands together, and the strands will disassemble, creating a 6 nt single-stranded
overhang.
17
1.4.1 IS1 expression platform
UE cloning method was previously used to develop a series of cloning vectors for gene expression in A.
nidulans [Hansen et al., 2011]. These vectors are all designed for integration into a deﬁned and characterized
site at the genome, designated Integration Site 1 (IS1) (Figure 1.8). The vectors contain one of two diﬀerent
promoters (PgpdA or PalcA) and one of two markers (argB or pyrG). All vectors contain 2 kb targeting
sequences, TS1 (upstream) and TS2 (downstream), for targeted integration into the correct site.
Figure 1.8: Integration into IS1, from [Hansen et al., 2011]. Linearized plasmid for gene expression contains
an expression cassette comprising promoter, gene, terminator, and selection marker. The cassette is ﬂanked
by targeting sequences for targeted integration into IS1 by homologous recombination.
All vectors for this platform contain a UE-cassette between the promoter and terminator, in which any
gene can be inserted that have compatible uracil-containing tails. Figure 1.9 describes the procedure for
inserting a gene into the UE-cassette: the vector is prepared by digestion with a restriction endonuclease
(AsiSI), and a nicking enzyme (Nb.BtsI) which will create long single-stranded overhangs. The gene is
ampliﬁed by PCR, using primers that contain a predeﬁned uracil-containing tail, complementary to the
overhangs of the digested vector. The digested vector and the PCR product are mixed and incubated with
the USERTM enzyme, which will remove uracils and expose single-stranded overhangs that can anneal to the
single-stranded overhangs of the vector. Subsequently, the mixture is transformed into chemically competent
E. coli, where the two fragments are ligated by the native E. coli T4 ligase. Correct plasmids are linearized
and transformed directly into A. nidulans.
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Figure 1.9: Principle of UE cloning, from [Hansen et al., 2011]. The vector is prepared by digestion with
AsiSI and Nb.BtsI to generate single-stranded overhangs. PCR product is ampliﬁed, mixed with prepared
vector, and incubated with USERTM enzyme to generate complementary overhangs, which anneal to the
overhangs of the vector.
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1.5 Secondary metabolism in Aspergillus
The term secondary metabolism can be perceived in many ways, and many compounds can be regarded as
both primary and secondary metabolites. In this thesis, I will use the term secondary metabolite only for
metabolites that do not exist in primary metabolism, and primary metabolism comprising all reactions and
metabolites that are essential for maintaining survival and growth in a non-competitive environment.
With respect to the above deﬁnition, secondary metabolites are organic molecules that are produced, in
addition to the primary metabolites, by a given organism. Secondary metabolites are not directly required for
sustaining life, but they may have essential roles within the cell e.g. protection againts UV-light (pigments),
warfare against competitors for nutrients (antibiotics, antifungals, insecticides) or intra-species signaling.
Many secondary metabolites have been isolated and structure elucidated, however, for most of them their
biological functions are yet unknown.
Primarily, three classes of secondary metabolites exist in ﬁlamentous fungi: polyketides (PKs), nitrogen-
containing non-ribosomal peptides (NRPs)/alkaloids, and terpenoids (examples are shown in Figure 1.10).
PKs are syntesized in long chains of adjoining ketide units by a polyketide synthase (PKS), which is similar to
the fatty acid synthase and employs the same mode of action. NRPs are, as the name implies, peptides that
are not synthesized by a ribosome, but by a non-ribosomal peptide synthase (NRPS) which selects and joins
speciﬁc amino acids via peptide bond formation. Terpenoids are hydrocarbon molecules which are composed
by C5 isoprene units. In the following I will describe synthesis of PKs by the PKS, the structure of the PKS,
and organization of a typical PK gene cluster. As my study has dealt primarily with biosynthesis of PKs, I
will not go into further detail with synthesis of NRPs, alkaloids, or terpenoids.
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Figure 1.10: Fungal secondary metabolites normally comprise three diﬀerent classes: polyketides (PKs), non-
ribosomal peptides (NRPs), and terpenoids. A compound may be hybrids of two (or all) diﬀerent classes.
1.5.1 Fungal polyketides
Polyketides are a group of secondary metabolites from bacteria, fungi, plants, and animals, which are pre-
dicted to have a great potential as antibiotics and natural colourants. In fungi, PKs are the most abundant
group of secondary metabolites [Keller et al., 2005]. Some of the best known fungal polyketides, produced
by type I iterative PKS, are the cholesterol lowering commercial drug lovastatin and the highly carcinogenic
aﬂatoxin, which is produced by e.g. Aspergillus ﬂavus. Although PKs are very diverse in structure and
function, they are synthesized in the same manner, from the same pool of extender units, using the same
types of enzymes.
These enzymes can either exist as a system of individual domains (type II polyketide synthase) or the
domains can be assembled into a multifunctional multi-domain enzyme structure (type I polyketide synthase)
(Figure 1.11). The type I PKS can further be divided into two categories: modular or iterative [Katz and
Donadio, 1993]. Modular PKSs comprise a number of modules, where one module contains the set of enzyme
domains that are needed for each round of elongation (addition of one extender unit) [Donadio et al., 1991].
As modular PKSs contain a domain for each single activity, and even in an orderly manner, it is possible to
predict the PK product of the modular PKS.
Iterative PKSs, however, contain only a single module, which is re-used in an iterative fashion until the
product is ﬁnished. In contrast to modular PKSs, the products of iterative PKSs cannot easily be predicted
[Cox and Simpson, 2009]. In fungi, the PKs are most often synthesized by a type I iterative PKS, why it is
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very diﬃcult to predict which compound(s) that are products of the PKSs. Much research have been done
in an eﬀort to unveil the mechanisms of determining chain length, and when to turn on speciﬁc domains, but
very little is still known abouth these mechanisms.
Figure 1.11: Types of polyketide synthases (PKSs). The type II PKS exists as discrete enzymes which form a
complex to synthesize the PK. The type I PKS is one single multidomain enzyme, and can be either modular
or iterative. The modular PKS contains several modules, each module containing the necessary domains for
one round of elongation. Iterative PKSs comprise only one module, which is re-used in an iterative fashion
until the ﬁnal PK has been synthesized.
Domains of the PKS
Basically, three domains are essential for synthesis of a PK by the PKS: the β-ketoacyl synthase (KS) domain,
the acyltransferase (AT) domain, and the acyl carrier protein (ACP) domain. These three domains alone can
recruit building blocks and synthesize the PK chain, but most often the PKS contains additional domains.
All known domains from type I iterative PKSs are summarized in Table 1.2.
PKSs are divided into three groups based on their potential to reduce polyketide backbones: non-reducing
PKSs (NR-PKSs), partly reducing PKSs, and highly reducing PKSs. The NR-PKSs do not contain any of
the reducing domains (KR, DH, or ER - see Table 1.2), whereas the reducing PKSs contain either KR or
KR/DH (partly reducing), or all three domains (highly reducing). The NR-PKSs are known to produce cyclic
PKs, which is not the case for reducing PKSs, and thus the NR-PKSs contain two additional domains which
have not been reported for any reducing PKS: the product template (PT) domain and the cyclization (CYC)
domain. The PT is responsible for correct folding of the PK, and the CYC domain is often a combined
cyclization/release mechanism [Crawford et al., 2008, 2009].
Methyl transferase (MT) domains are found in all types of PKS, and they catalyze the addition of a
methyl group to the growing PK chain, using S-adenosylmethionine (SAM) as a methyl donor [Cox and
Simpson, 2009].
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One activity that is very important in the aspect of producing PKs, is release of the ﬁnal PK from the
PKS. This can be accomplished in many ways, and is poorly understood. It is known that the CYC and
thioesterase (TE) domains can cleave the PK chain from the PKS by hydrolysis [Weissman, 2008, Schroeckh
et al., 2009]. It was also recently shown that the dehydratase (DH) domain of the A. terreus 6-methylsalicylic
acid (6-MSA) synthase was in fact a thioester hydrolase (TH) domain that mediated release of 6-MSA from
the PKS [Moriguchi et al., 2010]. Another known release mechanism is the thioester reductase (TR), but
this mechanism is more pronounced for release of NRPs from the NRPSs. Additionally, many PKSs rely
on discrete enzymes in the gene cluster for mediation of release e.g. the fumonisin PKS relies on Fum8 for
product release [Gerber et al., 2009].
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Minimal set of domains
KS (β-ketoacyl synthase) Catalyzes synthesis of the polyketide chain by joining building
blocks in a Claisen-like condensation reaction. KS is similar to the condensing enzyme
(CE) in the fatty acid synthase complex [Weissman, 2008].
M/AT (Malonyl/acyl transferase) Catalyzes the loading of the starter unit, as well as transfer
of acyl from acyl-CoA to the growing ketide chain [Cox, 2007].
ACP (Acyl carrier protein) Similar to ACP in fatty acid synthesis. ACP is a cofactor that
facilitates elongation of the polyketide chain by carrying malonate units and tran-
siently holding the growing ketide chain [Cox, 2007, Weissman, 2008]. This domain is
also known as the phosphopantetheine (PPT) attachment site as it contains a PPT
prostetic group which is required for covalent attachment to the acyl starter unit
[Long et al., 2002, Kroken et al., 2003, Cox, 2007, Weissman, 2008].
Reductive domains
KR (Keto reductase) Catalyzes the reduction of a ketone (C=O) into a hydroxyl group
(C-OH). This domain is only present in PKSs that are reducing or partially reducing.
DH (Dehydratase) Catalyzes dehydration of hydroxyl groups (obtained by the KR), into
an enoyl group (-C=C-).
ER (Enoyl reductase) Catalyzes the reduction of enoyl groups (obtained by the DH) into
a saturated carbon atom (-C-C-). This domain is only present in highly reducing
PKS.
Other domains
PT (Product template) Mediates the cyclization of aromatic polyketides from non-
reducing PKSs. This domains is believed to only be present in non-reducing PKSs
[Crawford et al., 2008, 2009].
CYC (Cyclization) Catalyzes cyclization of a reduced polyketide. This domain is often a
combined CYC/TE domain for simultaneous cyclization and release.
TE (Thioesterase) Mediates the release of the complete polyketide from the enzyme. This
domain is believed to be very substrate speciﬁc [Weissman, 2008, Schroeckh et al.,
2009].
TH (Thioester hydrolase) Newly assigned domain in 6-MSAS (Aspergillus terreus) cat-
alyzing product release by hydrolysis [Moriguchi et al., 2010].
MT (Methyl transferase) Catalyzes the addition of a methyl group to the (poly-)ketide,
using S-adenosylmethionine (SAM) as a methyl donor [Cox and Simpson, 2009].
Table 1.2: Overwiew of domains in the iterative type I PKS.
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1.5.2 Synthesis by the type I iterative polyketide synthases
As brieﬂy mentioned above, the type I iterative polyketide synthases diﬀers from type I modular polyketide
synthases, as they are multidomain enzymes that consists of only one module, wheareas type I modular
polyketide synthases consist of several modules. Thus, this one module is re-used a certain number of times
(3-20 iterations), depending on the length of the polyketide that is to be synthesized. The PK chain is
normally synthesized from acyl-CoA and elongated with malonyl-CoA units [Schumann and Hertweck, 2006]
(Figure 1.12), however the PKS may employ alternative starter units.
Figure 1.12: Schematic illustration of synthesis by a fungal iterative PKS. Acetyl-CoA is loaded onto the KS
domain, and the malonyl-CoA extender unit is loaded onto the ACP. Malonyl-ACP and acetyl-KS condense
in a Claisen-like reaction, extending the acetyl starter unit with one ketide and releasing CO2.
Synthesis of a PK always starts with activation of the PKS. Activation is accomplished by attachment of
a 4'-phosphopantheteinyl (PPT) prosthetic group to the ACP domain by a dedicated enzyme, the PPTase.
The PPT acts as the arm that carries the growing PK and exposes it to the domains of the PKS. A starter
unit acyltransferase (SAT), if present in the PKS, will choose the starter unit, otherwise an acetyl-CoA will
serve as the starter unit. The starter unit (-CoA) will be loaded onto the KS (see Figure 1.12), while the AT
recruits the extender unit (most often malonyl-CoA) and attaches it to the ACP. The acetyl-CoA starter unit
and the malonyl-CoA will condense in a decarboxylative Claisen-like reaction by a nucleophilic attack on the
carbonyl of acetyl-CoA, resulting in a β-keto thioester [Schumann and Hertweck, 2006, Sta]. Elongation of
the PK chain by addition of ketide units will continue until the ﬁnal length has been reached. At present, it
is not known how the PKS controls the length of the PK.
During synthesis, the PK chain may be modiﬁed by addition of methyl groups or by reduction of the
ketides (Figure 1.13). There are three degrees of reduction for the ketide: reduction of the carbonyl into a
hydroxyl (by the KR domain), dehydration of the hydroxyl into an enoyl (by the DH domain), and reduction
of the enoyl double bond into a single bond (by the ER domain). Even though a PKS contains all three
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reductive domains they may not be used in every iteration, why the ﬁnal PK from a highly reducing PKS
may contain a mixture of intact ketide units, hydroxyls, double bonds and saturated carbons. Thus the
presence of these domains add to the complexity and diversity of diﬀerent polyketides.
Figure 1.13: Reduction of the ketide unit. Ketoreductase (KR) reduces the keto-group to a hydroxyl-group,
dehydratase (DH) dehydrates the hydroxyl-group to a double bond, and the enoyl reductase (ER) reduces
the double bond to a single bond.
1.5.3 Secondary metabolite gene clusters
As mentioned above, the presence of additional methylation and reduction domains in a PKS increases the
complexity of the PK and the pool of diﬀerent PK varieties. In addition to these peri-synthetic modiﬁcations,
PK are often also modiﬁed post-synthetically i.e. after release from the PKS. Post-synthetic modiﬁcation
may also comprise methylation and/or reduction, but often the changes are more drastic e.g. reorganization
of the entire backbone as is the case for austinols [Lo et al., 2012]. The genes encoding the enzymes that
are required for post-synthetic modiﬁcation of PKs are most often located adjacent to the PKS gene, and
there are rarely any unrelated genes in between. As the genes are clustered together in the genome, they are
referred to as a gene cluster.
A PK gene cluster normally contains 5-15 genes, depending on the structure and nature of the ﬁnal PK.
Besides enzymes for modiﬁcation of the PK, the gene cluster may also encode other proteins that are necessary
for successful production of the PK. An important activity encoded by the gene cluster, is resistance to the
PK. Many of the secondary metabolites are used to kill other organism in the environment and thus the
compounds may also be toxic to the fungus itself. This problem can be solved by producing a protein that
directly confers resistance to the toxic compound, or by producing pumps that will export the compound
out of the cell. These activities will normally also be encoded by the gene cluster. A schematic of a typical
secondary metabolite gene cluster is shown in Figure 1.14.
1.5.4 Transcription factors
As secondary metabolites are very expensive molecules to produce for the cell, and not essential for growth
and survival in a non-competitive environment, the cell may employ strict regulation of a given PK in order to
ensure that the compound is only produced when necessary. This regulation may be global or local. A global
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regulation mechanism e.g. DNA acetylation, would aﬀect production of many or all secondary metabolites
in the cell, whereas a local regulation mechanism would only aﬀect production of a single or maybe a
few secondary metabolites within the cell. A local regulation mechanism can be obtained by employing
speciﬁc transcription factors (TFs) that either facilitate transcription (activators) or obstruct transcription
(repressors), and the genes that encode speciﬁc TFs are often located in the gene cluster (see Figure 1.14).
Figure 1.14: Schematic of a typical secondary metabolite gene cluster that is regulated by a TF. A stimulus
from the environment activates the TF or triggers expression of the TF. The TF activates expression of
all genes in the cluster, and simultaneously represses a second and diﬀerent gene cluster (shown in black).
The activated gene cluster produces a PKS and two tailoring enzymes that synthesize the ﬁnal PK, and an
ATP-binding cassette (ABC)-transporter for active transport of the PK out of the cell.
The ﬁrst discovery of genetic regulation was in the study of the lac operon in E. coli [Jacob and Monod,
1961], but it was not until twenty years later that the cis-acting regulatory elements were discovered [Davidson
et al., 1983]. A cis-acting regulatory element is a strech of DNA that regulates expression of a gene, and it
can be located upstream or downstream of the regulated gene, but it may also be located in an intron or
even in an exon. The cis-acting regulatory element is the sequence to which the transcription factor (TF)
binds, whether the TF acts as an activator or a repressor. A trans-acting regulatory element also refers to
a strech of DNA that regulates expression of a gene, however, in a diﬀerent way. Normally, the trans-acting
regulatory element comprises a DNA sequence that encodes a protein (e.g. a TF) or microRNA, which will
aﬀect regulation of one or several target genes.
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The general role of TFs is to regulate the processes that take place within a given organism: nutrition up-
take and degradation, production of secondary metabolites, growth, stress responses, and cell diﬀerentiation,
just to mention a few. The number of TFs in a given organism is linked to the complexity of the organism,
which is illustrated by the fact that E. coli contains 48 TFs, S. cerevisiae contains 169 TFs, and the human
genome contains ≈2600 TFs [Blattner et al., 1997, Goﬀeau et al., 1996].
Sequencing and subsequent annotation indicates that the A. niger genome contains almost a thousand
(944) TFs [Pel et al., 2007], while the A. nidulans genome merely contains 372 TFs [Galagan et al., 2005,
Wortman et al., 2009]. In this study I have used TFs for elucidation of biosynthetic clusters, and I have
systematically over-expressed A. nidulans TFs in an eﬀort to perturb metabolism and unveil new metabolites
(Chapter 6).
1.5.5 Heterologous expression of secondary metabolite genes in Aspergillus
The approach of expressing genes heterologously (in another organism) have been done for many years,
primarily using bacteria or yeast as host organisms. These organisms are good choices for production of
proteins or enzymes as they are well-characterized and easy to cultivate and manipulate genetically. However,
when studying secondary metabolism, there are good reasons why one should use a ﬁlamentous fungus as
host instead of bacteria or yeast. The primary reason is that ﬁlamentous fungi are natural producers of
a wide range of secondary metabolites, why they already possess the molecular machinery that facilitates
production thereof. Secondly, ﬁlamentous fungi are able to splice introns, which is not the case for bacteria
and simple yeasts e.g. S. cerevisiae.
Many bacteria are genetically well-characterized and easy to cultivate, however, there are many reasons
not to choose the bacterial cell factory for heterologous production of secondary metabolites. First, there
is often a codon-bias that necessitates codon-optimization for eﬃcient expression. Furthermore, access to
required building blocks, correct protein folding, any glycosylation or other posttranslational modiﬁcations
e.g. attachment of the PPT to the ACP domain of PKSs and NRPSs, may not be possible.
For the established cell-factory S. cerevisiae there are only a few successful examples of heterologous
expression of fungal PKSs [Kealey et al., 1998, Zhou et al., 2010, 2012, Ishiuchi et al., 2012], and only one
report on reconstruction of a biosynthetic pathway [Rugbjerg et al., 2013].
In contrast, there are many successful reports on heterologous expression of PKSs in A. nidulans, reviewed
in [Schumann and Hertweck, 2006]. Some of the important advances was cloning and expression of the
6-MSA synthase from A. terreus [Fujii et al., 1996], production of lovastatin by co-expression of several
genes [Kennedy et al., 1999], development of a systematic gene expression system [Hansen et al., 2011], and
reconstruction of the entire geodin cluster from A. terreus [Nielsen et al., 2013] (Chapter 11).
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Gene prediction
Successful expression of genes is dependent on correct gene prediction i.e. localization of the open reading
frame (ORF) and possible exons and introns within the ORF. The ORF, which comprises the entire stretch
of DNA to be transcribed, may also contain untranslated regions (UTRs) that can be located in both the
3' end and the 5' end of the gene. Prediction of putative genes in a genome is performed automatically by
applying one or several diﬀerent gene prediction algorithms, followed by manual inspection by experts. Even
so, the complexity of eukaryotic genes makes it diﬃcult to accurately predict the correct ORF, especially for
ﬁlamentous fungi for which only a few species have been genome sequenced, and little research have been
done to uncover the aspects of gene organization.
There are several web-based options for gene predictions, which can support the predictions provided
by the genome databases. For A. nidulans I have used the predictions provided by the Aspergillus Genome
Database (AspGD) (http://www.aspergillusgenome.org/), and for A. niger, A. aculeatus, and A. carbonarius
I have used the predictions provided by the DOE Joint Genome Institute (JGI) (http://www.jgi.doe.gov/).
When in doubt of correct prediction, I have used the two web-based gene predictors FGeneSH (Softberry,
Mount Kisco, NY, USA) and AUGUSTUS [Stanke et al., 2004, Stanke and Morgenstern, 2005] for support.
Prediction of introns within an ORF is very important for heterologous expression of the gene. Although
intron loss and gain in Aspergilli have been studied [Nielsen et al., 2004, Zhang et al., 2010, Torriani et al.,
2011, Croll and McDonald, 2012], no research has been conducted on the ability to identify and splice introns
from other organisms. Thus it would be optimal to use intron-free versions of genes that are expressed
heterologously. Basically, there are two ways to remove introns in a gene: to amplify the gene from cDNA
or to PCR amplify and fuse exons (Figure 1.15).
Transcription of a eukaryotic gene results in a pre-mRNA molecule that contains the entire ORF sequence
and in addition, it is capped in the 5' end and a poly-adenylation signal (poly-A tail) is attached to the 3' end
(Figure 1.15). The introns are then spliced out of the pre-mRNA, resulting in the mature mRNA that now
only contains the coding sequence (CDS) with the 5' cap and the 3' poly-A tail. At this point, total mRNA
can be extracted from the cell, and cDNA is produced in vitro by reverse transcription. The intron-free gene
is then PCR ampliﬁed from the cDNA template using gene-speciﬁc primers. Another way to produce an
intron-free gene is by fusion of exons (Figure 1.15). In this case, the predicted exons are PCR ampliﬁed using
primers with complementary tails. The exons can then be fused by any available method e.g. fusion PCR,
UE cloning, In-Fusion R©etc.
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Figure 1.15: Approaches for generating intron-free DNA. Intron-free DNA can be generated by reverse
transcription of mRNA into cDNA (left) or by fusion of exons (right). See text for details.
Each of the two approaches have advantages and disadvantages. The fusion approach is dependent on
correct intron prediction in order to produce a functional protein, and the eﬃciency of the fusion method
is dependent of the number of exons. If the gene contains only two exons the fusion may be possible by
any method, but if the gene contains >10 exons, fusion may be diﬃcult. The cDNA approach is the most
accurate: the mRNA is spliced and assembled correctly, producing an intact and functional protein. The
disadvantage of the approach is that it can be very diﬃcult to obtain long cDNA fragments. In this study I
have primarily expressed PKS genes, which are typically 7-10 kb in length. In my experience, it has been very
diﬃcult to obtain cDNA of this length, why I have not been able to use this approach in a robust manner.
Combined with the risk of incorrect intron prediction, I have chosen to use the entire ORF for heterologous
gene expression throughout this study. Thus I have assumed that introns and intron splicing has not evolved
much within fungi of the same genus, and I hypothesize that A. nidulans is able to correctly splice introns
from other Aspergilli.
1.6 Metabolite proﬁle analysis
In this thesis metabolite proﬁle analysis (MPA) refers to chemical analysis of wild-type or mutant strains
by UHPLC-DAD-TOFMS, followed by data analysis (dereplication) to reveal which compounds are present
in the sample. The MPA can be carried out manually or partly automated, and can comprise full analysis
of all compounds (often more than 100 compounds/sample), or analysis of selected relevant compounds. In
the following, I will describe just the basics of MPA, which will allow for an understanding of the obtained
results.
The ﬁrst step of MPA is to extract compounds from a given strain. As secondary metabolites are primarily
expressed on solid media [Andersen et al., 2013], the strain that is to be analyzed is most often grown on agar
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plates at an appropriate temperature. Compounds are extracted by cutting out a part of the agar/fungus
and extracting it with solvent(s) e.g. ethyl acetate, methanol, or water. If the chemical properties of the
compounds are right with respect to polarity etc., they will diﬀuse from the agar into the solvent. Thus, the
choice of solvent depends on the compound that one wishes to extract. In this study I have primarily used a
mixture of solvents, which will extract a wide range of secondary metabolites, and are therefore suitable for
analysis of the entire metabolite proﬁle [Smedsgaard, 1997].
After preparation of the extract it is processed on the UHPLC-DAD-TOFMS system, which comprises
three diﬀerent systems: the Ultra High Performance Liquid Chromatography (UHPLC) system that separates
the compounds based on chemical properties (in this case: polarity), the Diode Array Detector (DAD)
system that detects the compounds based on absorbtion of UV/Visible light, and the Time-of-Flight Mass
spectrometry (TOFMS) system that separates the ions based on their m/z ratio, by measuring the time-of-
ﬂight (TOF) i.e. how long time it takes for the ion to reach the detector (Figure 1.16). Thus the output for
each diﬀerent compounds is the retention time (RT) on the column, the UV/VIS spectrum, and the mass
spectrum, and in combination these features are almost unique for a given compound, or at least for a family
of compounds.
Figure 1.16: Principle of the UHPLC-DAD-TOFMS system. Extract is injected and compounds are separated
by polarity on on C18 column. Separated compounds (indicated by a red sphere) are subjected to a beam
of light. Non-absorbed light is dispersed by the grating and detected by sensors (DAD). Subsequently, the
compounds are dispersed into charged micro-droplets by the ESI and then enter the TOF in small portions
via the slicer mechanism. The ions are accelerated in the acceleration ﬁeld, and reﬂected back where the
time-of-ﬂight is measured by the detector.
1.6.1 Liquid chromatography
Liquid chromatography (LC), or Ultra-High Performance Liquid Chromatography (UHPLC) is a method
for separating chemical compounds based on their chemical properties. In this study I have used a C18
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column (the stationary phase), which separates compounds based on polarity. The C18 molecules present
in the column will interact with apolar compounds (e.g. hydrocarbon chains or steroids) but less so with
polar compounds (e.g. sugars, amino acids). The mobile phase is a liquid solvent used for elution of the
compounds. The mobile phase may be a mixture of diﬀerent solvents, and the ratio of solvents may vary
during the run.
Figure 1.17 shows an example of a chromatogram, which is the output from the UHPLC. The extract
shown is from the A. niger reference strain KB1001, cultivated on YES agar plates for 5 days at 30◦C. The
runtime of the sample is 15 minutes, and each peak in the chromatogram represents detection of one or more
speciﬁc compound(s). Thus, >100 compounds are detected in this sample. The intensity of a given peak
may be a qualitative measure of the amount of compound in the sample, however, the intensity may also
reﬂect the degree of ionization, which allows it to be detected.
As polar compounds do not interact strongly with the C18 column, these compounds will not be retained
by the stationary phase and they will elute ﬁrst. Apolar compounds will be retained longer and will have a
higher retention time (RT). Figure 1.17 shows three compounds that are produced by A. niger : pyranonigrin
A, which is a small very polar compound with a low RT (2.3 min); aurasperone B, which is a rather large
and semi-polar compound with an intermediate RT (6.6 min); and yanuthone D, which is a large and apolar
compound with a high RT (9.3 min).
Figure 1.17: Base peak chromatogram (BPC) of A. niger extract. For details, see text.
1.6.2 Diode Array Detection (DAD)
The Diode Array Detector (DAD) is a method for detection of compounds based on their ability to absorb
light. The DAD emits an array of UV/visible (UV/VIS) light (200-700 nm), and measures absorbtion of
32
light by the compound within the UV/VIS range. The output of this detection is the UV/VIS spectrum,
with wavelengths on the x-axis and relative absorbtion on the y-axis. Figure 1.18 shows the UV/VIS spectra
of pyranonigrin A, aurasperone B, and yanuthone D. All three compounds have chromophores consisting of
conjugated double bonds (marked in red), but the amount and position of conjugated double bonds determines
which wavelengths that can be absorbed. The UV/VIS spectrum can thus be considered a ﬁnger-print of a
compound family, as it is unique to the amount and organization of the chromophore.
Figure 1.18: UV spectra of pyranonigrin A, aurasperone B, and yanuthone D. Conjugated double-bonds are
shown in red.
1.6.3 Mass Spectrometry (MS)
Mass Spectrometry is a method for detecting compounds based on their masses. The basic priciple of the
analysis method is by formation of ions (positive or negative ionisation), and subsequent measuring the
mass-to-charge ratio (m/z ) of the resulting ions. The output of the MS is a mass spectrum, from which
information on the monoisotopic mass of the compound can be deduced. The mass spectra of pyranonigrin
A, aurasperone B, and yanuthone D are shown in Figure 1.19; m/z on the x-axis, and intensity on the y-axis.
The protonated compound is called the pseudo-molecular ion, and is designated [M+H]+ (shown in green).
Thus, the monoisotopic mass of the compound equals m/z -H+, if there is only one charge on the compound.
The remaining sticks in the mass spectrum are called adducts and are diﬀerent ions of the compound. There
are only a few possible adducts for each compound, why these are very useful in deducing which ion is the
pseudo-molecular ion.
Figure 1.19: Mass spectra of pyranonigrin A, aurasperone B, and yanuthone D. The pseudo-molecular ion is
shown in green, and adducts are shown in red.
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The mass spectrum provides much more information than just the mass of a given compound. The
time-of-ﬂight MS (TOFMS) is so accurate (<1 ppm error) that the precise chemical composition may be
deduced from the accurate mass alone. The mass spectrum thus also provides isotopic patterns, which reveal
the number of carbon, chlorine, bromine, and sulphur atoms in the compound. Hence, the combination of
UHPLC, DAD, and MS is very powerful for identiﬁcation of compounds, both known and unknown.
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Chapter 2
Overall results and discussion
2.1 Investigation of secondary metabolism in A. nidulans: a fungus
with a large genetic toolbox
As a model organism with a vast amount of available genetic tools, A. nidulans is very well studied with
respect to its secondary metabolism. Many eﬀorts have been put into identifying secondary metabolites,
and since the genome sequence of A. nidulans was released, many approaches have been undertaken in order
to investigate the entire secondary metabolism. The genome sequencing has revealed that the A. nidulans
genome contains 32 putative PKSs, although only a fraction of this number represents the amount of known
polyketides from A. nidulans.
Preceding genome sequencing of A. nidulans, only two genes were linked to a PKS: the conidial pigment
YWA1 was linked to the wA gene by heterologous expression of the wA gene in A. oryzae [Watanabe et al.,
1998, 1999, Clutterbuck, 1972], and sterigmatocystin was linked to stcA (ﬁrst named pksST ) by functional
inactivation of the stcA gene [Yu and Leonard, 1995, Brown et al., 1996].
Following genome sequencing many approaches have been applied for linking genes to PKs: global and
local activation of gene clusters, and co-cultivation with other organisms. Global activation strategies com-
prised deletion of sumO encoding a protein involved in sumoylation, linking asperthecin to the aptA PKS
encoding gene [Szewczyk et al., 2008], and using chromatin-regulator cclA loss-of-function mutants, iden-
tifying the monodictyphenone PKS encoding gene mdpA [Bok et al., 2009]. Aspyridone was linked to the
PKS-NRPS encoded by adpA by over-expression of the adpR TF by random integration [Bergmann et al.,
2007]; hybrid PK-NRP emericellamides were linked to easB by randomly deleting six NRPSs [Chiang et al.,
2008]; and asperfuranone was linked to the PKSs encoded by afoE/afoG by over-expression of the TF, replac-
ing the promoter of the TF with PalcA [Chiang et al., 2009]. A creative and interesting approach was applied
for linking orsellinic acid and derivatives to orsA; co-cultivating A. nidulans with 58 diﬀerent actinomycetes
[Schroeckh et al., 2009]. Recently, aspernidine A was identiﬁed in a mitogen-activated protein kinase deletion
35
mutant (mkpA∆) obtained from the genome-wide kinase deletion study [De Souza et al., 2013] and linked to
pkfA by gene deletion [Yaegashi et al., 2013].
We have used a genome-wide PKS deletion approach in order to identify PKs and link them to their
corresponding PKSs (Chapter 4). As a result of this study austinol and dehydroaustinol were linked to the
PKS encoded by ausA, and by over-expression of ausA we found that AusA synthesizes 3,5-dimethylorsellinic
acid which serves as a precursor to the austinols [Nielsen et al., 2011]. The biosynthesis towards austinols
was subsequently elaborated by Itoh et al. [2012], Lo et al. [2012] and Matsuda et al. [2013].
2.1.1 Systematic over-expression of phosphatases and TF triggers secondary
metabolite production in A. nidulans
The above mentioned eﬀorts comprise very diﬀerent approaches and illustrate how creativity is essential in the
investigation of fungal secondary metabolism. However, it is striking how diﬃcult it is to trigger secondary
metabolite production in a well-characterized model fungus with many available tools. Even by applying all
these diﬀerent approaches, only a third of the potential polyketides are known. This raises the question of
whether the availability of the full genome sequence has led us on a wild goose chase for linking imaginary
compounds to non-functional genes, which have just been carried down through evolution, or if the majority
of these compounds are indeed only expressed under extremely rare and speciﬁc conditions.
In order to address this question, I hypothesized that a drastic perturbation of the general metabolism
might stress the cell enough to completely reroute the secondary metabolism. Having developed a HTP
expression system, I assessed the possibilities of perturbing the metabolism by gene over-expression. Sopko
and co-workers had performed a genome-wide over-expression of all genes (>80 %) in S. cerevisiae, and
found that the cells were sentitive to perturbation of pathways deﬁned by proteins involved in cell-cycle
regulation, transcriptional activation, transport and signaling e.g. kinases and phosphatases. Inspired by
this result, I decided to over-express all 52 putative TFs from A. nidulans chromosome I and all 28 A.
nidulans phosphatases, under control of the doxycycline inducible O7 promoter (TetON/OFF) to prevent
possible lethal phenotypes.
In this study I have investigated these strains only by cultivation on minimal medium, allowing for easy
identiﬁcation of new compounds because A. nidulans normally only produces austinols and sterigmatocystin
on minimal medium. Indeed, some of the perturbations had a great eﬀect on the metabolite proﬁle. Most
strains did not display an obvious change of metabolite proﬁle, and some of the strains seemed to overall
down-regulate production of secondary metabolites. Importantly, some of the strains produced many more
metabolites than the reference, some of which may be novel compounds. Comparative examination of entire
metabolite proﬁles is a laborious task and should be performed by skilled analytical chemists, why I have only
examined a few selected strains in order to generally assess the response to over-expression of these genes.
Thus, examination of six selected strains veriﬁed that it is indeed possible to alter the metabolic proﬁle of
A. nidulans by systematic over-expression of phosphatases and TFs. Dereplication of the six strains revealed
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a high production of compounds that are not normally produced on minimal medium e.g. desferritriacetyl-
fusigen (NRP), arugosins and shamixanthones (PKs), violaceols (PKs), and asperugin B (PK). Interestingly,
I have also identiﬁed four unknown compounds which are produced in high amounts. UV spectra indicate
that three of them are NRPs, and one may be a heterodimer of a sterol and another compound, a conﬁgu-
ration which was only recently reported by Miao and co-workers [Miao et al., 2012]. Based on the fact that
the external environment (medium composition, pH, temperature etc.) has a great impact on regulation
of secondary metabolism, I hypothesize that cultivation of these strains under diﬀerent circumstances (e.g.
complex media) will provide an even stronger response to the gene over-expression and perhaps result in
production of many novel compounds.
Having identiﬁed possible novel compounds, it is important to keep in mind that we are studying a per-
turbed metabolic system. Thus there is a possibility that the new compounds are not naturally produced
by the fungus, but are products of cross-talk between diﬀerent biosynthetic pathways, which have been trig-
gered by abnormal regulation due to over-expression of the genes. Even so, identiﬁcation of these compounds
may help link compounds to genes and learn more about secondary metabolism in general, and even about
cross-talk between deﬁned pathways. Additionally, novel compounds may also prove bioactive and be of
commercial value, whether or not they are produced naturally.
Although only some of the strains seem to up-regulate production of secondary metabolites, I consider
this study a success. I have conﬁrmed that HTP gene expression is extremely fast and non-laborious using the
platform described in this study, why it is quick and easy to construct many strains. Random over-expression
of genes is not a profound intellectual approach, however, the current knowledge on regulation of secondary
metabolism is apparently not suﬃcient for understanding the complexity of these mechanisms. Using a
random approach may, in addition to detection of novel compunds, help identify genes that are involved with
local and global regulation mechanisms and shed some light upon the speciﬁc reactions employed by the cell.
Being able to prepare fungal strains in a HTP manner eases the application of random gene expression, as
the need for a high success-rate is less pronounced. Quick-and-dirty screening can even be accomplished
using the AMA1-based expression platform - also in Aspergilli, for which no genetic tools exist.
2.1.2 Assessment of novel genetic tools
In this study I have developed a system for HTP gene expression in A. nidulans. The system comprises two
diﬀerent parts: a background-free cloning vector and a background-free integration system for A. nidulans.
The background-free cloning vector contains the ccdB suicide gene, which is excised when the vector is
properly digested. This eliminates background from non-digested vector, and results in very high cloning
eﬃciencies. The background-free integration system is based on prior integration of the wA gene (or another
pigment producer) into a deﬁned integration site, using pyrG as a selection marker. Subsequently your
favorite gene is integrated on top of the prior construct (using a diﬀerent selection marker), thus looping
out wA and pyrG. Addition of 5-FOA, which is toxic to pyrG-expressing cells, will eliminate growth of false
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positive transformants as random integration will not excise pyrG. In addition, the YWA1 pigment will
no longer be produced, and a clear color change will be observed. Using only the color screen for correct
integration, it is even possible to visually destinguish between correct transformants and false positives (see
Figure 2.1).
Figure 2.1: Transformation plate using the background-free integration system for A. nidulans without
addition of 5-FOA to the medium.
In this study I have used the background-free HTP expression platform for over-expression of A. nidulans
phosphatases and TFs. As expected, strain construction was very fast and eﬃcient. Using the ccdB suicide
gene in the cloning vector truly eliminates false positives, and in combination with the robust and buﬀer-
tolerant USERTM enzyme it even allows for cloning with unpuriﬁed PCR products. The backround-free
integration system for A. nidulans worked very well, and made it easy to identify correct transformants.
Chiang and co-workers recently described an approach where they integrated genes into the yA locus of A.
nidulans, thus resulting in yellow conidia instead of the green conidia produced in the wild-type [Chiang et al.,
2013]. Curiously, this is the same approach as I have used in A. niger for one of the novel integration sites
I have identiﬁed. Although this approach works well, it is not very ﬂexible as it only allows for integration
into one speciﬁc site. As gene expression is highly locus-dependent a library of diﬀerent available integration
sites can be used to choose an appropriate level of expression, preferably in combination with a library of
diﬀerent promoters. Thus I have identiﬁed 11 new promoters and ﬁve new integration sites for A. nidulans.
Expression of lacZ and wA, respectively, conﬁrms that expression levels are very locus-dependent (see Figure
2.2). Discovery of IS5 was a very important result of this study. Providing an extremely high expression
level, this site can be used for high production of proteins or small molecules. In fact, with expression from
this site (plus a small contribution from IS1), A. nidulans is able to direct more than 22 % of the total carbon
into production of 6-MSA without signiﬁcantly aﬀecting the growth rate.
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Figure 2.2: Production of YWA1 from six diﬀerent integration sites in A. nidulans.
Even though high expression levels are required for some applications, it is equally important to be able to
choose low level gene expression. Low level expression is especially important for metabolic engineering [Pitera
et al., 2007], for production of toxic compounds, or for certain speciﬁc studies. In this study, integration
site IS3 (low expression) was used for testing autoregulation of the (+)-geodin TF, using the reporter gene
lacZ. If in fact autoregulation did happen, this eﬀect could have been masked by saturation if the protein
was highly expressed prior to induction.
2.2 Investigation of secondary metabolism in A. niger : a fungus
with few genetic tools
When this study was initiated, none of the metabolites in A. niger were linked to their corresponding gene
(cluster). However, it was known that A. niger possessed a gene cluster with strong homology to the fumonisin
gene cluster in G. moniliformis [Pel et al., 2007, Andersen et al., 2011], and it was shown that some strains
of A. niger were able to produce fumonisins [Frisvad et al., 2007].
During the past three years there have been a lot of advances within the ﬁeld of linking genes to their cor-
responding PK(s) in A. niger. The ﬁrst discovery was made simultaneously by Jørgensen and co-workers [Jør-
gensen et al., 2011] and Chiang and co-workers [Chiang et al., 2011] when they reported that the FwnA/AlbA
PKS is responsible for production of the black conidial pigment as well as production of naphtho-γ-pyrones.
Subsequently, Li and co-workers discovered that adaC encodes a PKS responsible for synthesis of tetracy-
clins [Li et al., 2011b]. This PKS was not previously identiﬁed in the A. niger genome, as the sequence was
incomplete. Li and co-workers obtained the full sequence by PCR and sequencing, and reported the domain
structure SAT KS AT PT ACP [Li et al., 2011b]. Gil Girol and co-workers identiﬁed the PKS responsible
for production of bicoumarins (e.g. kotanins and funalenone), encoded by ktnS [Gil Girol et al., 2012] and
ﬁnally, Zabala and co-workers reported the silent azaphilone gene cluster (aza) that is somewhat similar to
the asperfuranone gene cluster in A. nidulans [Zabala et al., 2012]. The otherwise silent aza cluster was
activated by over-expression of a TF embedded in the cluster by random integration.
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Compared to A. nidulans, genetic engineering in A. niger is more laborious, as only few genetic techniques
are available. Elimination of non-homologous end-joining by deletion/disruption of kusA∆ (Ku70 homologue)
greatly enhances the transformation eﬃciency [Meyer et al., 2007], and in combination with the use of bipartite
(split marker) transformation substrates [Nielsen et al., 2006] it is now possible to perform gene targeting
very eﬃciently. One of the remaining issues with genetic engineering in A. niger is the availability of selection
markers. Most A. niger strains are prototrophic and thus only allow for use of dominant selection markers e.g.
hph or bleR conferring resistance to hygromycin B and phleomycin, respectively. The few available markers
are not counter-selectable, thus greatly limiting the number of possible gene targeting events. Furthermore,
the lack of a known sexual cycle prevents combination of mutations by sexual crossing. Another Ph.D.
student in our research group is working to solve this problem, so I have not dealt with this issue in the
present study.
Another disadvantage of genetic engineering in A. niger is that there are no deﬁned integration sites
for ectopic or heterologous gene expression. It is important to use deﬁned loci for ectopic expression as
chromosomal positioning has a large impact on gene expression levels and epigenetic eﬀects [Verdoes et al.,
1995, Sousa et al., 1997, Thompson and Gasson, 2001]. I have identiﬁed four integration sites for A. niger
using three diﬀerent approaches: IS-NIG1 was identiﬁed based on gene expression data from a transcriptome
analysis, IS-NIG2 disrupts albA resulting in white transformants, and IS-NIG3/IS-NIG4 were identiﬁed based
on homology to the high-expression integration site IS5 in A. nidulans. IS-NIG1, 3, and 4 have not yet been
thoroughly investiated. Integration into IS-NIG2 greatly facilitates veriﬁcation of correct transformants, as
the color shift from black to white is visibly detectable. Furthermore, disruption of albA abolishes production
of naphtho-γ-pyrones which constitute the largest group of compounds produced by A. niger at all conditions
[Nielsen et al., 2009], and provides a clearer background for studying secondary metabolites. Coincidentally,
development of this integration site was essential for linking a second copy of the AlbA PKS, NapA, to
naphtho-γ-pyrone production (Chapter 9).
2.2.1 Heterologous expression links three PKSs to compounds
In this study I have linked three A. niger PKSs to known A. niger compounds: YanA produces 6-MSA,
which is a precursor to yanuthone D, NapA produces YWA1 - the precursor to naphtho-γ-pyrones, and
ASPNIDRAFT_44005 produces asperrubrol using cinnamic acid as a starter unit. Furthermore, I have
deduced the biosynthetic pathway towards yanuthone D using a combination of individual cluster gene
deletions in A. niger, heterologous expression of cluster genes in A. nidulans and feeding experiments with
labeled and unlabeled metabolites.
The overall approach of investigating the A. niger polyketome by heterologous expression of PKSs in
A. nidulans resulted in only a few success stories. From 37 PKSs (and hybrid NRPS/PKSs), only two
compounds (6-MSA and YWA1) were identiﬁed by chemical analysis. One PKS (NapA) provided an altered
phenotype, but it was far from trivial to deduce the actual PK that was produced (YWA1). A combination
40
of gene deletions and over-expression in A. niger resulted in many pieces of an overall puzzle, which was
very complex and diﬃcult to solve. In fact, and as mentioned above, the YWA1 product of NapA was only
discovered because I coincidentally used the albA locus as an integration site for over-expression of napA,
resulting in a white A. niger strain that still produced naphtho-γ-pyrones. AlbA and NapA apparently both
produce YWA1, which is the precursor to naphtho-γ-pyrones and black melanin in A. niger. However, as
napA seems to be silent under most circumstances, this gene could not have been linked to its product by
traditional gene deletion methods. Interestingly, napA is part of a typical gene cluster encoding all necessary
activities for conversion of YWA1 into naphtho-γ-pyrones, whereas AlbA does not appear to be part of a
gene cluster. Due to the similarities of the two proteins, they must have originated via divergent evolution. I
propose that one may have formed from the other by gene duplication, or that one (or both) have emerged as
a result of horizontal gene transfer. Unfortunately, I did not have time to ﬁnish this study before submitting
this thesis. I am still to construct and analyze two strains before submitting this study for publication: a
double deletion of albA and napA to examine if NapA is responsible for the fawn, and not entirely white,
conidia of the albA∆ strain, and a nap cluster deletion strain, which I expect will verify that without the
presence of the nap cluster, A. niger is still able to produce black conidia, but it is dependent on the nap
cluster and is no longer able to produce any naphtho-γ-pyrones.
Asperrubrol is a very good example of a PK that would not be linked to a PKS gene only by heterologous
expression approaches. In this case, heterologous expression of the gene in A. nidulans did not provide any
new products. The PKS did not contain any release domains, but there was a gene encoding a discrete
thioesterase located downstream of the PKS, which could serve as the release mechanism. Expression of
both the PKS and the thioesterase in A. nidulans did, however, still not provide any products. Intrigued
by this result, I deleted the PKS gene in A. niger, and examination of the metabolite proﬁle revealed that
asperrubrol was no longer produced by the deletion strain. Investigation of a proposed gene cluster suggested
that cinnamic acid might be a starter unit to the PKS. Indeed, lack of a suitable starter unit explains why
heterologous expression of the PKS did not result in a product. Heterologous expression of a cluster gene
did in fact produce cinnamic acid, substantiating this hypothesis. Thus, this example further illustrates the
beneﬁt of combining classical gene deletion approaches with heterologous expression in a suitable host.
2.2.2 Combining several approaches reveals the biosynthesis of yanuthone D in
A. niger
Although heterologous expression of yanA in A. nidulans identiﬁed 6-MSA as the product, it was not obvious
that yanuthone D was the end product. Thus yanA was only linked to yanuthone D by gene deletion in A.
niger. Reversely, if only gene deletion had been carried out the surprising discovery that 6-MSA is a precurser
to yanuthone D might not have been made. Even individual deletion of cluster genes or over-expression of
yanA in A. niger did not result in accumulation of 6-MSA, why heterologous expression of yanA in A. nidulans
indeed proved valuable for deduction of the yanuthone D biosynthetic pathway. In this particular study, I
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have combined a range of diﬀerent approaches for investigation of the biosynthetic pathway. Besides gene
deletions in A. niger and heterologous expression of yanA in A. nidulans, I have used a novel plasmid-based
expression platform for quick and dirty screening of cluster genes in A. nidulans. This approach provided
the ﬁrst tailoring enzyme to act on 6-MSA in the yanuthone D pathway. The ﬁrst part of the yanuthone D
pathway was not accounted for by gene deletions, why this tool helped investigation of the biosynthesis. In
addition, feeding with fully labeled 6-MSA was carried out, and conﬁrmed that 6-MSA is indeed incorporated
into yanuthone D. Using the newly developed integration sites I constructed a strain expressing yanA from
IS1 and IS5, resulting in a very high production of 6-MSA. In fact we were able to produce titers of 1.81 g/l
(0.227g/g glucose) fully labeled 98.7 % isotopic pure 6-MSA from fully 13C labeled glucose.
The complete yanuthone D study brilliantly illustrates the beneﬁts of combining diﬀerent approaches,
and how tool development and optimization can be essential for studying complex biological systems. De-
velopment of new integration sites may seem trivial and un-inventive, but if IS5 had not been discovered,
production of fully labeled 6-MSA would probably have been too expensive. Similarly, development of in-
tegration sites in A. niger coincidentally solved the complex puzzle of YWA1 production from AlbA and
NapA.
2.3 Investigation of secondary metabolism in fungi with no available
genetic tools
As brieﬂy mentioned in the introduction, 64 % of all new drugs are natural products or natural product mimics
[Newman and Cragg, 2012]. This number indeed suggests that there is a huge demand for discovery of many
novel bioactive compounds, if human kind is to continue medicinal development. Plants and ﬁlamentous
fungi are great sources of natural products, and it is estimated that there are more than 1,400,000 species
of ﬁlamentous fungi [Petersen, 2003]. Secondary metabolite production can vary greatly between species of
the same genus e.g. A. nidulans and A. niger barely share any common secondary metabolites. Mycologists
and natural product chemists are doing an amazing job investigating all sorts of exotic fungi, and they
often succeed in discovering novel compounds using traditional mycological methods such as varying medium
composition, pH, temperature ect. However, in the light of recent genome mining studies it has become clear
that we only see the tip of the iceberg when studying fungi by traditional methods in the laboratory. Even
for A. nidulans, whose secondary metabolism is extremely well-studied by traditional and several diﬀerent
genetic approaches, only a fraction of the potential compounds are known.
Thus there is also a need for discovery of secondary metabolites that are not produced under standard
laboratory conditions, but this is a very diﬃcult problem to solve. For a thorough investigation of the
secondary metabolism in a given fungus, it is necessary to have a system for genetic engineering. To set up
such a system can be extremely tedious, and may be diﬀerent for each species. Even the most basic techniques
e.g. transformation of DNA into the cell, may be diﬃcult to implement. The lack of development of genetic
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techniques for new fungi is in contrast to the steadily increasing number of whole genome sequences, which
allows for easy identiﬁcation of candidate genes.
Thus, in order to investigate secondary metabolism in a fungus with no available genetic techniques
there are basically two good options: heterologous expression of genes in a host with well-characterized
genetic techniques or expression of genes (or RNA) in the native fungus from an AMA1-based plasmid. Both
approaches have advantages and disadvantages, but in combination they may serve as a powerful tool.
We have successfully transferred the entire (+)-geodin cluster from A. terreus into the well-characterized
host A. nidulans. The cluster contained a TF, which was constitutively expressed in A. nidulans for positive
regulation of the entire gene cluster. After transfer of the cluster, it was possible to apply the A. nidulans
extensive genetic toolbox for investigation of individual genes in the (+)-geodin pathway.
The other approach I have used involved a combination of heterologous expression and expression in the
native host from AMA1-based plasmids. In this case I wanted to examine a genome-sequenced Aspergillus,
but for which no genetic tools existed. Only a few compounds had been reported for the industrial enzyme
producer A. aculeatus why this fungus posed an almost clean slate for studying secondary metabolism. I
ﬁrst examined the fully sequenced genome of A. aculeatus in a search for interesting candidates, and I have
included the results of this investigation in Appendix H. Interestingly, the genome of A. aculeatus contains
57 putative synthases, of which 24 are PKSs. Phylogenetic analyses revealed that one of the PKSs was very
similar to fungal 6-MSA synthases e.g. yanA from A. niger, suggesting that A. aculeatus might produce a
PK that uses 6-MSA as a precursor. As it is known that 6-MSA can be converted into toxic compounds e.g.
patulin, it was relevant to examine if this industrial fungus is in fact able to produce toxic compounds. First,
I veriﬁed that the putative 6-MSA synthase did produce 6-MSA by heterologous expression in A. nidulans.
As this was the case, the next logical step was to delete the gene in A. aculeatus in order to link the PKS
to a compound. In spite of several attempts and diﬀerent markers, I was not able to delete the 6-MSA
synthase gene in A. aculeatus. In stead I over-expressed the 6-MSA gene from an AMA1-based plasmid in
A. aculeatus, hoping to link the gene to a compound by up-regulating production of this compound. This
approach resulted in production of 6-MSA, but the remainder of the metabolite proﬁle remained unchanged.
This result suggested that if 6-MSA was a precurser to another compound, the appertaining gene cluster
might be silent under laboratory conditions. Therefore, I examined a possible gene cluster for a transcription
factor, and I located a putative TF just downstream of the 6-MSA synthase. Over-expression of the TF in A.
aculeatus indeed activated a biosynthetic pathway, resulting in production of ﬁve new compounds, of which
two have been structure elucidated by NMR spectroscopy. Feeding with fully 13C labeled 6-MSA conﬁrmed
that 6-MSA was incorporated into three of the compounds, which have not been structure elucidated at
present time.
As brieﬂy mentioned above one option for investigating secondary metabolism in fungi with no genetic
tools is by expression of RNA. Expression of antisense RNA or RNA interference (RNAi) is a way of silencing
a gene without having to delete the gene. This is a great advantage in fungi where it is not possible to
43
do direct genetic alterations, as the RNA can simply be expressed from AMA1-based plasmids. The use
of antisense RNA has been successfully employed for ﬁlamentous fungi e.g. for down-regulation of protease
production in industrially relevent strains of A. oryzae and A. awamori [Zheng et al., 1998, Moralejo et al.,
2002]. As silencing with antisense RNA is easy, but not very eﬃcient, is it also possible to silence a gene by
RNAi. Silencing by RNAi is more eﬃcient [Nakayashiki et al., 2005], but it is also more challenging to design
an optimal RNAi. Furthermore, studies have shown that RNAi constructs are unstable and lost throughout
cultivation of N. crassa and A. fumigatus [Goldoni et al., 2004, Henry et al., 2007]. However, for studying
secondary metabolism, strains are usually not subjected to prolonged cultivation and the eﬀect should last
long enough to detect the change in the metabolite proﬁle. Thus I propose that a combination of heterologous
expression, gene over-expression from AMA1-based plasmids, and silencing by RNA could pose a powerful
tool for investigating secondary metabolism in genome-sequenced fungi, for which no genetic tools exist.
2.3.1 A. nidulans as a host for heterologous gene expression
During this study A. nidulans was used as a host for heterologous expression of genes from A. niger, A.
aculeatus, A. carbonarius, and A. terreus. For A. niger genes, A. nidulans was used for individual expression
of 37 putative PKSs, as well as expression of selected cluster genes to illuminate biosyntheses of yanuthone
D (Chapter 10) and asperrubrol (Chapter 8). Additionally, A. nidulans was used for veriﬁcation of a 6-MSA
synthase from A. aculeatus, and a YWA1 synthase from A. carbonarius. Last, A. nidulans was used as a
host for transfer of the entire (+)-geodin cluster from A. terreus and subsequent examination thereof.
Generally, the abundance of genetic tools for A. nidulans, compared to other Aspergilli, makes A. nidulans
a suitable host for heterologous gene expression. Development of NHEJ deﬁcient strains signiﬁcantly increases
the transformation eﬃciencies, and in combination with the use of bipartite/split markers, screening for
correct transformants is no longer tedious. Application of the background-free integration system, developed
in the study, further increases the ease of gene expression in this fungus. Identiﬁcation of the ﬁve novel
integration sites also allows for simultaneous integration of more than one gene in a single reaction, and
enables individual expression of several cluster genes, regulated by deﬁned promoters.
Heterologous expression of 37 putative A. niger PKSs resulted in a very low success rate, as only three
PKSs were linked to a compound. However, the reason for the low success rate is most likely not due to A.
nidulans being the host. I assess that the problems were primarily due to incorrect prediction of the PKS
encoding genes, lack of speciﬁc starter units, or lack of a release mechanism. Thus, over-expression of the
genes in A. niger instead of A. nidulans might have provided a compound for the PKSs lacking a starter
unit or a release mechanism. Development of four new integration sites in A. niger enables this possibility.
Using AlbA as an integration site would allow for fast veriﬁcation of correct transformants and would even
make identiﬁcation of new compounds easier, as there would be no production of naphtho-γ-pyrones.
The approach of transferring the entire (+)-geodin cluster to A. nidulans was one way of overcoming the
obstacle of performing genetic engineering in A. terreus. The approach was successful, however, not very
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eﬃcient. Even by constitutive expression of the TF, only very small amounts of (+)-geodin were detected.
Thus the approach could be optimized by individual expression of the cluster genes, each controlled by a
deﬁned promoter. Such an approach would be more time-consuming for preparation of the strains, and one
would have to make sure that ORF of the genes are predicted correctly. Hence, this approach would also
serve as a veriﬁcation of correct gene prediction and aid in development of future algorithms for automatic
gene prediction in ﬁlamentous fungi.
One of the reasons why A. nidulans is a good choice for heterologous expression of biosynthetic genes
from e.g. A. niger, A. aculeatus, A. terreus, and A. carbonarius is that A. nidulans only share a few common
secondary metabolites. Although all belong to the genus Aspergillus, they belong to diﬀerent clades [Varga
et al., 2003] and are relatively distantly related. The distant relation may have allowed for adaptive evolution
and horizontal gene transfer within a deﬁned ecological niche, and would explain why the metabolite proﬁles
of these species are so diﬀerent. Thus, examination of secondary metabolism of closely related species (e.g.
A. ustus or A. versicolor) by heterologous expression in A. nidulans, may not prove as easy.
A. nidulans is most often regarded a model organism for studying cell biology in the lab, however, the
fact that A. nidulans is able to produce immense amounts of 6-MSA and YWA1 without being signiﬁcantly
impaired, suggests that A. nidulans might also be a good cell factory. A. nidulans does not naturally
produce enzymes or compounds of interest, and probably for that reason it was never considered an industrial
workhorse. However, it also does not produce vast amounts of by-products (e.g. citric acid), and it is very
well characterized. Thus, it may be possible that A. nidulans may have a future as a cell factory.
2.4 Concluding remarks and future perspectives
In this study I have used a wide range of diﬀerent genetic approaches for investigation of secondary metabolism
in Aspergilli including gene over-expression, heterologous gene expression, gene deletion, and site-directed
mutagenesis. For this purpose I have developed a series of new genetic tools for gene expression, including a
background-free HTP expression platform for A. nidulans and an AMA1-based expression platform for fungi
with no available genetic tools.
Genome-wide deletion of PKSs in A. nidulans identiﬁed the PKS responsible for production of austinols in
A. nidulans, AusA. Furthermore, HTP over-expression of A. nidulans phosphatases and transcription factors
resulted in altered metabolite proﬁles, and a brief inspection revealed four possible novel compounds.
The combination of genetic engineering and feeding experiments has helped reveal the PK product of
four A. niger PKSs. Furthermore, the entire biosynthesis towards yanuthone D in A. niger was deduced,
and it was discovered that A. niger contains two diﬀerent PKSs that produce YWA1, the precursor to
black melanin and naphtho-γ-pyrones. The PKS responsible for production of asperrubrol was identiﬁed
using classical deletion methods, and it was shown that this PKS requires a cinnamic acid starter unit.
Interestingly, two compounds that were previously classiﬁed as terpenoids (yanuthone D and asperrubrol),
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proved to be PK-derived.
I have shown that A. aculeatus contains a 6-MSA synthase, which deﬁnes a biosynthetic cluster. Over-
expression of a TF embedded in the cluster activated the biosynthetic pathway and revealed ﬁve novel
compounds. Feeding studies veriﬁed that 6-MSA was incorporated into three compounds, whose structures
have not yet been solved.
In conclusion, I have successfully elucidated many parts of fungal secondary metabolism by combining
genetic, mycological and chemical approaches. It is clear that fungal secondary metabolism is very complex,
why I predict that many biosynthetic clusters will not be identiﬁed merely by deleting or over-expressing
genes. Based on this experience, I will advice everyone working in the ﬁeld of secondary metabolism to join
forces to maximize the outcome of these studies. After all, we all share a common goal of making the world
a better place.
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Chapter 3
Development of novel tools for genetic
engineering in Aspergilli
During this study, I have developed new methods for simplifying HTP strain construction, and I have ex-
panded the current toolbox for performing genetic engineering in a simple and ﬂexible manner. These tools
and methods have been used sporadically in the following chapters, why I have chosen to brieﬂy introduce
the principles of the new tools and application thereof.
In this chapter I will describe the tools that I have developed: new promoters from A. nidulans and new
integration sites for A. nidulans and A. niger. Furthermore, I will describe the methods that I developed in
order to facilitate HTP strain construction in general: development of a plasmid-based expression platform for
Aspergilli, implementation of the ccdB -based background free UE-compatible cloning vector, and development
and implementation of a background-free transformation system for gene expression in A. nidulans.
3.1 Results and discussion
3.1.1 Expanding the library of promoters for A. nidulans
One thing that is important for strain construction is the availability of usable promoters for a suitable
expression level of your favorite gene (YFG). Until now, only a limited number of promoters have been
reported for use in Aspergilli e.g. the strong, constitutive promoters PgpdA from A. nidulans and the
glucoamylase promoter PglaA from A. niger [Ganzlin and Rinas, 2008]. Very recently, six new constitutive
promoters with varying strengths were characterized for use in A. niger [Blumhoﬀ et al., 2013]. Two inducible
promoters have also been described for use in Aspergilli: the alcohol-inducible PalcA from A. nidulans and
the sucrose-inducible sucA from A. niger. The latter was only recently described [Zuccaro et al., 2008, Roth
and Dersch, 2010] why the potential of this inducible promoter is not yet known. Additionally, our research
group has recently implemented use of the tunable O7 promoter (TetON/OFF) in A. nidulans, which was
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adapted to A. niger by Meyer and co-workers [Meyer et al., 2011].
Besides the need for strong, constitutively expressed promoters, there is also a general need for new
constitutively expressed promoters that do not necessarily have to provide high expression. This need has
emerged because it has become possible to express entire gene clusters in a heterologous host, with the aim of
uncovering unknown biosyntheses (Chapter 11) [Chiang et al., 2013]. If the genes are individually expressed,
it is an advantage to employ diﬀerent promoters, as this will decrease the risk of spontaneous direct repeat
loop-out events. Especially in the ﬁeld of secondary metabolite expression, compounds that are toxic to the
cell may induce a stress response, which could potentially increase the rate of recombination in an eﬀort to
get rid of the genes producing the toxic compound.
Eukaryotic promoters are complex and diverse, why they can be very diﬃcult to identify and characterize.
Regulatory elements may be present several kilobases from the transcriptional start, and these are very
diﬃcult, if not impossible, to predict. The characterized A. nidulans promoters PgpdA and PalcA are 2.3 kb
and 800 bp, respectively, and the A. niger glucoamylase promoter PglaA is 2 kb long. Note that these are
the promoter lengths that are applied by molecular biologists; the entire promoter may contain regulatory
elements elsewhere which have not been identiﬁed. Generally, a short promoter is preferred because it eases
PCR reactions and keeps vectors at a minimum size (many fungal expression vectors are >13 kb without
gene inserted), but it also decreases the risk of spontaneous recombination within the cell.
In this study I have tested 11 new promoters fra A. nidulans, based on micro-array data (kindly provided
by Mikael R. Andersen). With only one exception, I used 1 kb as a cut-oﬀ value. 8 of the promoters provided
good expression of genes, with varying expression levels, see Figure 3.1. The resuls are summarized in Table
3.1. One of the promoters with strong is a short (200 bp) strong bidirectional promoter (PAN4802/PAN4803).
Figure 3.1: Qualitative test of new promoters on X-gal plate. The amount of blue color is an indirect measure
of lacZ expression.
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Table 3.1: A. nidulans promoters analyzed in this study. AVG exp = average expression level in the A4
wiild-type strain on all media. A4 glc = expression levels in A4 on glucose, A4 glc = expression levels in A4
on glycerol, n.d. = not determined in this study, *Qualiﬁed based on β-galactosidase assay (Figure 3.1).
Locus AVG exp A4 glc A4 gly Length (kb) Expression at IS1*
AN0262 13.95 14.01 13.95 1 Strong
AN1122 14.06 13.99 14.06 1 Intermediate
AN4794 14.15 14.18 14.12 1 Strong
AN4802 13.96 13.91 13.94 0.2 Strong
AN4803 13.84 13.80 13.85 0.2 Strong
AN5997 14.21 14.32 14.14 1 Weak
AN6082 14.09 14.12 14.10 1 Intermediate
AN7354 14.13 14.17 14.10 1 Weak
AN8704 13.84 13.82 13.84 1 Strong
AN8856 13.99 14.02 13.97 1 Weak
AN10130 14.38 14.42 14.43 1 Strong
gpdA 14.33 14.51 14.37 2.3 Strong
gpdA 14.33 14.51 14.37 1 Strong
gpdA 14.33 14.51 14.37 0.5 Strong
alcA 10.41 9.33 14.28 0.8 n.d.
Six of the promoters provided strong expression, comparable to expression levels obtained with PgpdA.
All of these promoters belonged to ribosomal proteins (AN0262, AN4794, AN4802, AN4803, AN8704, and
AN10130). A single promoter belonging to a ribosomal protein, AN6082, only provided intermediate expres-
sion levels based on the quantitative X-gal assay.
AN5997 is involved in rRNA export, and AN8856 has a role in rRNA subunit assembly. Both of them
displayed weak expression. The two remaining promoters are from genes that encode proteins with no
putative function (AN1122 and AN7354), and displayed intermediate and weak expression, respectively.
Based on these data, it is clear that promoters that regulate expression of ribosomal proteins, are highly
expressed under the circumstances used in this study. This study was carried out on minimal medium (MM),
which is also the cultivation medium most frequently used in our laboratory, why promoters of genes encoding
ribosomal proteins are good targets for development of new constitutively expressed promoters for use in the
laboratory. For other applications, promoters should be tested accordingly.
The availability of these new promoters allow for gene expression of several individual genes, regulated by
diﬀerent constitutive promoters. This is a clear advantage for reconstitution of biosynthetic clusters, however,
I have not yet had an opportunity to use these promoters for such application.
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3.1.2 Development of ﬁve new integration sites in Aspergillus nidulans
For heterologous expression of genes, one may choose to either integrate the gene randomly or targeted
to a speciﬁc locus within the genome. Both approaches are commonly used, and each has its advantages
and disadvantages. Random integration is easy because it basically only requires a substrate containing
the gene and a selection marker, and it is eﬃcient for high expression as many copies may be integrated
during a single transformation event. In contrast, targeted integration requires a substrate with at least the
gene, the selection marker, and two ﬂanking targeting sequences. Usually, only one copy is integrated during
transformation, however it is possible (but not trivial) to do two or more targeted integrations, especially
when using multiple selection markers. The great beneﬁt, however, of targeted integration is that expression
levels are constant for all genes expressed from that locus. Thus gene expression from a deﬁned locus is highly
suitable for screening purposes e.g. when comparing promoter strengths or enzyme activities. Moreover, the
risk of disrupting genes will be prevented.
Many studies have been conducted in order to investigate the epigenetic eﬀects of gene insertion, and
it is clear that chromosomal positioning has a large impact on gene expression levels in all organisms e.g.
gram neagtive and gram positive bacteria, yeast, ﬁlamentous fungi, insects, and humans [Sousa et al., 1997,
Thompson and Gasson, 2001, Yamane et al., 1998, Verdoes et al., 1995, Markstein et al., 2008, Gierman
et al., 2007]. Thus it is important to have characterized sites for ectopic integration, which can be used for
standardized gene expression.
The work I have done on development of new integration vectors for A. nidulans is based on the integration
system that was developed by Hansen and co-workers [Hansen et al., 2011]. The system is based on UE
cloning, and allows for integration into a speciﬁc locus termed Integration Site 1 (IS1). This system is highly
eﬃcient, but limited because it is only possible to integrate at one site, although it is possible to re-use the
pyrG marker by counter-selection. Therefore, I wanted to expand the number of integration sites so it would
be possible to integrate several genes e.g. for reconstruction of a biosynthetic pathway, either by successive
transformation with the counter-selectable pyrG marker or by simultaneus transformation using diﬀerent
markers.
The procedure for locating new integration sites (ISs) was straight forward: I located highly expressed
regions in the genome (similar to identiﬁcation of new promoters, see section 3.1.1), and located a potential
IS within this region. The potential IS should fulﬁll the two following criteria: it should be located between
two highly expressed genes, and there should be a distance of >1 kb to either of the two ORFs, not to disrupt
any surrounding gene or regulation thereof. Based on these criteria ﬁve new ISs were tested, using lacZ and
wA as an indirect indicator for expression levels, respectively. An overview of the ISs is shown in table 3.2.
50
IS Adjacent gene Location AVG
exp.*
Distance
(nt)
Protein function
1 AN6638 (US) ChrI 4.35 27 DNA methylation, DmtA [Lee et al., 2008]
AN6639 (DS) ChrI 11.2 473 2-methylcitrate dehydratase, McdB
Note: Described in [Hansen et al., 2011]. AN6638 transcript may be disrupted by insertion.
2 AN4072 (US) ChrII 9.76 193 Putative histone deacetylase (CADRE)
AN4073 (DS) ChrII 13.6 156 Putative 40S ribosomal protein S12 (CADRE)
3 AN4770 (US) ChrIII 9.80 1,428 PAPS reductase
AN4769 (DS) ChrIII 10.8 1,579 ATP sulfurylase
Note: This IS is characterized in chapter 11.
4 AN4252 (US) ChrII 12.3 1,017 Unknown
AN4251 (DS) ChrII 10.4 1,110 Putative 40S ribosomal protein S2 (CADRE)
5 AN7554 (US) ChrIV 9.89 1,886 Putative oxidoreductase (CADRE)
AN7553 (DS) ChrIV 6.55 2,444 HLH transcription factor, DevR
Note: Very high expression from this site.
6 AN3180 (US) ChrVI 9.39 942 Unknown
AN3179 (DS) ChrVI 10.0 2,004 Unknown
7 AN8283 (US) ChrII 12.1 2,259 Putative CYP450, Cyp51B [Kelly et al., 2009]
AN8282 (DS) ChrII 7.69 2,287 WD repeat protein (CADRE)
Table 3.2: Insertion sites for A. nidulans. *Average gene expression in A4 with D-glucose as carbon source.
For each of the ﬁve ISs I constructed expression vectors with new targeting sequences, using argB and
pyrG (with and without direct repeats) as markers, respectively. All vectors contained an AsiSI/Nb.BtsI UE
cassette, exactly as described in Section 3.1.5. For each set of vectors, I inserted lacZ and wA, respectively,
and transformed the construct into A. nidulans. ISX::lacZ transformants (X being the intagration site
number) were plated on MM plates containing 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) for
qualitative assessment of expression levels (Figure 3.2).
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Figure 3.2: Test of A. nidulans integration sites using lacZ reporter gene.
It was clear that all strains produced a blue pigment compared to the reference, however, it appeared
that all ISs had approximately the same productivity except for IS3, which apparently produced less blue
pigment than the rest. This was in constrast to the qualitative result obtained with the wA expressing strains,
which are depicted in Figure 3.3. In this case there was a clear diﬀerence in the production of YWA1: IS7
produced approximately the same amount as IS1; IS4 and IS6 had a high production; and IS5 had extremely
high production without aﬀecting the growth rate much. Additionally, it was conﬁrmed that IS3 had low
production of YWA1.
Figure 3.3: Test of A. nidulans integration sites using wA reporter gene.
IS3 has been used for investigating aspects of the geodin biosynthetic pathway in A. terreus, by het-
erologous expression of cluster genes in nidulans (Chapter 11). IS5, providing extremely high production of
PKs, has been used for production of fully 13C labeled 6-methylsalicylic acid (6-MSA) for use in labeling
experiments (see Chapter 10). In fact, expression from this site combined with expression from IS1 resulted
in a titer of 1.81 g/l 98.7 % isotopic pure 6-MSA (this study, data not shown).
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3.1.3 Development of four integration sites in Aspergillus niger
For productivity purposes random gene insertion is a strong approach, as many copies can be integrated ot
once, and the resulting strains are screened for productivity and growth. However, in some cases this approach
is not optimal: there is a risk that a random gene insertion disrupts important genes and chromosomal
positioning also have a large eﬀect on gene expression levels, as shown in section 3.1.2. These side-eﬀects
are especially important when studying cell biology where gene disruptions might result in a completely
diﬀerent phenotype, and when comparing activities of diﬀerent genes it is preferrable to have identical gene
expression levels. For identiﬁcation of insertion site IS-NIG1, I used the same approach as for A. nidulans
(see section 3.1.2). For identiﬁcation of the remaining three insertion sites, I used diﬀerent approaches, which
will be described below. Table 3.3 summarizes data for the four integration sites.
IS Adjacent gene AVG exp.* Distance (nt) Predicted protein function
NIG1 185605 (US) 9.79 1,645 Mitochondrial 18 KDa protein (CDD)
56528 (DS) 7.99 473 Histidinol phosphate phosphatase (CDD)
NIG2 (albA) albA (US) 6.79** 0 YWA1 PKS
albA (DS) 6.79** 0 YWA1 PKS
Note: disrupts albA gene, resulting in white conidia.
NIG3 56332 (US) 8.70 4,384 Oxygenase (CDD)
40564 (DS) 3.79 3,419 No conservation
Note: 56332 is a homologue of AN7554 (A. nidulans)
NIG4 40564 (US) 3.79 1,723 No conservation
181931 (DS) 7.64 2,193 HLH transcription factor (CDD)
Note: 181931 is a homologue of AN7553 (A. nidulans)
Table 3.3: Insertion sites for A. nidulans. *Average gene expression in ATCC1015 from liquid culture.
**Secondary metabolism is highly down-regulated in liquid cultivations.
Identiﬁcation and test of IS2, replacing albA/fwnA conidial pigment gene
Based on the test of new integration sites for A. nidulans (Section 3.1.2) it was clear that the approach of
locating highly expressed sites for integration by merely looking at expression levels of surrounding genes,
was not consistently successful. Therefore, I wondered if there was another, perhaps more clever, way of
designing an integration site for A. niger. Screening of A. niger transformants is cumbersome because
diagnostic (spore) PCR rarely works. As I have noted this problem for several black Aspergilli (A. niger, A.
aculeatus and A. carbonarius), but not for the green A. nidulans, I assume that the black pigment inhibits
the PCR reaction whereas the green does not, at least to the same extent. Based on this hypothesis, it was
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clear that an integration site that would abolish production of the black conidial pigment by simultaneous
integration of your favorite gene (YFG), would be ideal. Moreover, a switch from black to white colonies
would make screening for correct transformants very eﬃcient. A second advantage of this approach is that it
is not necessary to do the transformations in a kusA∆ background, and the pyrG marker would be available
as a selectable and counter-selectable marker for multiple transformations.
Last, this approach would yield yet another advantage when studying secondary metabolism: albA is
responsible for production of naphtho-γ-pyrones (e.g. the aurasperones), which constitute the majority of
the A. niger secondary metabolite pool under all tested conditions [Nielsen et al., 2009]. Hence, the absence
of these compounds would make it easier to study secondary metabolites which do not belong to the naphtho-
γ-pyrone family. In A. nidulans the homologue of albA, wA, is only expressed in conidia. Thus ectopic gene
integration in this site in A. nidulans, even if accompanied by a constitutively expressed promoter, may be
silenced in other tissue than conidia and may not be suited for studying cell biology. However, very recently,
Chiang and co-workers successfully applied this approach to study biosynthesis of secondary metabolites from
A. terreus [Chiang et al., 2013]. As albA in A. niger is also responsible for production of naphtho-γ-pyrones,
which are detected under all tested conditions, I assume that this gene is not silenced under any known
conditions, and that it is expressed in high amounts.
In this case, I could not use wA as an indirect marker for gene expression as this gene is the homologue
of the gene I was trying to delete. Thus transformants would produce black spores, and the screening system
was of no use. Instead I integrated the gene encoding red ﬂuorescent protein (RFP), rfp, and the resulting
transformants did indeed produce white conidia (Figure 3.4).
Figure 3.4: Test of A. niger integration site 2 (IS-NIG2). Insertion of rfp into IS-NIG2 (albA) abolishes
production of black conidia. KB1001 = reference strain.
Although I did not have time to characterize this integration site any further, it seems it has the potential
of being a suitable integration site for HTP strain construction. I have used this integration site, as well as
IS-NIG1, for unveiling details of the naphtho-γ-pyrone biosynthesis in A. niger, which is presented in Chapter
9.
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Identiﬁcation of IS-NIG3 and IS-NIG4, based on results from A. nidulans
Identiﬁcation of the IS-NIG3 and IS-NIG4 insertion sites were based on the results obtained from the new
ISs in A. nidulans (see Section 3.1.2). In A. nidulans one of the ISs, IS5, had turned out to be a super-
site for ectopic expression. Therefore I searched for, and found, homologues of the adjacent genes in A.
niger. ASPNIDRAFT_56332 (56332, AN7554 homologue) and ASPNIDRAFT_181931 (181931, AN7553
homologue) were located closely, however, there was one gene, ASPNIDRAFT_40564 (40564), in between.
A BLAST search revealed that the 40564 gene is not conserved among Aspergilli, and expression data indicate
that it is very poorly expressed. As I did not know the signiﬁcance of the 40564 gene, if any, I dicided to
insert the wA gene on the left (IS-NIG3) and on the right (IS-NIG4) ﬂank of 40564, without disrupting any
genes.
The resulting transformants did indeed produce high amounts of yellow pigment, however, integration
into IS-NIG4 yielded more pigment that integration into IS-NIG3. Furthermore, integration of wA into IS-
NIG4 seemed to aﬀect growth of the fungus compared to integration into IS-NIG3 (see Figure 3.5). This is
an interesting observation as the integration sites are so closely positioned, and only separated by the 40564
gene. Unfortunately, I did not have time to pursue this any further, and these two new ISs have not yet
been used any further. However, the strains did not display any devastating morphologies, why both sites
are potentially suitable for gene expression.
Figure 3.5: Test of A. niger integration sites 3 and 4. Insertion of rfp into IS-NIG2 (albA) abolishes production
of black conidia.
3.1.4 Development of a non-integrative (AMA1-based) expression platform for
Aspergillus Spp.
In addition to the newly developed integration sites, I have constructed an expression cassette within an
AMA1-containing non-integrative vector. The AMA1 sequence, which comprise two long perfect inverted
repeats seperated by a unique spacer, allows for autonomous plasmid replication in A. nidulans, A. niger,
and A. oryzae [Gems et al., 1991, Aleksenko et al., 1996].
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Similar to existing integration vectors, the AMA1 expression vector contains the PgpdA0.5kb promoter and
the TtrpC terminator. I constructed three vectors with diﬀerent markers: argB (pDHX1), pyrG (pDHX2)
and hph (pDHX3) (see Figure 3.6). The latter, containing the hygromycin phosphatase hph marker, is
independent of auxotrophies and can be used for gene expression in wild-type Aspergilli, and maybe even
ﬁlamentous fungi belonging to other genera.
Figure 3.6: AMA1-based expression vectors developed in this study. pDHX1 contains an argB selectable
marker, pDHX2 contains pyrG, and pDHX3 contains hph.
There are advantages and disadvantages of expressing genes from a plasmid versus integrating the ex-
pression cassette into the genome. One of the main advantages is that AMA1 plasmids have a higher trans-
formation frequency than linear substrates [Gems et al., 1991], and thus it is easier to obtain transformants
- even for strains or species that make poor competent cells e.g. protoplasts. In continuation of this, it is
possible to transform with diﬀerent plasmids carrying diﬀerent selection markers, and obtain transformants
that contain all of these plasmids. For targeted integration it is diﬃcult to integrate more than one substrate,
and at the least it requires excellent protoplasts.
On the other hand, the use of AMA1 plasmids have several drawbacks: plasmids are easily lost if selection
is not maintained, and the copy number of the plasmids vary throughout the mycelium. To test the behavior
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of the AMA1 plasmids, I transformed a wA∆ yA∆ (white) strain of A. nidulans with two diﬀerent plasmids;
one carrying wA and one carrying yA (see Figure 3.7).
Figure 3.7: Test of AMA1 expression vectors using a color screen: wA∆ yA∆ (white) strain transformed
with pDHX1-yA (argB) and pDHX2-wA (pyrG) results in production of yellow and green conidia.
Clearly, both wA and yA were expressed as the strain was able to produce green conidia (consult Figure 1.6
for explanation). As expected, the strain produces a mixture of white, yellow, and green conidia, indicating
that the plasmids are not distributed evenly throughout the nuclei. However, this tool is very suitable for
quick and dirty screening purposes due to the ease of strain construction.
3.1.5 Development of a HTP gene expression platform for A. nidulans
In the following I will describe two approaches for optimizing HTP fungal strain construction; both with
the aim of eliminating or drastically decrease the amount of screening. The entire HTP setup has been
applied and is described in Chapter 6, why this section will provide only a brief introduction to the novel
background-free cloning vectors and the background-free gene expression system for A. nidulans.
Development of background-free cloning vectors
One of the great challenges of HTP strain construction is to eliminate or highly reduce the amount of screening
at each step. One of the bottlenecks I identiﬁed during semi-HTP PKS expression (Chapter 8) was screening
for correct E. coli clones. The false positives background of the existing UE-compatible vectors could result
from either incomplete digestion of the vector or from religation of a fully digested vector. I had observed
that some of the cassettes had a higher rate of false positives than others, why I hypothesized that the false
positives primarily were due to incomplete digestion by the restriction enzymes. Based on this hypothesis, I
wished to develop a vector which would only be viable if completely digested.
Inspired by the background-free GatewayTM Cloning system (Life Technologies/Invitrogen), which was
used in our laboratory for a while, I wondered if it was possible to transfer the ccdB suicide gene from the
GatewayTM Cloning system into the UE-compatible vectors in a meaningful manner. Thus I inserted the
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ccdB gene, containing 3' and 5' ﬂanking sequences to reconstitute the AsiSI/Nb.BtsI cassette on either side of
the suicide gene, into the cloning cassettes of CMBU1111, resulting in the vector pDH56 (see ﬁgure 3.8). The
vectors were tested and proved to have extremely little background (<1 percent)(data not shown). Therefore,
all of the vectors I have made in this study contains the ccdB suicide gene in between two identical (inverted)
UE-cassettes, as shown in Figure 3.8. Digestion of pDH56 with AsiSI and Nb.BtsI releases the ccdB ::camR
cassette, leaving 8 bp single stranded overhangs in both ends. The digested pDH56 is identical to the fully
digested CMBU1111 vector.
Figure 3.8: Schematic of the original expression vector CMBU1111 [Hansen et al., 2011], and the new
background-free expression vector pDH56, containing the suicide gene ccdB.
Development of a background-free integration system
During fungal strain construction, screening for correct fungal transformants is by far the predominant
bottleneck. In most cases, several transformants must be puriﬁed and re-cultivated for extraction of genomic
DNA, which is used for veriﬁcation of the strain by diagnostic PCR and/or southern blot. For a few strains this
task is manageable, but for many strains the process is tedious and laborious. For targeted gene expression,
I have developed a system that employs visual detection of false positive transformants, and even elimination
of false positives by using counter-selectable markers.
The principle of the system is to prepare a primary strain that will serve as recipient of the genes that one
wishes to express (Figure 3.9). The primary strain is constructed by integration of the wA gene, using pyrG
as a selection marker (Figure 3.9-A). The primary strain is then used for transformation with your favorite
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gene (YFG), which is any gene that one wishes to express (Figure 3.9-B), and this construct contains a
diﬀerent selection marker (here: argB). This construct will replace the existing cassette and loop out wA and
pyrG by direct repeat recombination. Correct transformants will no longer produce the yellow compound
YWA1, and are easily recognizable on the transformation plate (see Figure 2.1). Addition of 5-FOA to the
transformation medium will kill all cells that express pyrG, thus eliminating false positive transformants. For
integration sites with medium or high expression levels, addition of 5-FOA to the transformation medium is
not essential, as the clear color shift from yellow to wild-type is easily distinguishable on the transformation
plate.
Figure 3.9: Background-free transformation system in A. nidulans. A. The primary (recipient) strain, which
will be used for all future transformations, is constructed by targeted integration of the wA gene, which is
responsible for production of the yellow pigment YWA1. The construct carries a selectable marker, in this
case pyrG. B. The primary (recipient) strain is transformed with a construct carrying your favorite gene
(YFG) and a second selectable marker, here argB. By targeted integration, the wA and pyrG cassette is
looped out, and the pigment is no longer produced. For elimination of background, 5-FOA can be added to
the transformation medium, killing all cells that still express pyrG.
This system is truly eﬃcient, and I have successfully used the system for HTP site-directed mutagenesis in
a commercial protease (not presented in this thesis), and for HTP over-expression of A. nidulans phosphatases
and transcription factors (described in Chapter 6).
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3.2 Concluding remarks
In this study I have sought to improve existing tools and develop new tools for genetic engineering in Aspergilli.
I have identiﬁed six novel promoters from A. nidulans which, based on a qualitative X-gal assay, appear to
be strongly and constitutively expressed under laboratory conditions. Two of the these comprise a short (200
bp) bidirectional promoter, providing very high expression levels in either direction.
Furthermore, I have developed ﬁve new integration sites for A. nidulans, making a total of eight deﬁned
integration sites, including the yA locus, as applied by Chiang and co-workers [Chiang et al., 2013]. One of
the novel integration sites, IS5, proved extremely eﬃcient and expression of PKSs from this site provides vast
amounts of secondary metabolites (e.g. 6-MSA and YWA1). Additionally, I have identiﬁed four integration
sites for A. niger, one of which targets the albA gene, responsible for black pigmentation of conidia. In total,
nine novel integration sites were developed in this study, allowing for ectopic or heterologous expression of
several genes in the same strain.
An important result of this study was development of an AMA1-based gene expression platform. AMA1
allows for autonomous replication in several Aspergilli, and is independent of genetic tools for genomic
integration. Furthermore, AMA1-based plasmids have a much higher transformation eﬃciency than linear
substrates [Gems et al., 1991], why this method is also valuable for for fungi that transform poorly, whether
be it by protoplastation or electroporation.
Last, I have developed a system for HTP gene integration, comprising a concept for background-free
cloning vectors and a background-free integration system for A. nidulans. The background-free cloning
vectors contain a suicide gene (ccdB) which is excised when a fragment is correctly inserted. This system
has been applied for all of the cloning vectors prepared during this study. The background-free integration
system uses a recipient strain carrying a counter-selectable pyrG marker and a PKS gene producing the
yellow compound YWA1. Correct integration will excise the wA::pyrG cassette, and counter-selection for
pyrG with 5-FOA will allow growth of only correct transformants. It is possible to use any markers if the
PKS is highly expressed, as the color-shift makes it easy to verify correct transformants. Thus, this system
should also be fully applicable onto other ﬁlamentous fungi.
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3.3 Experimental
3.3.1 Fungal strains
The A. nidulans strain NID1 (IBT 29539) (argB2 pyrG89 veA1 nkuA∆) [Nielsen et al., 2008] was used as a
reference and for insertion of all genes. For A. niger, KB1001 (pyrG∆ kusA::AFpyrG) [Chiang et al., 2011]
was used as a reference and for genetic engineering.
Table 3.4: Fungal strains used and constructed in this study. hph* contains a silent point mutation eliminating
an AsiSI restriction site. oriR* contains a point mutation eliminating a Nb.BtsI nicking site. FGSC = Fungal
Genetics Stock Center, CMB SC = CMB Aspergillus Strain Collection.
Strain Genotype Source
A. nidulans strains
A4 (FGSC) - FGSC
NID1 argB2 pyrG89 nkuA∆ [Nielsen et al., 2008]
Prom1 argB2 pyrG89 nkuA∆ IS1::PAN0262::lacZ ::TtrpC ::argB This study
Prom2 argB2 pyrG89 nkuA∆ IS1::PAN1122::lacZ ::TtrpC ::argB This study
Prom3 argB2 pyrG89 nkuA∆ IS1::PAN4794::lacZ ::TtrpC ::argB This study
Prom4 argB2 pyrG89 nkuA∆ IS1::PAN4802::lacZ ::TtrpC ::argB This study
Prom5 argB2 pyrG89 nkuA∆ IS1::PAN4803::lacZ ::TtrpC ::argB This study
Prom6 argB2 pyrG89 nkuA∆ IS1::PAN5997::lacZ ::TtrpC ::argB This study
Prom7 argB2 pyrG89 nkuA∆ IS1::PAN6082::lacZ ::TtrpC ::argB This study
Prom8 argB2 pyrG89 nkuA∆ IS1::PAN7354::lacZ ::TtrpC ::argB This study
Prom9 argB2 pyrG89 nkuA∆ IS1::PAN8704::lacZ ::TtrpC ::argB This study
Prom10 argB2 pyrG89 nkuA∆ IS1::PAN8856::lacZ ::TtrpC ::argB This study
Prom11 argB2 pyrG89 nkuA∆ IS1::PAN10130::lacZ ::TtrpC ::argB This study
NID545 argB2 pyrG89 nkuA∆ IS1::PgpdA0.5kb::lacZ ::TtrpC ::pyrG CMB SC
IS3-lacZ argB2 pyrG89 nkuA∆ IS3::PgpdA0.5kb::lacZ ::TtrpC ::pyrG This study
IS4-lacZ argB2 pyrG89 nkuA∆ IS4::PgpdA0.5kb::lacZ ::TtrpC ::pyrG This study
IS5-lacZ argB2 pyrG89 nkuA∆ IS5::PgpdA0.5kb::lacZ ::TtrpC ::pyrG This study
IS6-lacZ argB2 pyrG89 nkuA∆ IS6::PgpdA0.5kb::lacZ ::TtrpC ::pyrG This study
IS7-lacZ argB2 pyrG89 nkuA∆ IS7::PgpdA0.5kb::lacZ ::TtrpC ::pyrG This study
IS1-wA argB2 pyrG89 nkuA∆ IS1::PgpdA0.5kb::wA::TtrpC ::pyrG This study
IS3-wA argB2 pyrG89 nkuA∆ IS3::PgpdA0.5kb::wA::TtrpC ::pyrG This study
IS4-wA argB2 pyrG89 nkuA∆ IS4::PgpdA0.5kb::wA::TtrpC ::pyrG This study
IS5-wA argB2 pyrG89 nkuA∆ IS5::PgpdA0.5kb::wA::TtrpC ::pyrG This study
Continued on Next Page
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Table 3.4  Continued
Strain Genotype Source
IS6-wA argB2 pyrG89 nkuA∆ IS6::PgpdA0.5kb::wA::TtrpC ::pyrG This study
IS7-wA argB2 pyrG89 nkuA∆ IS7::PgpdA0.5kb::wA::TtrpC ::pyrG This study
wA∆ yA∆ argB2 pyrG89 nkuA∆ wA∆ yA∆ This study
2xAMA1 argB2 pyrG89 nkuA∆ pDHX1-yA pDHX2-wA This study
A. niger strains
KB1001 pyrG∆ kusA::AFpyrG PNNL
IS-NIG2-rfp pyrG∆ kusA::AFpyrG IS-NIG2::PgpdA0.5kb::rfp::TtrpC ::hph* This study
IS-NIG3-wA pyrG∆ kusA::AFpyrG IS-NIG3::PgpdA0.5kb::wA::TtrpC ::hph* This study
IS-NIG4-wA pyrG∆ kusA::AFpyrG IS-NIG4::PgpdA0.5kb::wA::TtrpC ::hph* This study
3.3.2 Media
Minimal medium for A. nidulans was made as described in [Cove, 1966] but with 1% glucose, 10 mM NaNO3
and 2% agar. Minimal medium for A. niger was prepared as described in [Chiang et al., 2011]. YES, MEA and
CYA media were prepared as described by Frisvad and Samson [Samson et al.]. When necessary, media were
supplemented with 0.122 mM 5-bromo-4- chloro-3-indoyl-β-D-galactopyranoside (X-gal), 4 mM L-arginine,
10 mM uridine, 10 mM uracil and/or 100 µg/ml hygromycin B (Invivogen, San Diego, CA, USA) when
necessary.
3.3.3 PCR, cloning and transformation
All primers are listed in Table 3.3.3. All PCR reactions were carried out using the PfuX7 polymerase
[Nørholm, 2010], and either HF or Phire PCR buﬀer (Finnzymes/Thermo Scientiﬁc). The PCR program
was: 98◦C for 1 min, 98◦C for 15 s, 60◦C for 30 s, 72◦C for 30s/kb, and 72◦C for 5 min. Normally, I
performed 35 cycles of ampliﬁcation. Diagnostic (conidial) PCR was performed as a regular PCR reaction,
except initial denaturation step was 20 min.
Fragments were assembled via uracil-excision fusion [Geu-Flores et al., 2007] into a compatible vector.
Correct clones were veriﬁed by restriction digestion. Protoplasting and gene-targeting procedures were per-
formed as described previously [Johnstone et al., 1985, Nielsen et al., 2006]. pDH56 was prepared as described
in Chapter 10.
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Construction of strains with new promoters
Promoter regions were ampliﬁed using primers Prom-X-FW and Prom-X-RV, where X is the locus of the
gene downstream of the promoter (primers 1-22 in Table 3.3.3). The promoter fragments were inserted into
plasmid p68 as described in [Hansen et al., 2011]. Plasmids were veriﬁed by restriction analysis, linearized
with NotI and transformed into NID1. Correct transformants were veriﬁed by diagnostic PCR as described
in [Hansen et al., 2011].
Construction of plasmids with new integration sites
Plasmids for integration into new sites were constructed by uracil excision (UE) fusion of ﬁve fragments:
(1) one fragment comprising E. coli origin of replication oriR and ampicillin resistance gene ampR, (2) the
upstream (US) targeting sequence, (3) one fragment comprising PgpdA0.5kb, UE cassette containing ccdB and
cmR, and TtrpC, (4) marker, and (5) downstream (DS) targeting sequence.
Fragments 1 and 3 were ampliﬁed from pDH57 (primers 52+53 and primers 54+55, respectively) 10.
Fragment 4 (marker) was ampliﬁed from pDH57 (argB, primers 57+58), CMBU2111 (pyrG, primers 59+60
or 61+62) [Hansen et al., 2011], or pCB1003 (hph, primers 98+99) [McCluskey et al., 2010]. US and DS
fragments were ampliﬁed from A. nidulans or A. niger genomic DNA, using primers 25-28 (IS7), primers
29-32 (IS4), primers 33-36 (IS3), primers 37-40 (IS5), primers 41-44 (IS6), primers 67-70 (IS-NIG1), primers
73-76 (IS-NIG2), primers 77-80 (IS-NIG3), or primers 83-86 (IS-NIG4).
Construction of strains for testing new integration sites
Istegration sites were tested by expression of lacZ and wA, respectively, or rfp. lacZ was PCR ampliﬁed from
p68 using primers 100 and 101, wA was PCR ampliﬁed from A. nidulans IBT29539 gDNA using primers 102
and 103, and rfp was ampliﬁed from CMBU2111-rfp (kindly provided by Diana C. Anyaogu) using primers
92+93. The PCR fragments were inserted into digested plasmids (described above), veriﬁed, linearized by
digestion with SwaI (for pyrG containing plasmids), and transformed into A. nidulans IBT29539 or A. niger
KB1001. Correct transformants were veriﬁed by diagnostic PCR.
Construction of strain for testing expression from AMA1 plasmids
The 2xAMA1 strain was constructed for testing the expression platform in the novel AMA1-based plasmids.
wA and yA were PCR ampliﬁed from A. nidulans IBT29539 gDNA (primers 102+103 and 104+105) and
inserted into pDHX2, and pDHX1, respectively. Clones were veriﬁed and transformed directly into the wA∆
yA∆ strain as described above.
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Table 3.5: Primers used in this study. All primers are shown in 5'-3' direction
Primer number Primer name Sequence
1 Prom-AN5997-FW AGAGCGAUAGAAGGAGGAGTCCGATG
2 Prom-AN5997-RV TCTGCGAUGGATGGCGTGTCGCTGTT
3 Prom-AN8856-FW AGAGCGAUATCGAGGTGTTTGTGCTGA
4 Prom-AN8856-RV TCTGCGAUTGTCGCAGTGTCGAAAGTCG
5 Prom-AN4794-FW AGAGCGAUCAGGCCTTTTGTGTTGGAC
6 Prom-AN4794-RV TCTGCGAUTGTCGCGAAGAAAAGAAGC
7 Prom-AN7354-FW AGAGCGAUGAGCTTTGTGCTGGAGTT
8 Prom-AN7354-RV TCTGCGAUGTCGAAATCGGTCTCGAAATT
9 Prom-AN6082-FW AGAGCGAUGATGGCGCTCATATCGGT
10 Prom-AN6082-RV TCTGCGAUATGAGATGCAAAAAGACGGT
11 Prom-AN1122-FW AGAGCGAUATCTCACTCCACTAGAATTCCT
12 Prom-AN1122-RV TCTGCGAUAAATGAGTCGAGAATGGCG
13 Prom-AN0262-FW AGAGCGAUTCCAAGCTTAACCCGTCC
14 Prom-AN0262-RV TCTGCGAUAGAGGAGGGAAAGATTCGAG
15 Prom-AN8704-FW AGAGCGAUGGGGTAGGTGCTAGATGTC
16 Prom-AN8704-RV TCTGCGAUGACCGGTTGGGACGAGATG
17 Prom-AN4802-FW AGAGCGAUCGAATAACTCAGCTGAACGACTT
18 Prom-AN4802-RV TCTGCGAUGAAAACGAAGAAGTCCCTCGAT
19 Prom-AN4803-FW AGAGCGAUGAAAACGAAGAAGTCCCTCGAT
20 Prom-AN4803-RV TCTGCGAUCGAATAACTCAGCTGAACGACTT
21 Prom-AN10130-FW AGAGCGAUTGCATCTTTCGAGTCCCTATTT
22 Prom-AN10130-RV TCTGCGAUGTTGTTGAGAGCTGCGAG
23 ccdB-camR-fw AGAGCGAUCGCAGAAGCCTACTCGCTATTGTCCTCA
24 ccdB-camR-rv TCTGCGAUCGCTCTTGCGCCGAATAAATACCTGT
25 AN8282-US-Fw AAGCAGCUATCGGTCATGTGATGCTGAGG
26 AN8282-US-Rv ATATTGGGCUGCTTGGAATATTATGATGATTCAGC
27 AN8282-DS-Fw ACTAGGTAAUCTTCGGACTTATCAACCCAGTG
28 AN8282-DS-Rv AGTGGGGAUAGGCAGGCCAATCGACTAA
29 AN4252-US-Fw AAGCAGCUCTCAGAGCATCTTTCTCTACCCAT
30 AN4252-US-Rv ATATTGGGCUGGACCGCATCTGATTGAACG
31 AN4252-DS-Fw ACTAGGTAAUCTAGTTGTCAGTAGTACGGCAAGC
32 AN4252-DS-Rv AGTGGGGAUTCCAATGGTAGGGACATTGTTG
Continued on Next Page
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Table 3.5  Continued
Primer number Primer name Sequence
33 AN4770-US-Fw AAGCAGCUCAAGAGGTACCCGCTACAGCA
34 AN4770-US-Rv ATATTGGGCUAGCCTTCATTGACCAGCTTCG
35 AN4770-DS-Fw ACTAGGTAAUTGAATGTTGGAATAGGCTGTGC
36 AN4770-DS-Rv AGTGGGGAUCTGCATACCCGTCGTAGTCCT
37 AN7553-US-Fw AAGCAGCUGTTTGCCATGCTGCAACTGT
38 AN7553-US-Rv ATATTGGGCUTCGCTGAGTGTGAGTCTGACTTC
39 AN7553-DS-Fw ACTAGGTAAUGCATGGCAATCAAGTCCCT
40 AN7553-DS-Rv AGTGGGGAUAGGGAACGGTTGTCGATGG
41 AN3180-US-Fw AAGCAGCUTAAGGGAGACCGTCAGAGTTTG
42 AN3180-US-Rv ATATTGGGCUACGTCTCCTGCAGAGTAGCTGT
43 AN3180-DS-Fw ACTAGGTAAUCAAGCTAGACTGTCAAGGGACATT
44 AN3180-DS-Rv AGTGGGGAUTGCTGAGGATGCTGAGATGAAG
45 IS4252-chk-RV GAGAGACAACCAGCTTTCACCA
46 IS7553-chk-RV GGTGAATACTGGAATGCGCTAAT
47 IS4770-chk-RV TCGTCAATTGTAAGAATAGCAAGGT
48 IS3180-chk-RV AGAACCGGGTTCTGTGGATG
49 IS8282-chk-RV TCTGAAACTCACCGTCAGTGCTTA
50 ampR-PM-FW AGCGCTACAUAATTCTCTTACTGTCATGCCATCC
51 ampR-PM-RV ATGTAGCGCUGCCATAACCATGAGTGATAACACTG
52 ori-coli-FW ATCCCCACUACCGCATTAAGACCTCAGCG
53 ampR-RV AGCTGCTUCGTCGATTAAACCCTCAGCG
54 p71-prom-ter-short-usF AGCCCAATAUTAAGCTCCCTAATTGGCCC
55 p71-prom-ter-dsR ATTACCTAGUGGGCGCTTACACAGTACA
56 p71-prom-ter-IS-dsR AGCTCACUGGGCGCTTACACAGTACA
57 argB-FW ACTAGGTAAUATCGCGTGCATTCCGCGGT
58 argB-RV-forIS ATTACCTAGUGCCTCAGCGCCACCTACA
59 pyrG-FW-C1 ACTAGGTAAUATGACATGATTACGAATTCGAGCT
60 pyrG-RV-forIS ATTACCTAGUGCCTCAATTGTGCTAGCTGC
61 pyrG-FW-DR-forIS AGTGAGCUTGGATAACCGTATTACCGCC
62 pyrG-RV-DR-forIS ATTACCTAGUTGCCAAGCTTAACGCGTAC
63 amdS-fw ACTAGGTAAUTGGATAGGCAGATTACTCAGCCT
64 amdS-rv AGTGGGGAUGGACAGTCTGCACGTTACTGCT
65 BleR-fw ACTAGGTAAUGCTGATTCTGGAGTGACCCAG
Continued on Next Page
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Table 3.5  Continued
Primer number Primer name Sequence
66 BleR-rv AGTGGGGAUCGTTGTAAAACGACGGCC
67 ASN-IS1-US-Fw AAGCAGCUACGCTTGGATAAGAAGTGAGAAGT
68 ASN-IS1-US-Rv ATATTGGGCUTCTACACCGATATGGAGCTCTTT
69 ASN-IS1-DS-Fw ACTAGGTAAUAAGTAAGCGTGCGTGAAACAG
70 ASN-IS1-DS-Rv AGTGGGGAUTAATTATAACTGGTCAGCCACTGAC
71 Chk-ASNIS1-US-Fw GGAGTTTCGGTGGAGTCTACGGAG
72 Chk-ASNIS1-DS-Rv TGGGTTACATACCTCTTCTGGGT
73 AlbA-US-FW AAGCAGCUATCCGTCGGTCAGGCTGCT
74 AlbA-US-RV ATATTGGGCUCACACGAGATGGACCCTCCAT
75 AlbA-DS-FW ACTAGGTAAUTCCCGCTAGGACTGACAACA
76 AlbA-DS-RV AGTGGGGAUCTCCCTCGTATTCGCCTCCT
77 ISU3-US-Fw AAGCAGCUAGTTAGGGACTTAGCCTCGGAC
78 ISU3-US-Rv ATATTGGGCUCTCTTCGAGACTGGCTAGATAGATAG
79 ISU3-DS-Fw ACTAGGTAAUCACTAGACAGGTTGAAGGTACTTTGT
80 ISU3-DS-Rv AGTGGGGAUTCGCATGTACAGTGGTCTCTTATG
81 Chk-ISU3-Fw TTAGTTCATGGATGCTCGCCT
82 Chk-ISU3-Rv TCAGACAGCATGATAACAGCCA
83 ISU4-US-Fw AAGCAGCUTACTTGGTGGCTGTAAGAGTATGACTA
84 ISU4-US-Rv ATATTGGGCUTGTGGCACTGGTGTCTCGTC
85 ISU4-DS-Fw ACTAGGTAAUGTCTGGTTCCTGTGAACTAACTAGAC
86 ISU4-DS-Rv AGTGGGGAUTCATGTTCAGGGATCGGCA
87 ISU4-DS-Rv2 AGTGGGGAUAGTATTCTGATGTGTTTCGAGACCA
88 Chk-ISU4-Fw CATGTTGGAAAGTCTGATGATAATAATC
89 Chk-ISU4-Rv GTACTCTGAGGCATGGACCAAT
90 hph-PM-Fw ATGCGATUGCTGCGGCCGATCTTAGC
91 hph-PM-Rv AATCGCAUCCATGGCCTCCGCGAC
92 mRFP-ORF-Fw AGAGCGAUATGGCCTCCTCCGAGGAC
93 mRFP-ORF-Rv TCTGCGAUTTAGGCGCCGGTGGAGT
94 AMA1-FW AAGCAGCUGACGGCCAGTGCCAAGCT
95 AMA1-RV ATATTGGGCUGGAAACAGCTATGACCATGAGATCT
96 AMA-3'-Fw ACCCCAAUGGAAACGGTGAGAGTCCAGTG
97 AMA-5'-Rv ATTGGGGUACTAACATAGCCATCAAATGCC
98 hph-1003-pX-Fw ACTAGGTAAUGCTAGTGGAGGTCAACACATCA
Continued on Next Page
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99 hph-1003-pX-Rv AGTGGGGAUCGGTCGGCATCTACTCTATT
100 lacZ-Fw AGAGCGAUATGACCATGATTACGGATTC
101 lacZ-Rv TCTGCGAUTTATTTTTGACACCAGACCA
102 AN8209-Fw AGAGCGAUATGGAGGACCCATACCGTGT
103 AN8209-Rv TCTGCGAUTATTAGAACCAGAGGATTATTATTGTT
104 AN6635-Fw AGAGCGAUATGTACCTCTCCACGGTCCT
105 AN6635-Rv TCTGCGAUCTAAGAATCCCAAACATCAAC
Table 3.6: Plasmids used in this study. All plasmids aer oriR ampR. hph* contains a silent point mutation
eliminating an AsiSI restriction site. oriR* contains a point mutation eliminating a Nb.BtsI nicking site.
UEC = AsiSI/Nb.BtsI uracil excision cassette
Plasmid Genotype Source
p68 TS1::UEC::lacZ ::TtrpC ::argB ::TS2
CMBU1111 TS1::PgpdA::UEC::TtrpC ::argB ::TS2 [Hansen et al., 2011]
CMBU1211 TS1::PalcA::UEC::TtrpC ::argB ::TS2 [Hansen et al., 2011]
CMBU2111 TS1::PgpdA::UEC::TtrpC ::pyrG ::TS2 [Hansen et al., 2011]
pProm1 TS1::PAN0262::lacZ ::TtrpC ::argB ::TS2 This study
pProm2 TS1::PAN1122::lacZ ::TtrpC ::argB ::TS2 This study
pProm3 TS1::PAN4794::lacZ ::TtrpC ::argB ::TS2 This study
pProm4 TS1::PAN4802::lacZ ::TtrpC ::argB ::TS2 This study
pProm5 TS1::PAN4803::lacZ ::TtrpC ::argB ::TS2 This study
pProm6 TS1::PAN5997::lacZ ::TtrpC ::argB ::TS2 This study
pProm7 TS1::PAN6082::lacZ ::TtrpC ::argB ::TS2 This study
pProm8 TS1::PAN7354::lacZ ::TtrpC ::argB ::TS2 This study
pProm9 TS1::PAN8704::lacZ ::TtrpC ::argB ::TS2 This study
pProm10 TS1::PAN8856::lacZ ::TtrpC ::argB ::TS2 This study
pProm11 TS1::PAN10130::lacZ ::TtrpC ::argB ::TS2 This study
pDH56 TS1::PgpdA::UEC::ccdB ::cmR::UEC::lacZ ::TtrpC ::argB ::TS2 This study
pDH57 TS1::PgpdA::UEC::ccdB ::cmR::UEC::lacZ ::TtrpC ::argB ::TS2 This study
pDH58 TS1::PalcA::UEC::ccdB ::cmR::UEC::lacZ ::TtrpC ::argB ::TS2 This study
pDH59 TS1::PalcA::UEC::ccdB ::cmR::UEC::lacZ ::TtrpC ::argB ::TS2 This study
Continued on Next Page
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pDHU1 TS-NIG1A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::hph* ::TS-NIG1B This study
pDHU2 TS-NIG2A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::hph* ::TS-NIG2B This study
pDHU2002 TS-NIG2A::PgpdA0.5kb::rfp::TtrpC ::hph* ::TS-NIG2B This study
pDHU3 TS-NIG3A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::hph* ::TS-NIG3B This study
pDHU3000 TS-NIG3A::PgpdA0.5kb::lacZ ::TtrpC ::hph* ::TS-NIG3B This study
pDHU4 TS-NIG4A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::hph* ::TS-NIG4B This study
pDHU4000 TS-NIG4A::PgpdA0.5kb::lacZ ::TtrpC ::hph* ::TS-NIG4B This study
pDHA3 TS3A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::argB ::TS3B This study
pDHP3 TS3A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::pyrG ::TS3B This study
pDHP3000 TS3A::PgpdA0.5kb::lacZ ::TtrpC ::pyrG ::TS3B This study
pDHP3001 TS3A::PgpdA0.5kb::wA::TtrpC ::pyrG ::TS3B This study
pDHD3 TS3A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::DR-pyrG-DR::TS3B This study
pDHA4 TS4A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::argB ::TS4B This study
pDHP4 TS4A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::pyrG ::TS4B This study
pDHP4000 TS4A::PgpdA0.5kb::lacZ ::TtrpC ::pyrG ::TS4B This study
pDHP4001 TS4A::PgpdA0.5kb::wA::TtrpC ::pyrG ::TS4B This study
pDHD4 TS4A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::DR-pyrG-DR::TS4B This study
pDHA5 TS5A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::argB ::TS5B This study
pDHP5 TS5A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::pyrG ::TS5B This study
pDHP5000 TS5A::PgpdA0.5kb::lacZ ::TtrpC ::pyrG ::TS5B This study
pDHP5001 TS5A::PgpdA0.5kb::wA::TtrpC ::pyrG ::TS5B This study
pDHD5 TS5A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::DR-pyrG-DR::TS5B This study
pDHA6 TS6A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::argB ::TS6B This study
pDHP6 TS6A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::pyrG ::TS6B This study
pDHP6000 TS6A::PgpdA0.5kb::lacZ ::TtrpC ::pyrG ::TS6B This study
pDHP6001 TS6A::PgpdA0.5kb::wA::TtrpC ::pyrG ::TS6B This study
pDHD6 TS6A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::DR-pyrG-DR::TS6B This study
pDHA7 TS7A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::argB ::TS7B This study
pDHP7 TS7A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::pyrG ::TS7B This study
pDHP7000 TS7A::PgpdA0.5kb::lacZ ::TtrpC ::pyrG ::TS7B This study
pDHP7001 TS7A::PgpdA0.5kb::wA::TtrpC ::pyrG ::TS7B This study
pDHD7 TS7A::PgpdA0.5kb::UEC::ccdB ::cmR::UEC::TtrpC ::DR-pyrG-DR::TS7B This study
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Chapter 4
A genome-wide polyketide synthase
deletion library uncovers novel genetic
links to polyketides and meroterpenoids
in Aspergillus nidulans
This chapter contains the paper A genome-wide polyketide synthase deletion library uncovers novel genetic
links to polyketides and meroterpenoids in Aspergillus nidulans, published in FEMS Microbiology Letters,
of which I am a co-author.
In this study we have individually deleted all putative polyketide synthases in A. nidulans and analyzed
the metabolite proﬁles of the resulting strains. This resulted in identiﬁcation of the polyketide synthase
responsible for producing 3,5-dimethylorsellinic acid (DMOA) which proved to be the precursor to meroter-
penoids austinol and dehydroaustinol. After publication of this paper, the complete biosynthesis towards
these meroterpenoids was reported in detail by Itoh et al. [2012], Lo et al. [2012], and Matsuda et al. [2013].
My contribution to this study comprises over-expression of ausA, site-directed mutagenesis in ausA,
preparation of large metabolite extract from IS1 -ausA, and subsequent isolation and puriﬁcation of 3,5-
dimethylorsellinic acid. Supporting information is included in Appendix A.
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Abstract
Fungi possess an advanced secondary metabolism that is regulated and coordi-
nated in a complex manner depending on environmental challenges. To under-
stand this complexity, a holistic approach is necessary. We initiated such an
analysis in the important model fungus Aspergillus nidulans by systematically
deleting all 32 individual genes encoding polyketide synthases. Wild-type and all
mutant strains were challenged on different complex media to provoke induction
of the secondary metabolism. Screening of the mutant library revealed direct
genetic links to two austinol meroterpenoids and expanded the current under-
standing of the biosynthetic pathways leading to arugosins and violaceols. We
expect that the library will be an important resource towards a systemic under-
standing of polyketide production in A. nidulans.
Introduction
It is well known that filamentous fungi produce a large
number of bioactive secondary metabolites (Be´rdy, 2005;
Cox, 2007; Newman & Cragg, 2007). Polyketide (PK)
compounds constitute a major part of these metabolites
and have long been recognized as a valuable source of
diverse natural compounds of medical importance, for
example lovastatin (cholesterol lowering) (Lai et al., 2005),
griseofulvin (antibiotic) (Chooi et al., 2010) and myco-
phenolic acid (immunosuppressant) (Bentley, 2000). How-
ever, polyketides also include many toxic compounds that
pose a serious threat to human health, for example patulin,
ochratoxins, fumonisins and aflatoxin (Frisvad et al., 2004;
Ma˚nsson et al., 2010). Polyketides are biosynthesized by
large multidomain polyketide synthases (PKSs), which be-
sides acyl transferase, b-ketoacyl synthase and acyl carrier
domains may also contain keto reductase, dehydratase,
cyclization and methyl-transferase domains (Cox, 2007;
Smith & Tsai, 2007; Hertweck, 2009). In fungi, the different
catalytic activities often work in an iterative manner (fungal
type I) and it is generally difficult to predict the exact
product formed by a given PKS from its sequence alone
(Keller et al., 2005). Product prediction is further compli-
cated by the fact that the resulting polyketide structure may
be decorated by tailoring enzymes. Such genes are often
physically associated with the PKS gene in a gene cluster
allowing for coordinated regulation (Schu¨mann & Hert-
weck, 2006). The fact that natural products may be of mixed
biosynthetic origin, combining elements such as polyketides
with terpenes (meroterpenoids) and/or nonribosomal pep-
tide units, adds to the complexity (Chang et al., 2009; Geris
& Simpson, 2009; Hertweck, 2009; Scherlach et al., 2010).
As a consequence of their bioactivity, societal importance
and also the prospect of reprogramming the biosynthetic
machinery for drug development (Cox, 2007), there is
tremendous interest in the discovery and understanding of
fungal polyketide biosynthesis. The availability of full gen-
ome sequences of a number of filamentous fungi has
provided a means to address the discovery of polyketides
because the PKS genes are large and contain several con-
served protein domains. Importantly, analysis of the
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genomic sequences from filamentous fungi (including Asper-
gillus nidulans, teleomorph, Emericella nidulans) predict num-
bers of individual PKS genes that exceeds significantly the
number of polyketides that these fungi are known to produce
(Galagan et al., 2005). In fact, the genome of A. nidulans
(Galagan et al., 2005) appears to contain as many as 32
individual PKS genes (Nierman et al., 2005; Szewczyk et al.,
2008; von Do¨hren, 2009), but until now only nine genes have
been linked to eight polyketides (Yamazaki & Maebayas, 1982;
Bergmann et al., 2007; Chiang et al., 2008; Szewczyk et al.,
2008; Bok et al., 2009; Chiang et al., 2009; Schroeckh et al.,
2009) (see Supporting Information, Fig. S1). This may reflect
that many polyketides are either produced in small amounts,
under special conditions, or in developmental stages that are
rarely observed under laboratory conditions.
Towards a more complete genetic mapping of the second-
ary metabolism in A. nidulans, we first cultivated a reference
strain on an array of different growth media to uncover
polyketides that were not previously linked to a gene cluster.
This analysis revealed several compounds, including austinols,
violaceols, arugosins and prenylated xanthones. Next, genetic
links to these compounds were established by constructing
and screening an A. nidulans mutant library containing
individual deletions of 32 putative PKS genes.
Materials and methods
Strains
The A. nidulans strain IBT29539 (argB2, pyrG89, veA1,
nkuAD) (Nielsen et al., 2008) was used as the reference
strain and for deletion-strain constructions. Escherichia coli
strain DH5a was used for cloning.
Media
Fungal minimal medium (MM) was as described in Cove
(1966), but with 1% glucose, 10mM NaNO3 and 2% agar.
Medium for alcA promoter induction consisted of MM
supplemented with 100mM L-threonine and 100mM glycerol
as carbon source instead of 1% glucose. Polyketide screening
media variants CYA, CYAs, YES and RTwere prepared as per
Frisvad & Samson (2004). CY20 medium consisted of CYA
with 170 g sucrose; RTO contained RT with 30g organic oat
meal; and YE was made as YES but without sucrose. All media
variants were supplemented with 10mM uridine, 10mM
uracil and/or 4mM L-arginine where appropriate.
Construction of A. nidulans gene deletion
library
Individual PKS gene deletions were carried out as described
previously (Nielsen et al., 2006), except that the targeting
fragments were assembled using Gateway technology (Hartley
et al., 2000) (see Table S1 for PCR oligonucleotide and
Fig. S2 for an overview of the procedure). The A. nidulans
transformants were streak purified and rigorously screened
through three complementing diagnostic PCRs. Subse-
quently, the Aspergillus fumigatus pyrG marker was elimi-
nated from all strains by selecting on 5-fluoroorotic acid
medium before final verification by two additional comple-
menting diagnostic PCRs (see Fig. S3 and Table S2). All
strains have been deposited in the IBT strain collection,
DTU, (http://www.fbd.dtu.dk/straincollection/).
Construction of the ausA-S1660A strain
The amino acid substitution of serine to alanine, S1660A, in
ausA (AN8383) was created by USER fusion (Geu-Flores
et al., 2007) according to the method described by Hansen
et al. (2011). The allele was transferred to IBT29539 and the
pyrGmarker was eliminated by direct repeat recombination,
creating strain IBT31032 containing only the desired point
mutation. The strain was verified to contain the ausA-
S1660A allele by sequencing (StarSEQ, Germany). See Table
S3 for primer details.
Ectopic integration of ausA into IS1
The gene, ausA, was PCR amplified by USER fusion (Geu-
Flores et al., 2007) and inserted into both pU1111-1 and
pU1211-1 (Hansen et al., 2011) creating pDH23 (gpdA
promoter) and pDH24 (alcA promoter), respectively. For both
plasmids, the gene-targeting substrate was excised by NotI
digestion and transformed into IBT28738 using A. nidulans
argB as a selectable marker. Transformants were streak purified
and verified for correct integration into the IS1 site (Hansen
et al., 2011) by two complementing diagnostic PCRs.
Chemical analysis of the mutants
Strains were inoculated as three point stabs on solid media
and incubated for 7 days at 37 1C in the dark. Metabolite
extraction was performed according to the micro extraction
procedure (Smedsgaard, 1997). Extracts were analyzed by two
methods: (1) Ultra-high performance liquid chromatography-
diode array detection (UHPLC-DAD) analyses using a Dionex
RSLC Ultimate 3000 (Dionex, Sunnyvale, CA) equipped with
a diode-array detector. Separation of 1mL extract was obtained
on a Kinetex C18 column (150 2.1mm, 2.6mm; Phenomen-
ex, Torrence, CA) at 60 1C using a linear water–acetonitrile
gradient starting from 15% CH3CN to 100% (50ppm
trifluoroacetic acid) over 7min at a flow rate of 0.8mLmin1.
(2) Exact mass, HPLC-DAD-HRMS, was performed on a
5 cm 3mm, Luna C18(2) column (Phenomenex) using a
water–acetonitrile gradient from 15% CH3CN to 100% over
20min (20mM formic acid). LC-DAD-MS analysis was
performed on a LCT oaTOF mass spectrometer (Micromass,
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Manchester, UK) as in Nielsen & Smedsgaard (2003) and
Nielsen et al. (2009).
Isolation and structure elucidation of secondary
metabolites
3,5-Dimethylorsellinic acid and dehydroaustinol were pur-
ified from large-scale ethyl acetate extracts prepared from
100 MM agar plates after 4 days’ cultivation in darkness at
37 1C. The compounds were purified using a 10 250mm
Phenomenex pentafluorophenyl column (5mm particles)
with a water–acetonitrile gradient from 15% to 100%
CH3CN in 20min using a flow of 5mLmin
1. Arugosin A
was isolated from an ethyl acetate extract of the reference
strain grown on 200 CYAs agar plates using a Waters
19 300mm C18 Delta Pak column (15 mm particles),
gradient from 80% to 90% CH3CN in 10min, and a flow of
30mLmin1. The NMR spectra were acquired on a Varian
Unity Inova 500MHz spectrometer using standard pulse
sequences. Additional details about the compound identifi-
cation can be found in the supporting information.
Results and discussion
Selecting media that support secondary
metabolite production in A. nidulans
The principle of using different media and/or incubation
conditions for fungal secondary metabolite production has
often been promoted (Oxford et al., 1935; Davis et al., 1966;
Pitt et al., 1983; Bode et al., 2002; Scherlach & Hertweck,
2006). Based on our previous experiences (Frisvad, 1981;
Frisvad & Filtenborg, 1983; Filtenborg et al., 1990; Frisvad
et al., 2007), eight different media, CYA, CYAs, CY20, MM,
RT, RTO, YE and YES, were initially selected for the analysis
(Fig. 1a). HPLC analyses revealed a large number of different
secondary metabolites produced by the A. nidulans reference
strain on CYA, CYAs, CY20, RT, RTO and YES (Fig. 1b) and
these metabolites served as a source for further investigation.
Fig. 1. (a) The appearance of the Aspergillus nidulans reference strain, IBT29539, cultivated on different media. (b) UV-chromatograms (210 nm) of
extracts of the reference strain provides an excellent demonstration of the profound effect different media compositions have on production of
secondary metabolites. From the bottom: minimal media (MM), yeast extract (YE), Raulin-Thom oatmeal (RTO), yeast extract sucrose (YES), Czapek
yeast salt (CY20), Raulin-Thom (RT), Czapek yeast agar salt (CYAs), and Czapek yeast agar (CYA). The metabolite profiles on MM and YE media were
considered to be redundant and these two media were therefore not used for further screening. Numbers above peaks correspond to compound
identity as follows: monodictyphenone (1), orsellinic acid (2), sterigmatocystin (4), arugosin A (5), arugosin H (6), 2-o-dihydroxyemodin (7), o-
hydroxyemodin (8), emodin (9), emericellin (10), shamixanthone (11), epi-shamixanthone (12), violaceol I (13), violaceol II (14), lecanoric acid (15),
F9775A (16), F9775B (17), austinol (18) and dehydroaustinol (19).
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Construction and initial characterization of a
genome-wide PKS gene deletion library
To investigate whether any of the compounds observed in
Fig. 1 could be genetically linked to a PKS gene, we decided
to take a global approach and individually deleted all 32
(putative and known) PKS genes in the A. nidulans genome
(see Fig. S4), as defined from the annotation of the genome
databases at the Broad Institute of Harvard and MITand the
Aspergillus Genome Database at Stanford (Arnaud et al.,
2010). All genes were individually deleted by replacing the
entire ORFs using gene-targeting substrates based on the pyrG
marker from A. fumigatus for selection. Before analyzing the
deletion mutant strains, the pyrGmarker was excised by direct
repeat recombination (Nielsen et al., 2006) in each case. This
was carried out to ensure that the analyses of individual
mutant strains were comparable to and not influenced by
differences in the primary metabolism due to gene cluster-
specific expression levels of the pyrG marker. All 32 deletion
mutant strains (see Table S4) were viable and able to sporulate,
showing that none of the 32 genes are essential for growth and
that no polyketide product is essential for conidiation. As
expected, the one strain carrying the wAD mutation formed
white conidiospores as it fails to produce the naphthopyrone,
YWA1, the precursor of green conidial pigment (Watanabe,
1998; Watanabe et al., 1999).
In addition to wA, eight additional PKS genes have
previously been linked to metabolites. In our analysis, key
compounds representing four of these gene clusters could be
detected: monodictyphenone (1) (observed on RTO, YES
and CY20), orsellinic acid (2) (observed on YES, CY20, RT,
CYAs and CYA), emericellamide (A) (3) (observed on all
media) and sterigmatocystin (4) (observed on RTO, CYAs
and CYA). To verify the previously published gene links to
these compounds, we individually compared the metabolic
profiles of the reference strain to the corresponding profiles
obtained with the single PKS gene deletion mutant strains.
In agreement with previous analyses, these four compounds
Fig. 2. The late portion of the UV-chromatogram (210 nm) of the
Aspergillus nidulans reference strain and mdpGD on RTO medium. The
deletion abolishes formation of arugosin A (5), arugosin H (6), emericellin
(10), shamixanthone (11) and epi-shamixanthone (12) and a few
unidentified peaks.
Fig. 3. Proposed biosynthetic route of the
arogusins and shamixanthones. As seen in Fig. 2,
arugosin A is produced in large amounts relative
to the expected end products: emericellin (10)
and shamixanthones (11 and 12). DMAPP,
dimethylallylpyrophosphate. MdpG and XptA
are enzymatic activities as proposed by Sanchez
et al. (2011).
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disappeared in mdpG (Bok et al., 2009), orsA (Schroeckh
et al., 2009), easB (Chiang et al., 2008) and stcA (Yu &
Leonard, 1995) deletion strains of our library (Fig. S5).
Compounds resulting from the remaining four PKS genes
were identified by activating the gene clusters by controlled
expression of the transcription factor gene in the cluster
(Bergmann et al., 2007; Chiang et al., 2009) or by deleting
sumO that influences regulation of biological processes at
many different levels (Szewczyk et al., 2008). Expression
from these clusters is apparently not triggered by growth on
any of our media, and natural conditions provoking their
activation remain to be discovered.
Next, we performed a comparison of the metabolite
profiles from the 32 deletion mutants with those obtained
with the reference strain with the aim of uncovering novel
genetic links between PKS genes and polyketides. The most
significant changes are described below.
mdpG is involved in the biosynthesis of
arugosins
First we focused our attention on the most prominent
compound produced on RTO, YES, CY20 and RT media,
which eluted as a broad peak around 7.2min. This compound
completely disappeared in the mdpGD strain (Fig. 2 and
Fig. S6). Moreover, it had a characteristic UV spectrum in
the UHPLC analysis indicating an arugosin-like metabolite.
MS analysis indicated the compound to be arugosin A
(m/z 425 a.m.u. for [M1H]1), which to our knowledge has
not been reported before from A. nidulans. We therefore
decided to confirm the structure of this compound (5). A
large-scale extraction was performed and the metabolite was
purified. The NMR data in dimethyl sulfoxide are in agree-
ment with the literature (Kawahara et al., 1988) for the
hemiacetal form of arugosin A except that the equilibrium
was shifted completely to the open form (Fig. 3). In methanol,
the NMR data showed that the compound exists in equili-
brium between the closed and open ring form (data not
shown), explaining the broad peak observed in Fig. 2. Aminor
peak could be assigned as a mono-prenylated arugosin as
[M1H]1 at m/z 357 a.m.u. The MS data of this compound
did not indicate loss of a prenyl moiety, suggesting that it is
arugosin H (6), a likely immediate precursor of arugosin A
(Fig. 3). Hence, our data show thatmdpG, which is known for
its role in formation of monodictyphenone, is also involved in
formation of arugosins.
It is not unusual that one PKS gene cluster is responsible
for the biosynthesis of a family of structurally similar
compounds (Walsch, 2002; Kroken et al., 2003; Frisvad
et al., 2004; Amoutzias et al., 2008). In the original analysis
of themdpG gene cluster, it was activated due to remodeling
of the chromatin landscape, which occurs in a cclA deletion
strain (Chiang et al., 2010). That study genetically linked the
mdpG gene cluster to eight emodin analogues, including
several aminated species, which were detected and tenta-
tively identified. In our analyses, we also detected several
emodins including 2-o-dihydroxyemodin (7), o-hydroxye-
modin (8) and emodin (9), as well as the more apolar
compounds emericellin (10), shamixanthone (11) and epi-
shamixanthone (12) (Fig. 1 and Fig. S7). Like in the original
study, all emodins disappear in our mpdGD strain.
Recently, it was demonstrated that the polyketide part of
prenylated xanthones also could be coupled to mpdG
(Sanchez et al., 2011). Our finding that mpdG is involved in
formation of arugosins indicates that these compounds
serve as intermediates in the conversion of monodictyphe-
none into xanthones, Fig. 3. In agreement with this,
previous studies have reported arugosins to be precursors
for emericellin (10) and shamixanthones (11) and (12)
(Ahmed et al., 1992; Kralj et al., 2006; Ma´rquez-Ferna´ndez
et al., 2007), but have not established a genetic link tompdG.
AN7903 and orsA are involved in violaceol
production
Our reference strain produces the antibiotic violaceol I (13)
and II (14), in significant amounts (Fig. 4 and Fig. S8).
These two diphenyl ethers have been identified in Emericella
min6.00 8.00
Reference
orsAΔ
AN7903Δ
Violaceol II, I stdReference
AN7903Δ
2.50 5.00
Reference
(a) (b)
(c) (d)
AN7903Δ
min 5.00 7.50 min
Reference
AN7903Δ
8.00 10.00min
2
15
16
14
17
13
orsAΔorsAΔ
orsAΔ
Fig. 4. Extracted ion chromatograms of metabolic extracts from the
reference strain and the two mutants orsAD and AN7903D after
cultivation on YES medium. Compounds shown are (a) m/z 167 [M-H],
orsellinic acid (2), (b) m/z 397 [M1H]1, F9775A and B (16 and 17,
respectively), (c) m/z 317 [M-H], lecanoric acid (15) and (d) m/z 261 [M-
H], violaceol I and II (13 and 14). An extracted ion chromatogram of a
violaceol I and II in house standard is included in (d).
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violacea, Aspergillus sydowi and Aspergillus funiculosus
(Taniguchi et al., 1978; Yamazaki & Maebayas, 1982) and
recently also in A. nidulans (Nahlik et al., 2010). Our
analysis now links the biosynthesis of the two violaceols to
orsA as they disappear in our orsAD strain. It has previously
been shown that orsA (AN7909) is involved in the formation
of orsellinic acid (2), lecanoric acid (15), the two colored
compounds F-9775A (16) and F-9775B (17), orcinol, dior-
cinol, gerfeldin and deoxy-gerfeldin. (Schroeckh et al., 2009;
Sanchez et al., 2010). Our analysis confirms the link between
orsellinic acid, lecanoric acid, diorcinol, F-9775A, F-9775B
to orsA as these compounds are missing in the orsAD strain.
However, we have not been able to detect the gerfeldins in
any of our strains, and apparently our conditions favor
violaceol and not gerfeldin formation.
The violaceols are formed by dimerization of two C7
monomers of 5-methylbenzene-1,2,3-triol, a compound
that we could tentatively detect as [M-H] at m/z 139 in
cultivation extracts. The C7 backbone of 5-methylbenzene-
1,2,3-triol, may conceivably be formed by decarboxylation
of a C8 aldol intermediate as suggested by Turner 40 years
ago (Turner, 1971) (Fig. 5). This C8 intermediate also serves
as a branch point towards orsellinic acid.
Interestingly, the same compounds that disappear in the
orsAD strain also disappear in AN7903D, a strain missing a
PKS gene separated from orsA by only 20 kb (Fig. 4). This
result does not contradict the original assignment of orsA as
the PKS gene responsible for production of orsellinic acid.
Although the enzymes encoded by the two genes are
predicted to share many of the same functional domains,
AN7903 is larger by around 500 amino acid residues and
contains a methyl-transferase domain, which is not required
for orsellinic acid production. Moreover, we note that
Schroeckh et al. (2009) observed that both AN7903 and
orsA were upregulated when orsellinic acid was induced by
co-cultivation with Streptomyces hygroscopicus, indicating
cross-talk between the two clusters. Surprisingly, what
appear to be trace amounts of orsellinic acid can be detected
as m/z 167 [M-H] in both the AN7903D and the orsAD
strains (Fig. 4). The source of this residual orsellinic acid
remains elusive, but it could possibly stem from unmethy-
lated byproducts from the PKS, AN8383, that produces 3,5-
dimethylorsellinic acid, see below.
AN8383 is responsible for austinol and
dehydroaustinol biosynthesis
Interestingly, production of austinol (18) and dehydroaus-
tinol (19) was observed in the reference strain on several
media (Fig. 1). Despite the fact that the production of these
compounds is known from A. nidulans (Szewczyk et al.,
2008), they have not yet been assigned to a specific gene.
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Fig. 5. Proposed biosynthetic pathways related
to the orsA gene cluster. A common C8 aldol
intermediate, presented in the bracket, can by
loss of water and enolization lead to orsellinic
acid and by further esterification to lecanoric
acid, or be decarboxylated and further oxidized
to yield the C7 compound 5-methyl-benzene-
1,2,3-triol. This compound is the precursor of the
two diphenyl ethers violaceol I and II and the
pigments F-9775A and B.
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Only the AN8383D strain failed to produce the two austinols
on all the media, which triggered austinol production in the
reference strain (Fig. 6a). This, phenotype could be rescued
by inserting the structural gene of AN8383 under the control
of the gdpA promoter into an ectopic locus, IS1 (Hansen
et al., 2011) (Fig. 6a). Moreover, a point mutant strain
AN8383-S1660A also failed to produce austinols on these six
media (Fig. 6a). In this strain, the DSL motif of the AN8383
PKS has been mutated to DAL, preventing the phospho-
pantetheine moiety of coenzyme A to attach to the acyl
carrier protein domain of the PKS, thus disrupting polyke-
tide synthesis (Evans et al., 2008). The lack of austinols can
thus be linked directly to an AN8383-encoded function
rather than to silencing of another gene caused by chroma-
tin changes provoked by the AN8383 deletion.
To confirm the role of AN8383 in austinol production, we
constructed a new strain that expresses the AN8383 ORF
controlled by the inducible alcA promoter from the ectopic
locus, IS1 (Hansen et al., 2011). On inductive medium, the
subsequent LC-MS analysis showed a large novel peak
eluting at ca. 6min (see Fig. S9). The corresponding
compound was purified and the structure was elucidated
by NMR (Fig. S10), identifying 3,5-dimethylorsellinic acid
(20), which is in good agreement with the route of synthesis
previously proposed for austinol (Fig. 6b; Geris & Simpson,
2009). In a parallel analysis using a strain expressing
AN8383 under the control of the constitutive gpdA promo-
ter we obtained the same result (data not shown).
Together, the results strongly indicate that AN8383
encodes a PKS producing 3,5-dimethylorsellinic acid and
that this compound serves as the first intermediate in the
complex biosynthesis of austinol and dehydroaustinol that
also involves a yet unidentified prenyl transferase(s). Based
on these results, we have named the locus AN8383, ausA.
Concluding remarks
In the present study, we constructed a genome-wide PKS
deletion library, which we screened for effects on polyketide
production on a variety of media. This analysis has provided
novel links between PKS genes and polyketide products
demonstrating the strength of this approach. Many PKS
genes still remain to be functionally connected to products,
as many gene clusters have not yet been activated. As the
repertoire of tools and methods to induce gene expression is
rapidly increasing, new polyketide compounds will likely
soon be uncovered in A. nidulans. To this end, the genome-
wide PKS gene deletion library presented here will undoubt-
edly serve as a useful resource.
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Chapter 5
Genetics of Polyketide Metabolism in
Aspergillus nidulans
This chapter comprises the review Genetics of Polyketide Metabolism in Aspergillus nidulans, published in
Metabolites, of which I am a co-author. The present review describes the characterized genetics of polyketide
metabolism in A. nidulans until December 2011, and oﬀers an overview of polyketide biosyntheses in A.
nidulans. This review may be consulted during the following chapters for details.
My primary contribution to this review is the section on austinol and dehydroaustinol, which was linked
to the ausA gene in the study presented in Chapter 4. As this review was published prior to the studies
by Itoh et al. [2012], Lo et al. [2012] and Matsuda et al. [2013], the review does not contain details about
austinol and dehydroaustinol biosynthesis, and these will not be discussed in the present thesis.
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Abstract: Secondary metabolites are small molecules that show large structural diversity 
and a broad range of bioactivities. Some metabolites are attractive as drugs or pigments 
while others act as harmful mycotoxins. Filamentous fungi have the capacity to produce a 
wide array of secondary metabolites including polyketides. The majority of genes required 
for production of these metabolites are mostly organized in gene clusters, which often are 
silent or barely expressed under laboratory conditions, making discovery and analysis 
difficult. Fortunately, the genome sequences of several filamentous fungi are publicly 
available, greatly facilitating the establishment of links between genes and metabolites. 
This review covers the attempts being made to trigger the activation of polyketide 
metabolism in the fungal model organism Aspergillus nidulans. Moreover, it will provide 
an overview of the pathways where ten polyketide synthase genes have been coupled to 
polyketide products. Therefore, the proposed biosynthesis of the following metabolites will 
be presented; naphthopyrone, sterigmatocystin, aspyridones, emericellamides, asperthecin, 
asperfuranone, monodictyphenone/emodin, orsellinic acid, and the austinols. 
Keywords: secondary metabolites; polyketides; polyketide synthases; gene clusters; 
biosynthesis; Aspergillus nidulans 
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1. Introduction 
Aspergillus nidulans, teleomorph Emericella nidulans, is one of the most significant biological 
model systems in the fungal kingdom. This was pioneered by Pontecorvos’ [1] work in the middle of 
the last century, which demonstrated that A. nidulans, in addition to the asexual state, also proliferate 
via sexual and parasexual life cycles, hence, offering an ideal platform for genetic studies. Related 
species in the genus Aspergillus include important industrial cell factories, A. niger and A. oryzae, species 
that cause allergic diseases, A. clavatus, as well as opportunistic pathogens, such as A. fumigatus. 
A common feature of aspergilli and filamentous fungi in general is their capacity to produce 
secondary metabolites (SMs). As opposed to the primary metabolites, SMs are not essential for cellular 
growth, but provide fungi, as well as bacteria and plants, with a competitive advantage in nature,  
e.g., by serving as agents for chemical warfare or as signal molecules. Hence, an impressive range of 
compounds with broad ranging bioactivities has evolved. SMs can be divided into four main chemical 
classes: Polyketides (PK), terpenoids, shikimic acid derived compounds, and non-ribosomal peptides 
(NRP). Moreover, hybrid metabolites composed of moieties from different classes are common, as in 
the meroterpenoids, which are fusions between PKs and terpenes. Hybrid molecules significantly add 
to the complexity and variety of the fungal metabolomes. 
In addition to their likely important ecological roles in their natural biological niches, SMs also 
have a considerable impact on human life. For instance aflatoxins, ochratoxins, and fumonisins act as 
mycotoxins by having a detrimental effect on humans and livestock, whereas others are beneficial and 
serve as food additives, pigments, cholesterol-lowering drugs, immunosuppressants, antibiotics and 
anticancer agents. The different aspects of SM action and application have spurred a tremendous 
interest in fungal secondary metabolites, which is further underlined by the fact that around 63% of all 
small molecule drugs, which reached the market from 1981–2006 were inspired by natural products or 
derivatives thereof [2]. 
In filamentous fungi, the competitive race in SM development and the cost of producing and 
secreting complex compounds have resulted in the evolution of a multifaceted regulation of SM 
biosynthesis to avoid unnecessary use of resources. This hampers their discovery since production of 
most SMs is not induced under laboratory conditions. Analysis of full genome sequences of eight 
different aspergilli have demonstrated that for the majority of genes that putatively encode enzymes for 
SM production, the product is not known or detected. In this review, we will provide highlights of the 
use of genome mining, sophisticated molecular biological and chemical tools to trigger the production 
of SMs from cryptic gene clusters and discuss how these techniques have accelerated our 
understanding of PK production and regulation in A. nidulans. 
1.1. Polyketide Biosynthesis in A. nidulans 
PKs in fungi are synthesized by the use of acyl-CoA units. They act as the general substrates for 
large multi-domain enzymes named polyketide synthases (PKSs), which resemble eukaryotic fatty-acid 
synthases (FASs) in domain architecture. PKSs are divided into three types of PKSs based on their 
catalytic organization, however, only the iterative type I PKS (iPKS) has been reported in A. nidulans. 
The iPKS repeat the use of a single module containing several catalytic domains until the growing 
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chain of acyl-CoA units block further elongation. For descriptions of PKSs in general, excellent 
reviews by Crawford [3], Hertweck [4] and Cox [5] can be consulted. The most commonly encountered 
catalytic activities in fungal PKSs will be addressed as a general introduction to fungal PKSs in the 
following three paragraphs. 
Three fundamental domains are found in all iPKSs in A. nidulans like in filamentous fungi in 
general; β-ketosynthase (KS), acyltransferase (AT), and the acyl carrier protein (ACP). The KS 
catalyzes the C–C bond formation via decarboxylation reactions through Claisen condensations 
between thioesters. The ACP domain is responsible for transiently holding the growing acyl chain, hereby 
allowing the loading of malonyl extender units. The acyl groups are transferred from CoA by AT onto 
KS and ACP. The iterative use of the three domains results in a non-reduced PK, a β-keto thioester. 
Additional domains can be present in the PKS allowing the introduction of further chemical complexity. 
iPKSs in fungi can, based on their catalytic domains, be classified as non-reducing (NR-PKSs), 
partially reducing (PR-PKSs), or highly reducing (HR-PKSs) [6]. This is based on their ability to 
reduce the β-keto carbon. In PR- and HR-PKSs, reduction occurs through the β-ketoreductase (KR) 
domain that converts the β-ketone to a hydroxyl group. The resulting hydroxyl can go all the way to 
saturation by elimination of water through the dehydratase (DH) domain followed by hydrogenation by 
enoyl reductase (ER). In addition, reducing PKSs can also possess a methyltransferase domain (MT) 
responsible for C-methylation of the growing PK chain, using S-adenosylmethionine (SAM) as a 
carbon-donor. The degree of modifications and their position in the PK product is always the same for 
the individual PKSs. However, it is presently unknown how deployment of the various modifying 
domains is programmed into the PKS enzyme. 
NR-PKSs differ in domain architecture from reducing PKS by not having any of the reducing 
domains and by having an N-terminal starter unit-ACP transacylase (SAT) domain and an internal 
product template (PT) domain. The SAT domain is responsible for selecting the starter unit to be 
extended by the enzyme [7], while the PT domain is responsible for folding and cyclization of the  
non-reduced PK backbone [3,8]. The number of iterations within the PKS and thereby the display of 
functional groups and the size of the final product is likely determined by the size of the active site cavity in 
the iPKS [9]. Once the length of the final product has been achieved, the PK chain is released from the 
PKS, catalyzed by either a thioesterase (TE), a Claisen cyclase (CLC) domain if present, or by accessory 
enzymes. A more detailed discussion on PKS release mechanisms is reviewed by Du and Lou [10]. 
It should be noted that it currently is impossible to reliably predict the product of iPKSs based on 
their amino acid sequences and domain architecture. This is in part due to the inability to predict the 
number of iterations performed by the iPKS and in part due the lack of understanding of how 
deployment of tailoring domains in individual iterations are programmed into the enzyme. 
Interestingly, the PKS encoding gene tends to reside in clusters of genes coding for a broad range of 
enzymatic activities. The compound coming directly from the PKS rarely seem to be the final product 
in the biosynthesis, but usually undergoes further modifications by tailoring enzymes from small 
decorations to drastic and large intervention and couplings. 
Through inspection of the genome sequence (genome mining), the latest estimate of genes encoding 
PKSs in A. nidulans is 32 open reading frames (ORFs) [11] (Figure 1), indicating that the number of 
PK containing end products in A. nidulans should count at least 32 plus stable intermediates. The 
compounds detected under a given condition do not necessarily reflect the final outcome of a PK 
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pathway, since the presence of intermediates and shunt products depends on other downstream 
enzymes and regulation. 
Figure 1. An overview of the relative distribution of the 32 putative polyketide synthases 
(PKS) open reading frames (ORFs) on the eight chromosomes of A. nidulans. Green and 
red AN numbers represent assigned and unassigned PKS genes, respectively. Dark grey 
circles and ends symbolize centromeric and telomeric regions, respectively, and should not 
be considered to scale. 
 
At present, a total of nine PKS genes have been coupled to the polyketome (collection of PKs and 
their synthesis) in A. nidulans, and numerous endeavors are currently attempting to unveil the mechanisms 
of PK metabolism in this model fungus. The pathways described in this review will follow in 
chronological order with respect to the discovery from PK to genes. For each of the PK gene clusters 
that have been linked to products so far we will focus on the PK compounds, their discovery, genetics 
as well as their biosynthetic pathway: Naphthopyrone, sterigmatocystin, aspyridones, emericellamides, 
asperthecin, asperfuranone, monodictyphenone (emodin), orsellinic acid, and the austinols. 
2. Naphthopyrone 
Spores from A. nidulans are characterized by a dark grey-green macroscopic appearance. This is 
due to deposition of pigments in the conidial wall as shown by ultrastructure studies using transmission 
electron microscopy (TEM) [12]. The responsible pigment is based on the PK-naphthopyrone YWA1 
and the function of the pigment layer has been shown to include quenching of reactive oxygen species [13] 
and increased resistance to UV radiation [14]. The work on naphthopyrone synthesis in A. nidulans has 
paved the way for understanding iPKS domain structure. 
The study of conidial pigmentation in A. nidulans has been extremely valuable for genetic screens. 
The first pigment mutant recorded in literature was the spontaneous white alba (wa) strain reported by 
84
Metabolites 2012, 2              
 
 
104
Yuill in 1939 [15]. In addition to the white mutant class, yA− mutants producing yellow conidia were 
discovered. These available color variants served as easy recognizable markers (green, white, and 
yellow) that allowed the establishment of fundamental genetic tools in A. nidulans [1]. Interestingly, 
sexual crossing showed that the wA− mutation masked the effect of the yA− mutation (epistatic) [1,16]. 
Clutterbuck and co-workers [16] proposed that WA synthesized the yellow pigment that was observed 
in yA mutants and that the YA enzyme converted this compound into the green conidial pigment. In 
1967, Agnihotri and co-workers [17] found that the wild type strains if grown under copper limiting 
conditions could mimic the yellow phenotype of the yA− strain. yA (AN6635) and wA (AN8209) were 
isolated and mapped to loci, chromosome I and II respectively, by complementation of a cosmid based 
library in 1989 and 1990, respectively [18,19]. Later, cross-feeding experiments performed by 
Clutterbuck [16] revealed that the yA phenotype was caused by the lack of a copper dependent 
extracellular laccase (p-diphenol oxidase). The wA functionality in pigment formation was confirmed 
by gene-deletion studies [19]. The lack of clustering of the two A. nidulans conidial pigment genes 
also became evident by their different expression patterns and the finding that they are controlled by 
different regulatory systems [20,21]. The yA gene is expressed in phialide cells and primary sterigmata 
(metulae) [18], and controlled by BrlA and AbaA [21], while wA is expressed only in phialides [22] 
and controlled by WetA [20]. Interestingly, none of the genes are expressed in the conidia. 
Characterization of the WA PKS was accomplished by Northern blotting, which revealed that wA 
encoded a 7.5 kb large transcript [19], and sequencing of the locus [22]. Re-sequencing of the 3′ region in 
1998 led to a revised gene model of the PKS with the following domain structure KS-AT-ACP-CLC. 
This novel CLC domain [23] catalyzed release of the product and cyclization of the second aromatic 
ring of YWA1 via a Claisen condensation reaction [24]. 
Heterologous expression of wA in A. oryzae resulted in the production of the yellow compound, as 
observed in yA− mutants, which was identified to be the heptaketide naphthopyrone named YWA1 [25]. 
In 2002, wA was used for constructing a collection of chimeric PKSs (cPKS) by mixing its domains 
with those of Colletotrichum lagenarium pks1, known to produce the tetraketide 1,3,6,8-
tetrahydroxynaphthalene (T4HN). One of the resulting cPKSs, SW-B, produced several new 
compounds including both tetra- and pentaketides [26]. The results prompted a reanalysis of the two 
PKSs, which revealed the existence of two previously overlooked conserved domains; an N-terminal 
and a central domain. These domains were later identified as a SAT and PT domain, respectively, thus 
providing the full domain structure SAT-KS-AT-PT-ACP-CLC [3,7,8]. With the organization within 
WA in mind, the biosynthetic pathway can be envisioned as condensations of an acetyl-CoA with six 
malonyl-CoA units in six successive reactions resulting in the formation of YWA1 [25] (Figure 2). 
  
85
Metabolites 2012, 2              
 
 
105
Figure 2. Biosynthetic pathway for formation green conidial pigment in A. nidulans  
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YWA1 is then believed to be dimerized or polymerized by the YA laccase into the green conidial 
pigment(s) via phenolic oxidative coupling. However, to date no one has succeeded in characterizing 
the chemical structure of the green conidial pigmentation in detail. As the final product remains 
elusive, it is impossible to predict if other tailoring enzymes further modify the YWA1 backbone or 
reactions occur with other metabolites or cellular components, e.g., the cell wall. 
3. Sterigmatocystin 
Sterigmatocystin, a PK, was first partially purified from a Sterigmatocytis sp. in 1948 by Nekam 
and Polgar [27]. Hatsuda and co-workers [28,29] successfully isolated sterigmatocystin in 1954 from 
A. versicolor. The correct relative structure was determined in 1962 by Bullock et al. [30]. By 
performing degradative experiments it was shown that the stereochemistry of sterigmatocystin was the 
same as that of aflatoxin [31], which had the absolute stereochemistry determined in 1967 [32]. The 
absolute stereochemistry of sterigmatocystin was confirmed via crystallography [33,34]. 
The aflatoxins are among the most carcinogenic mycotoxins and the research in aflatoxin and 
sterigmatocystin intensified with the Turkey X disease caused by aflatoxins in the middle of the last 
century [35]. Aflatoxins are reported to be produced only by a few aspergilli. A. nidulans does not 
produce aflatoxins, as the biosynthesis stops at sterigmatocystin, a late, yet stable precursor of the 
pathway. Sterigmatocystin is a powerful mycotoxin, though it is estimated to be 150 times less 
carcinogenic than the most potent aflatoxin, B1 [36]. Fungi that are able to produce aflatoxins and/or 
sterigmatocystin are common contaminants of food, feed, and indoor environments and may be 
mammalian and plant pathogens [37,38]. Due to the high toxicity and prevalence of sterigmatocystin 
and aflatoxins, they are likely the most extensively studied examples of secondary metabolism in fungi 
both in terms of biosynthesis and biological function, and there are several excellent and 
comprehensive reviews for further reading on aflatoxin biosynthesis [39,40]. Studies on the 
biosynthesis of aflatoxin and sterigmatocystin have been carried out in several fungi (A. flavus,  
A. nidulans and A. parasiticus) and some of the assigned gene functions in A. nidulans are proposed 
based on gene homology to these two other species. 
The biosynthetic cluster of sterigmatocystin in A. nidulans was first characterized by Brown and  
co-workers in 1996 [41]. They identified a 60 kb region in the A. nidulans genome responsible for the 
synthesis of sterigmatocystin. The cluster contains 27 genes named stcA-X (Figure 3), reflecting their 
order of appearance on the chromosome [41]. 
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Figure 3. The sterigmatocystin gene cluster. The black arrows are predicted stc ORFs, 
while light grey arrows are genes with unassigned functions. 
 
The PKS catalyzing the production of the PK backbone of sterigmatocystin was identified by Yu and 
co-workers in 1995 [42] and originally named pksST, but was later renamed to stcA by Brown et al. [41] 
to simplify nomenclature. Besides the PKS, the stc gene cluster is predicted to contain two 
transcription factors (aflR, aflJ), six monoxygenases (stcB, stcC, stcF, stcL, stcM, stcS, stcW), two 
dehydrogenases (stcG, stcV), an esterase (stcI), an O-methyltransferase (stcP), two ketoreductases 
(stcE, stcU), a VERB synthase (stcN), an oxidase (stcO), a monooxydase/oxidase (stcQ), a Baeyer-
Villiger oxidase (stcR), a fatty acid synthase composed by the two subunits HexA and HexB (encoded 
by stcJ and stcK, respectively), and five unassigned genes (stcD, stcH, stcR, stcT, stcX), which may 
also be part of the cluster [39–41,43–47]. 
The stc cluster is a relatively large gene cluster, and studying the gene regulation has led to 
important discoveries. The two TFs were found to be present within the cluster. The AflR is a Zn2Cys6 
TF that regulates transcription of the stc locus in A. nidulans [41,48], while AflJ (also named AflS) 
have been shown to have a role in the regulation of aflatoxin biosynthesis in A. flavus and is likely to 
have a similar function in A. nidulans [49]. Interestingly, Bok and Keller [50] discovered a novel 
regulator (LaeA) of secondary metabolism in A. nidulans in a mutant screen for loss of aflR 
expression. Deletion of laeA resulted in a significantly decreased production of different classes of 
SMs like sterigmatocystin and penicillin. LaeA, a putative methyl transferase was moreover acting in a 
feedback loop with AflR since overexpression of aflR downregulates laeA expression, and 
overexpression of laeA could not increase production of sterigmatocystin [50]. LaeA was shown to be 
a part of the conserved Velvet complex, which is important for regulation of fungal development and 
secondary metabolism [51]. Another hint on chromatin regulated gene expression came from the 
deletion of a histone deacetylase, hdaAΔ, which led to significant increase in the expression of two stc 
cluster genes, stcU and aflR compared to the reference [52]. 
Applying this strategy of deleting and overexpressing genes encoding global epigenetic regulators 
has paved the way for novel discoveries in secondary metabolism. Moreover the alternative of utilizing 
a chemical epigenetic approach through epigenetic modifier molecules has proven successful in 
activating gene clusters in A. niger [53]. 
The first step in the biosynthesis of sterigmatocystin (Figure 4) is the production of hexanoate by 
the FAS units, StcJ and StcK [41]. Watanabe and Townsend [54] showed that the hexanoyl-CoA is not 
an intermediate freed from the complex, indicating that hexanoate is transferred directly to the SAT 
domain of the PKS. The PK backbone is assembled by StcA by condensation of the starter unit, 
hexanoyl-CoA and seven malonyl-CoA extender units followed by cyclization and release of 
norsolorinic acid anthrone [42]. The oxidation of norsolorinic acid anthrone to norsolorinic acid may 
be catalyzed by stcM, a monooxygenase ortholog to hypC that converts norsolorinic acid anthrone to 
norsolorinic acid in A. parasiticus [43]. Norsolorinic acid is the first stable intermediate in the 
biosynthesis of sterigmatocystin and is converted into averantin by StcE, reducing the hexanoate 
ketone to an alcohol [41,55,56]. 
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Figure 4. Proposed biosynthesis of sterigmatocystin. StcA contains starter unit-ACP 
transacylase (SAT), β-ketosynthase (KS), acyltransferase (AT), product template (PT), acyl 
carrier protein (ACP) and thioesterase/claisen cyclase (TE/CLC) domains. *Indicates a 
proposed, but not confirmed, enzyme. Multiple arrows indicate that the number of 
enzymatic steps is unknown. 
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Yabe et al. [55] showed that 5′-hydroxyaverantin is a step towards aflatoxin in A. parasiticus and a 
later study showed that the oxidation of averantin into 5′-hydroxyaverantin is catalyzed by StcF [57]. 
The conversion of 5′-hydroxyaverantin to 5′-oxyaverantin is likely catalyzed by StcG [39,44]. In a study in 
A. parasiticus by Yabe and co-workers it was shown that both (1′S, 5′S)- and (1′S, 5′R)-hydroxyaveratin are 
formed in the conversion of averatin to 5′-oxyaveratin [58]. Disruption of aflH in A. parasiticus 
resulted in the accumulation of 5′-hydroxyaverantin, however, small amounts of O-methylsterigmatocystin 
present suggested that other enzymes may be involved in the reaction [44,59]. The gene(s) responsible 
for the conversion of 5′-oxyaverantin to averufin have not been identified [39,60]. 
Individual disruption of StcB and StcW resulted in elimination of sterigmatocystin and 
accumulation of averufin, indicating that both enzymes catalyze the conversion of averufin to  
1-hydroxyversicolorone [57]. It was not possible for the authors to determine why two 
monooxygenases were required for this reaction step [57]. No gene products have been identified as 
being responsible for the conversion of 1-hydroxyversicolorone to versiconal hemiacetal acetate. StcI 
is thought to catalyze the reaction from 1-hydroxyversicolorone to versiconal based on studies of the 
ortholog AflJ in A. parasiticus, though other genes capable of this reaction may be present in  
A. nidulans [44,61]. 
Deletion of stcN did not result in the production of sterigmatocystin or other intermediates [44]. 
However, StcN show homology to AflK and the versicolorin B synthase, Vbs, in A. parasiticus, indicating 
that the biosynthetic step from versiconal to versicolorin B may be catalyzed by StcN [39,44,62]. StcL 
was shown by Kelkar et al. [63] to catalyze the conversion of versicolorin B to versicolorin A. 
Inactivation of stcL resulted in accumulation of dihydrosterigmatocystin, leading to a branching of the 
sterigmatocystin biosynthesis as seen in the aflatoxin biosynthesis. Addition of versicolorin A to the 
mutant gave production of sterigmatocystin, and that indicated that this enzyme functions before 
versicolorin A [63]. 
Keller and co-workers [64,65] showed that StcU and StcS are involved in the conversion of 
versicolorin A to demethylsterigmatocystin. Individual disruption of stcU and stcS led to the 
accumulation of versicolorin A and eliminated production of sterigmatocystin in A. nidulans [64,65]. 
Henry and Townsend [45] studied the same step in the aflatoxin biosynthesis in A. parasiticus and 
proposed an oxidation-reduction-oxidation mechanism, involving at least a ketoreductase AflM and a 
monooxygenase AflN, orthologs to stcU and stcS, respectively. Ehrlich et al. [46] and Cary et al. [47] 
identified two enzymes, AflY, a Baeyer-Villiger oxidase and AflX, an oxidoreductase, to be involved 
in the conversion of versicolorin A to demethylsterigmatocystin in A. parasiticus and A. flavus, 
respectively. aflX and aflY are homologous to stcQ and stcR, which suggests that these genes might be 
involved in the biosynthetic step from versicolorin A to demethylsterigmatocystin [46,47]. 
The final step in the biosynthesis of sterigmatocystin is the methylation of demethylsterigmatocystin 
catalyzed by StcP [66]. The conversion of sterigmatocystin to aflatoxin involves two additional 
biosynthetic steps; an O-methylation of sterigmatocystin by aflP followed by involvement of aflQ to 
produce aflatoxin [39]. Slot and Rokas have recently showed that the sterigmatocystin gene cluster in 
Podospora anserina was horizontally transferred from Aspergillus, which shows that transfer of large 
metabolite clusters between fungi are possible [67]. 
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4. Aspyridone 
Aspyridone is a PK-NRP hybrid and a fascinating example on how PK-NRP compounds in  
A. nidulans can be assembled from the activity of a single fusion enzyme. The aspyridones have shown 
to display moderate cytotoxicity [68]. The responsible gene cluster was discovered by Bergmann and 
co-workers [68] using a genome mining approach. Using the Aspergillus genome sequence, they 
identified a SM gene cluster, which contained a putative TF (AN8414/apdR) that the authors 
hypothesized could trigger activation of the genes in the cluster. Accordingly, the authors 
overexpressed the TF under the control of an inducible alcA promoter by integrating it randomly in the 
genome. In agreement with the hypothesis, it was demonstrated by Northern blot analysis that six of 
the nearest neighbor genes were up-regulated in this strain on inductive medium, and that the 
aspyridones and two intermediates or shunt products could also be detected. Prediction of the catalytic 
potential for the six upregulated genes (apdA, apdB, apdC, apdD, apdE, and apdG) combined with the 
structure of the accumulating compounds allowed the authors to propose a model for the biosynthesis 
of aspyridones including an assignment of the involved enzymes (Figure 5). 
Figure 5. Proposed biosynthesis of aspyridone A and B. (a) Based on proposed 
biosynthesis by [68,72,73]; (b) Based on results by Halo et al. [78] Multiple arrows 
indicate that the number of enzymatic steps is unknown.  
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apdA was deleted by Chiang et al. [69] and confirmed to be involved in aspyridone biosynthesis as 
reported by Bergmann et al. [68]. 
The structure of aspyridone A and B suggested that their synthesis involved both PKS and NRPS 
activity. Indeed, analysis of the AN8412 structure revealed domains characteristic for a HR-PKS as 
well as NRPS in one ORF spanning more than 11 kb. This is a special subclass of reducing PKSs, 
where the PKS has been directly fused with a single NRPS module at the C′-terminal end. This 
architecture allows for the incorporation of amino acids or carboxylic acids into the carboxylic end of 
the growing PK chain. Only one of these fusion enzymes has been found in A. nidulans, but has been 
reported in other fungi [70,71]. Since AN8412 is the first enzyme to act in the pathway, the gene was 
named apdA. ApdA catalyzes the assembly of the PK-amino acid backbone of the aspyridones by three 
Claisen condensations of malonyl-CoA, and KR-DH-ER-MT carries out full reduction of the β-keto 
and the methylations, which are required. However, as ApdA lacks a functional ER domain, the ER 
activity is most likely provided by ApdC, a homolog to an enoyl reductase (LovC) from the lovastatin 
biosynthetic gene cluster [68]. The resulting triketide is transferred to the NRPS module, where it is 
linked to tyrosine [68]. Bergmann and co-workers listed the domains through protein homology in the 
NRPS as condensation (C), adenylation (A), peptidyl carrier protein (PCP) and reductase domain 
(RED).The release of the PKS-NRPS hybrid product was proposed to be a NADPH-dependent 
reductive release followed by an intramolecular Knoevenagel condensation and enzymatic oxidation [68]. 
Biochemical studies of the role of ApdA and ApdC in the biosynthetic pathway of the aspyridones 
have been performed by Liu et al. [72] and Xu et al. [73]. Liu and co-workers [72] defined the NRPS 
module as C-A-T-R with the latter two being thiolation and reductase, which is an alternative to the 
more frequent C-A-T-TE found in these modules. However, this reductase domain (R*) in the NRPS 
module of ApdA is not the standard SDR superfamily dehydrogenase since tyrosine in the Ser-Tyr-Lys 
catalytic triad is mutated suggesting a redox-independent condensation reaction and the release of a 
tautomer of preaspyridone from ApdA by a Dieckmann cyclization, which was first shown by Halo 
and co-workers [74]. This result has been confirmed by Xu et al. who expressed the apdA and apdC 
genes in Saccharomyces cerevisiae and Escherichia coli, respectively [73]. The purified enzymes 
(ApdA and ApdC) were incubated in the presence of cofactors and building blocks and the 
predominant product was preaspyridone [73]. 
The formation of preaspyridone into aspyridone A and B was proposed by Bergmann et al. [68], 
(and outlined in Figure 5a) using the predicted functions of the remaining genes of the apd gene 
cluster. The proposed biosynthesis involved ApdB and ApdE which shows similarity to cytochrome 
P450 oxygenases and cytochrome P450 alkane hydroxylases, respectively, and were believed to 
catalyze the formation of hydroxypreaspyridone [68]. Based on the study of pyridone rearrangement in 
metabolites related to aspyridone it was suggested that ApdE or ApdB were involved in the pyridone 
rearrangement [68,75–77]. Moreover, aspyridone A was hypothesized to be converted into aspyridone 
B by ApdD, a putative FAD-dependent monooxygenase, which is related to other ring hydroxylases [68]. 
Aspyridone has a similar structure to other pyridines isolated from fungi, e.g., tenellin whose 
biosynthetic gene cluster also has been identified [75,76]. The proposed biosynthesis of aspyridone 
was, as described above, based on predicted gene functions and not isolated intermediates. However, a 
study on the biosynthesis of the related metabolite tenellin by Halo and co-workers [78] showed that 
the suggested biosynthesis may be incorrect and an alternative biosynthesis was suggested (as shown 
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in Figure 5b). In this biosynthesis preaspyridone is not converted into hydroxyaspyridone but ring 
expanded by ApdE to aspyridone A similar to the biosynthesis of tenellin [78]. Halo et al. also showed that 
the hydroxylated metabolite of pretenellin is a shunt metabolite as it could not be converted into tenellin. 
5. Emericellamides 
The emericellamides are other examples of hybrid compounds that are formed between PKs and 
NRPs. In this case the biosynthesis requires a PKS and a NRPS rather than a fusion PKS-NRPS as 
used in the production of the aspyridones. Emericellamides are cyclic depsipeptides and a total of five 
variants, A, C–F, of these metabolites have been found in A. nidulans. Initially, emericellamide A and 
B were isolated and described from an unidentified marine-derived Emericella strain in a screen due to 
their antibacterial activity against methicillin-resistant Staphylococcus aureus [79]. 
In order to discover novel natural products, Chiang and co-workers [69] searched the genome 
sequence of A. nidulans for NRPS gene candidates. Subsequently, six of these genes were randomly 
chosen and deleted by gene targeting. One of the resulting mutants, AN2545Δ, showed a metabolite 
profile where emericellamide A was missing. Furthermore, HPLC profiles and dereplication using 
mass spectrometry and database searches revealed four additional compounds, which disappeared in 
the mutant metabolite profile. Since these compounds had not previously been described in  
A. nidulans, they were purified and their structures solved by NMR analysis revealing that they were 
novel analogues of emericellamide A and B, thus named emericellamide C–F [69]. 
To investigate whether AN2545, now called easA, defines a gene cluster encoding all necessary 
enzymatic activities in the emericellamide biosynthetic pathway, the genes from AN2542 to AN10325, 
a total of ten, were deleted [69]. Most of these gene deletions did not affect emericellamide production 
as judged by LC-MS analysis, demonstrating that they do not participate in the biosynthesis. However, 
the emericellamides were absent in four of the deletion strains, now named easA-easD, indicating that 
these genes are involved in the pathway. 
Bioinformatic analysis of the three additional genes suggested that they all encode activities that are 
relevant for emericellamide biosynthesis. Specifically, easB (AN2547), a PKS, easC (AN2548), an 
acyl transferase, and easD (AN2549), an acyl-CoA ligase. Based on these putative activities, the 
authors proposed a biosynthetic pathway for emericellamide production (Figure 6). In this model, the 
biosynthesis is initiated by EasB, a HR-PKS composed of the domains KS-AT-MT-DH-ER-KR-ACP. 
Since the PK component of the different emericellamide variants differ with respect to chain length 
and methylation pattern, it indicates that iterativity of this PKS is flexible [69]. 
Next, the PK carboxylic acid is converted to a CoA thioester by the acyl-CoA ligase, EasD, loaded 
onto the acyltransferase EasC, and then transferred to the thiolation (T) domain of EasA. This NRPS is 
a multi-modular enzymatic assembly containing 18 domains grouped into five modules. Among those, 
the authors propose that the first T domain is responsible for accepting the incoming PK from EasC 
(Figure 6). Moreover, the remaining domains fit well with the fact that five amino acids are 
incorporated into emericellamides. The authors note that this NRPS does not contain a TE domain at 
the end of module 5, indicating that this enzymatic activity is not necessary for cyclization of the 
emericellamides [69]. 
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Figure 6. Proposed biosynthesis of the emericallamides. The order of the 
methyltransferase (MT) and dehydratase (DH) domain as suggested by Chiang et al. [69], 
however a BLASTp analysis suggests a swapping of the MT and DH domains. The NRPS, 
EasA, contains 18 (T, E (epimerization), C, A) domains grouped into five modules. 
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6. Asperthecin 
Asperthecin is a PK compound that was first isolated from A. quadrilineatus by Howard and 
Raistrick in 1955 [80], however, the structure was not fully determined until six years later [81]. 
Initially, various chemical derivatizations and spectroscopic data determined a partial structure of 
asperthecin [80]. Neelakantan and co-workers [82] reduced the number of possible structures to two, 
and further derivatizations of asperthecin by Birkinshaw and Gourlay resulted in the final structure [81]. 
A. quadrilineatus is a member of the A. nidulans group, therefore Howard and Raistrick [80] extended 
the search of asperthecin to additional members of the A. nidulans group. No other was as rich in 
asperthecin production as A. quadrilineatus, yet small amounts of crystallized asperthecin could be 
obtained from cultures of A. nidulans and A. rugulosus indicating that production of asperthecin was 
possible in other aspergilli [80]. 
About 50 years later, Szewczyk and co-workers [83] used a molecular genetics approach to find the 
gene cluster responsible for the production of asperthecin in A. nidulans. Since many aspects of the 
regulation in the polyketome were unknown, the authors speculated whether sumoylation had an 
effect. SUMO is a small ubiquitin-like protein which is post-translationally added to proteins in the 
cell, as it plays a role in regulating transcription. A. nidulans contains one SUMO encoding gene, 
sumO [84], deletion of which led to a decrease in the production of SMs such as austinol, 
dehydroaustinol, and sterigmatocystin, and an increase in the production of a metabolite identified to 
be asperthecin, whereas the production of emericellamides were not affected [83]. Due to the aromatic 
structure of asperthecin, Szewczyk et al. [83] studied the domain prediction in 27 putative PKS-protein 
sequences using the A. nidulans genome sequence and available tools, in order to identify potential 
producers of non-reduced PKs. Ten NR-PKSs were identified and a deletion series of all NR-PKS 
genes was performed in the sumO∆ background [83]. While nine of the PKS-deletion strains still 
produced asperthecin, the AN6000 (aptA) PKS-deletion strain failed to synthesize asperthecin [83]. 
With the notion that most end compounds in PK biosynthesis are made by a clustered gene collective, 
six candidate genes surrounding aptA were picked in an attempt to identify the apt biosynthetic cluster. 
Two of these genes, aptB (AN6001) and aptC (AN6002), were found to be required for asperthecin 
production [83]. One strain (AN5999Δ) had a significantly lower production of asperthecin compared 
to the reference strain, but asperthecin was still present in the metabolite extracts, and as the strain 
showed poor growth, it was not included in the apt gene cluster. 
Interestingly, AptA was shown to have SAT-KS-AT-PT-ACP domains, but lack a TE/CLC  
domain [83,85–88]. Independent groups have used this case as a model system to study the mode of PK 
release, and two alternating mechanisms for the biosynthesis of asperthecin are shown in Figure 7 [86,87]. 
The first model suggests the formation of the PK backbone by condensations of one acetyl-CoA and 
seven malonyl-CoA units [86], with the β-lactamase AptB releasing the octaketide from AptA [83]. 
This assumption was based on a study by Awakawa and co-workers [85] in A. terreus, where there was 
a release of atrochrysone carboxylic acid from the atrochrysone carboxylic acid synthase (ACAS) 
lacking a TE/CLC domain, in the presence of the atrochrysone carboxylic ACP thioesterase (ACTE), a 
member of the β-lactamase superfamily [85]. The unstable atrochrysone carboxylic acid then 
undergoes a series of reactions; decarboxylation, dehydration, and various oxidations where the 
monooxygenase AptC is believed to be involved, and in the end yielding asperthecin [86]. 
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Figure 7. Proposed biosynthesis of asperthecin (a) As suggested by Chiang et al. [86];  
(b) Based on proposed biosynthesis by Li et al. [87]. AptA contains SAT, KS, AT, PT and 
ACP domains. Multiple arrows indicate that the number of enzymatic steps is unknown. 
 
In another approach, Li et al. [87] introduced aptA, aptB, and aptC into S. cerevisiae, which 
resulted in the production of a nonaketide (here called preasperthecin), and not the octaketide as 
proposed by Chiang et al. [86]. Expressing aptA and aptB without aptC resulted in a product identical 
to preasperthecin except for the lack of C2-OH, confirming that AptC is responsible for this step [87]. 
Expression of aptA and aptC alone did not lead to the production of preasperthecin or any other 
traceable compounds, confirming that AptB is needed for release of the PK from AptA [87]. These 
results were confirmed by an in vitro assay after expressing aptA, aptB and aptC in E. coli [87]. 
Further insight into AptA functionality came from expressing the AptA-PT domain in E. coli, and 
combining it with the Gibberella fujikuroi PKS4, which can produce nonaketide products in vitro [88]. 
The experiment revealed that AptA-PT can catalyze C6-C11 cyclization, and most likely also the  
C4-C13 cyclization. Further, a spontaneous C2-C15 cyclization was followed by a C1-C17 
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esterification [88]. The apt gene cluster appears likely to consist of additional genes, which are 
responsible for the conversion of preasperthecin into asperthecin. 
7. Asperfuranone 
Asperfuranone is an example of a novel PK metabolite discovered through genetic mining in  
A. nidulans, as this compound had not previously been reported in the literature before Chiang and  
co-workers [89] in 2009. Asperfuranone was later shown to possess bioactive properties as it inhibited 
proliferation of human non-small A549 cancer cells [90]. Investigating the loci containing putative 
PKS gene clusters, Chiang and co-workers [89] noticed that a NR-PKS gene (AN1034, afoE) and a 
HR-PKS gene (AN1036, afoG) were located close to each other on chromosome VIII. Since no 
products had ever been detected from activity of this locus, and due to the rare constellation of two 
neighbor PKSs, the authors speculated whether a novel metabolite could be revealed. A putative 
transcriptional activator (AN1029, afoA) was found near the PKS and the authors replaced the 
upstream sequence of afoA, estimated to be the native promoter, with the inducible alcA promoter [89]. 
This indeed turned on the expression of the cluster, since asperfuranone and a precursor metabolite 
were detected. The structure of asperfuranone was determined based on one- and two-dimensional 
NMR experiments and the absolute configuration by a modified Mosher’s method, whereas the 
precursor preasperfuranone had already been determined in the literature [89,91]. With these two 
compounds being identified, a gene-deletion strategy was performed to map the other genes assigned 
to the afo gene cluster, which involved twelve surrounding genes including the two PKSs [89]. Four 
deletion strains afoD∆, afoE∆, afoF∆, and afoG∆ fully eliminated asperfuranone production whereas 
afoB∆ and afoC∆ strongly reduced production of asperfuranone [82]. The deletions confirmed that 
both afoE and afoG were responsible for the production of asperfuranone, and that the deletion of 
afoD, encoding a putative hydroxylase, resulted in the production of preasperfuranone [89]. Deletion 
of afoB reduced the production of asperfuranone and due to a high homology to efflux pumps, Chiang 
and co-workers [89] suggested that it was responsible for the transport of asperfuranone out of the cell. 
With the gene cluster and predicted functionalities of the gene products defined, a biosynthetic 
pathway of asperfuranone was proposed (Figure 8) [89]. The assembly of the primary reduced 
tetraketide is synthesized by AfoG from one acetyl-CoA, three malonyl-CoA, and two SAM. The 
tetraketide is transferred to the SAT domain of AfoE and extended with four malonyl-CoA and one 
SAM [89]. The octaketide is released from AfoE after aldol condensation and reductive release from a 
C-terminal reductase (R) domain, which resembles a reductive release mechanism to generate the 
aldehydes described by Bailey et al. [92], forming the aldehyde preasperfuranone [89]. The 
biosynthetic steps from preasperfuranone to asperfuranone are uncharacterized and the suggestions are 
not based on identified metabolites [89]. Accumulation of preasperfuranone in the afoDΔ suggested 
AfoD to be the next enzyme in the biosynthesis of asperfuranone. The deletions of afoF, encoding a 
putative FAD/FMN-dependent oxygenase and afoC, initially believed to code for a homologue to 
citrinin biosynthesis oxidoreductase, did not reveal any intermediates, the order of reactions and the 
exact enzymatic functions for AfoF and AfoC have not been determined. In afoC∆, the production of 
asperfuranone was not fully eliminated, which Chiang and co-workers [89] suggested could be due to 
other enzymes catalyzing the reaction, however less efficiently. 
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Figure 8. Proposed biosynthesis of asperfuranone. The highly reducing (HR)-PKS, AfoG, 
contains KS, AT, DH, CM, ER, KR, and ACP domains whereas the NR-PKS, AfoE, 
contains SAT, KS, AT,PT, ACP, CM , and R domains. The only intermediate isolated in 
the biosynthesis is preasperfuranone [89]. Multiple arrows indicate that the number of 
enzymatic steps and reaction order is unknown.  
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Other puzzling discoveries have been made in connection to the asperfuranone production. When 
trying to activate a cryptic NRPS gene cluster containing two NRPSs, inpA (AN3495) and inpB 
(AN3496), by overexpression of a regulatory gene, scpR (AN3492), Bergmann et al. [93] also 
activated asperfuranone. This is an interesting example of a regulatory gene located on chromosome II 
that activates the afo cluster located on chromosome VIII [93]. Lui et al. [94] have attempted to 
engineer the production of a new metabolite by swapping the SAT domain of AfoE with the  
StcA-SAT. This led to the production of a new metabolite though having the same length as the native 
AfoE product, asperfuranone [94]. 
8. Monodictyphenone/Emodin 
The PK monodictyphenone was first reported in A. nidulans in 2005 [95] and the genes behind the 
production of monodictyphenone were mapped four years later [96]. This discovery not only enabled 
the establishment of a biosynthesis model for monodictyphenone in A. nidulans, it has subsequently 
revealed that more than ten different stable products among different classes of related polyketides can 
be linked to monodictyphenone biosynthesis [11,96–98]. These metabolites count monodictyphenone, 
emodin and the emodin derivates 2-hydroxyemodin, 2-aminoemodin, ω-hydroxy emodin, and emodic 
acid. Moreover, the arugosins and prenyl-xanthones are also coupled to the pathway [11,98]. The 
compound emodin has been studied for more than a century [99], and is an anthraquinone found in a 
wide array of both plants and fungi [100,101]. Emodin and several derivatives (e.g. emodic acid) have 
been shown to possess anti-bacterial and cancer preventive properties [102–106]. 
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The presence of the SM clusters in silent areas of chromosomes, e.g. near telomeres and 
centromeres, suggests that chromatin remodeling factors can influence the expression of genes 
responsible for SMs. As rationalized by Bok and co-workers [96], removal of histone-tail methylation 
could open heterochromatic regions for transcription. The authors deleted an ortholog, cclA, to the 
yeast BRE2 gene, encoding an enzyme partner of the COMPASS transcriptional regulator complex 
conserved in eukaryotes, which rendered A. nidulans defective in di- and trimethylation of lysine 4 of 
the histone 3 tails (H3K4). The cclA deletion was established in a mutant strain, stcJΔ, to avoid 
interference of high amounts of sterigmatocystin in purification of other metabolites. The effect was 
striking as the loss of CclA in HPLC analysis showed an altered chemical landscape compared to the 
stcJΔ reference [96]. 
As the compounds appearing were UV-active suggesting high conjugation likely due to aromaticity, 
the ten NR-PKSs investigated in the asperthecin and asperfuranone studies were individually deleted in 
the cclAΔ stcJΔ double deletion background. This screen revealed six products that all were linked to 
one PKS, AN0150 (mdpG) [96]. Delineation of the cluster was achieved by inspecting the genome 
sequence for possible cluster candidates followed by Northern blotting for gene-expression analysis in 
the cclAΔ stcJΔ, where the products were detected. The cluster was found to span 12 putative ORFs 
(AN10021-AN10023 (mdpA-L)) [97] of which two genes AN0147 (mdpD) and AN10035 (mdpI), did 
not show altered expression from the reference [96,97]. The mdp-cluster candidates were also deleted 
in the cclAΔ stcJΔ mutant strain to confirm the expression analysis data and to draw the borders of the 
cluster [97]. The authors suggest that two transcriptional activators are present within the cluster; 
MdpE as a main activator (homologue to AflR) and that MdpA is a co-activator. The mdp locus is 
located near the telomere of chromosome VIII, and activation of the genes in the cclAΔ strain supports 
the hypothesis of epigenetic regulation in these areas through chromatin remodeling [96]. 
Two groups cultivated A. nidulans on complex growth media, which revealed six additional 
metabolites. First Sanchez et al. [98] discovered that emericillin, variecoxanthone A, shamixanthone, 
and epi-shamixanthone were also products of the mdp cluster, and subsequently Nielsen and co-
workers [11] added arugosin A and H to the pathway. Since these PKs are prenylated, a BLAST search 
of the A. nidulans genome sequence was performed and pathway-candidate genes were deleted. Two 
prenyl transferases encoded by xptA and xptB, and one neighbor GMC oxidoreductase encoded by 
xptC, were found to be involved in the pathway, though they were located on other chromosomes than 
the mdp cluster (for cluster overview see Sanchez et al. [98]). This is an intriguing example of  
SM-cluster members located on more than one chromosome, however, prenyl transferases are known 
to have broad substrate specificity, and it is currently not known whether they are involved in other 
processes than prenyl-xanthone formation [98]. 
MdpG synthesizes the main PK backbone. Since MdpG lacks a CLC/TE domain, MdpF, a putative 
zinc dependent hydrolase, is believed to catalyze the release of the PK from MdpG [97]. The 
mechanism is believed to follow the case of ACAS and ACTE as introduced previously in the 
asperthecin section. Awakawa and co-workers [85] demonstrated that the direct product of the 
ACAS/ACTE is not emodin anthrone as proposed earlier [107,108], but more likely atrochrysone 
carboxylic acid (Figure 9). Atrochrysone carboxylic acid was not observed in vitro, instead the 
decarboxylated product atrochrysone was the major product in the assays and therefore proposed to be 
an intermediate to emodin, as suggested by Couch and Gautier [109]. Conversion of atrochrysone to 
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emodin requires dehydration (forming emodin anthrone) and a final oxidation (Figure 9), however, 
Awakawa and co-workers [85] observed small amounts of both emodin anthrone and emodin in vitro 
showing that these reactions may occur non-enzymatically. Based on these observations, Chiang and 
co-workers [97] proposed that mdpH encodes a decarboxylase, catalyzing the conversion of 
atrochrysone carboxylic acid to atrochrysone. The deletion of mpdH resulted in accumulation of a 
shunt product endocrocin produced via endocrocin anthrone. Enzymes responsible for dehydration of 
atrochrysone or modification of emodin into the observed derivatives have not yet been identified. 
Figure 9. Proposed biosynthesis of emodin. MdpG contains SAT, KS, AT, PT, and ACP domains. 
 
The first stable intermediate following emodin towards the prenyl-xanthones is monodictyphenone 
[97,98], and gene-deletion studies points to at least the five following enzymes are involved; a 
dehydratase (MdpB), a ketoreductase (MdpC), a glutathione S transferase (MdpJ), an oxidoreductase 
(MdpK), and a Baeyer-Villiger oxidase (MdpL) [97]. The mechanism has been proposed to be 
analogous to the conversion of versicolorin A to demethylsterigmatocystin which is known to proceed 
through oxidation-reduction-oxidation catalyzed by a cytochrome P450 monooxygenase (VerA) and a 
ketoreductase (StcU) [45,65,110]. However, none of the above mentioned Mdp enzymes appear to be 
homologous to VerA, and the role of the individual enzymes has not been investigated further [97]. 
The biosynthesis of the six monodictophenone derived metabolites is based on hydroxylation 
(MdpD), C-prenylation (XptA), O-prenylation (XptB), and carboxylic acid reduction (unidentified 
enzyme) [11,98]. Central in the pathway is the hydroxylation of C2 in monodictyphenone 
accompanied by reduction of the carboxylic acid. The carboxylic acid is suggested by Sanchez and co-
workers [98] to be reduced to a hydroxy group, the B-ring is closed by dehydration and the 
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intermediate is O-prenylated at C2 to yield variecoxanthone A, which in turn is C-prenylated to 
emericillin (Figure 10). The final known step in prenyl-xanthone biosynthesis gives rise to the 
stereoisomers shamixanthone and epishamixanthone and is catalyzed by XptC [98]. Alternatively, 
Nielsen and co-workers include synthesis of arugosins by partially reducing the carboxylic acid to an 
aldehyde, followed by C-prenylation, yielding arugosin H and O-prenylation to give arugosin A. 
Subsequent reduction of the aldehyde to a hydroxyl group, and ring closure by dehydration then gives 
emericillin and shamixanthones [11]. 
Figure 10. Suggested biosynthesis of the shamixanthons from emodin. Multiple arrows 
indicate that the number of enzymatic steps are unknown. 
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9. Orsellinic Acid 
In addition to the mdp cluster, the loss of CclA also led to the discovery of another gene cluster 
driven by an NR-PKS [96]. Two PK products, the cathepcin K inhibitors F-9775A and F-9775B, first 
isolated from Paecilomyces carneus [111], were detected and mapped to AN7909. Following this 
discovery, Schroeckh and co-workers [112] found the primary metabolite from AN7909 (orsA) to be 
orsellinic acid, an archetypal metabolite [113]. Moreover, the metabolite lecanoric acid typically found 
in lichens and produced by mycobiots such as Umbilicaria antarctica [114] was linked to OrsA [112]. 
Following the initial observations, the number of detected metabolites from the orsA gene cluster has 
expanded to gerfelin, a C10-deoxy-gerfelin, diorcinol, orcinol, cordyol C, and violaceol I and II [115,116]. 
The biosynthetic activities of the orsA cluster are as yet not elucitated, and this illustrates the need for 
applying different eloquent strategies to trigger production of these metabolites. 
The deficiency in methylation of H3K4 in the cclAΔ strain resulted in activation of both mdp and 
ors gene clusters. Expression analysis revealed that the annotated ORFs from AN7909-AN7915 were 
possible cluster members, hereby indicating candidates for a gene cluster [96]. The ors gene cluster, 
orsB-orsE, was identified by Schroeckh and co-workers [112] as four additional ORFs spanning 
AN7911-AN7914, which was confirmed by Sanchez et al. [115], who deleted all genes from AN7901 
to AN7915. Interestingly, the neighbor PKS to the ors locus, AN7903, was deleted by Nielsen et al. [11] 
and the resulting strain failed to produce F-9775A and B like AN7909Δ under the conditions tested. 
Schroeckh and co-workers [112] defined orsA-E using gene-expression analysis through both an 
Aspergillus secondary metabolism array (ASMA) and relative expression analysis in quantitative 
reverse-transcriptase PCR (qRT-PCR). The induction of orsA was achieved by co-cultivating with a 
soil bacterium, Streptomyces rapamycinicus (initially named S. hygroscopicus) and extracting mRNA 
from the fungus [112]. This response on SM level was further investigated by Nützmann and  
co-workers [117]. Since the loss of H3K4 methylation induced gene expression in ors locus [96], the 
rationale was that the transcriptional activation of silent secondary-metabolism genes by acetylation of 
lysines on histone tails, especially H3K9, is equally important and the search for histone acetyl 
transferases (HATs) in the genome sequence was commenced [117]. Forty HATs were found and 
deleted, and only four proved to be essential. Of the 36 deletions of nonessential HATs in A. nidulans, 
the deletions of gcnE and adaA, both essential core parts of the multi-subunit Saga/Ada complex, an 
important complex for HAT activity in A. nidulans, significantly lowered the ors transcripts 
investigated [117]. Thus, Saga/Ada plays a role in the response to S. rapamycinicus and loss of this 
complex downregulated orsellinic acid metabolites, as well as sterigmatocystin, terrequinone, and 
penicillin [117]. 
Four additional orsellinic acid derived compounds were found in a defect COP9 signalosome (CSN) 
mutant strain [116]. The multiunit CSN complex is found in higher eukaryotes, albeit with different 
functional roles depending on the tissues. In A. nidulans the CSN is required for fruiting body 
formation and is not essential for asexual growth. By deleting csnE; orcinol, cordyol C, and violaceol 
I+II were produced, and the genes orsA-orsE were shown to be differentially expressed [116]. The link 
of the violaceol metabolites to ors was confirmed by Nielsen and co-workers [11] who applied an 
OSMAC strategy on their reference strain and compared this to their deletion library. 
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Very little is known about the biosynthesis of the metabolites of the ors locus. One acetyl-CoA and 
three malonyl-CoA units can yield a C8 aldol intermediate, and as proposed by Nielsen et al. [11], this 
can lead to the tetraketide orsellinic acid through loss of water and enolization and to the C7 compound 
orcinol by decarboxylation and enolization. Oxidation of orcinol in the para position then leads to  
5-methyl-benzene-1,2,3-triol which is believed to either dimerize with the loss of water to give 
violaceol I and II, Figure 11, or to give F-9775A+B, Figure 12, in an unknown series of synthesis 
steps. Another outcome is the formation of lecanoric acid by dimerization of orsellinic acid. Though 
the steps in the pathway have been hypothesized, most steps are not accounted for. It has been reported 
that OrsA having the domains SAT-KS-AT-PT-ACP-TE is responsible solely to form orsellinic acid. 
OrsA, OrsB, and OrsC seem to be sole responsible for F-9775A+B formation. Moreover, it has been 
shown that gerfelin and a C10-deoxy derivative of gerfelin accumulate in orsBΔ, whereas diorcinol 
was found in high amounts in the orsCΔ strain [115]. Gerfelin, C10-deoxy gerfelin and cordyol C are 
all dimers built up of two of the three suggested monomer units, orsellinic acid, orcinol and  
5-methylbenzene-1,2,3-triol. 
Recently Scherlach and co-workers [118] continuously cultivated A. nidulans under nitrogen-
limitation and carbon-limitation. At nitrogen limiting conditions in continuous cultivations two novel 
products, denoted as spiroanthrones, were found. They could not be detected at batch cultivation. The 
metabolites were based on anthraquinone and orsellinic acid derived phenols. The induced expression 
of both mdpG and orsA confirmed increased activity under the N-limiting continuous cultivation 
conditions. 
10. Austinol and Dehydroaustinol  
The meroterpenoids austinol and the related compound dehydroaustin were first isolated from  
A. ustus by Simpson and co-workers in 1982 [119], where the structure of austinol was elucidated by 
1H and 13C NMR. Austinol and dehydroaustinol are just two examples out of many meroterpenoids 
that are derived from 3,5-dimethyl orsellinic acid as presented in the excellent review by Geris and 
Simpson [120]. 
The two austinols were detected for the first time in A. nidulans four years ago [121], where it was 
further substantiated that austinol was indeed of partly PK origin. Deletion of the phosphopantheteinyl 
transferase (PPTase) cfwA/npgA in A. nidulans resulted in a strain that among many other compounds 
did not produce austinol and dehydroaustinol [121]. The PPTase is responsible for attaching the 
phosphopantetheine moiety to the acyl carrier domain of the PKSs and NRPSs, thus it is an activator of 
the enzyme complexes. Hence, the abolition of austinol and dehydroaustinol production in the PPTase 
deficient strain strongly suggests a PK origin of these compounds. 
In 2011, Nielsen and co-workers [11] discovered the PKS responsible for synthesis of the PK part 
of austinol and dehydroaustinol in A. nidulans. A deletion library of all 32 putative PKS genes in  
A. nidulans was created and screened using an OSMAC approach [122] to enable activation of 
different clusters on different media. One single strain deleted in AN8383 (ausA) failed to produce 
austinol and dehydroaustinol [11]. This discovery was supported by the introduction of a point 
mutation at the phosphopantetheine attachment site, thus abolishing activation of the enzyme by the 
PPTase to ensure the loss of austinols was not an indirect effect e.g., at chromatin level. The ausAΔ 
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strain was complemented by re-introducing the ausA gene into the deletion strain. Introducing the gene 
under control of the inducible alcA promoter revealed that 3,5-dimethyl orsellinic acid (3,5-MOA) was 
indeed the precursor for austinol and dehydroaustinol in A. nidulans, as shown experimentally via 
labeling studies by Simpson and co-workers 20 years earlier [11,123,124]. 
Figure 11. Proposed biosynthesis of orsellinic acid and its derivatives of orsellinic acid. 
The enzymes that catalyze the individual reactions in the biosynthesis of the metabolites 
are so far unknown and biosynthesis is proposed based on the observed metabolites.  
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Figure 12. The proposed enzymes involved in the biosynthesis of F-9775A and F-9775B 
of the figure here. 
 
A more detailed understanding of the biosynthesis of the austinols has not been established yet. 
However, it is well established that 3,5-dimethyl orsellinic acid is synthesized from condensation of an 
acetyl-CoA unit with 3 malonyl-CoA units to form the PK backbone, which is methylated twice, 
catalyzed by AusA. The PK part is then alkylated with farnesyl pyrophosphate to form a transient 
intermediate (Figure 13), which can then act as a precursor for several similar meroterpenoids, such as 
andibenins, austin, berkeleyones and andrastins [120]. Recently we tentatively identified neoaustin and 
austinolide in A. nidulans extracts by LC-MS analysis (unpublished data), which makes us hypothesize 
that the biosynthesis towards the austinols involves (i) oxidation and acyl shift in the D ring (ii) 
lactonization from the substituent groups of the D ring, a Baeyer-Villiger type oxidation and 1,2 alkyl 
shift in the A ring to give neoaustin. Neoaustin is subsequently oxidized in the D ring by another 
Baeyer-Villiger type oxidation to give austinolide that upon further oxidation and ring condensation 
leads to austinol and dehydroaustinol, Figure 13. 
11. Concluding Remarks 
Secondary metabolism represents chemical diversity and span in biological functionality to the 
extreme. As shown above, individual compound classes can even form hybrid molecules to other 
compound classes. There is a high commercial interest in discovery and utilization of SMs in general 
as drugs or additives, or to avoid mycotoxins in food and feeds. Mapping PK biosynthesis to genes in 
A. nidulans as presented in this review involves great complexity. One challenge is to find and activate 
the genes required to produce the compounds. As shown, it takes in-depth understanding of fungal 
biology, nutrient sensing, chromatin remodeling, as well as analysis on all levels from DNA to 
metabolites to unveil cryptic gene clusters and their products. Moreover, the majority of the pathways 
described in this review have been elucidated in a relatively short time span. This has been possible 
due to bioinformatics. The availability of the genome sequence, as well as resources and tools in, e.g., 
Aspergillus Comparative Database (ACD), Aspergillus Genome Database (AspGD), and the Central 
Aspergillus REsource (CADRE) have been key aids to perform the extensive genome mining. 
The ability to predict enzymatic function based on gene sequences has proven fruitful in 
characterization of secondary metabolism, since this has revealed the location of e.g., PKS genes. 
Additionally, the presence of gene cluster specific TFs was utilized in activation of silent SM clusters 
both in the case of aspyridones and asperfuranone. The asperfuranone biosynthesis is moreover an 
example of a previously unknown compound, with a potential to be a novel drug, has been found in a 
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well-known filamentous fungus. Another case of a metabolite with attractive properties is emodin, 
which has been known for more than a century, but just recently had the biosynthetic machinery 
uncovered in A. nidulans. Both asperthecin and the emericellamides were firstly discovered and 
isolated from less well described aspergilli, however, after the compounds were observed in  
A. nidulans, the candidates for responsible genes in biosynthesis were found in a few months. The 
study of conidial pigment biosynthesis in A. nidulans has contributed to our basic understanding of 
fungal development and PKS organization, and provided researchers with an easy assayable marker 
system for genetic studies. Interestingly, the structure of the final pigment(s) still remains unknown 
after more than 70 years of research, underlining the difficulties in elucidating structures of highly 
polymerized PKs. 
Figure 13. Proposed biosynthesis of austinol and dehydroaustinol. All genes in the 
biosynthesis of austinol and dehydroaustinol, except AusA, are unknown. 
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Epigenetic regulation through chromatin remodeling has shown to be involved in activation of 
several SM gene clusters. Conserved chromatin remodeling factors have influenced both local 
activation of some SM clusters and more global responses within the genome. Gene clusters producing 
sterigmatocystin, orsellinic acid, emodins, and austinols have shown to respond to specific factors. The 
presence of SM producing genes outside gene clusters, e.g., in prenyl-xanthone production, is probably 
more common than observed so far. Moreover, cross-talk between pathways is frequently observed, as 
more pathways become known. This can open a discussion whether common pools of intermediates or 
enzymes can exist. In addition, the compartmentalization of SM production is an area to be explored. 
Furthermore, controlling compartmentalization of production as well as secretion will influence yields 
and downstream applications which are important factors for exploiting SM production commercially. 
Existing compounds can be modified genetically to add/remove chemical groups on existing drugs, 
mix moieties from different SM classes or species by for example domain swapping, and to 
considerably increase/abolish a specific production. 
Altogether the recent uncovering of secondary metabolism in A. nidulans is an illustrative example 
of strong interdisciplinary efforts requiring strong expertise within chemistry, biology, microbiology, 
molecular genetics, protein chemistry, computer science, and engineering. Ultimately, the efforts 
described in this review can form the basis for uncovering of the specific biological roles of the 
chemical arsenal in the fungus. 
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Chapter 6
Identiﬁcation of novel secondary
metabolites by over-expression of
phosphatases and transcription factors
from A. nidulans
6.1 Introduction
A. nidulans is a well-characterized ﬁlamentous fungus with respect to genetics and secondary metabolism.
The genome sequencing of A. nidulans [Galagan et al., 2005] revealed that its genome contained at least
32 polyketide synthases (PKS), which are large multidomain enzymes that are responsible for synthesis of
polyketides (PKs). However, this number greatly exceeds the number of known PKs from A. nidulans and
although quite a few A. nidulans polyketides are actually characterized they are rarely produced under the
same circumstances, further complicating the investigation of the polyketome and appertaining PKSs. For
instance, the huge impact on the polyketide production by the composition of growth medium is shown in
Figure 6.1 [Klejnstrup, 2012]. Additionally, pH, water activity, temperature, atmosphere, light etc. also
inﬂuence the regulation of secondary metabolism [Samson et al., 2010].
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Figure 6.1: Impact of growth medium composition on the A. nidulans polyketome. Figure from [Klejnstrup,
2012].
Many diﬀerent eﬀorts have been done in order to illuminate the polyketome of A. nidulans and link
genes to their corresponding PK, including heterologous expression of PKSs [Watanabe et al., 1998, 1999,
Clutterbuck, 1972], over-expression of local transcription factors (TFs) [Bergmann et al., 2007, Chiang et al.,
2009], gene deletion or inactivation [Chiang et al., 2008, Nielsen et al., 2011, Yaegashi et al., 2013, Yu and
Leonard, 1995, Brown et al., 1996], global chromatin regulation [Bok et al., 2009], perturbation of sumoylation
[Szewczyk et al., 2008], and co-cultivation with other organisms [Schroeckh et al., 2009]. In total, 10 PKSs
have been linked to nine PKs in A. nidulans, suggesting that there may still be more than twenty PK awaiting
discovery.
As many creative and original approaches have already been applied for triggering production of PKs, the
solution for activating the remaining silent clusters may not be obvious or trivial. Having developed a system
for high-throughput gene expression in A. nidulans, I assessed the possibility to systematically over-express
A. nidulans genes and examine the metabolite proﬁles of the resulting strains. As A. nidulans contains 9,541
putative protein encoding genes [Galagan et al., 2005], over-expression of each individual gene would entail
a tremendous workload. Sopko and co-workers have previously performed systematic over-expression of all
genes in S. cerevisiae, and reported that the cells were more sensitive to perturbations of pathways that are
deﬁned by proteins involved in transport, cell-cycle regulation, transcriptional activation, and signaling e.g.
kinases and phosphatases [Sopko et al., 2006].
In a very recent study Yaegashi and co-workers have shown that deletion of a kinase indeed activated
a silent cluster in A. nidulans [Yaegashi et al., 2013, De Souza et al., 2013], and results from previous
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studies on A. nidulans secondary metabolism have shown that over-expression of TFs also could lead to
activation of silent gene clusters. A. nidulans contains 28 putative phosphatases, which are the protein
kinase counterparts that catalyze protein dephosphorylation [Son and Osmani, 2009], and 372 putative TFs
[Galagan et al., 2005]. As a proof-of-concept study I decided to over-express all 28 phosphatases and all 52
annotated putative TFs on chromosome I, comprising 80 genes in total. If successful, novel PKs could easily
be linked to their corresponding PKSs in combination with the genome-wide PKS deletion library constructed
in [Nielsen et al., 2011] (Chapter 4).
6.2 Results and discussion
This study was used as a test case for high-throughput fungal strain construction, and comprised very little
manual work. PCR primers were designed using the PHUSER program (Chapter 7), PCR reactions were
set up using a Hamilton STAR liquid handler, PCR fragment lengths were determined via capillary elec-
trophoresis, assessed via a novel computer program, VirtualPCR (Ali Altintas, not published), and inserted
directly into the cloning vector pDH124 without puriﬁcation (Figure 6.2). Likewise, plasmids were linearized
by digestion and transformed directly into A. nidulans without puriﬁcation. The cloning vector contained
the O7 promoter (TetON/OFF), which allows tunable expression by diﬀerent concentrations of doxycycline
(DOX). The A. nidulans recipient strain allowed for background-free insertion of expression constructs into
IS1, enabling extremely fast veriﬁcation of correct transformants.
Figure 6.2: Background-free cloning vector pDH124 employing TetON/OFF.
6.2.1 Over-expression of phosphatases aﬀects growth rate and morphology
The phosphatase expression strains were constructed as part of my external research stay at Ohio State
University, and for some reason I had problems with preparation of protoplasts, why only half of the constructs
provided transformants. However, 13 correct phosphatase expression strains were constructed using the
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background-free integration system. As I had no prior experience with the use of the TetON/OFF system,
I used four diﬀerent concentrations of DOX for assessment of the morphologies. The morphologies of the
strains grown on MM+DOX are shown in Figure 6.3, large pictures are found in Appendix B.
Figure 6.3: Macromorphologies of phosphatase over-expression strains cultivated at four diﬀerent concentra-
tions of DOX. GFP = reference with gfp inserted, RFP = reference with rfp inserted.
Two strains seem to be only little aﬀected by over-expression of the phosphatases: AN3810 and AN10570.
In contrast, the remaining 13 strains, including the GFP- and RFP-expressing references, had markedly
reduced growth. The colony diameters are listed in Table 6.2.1, and plotted in Figure 6.4. Intriguingly,
the strains seem to form wild-type appearing wedges from the slow-growing colonies, which also results in
large error-bars in the plot for some of the strains. The wedges may be formed as a result of a spontaneous
loop-out event in an eﬀort to get rid of the clearly toxic gene. The construct does not contain an apparent
direct repeat, so it would be interesting to sequence the strains and examine what has happened.
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Table 6.1: Average colony diameters (mm) of phosphatase over-expression strains.
Strain 0 µg/ml DOX 0.1 µg/ml DOX 1.0 µg/ml DOX 10 µg/ml DOX 20 µg/ml DOX
RFP 15.4 ± 0.4 13.0 ± 0.9 11.7 ± 0.6 N/A N/A
GFP 12.8 ± 0.0 9.8 ± 0.9 6.7 ± 0.6 6.9 ± 0.4 6.9 ± 0.4
AN0129 13.0 ± 0.4 8.1 ± 0.7 4.3 ± 0.4 6.1 ± 3.3 5.7 ± 1.9
AN0164 (ppg1A) 13.0 ± 0.4 8.0 ± 0.7 4.4 ± 1.1 4.8 ± 0.4 4.3 ± 1.3
AN0914 11.3 ± 0.4 7.6 ± 0.4 5.2 ± 0.4 4.3 ± 0.4 4.4 ± 0.0
AN3793 (ppzA) 13.7 ± 0.9 6.5 ± 0.7 6.1 ± 0.0 N/A N/A
AN3810 13.5 ± 0.4 12.8 ± 0.6 11.5 ± 0.4 11.7 ± 0.0 11.1 ± 0.0
AN3941 (nimT ) 12.0 ± 0.4 5.7 ± 0.9 2.8 ± 1.1 2.6 ± 0.4 2.2 ± 2.2
AN4426 11.7 ± 0.6 5.2 ± 0.4 1.3 ± 0.4 1.1 ± 0.6 0.6 ± 0.0
AN5057 (cdcA) 11.1 ± 0.6 7.8 ± 3.3 4.8 ± 2.6 4.1 ± 0.9 4.3 ± 1.3
AN6892 (ptcA) 11.7 ± 0.0 4.6 ± 0.4 3.7 ± 1.5 5.7 ± 0.9 3.1 ± 0.9
AN8820 (cnaA) 11.5 ± 0.4 8.5 ± 0.4 5.9 ± 2.4 4.1 ± 0.4 3.9 ± 1.1
AN10138 12.4 ± 0.4 8.1 ± 0.4 6.7 ± 2.2 4.4 ± 0.6 5.2 ± 0.4
AN10281 13.0 ± 0.4 7.6 ± 0.4 4.4 ± 0.6 4.3 ± 0.4 3.7 ± 1.9
AN10570 (ltpA) 13.3 ± 0.6 12.4 ± 0.4 12.6 ± 0.4 12.4 ± 0.4 13.1 ± 0.4
Figure 6.4: Histogram of colony diameters of phosphatase over-expression strains. Series values represent
DOX concentration (µg/ml).
6.2.2 Over-expression of TFs results in several new phenotypes
In addition to the phosphatase strains, 39 correct TF expression strains were constructed. As the morpholo-
gies of the phosphatase strains did not change much between 1 µg/ml and 20 µg/ml DOX, the TF expression
strains were cultivated on MM+0.1 µg/ml DOX and MM+1 µg/ml DOX for assessing the eﬀect of gene
over-expression on morphology and growth rate. An overview of the strains are shown in Figure 6.5, and
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large pictures are found in Appendix B.
Surprisingly, the TF over-expression strains did not seem severely impaired, not did they display the same
tendency to form wedges as was observed for the phosphatase over-expression strains. In constrast, the TF
strains looked mostly healthy, although somewhat growth impaired. Diameters of the colonies are listed in
Table 6.2.2. Additionally, the TF strains displayed very diverse morphologies including changes in conidiation
levels and production of pigments. An interesting observation is that the AN10763 strain, in constrast to the
other strains, is greener and more healthy-looking on 1.0 µg/ml DOX than on 0.1 µg/ml DOX, which may
indicate a higher degree of conidiation on 1.0 µg/ml DOX. A puzzling observation for many of the strains is
that the colonies diﬀer a lot in size i.e. the growth rates seem to vary for individuals of the same strain.
Figure 6.5: Macromorphologies of TF over-expression strains cultivated at two diﬀerent concentrations of
DOX. NID3 = reference with no insert, RFP = reference with rfp inserted.
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Table 6.2: Average colony diameters (mm) of TF over-expression strains.
Strain 0.1 µg/ml DOX 1.0 µg/ml DOX Comments
NID3 45 ± 2 34 ± 10
RFP 50 ± 1 40 ± 2
AN5859 40 ± 3 38 ± 6
AN5894 35 ± 3 24 ± 5
AN5955 25 ± 4 21 ± 4 Poor conidiation, production of red pigment
AN5966 30 ± 1 24 ± 7 Poor conidiation
AN6030 26 ± 3 28 ± 5 Poor conidiation, production of red pigment
AN6062 39 ± 7 39 ± 4
AN6091 42 ± 1 41 ± 0
AN6166 38 ± 5 33 ± 6
AN6178 39 ± 7 39 ± 4
AN6195 (creA) 37 ± 8 35 ± 2
AN6221 (areB) 29 ± 6 30 ± 3
AN6223 30 ± 2 42 ± 2
AN6293 (acuM ) 29 ± 7 33 ± 10
AN6295 31 ± 10 30 ± 2
AN6325 38 ± 12 40 ± 3
AN6385 21 ± 3 22 ± 7 Poor growth
AN6420 33 ± 2 30 ± 0
AN6492 (hapE ) 32 ± 4 28 ± 4
AN6508 (gsk3 ) 35 ± 1 22 ± 4 Poor conidiation
AN6536 (hisB) 36 ± 4 16 ± 4
AN6549 34 ± 10 27 ± 1
AN6569 25 ± 4 36 ± 6
AN6575 34 ± 11 32 ± 9 Production of red pigment
AN6650 (mscA) 36 ± 4 41 ± 1
AN6687 36 ± 8 36 ± 5
AN6696 30 ± 12 30 ± 8
AN6715 28 ± 10 19 ± 7
AN6733 23 ± 3 21 ± 0 No conidiation, uneven colony periphery, poor growth
AN6762 39 ± 6 37 ± 4
AN6788 26 ± 1 28 ± 3
Continued on Next Page
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Table 6.2  Continued
Strain 0.1 µg/ml DOX 1.0 µg/ml DOX Comments
AN6814 34 ± 9 24 ± 4
AN6828 32 ± 10 30 ± 1
AN6849 18 ± 2 15 ± 1 Poor growth
AN6900 (tpiA) 22 ± 2 15 ± 1 Poor growth
AN10763 (adaB) 45 ± 3 41 ± 1 Seems unaﬀected
AN10789 33 ± 11 29 ± 6
AN10809 29 ± 5 26 ± 1
AN11918/AN6430 38 ± 2 18 ± 2
AN12045 30 ± 7 16 ± 3
6.2.3 Metabolite proﬁle analysis reveals production of novel metabolites
Metabolite proﬁles were analyzed by UHPLC-DAD-TOFMS, and the chromatograms were visually inspected
for drastic changes in the metabolite proﬁles. All chromatograms (ESI+, ESI−, DAD) are shown in Appendix
B. Based on the overall metabolite proﬁles I have selected two phosphatase strains (AN3793 (ppzA), AN8820
(cnaA)) and four TF strains (AN5955, AN6221 (areB)), AN6420, AN6733) to examine further. BPC (ESI+,
ESI−) and DAD chromatograms of these six strains are shown in Figures 6.6, 6.7, and 6.8, respectively.
Examination of the chromatograms revealed that these six strains did indeed have altered metabolite
proﬁles. Normally, only austinol, dehydroaustinol, and sterigmatocystin are produced in reasonable amounts
on MM (see Figure 6.1), but apparently over-expression of both phosphatases and TFs can induce expression
of other known metabolites on MM. Over-expression of AN3793 (phosphatase) and AN6733 (TF) induces
expression of the antibiotic desferritriacetylfusigen (Figure 6.9), which is not normally observed on stan-
dard media. AN8820 (cnaA, phosphatase) induces expression of arugosins and shamixanthones, which are
products of the monodictyphenone pathway, and AN5955 (TF) induces expression of violaceols, which are
derived from orsellinic acid (Chapter 5). Over-expression of AN6420 results in production of asperugin B,
which is a polyketide that was only recently discovered and is also believed to origin from orsellinic acid
[Klejnstrup, 2012]. It is noteworthy that both AN3793, AN8820 (cnaA), and AN6221 produce high amounts
of sterigmatocystin, and in addition they produce high amounts of averantin, averuﬁn, and versicolorin B,
which are intermediates in the pathway towards sterigmatocystin in A. nidulans, and are only detected in
trace amounts in a wild-type.
Interestingly, some of these strains also produce novel metabolites. Dereplication of the six metabolite
proﬁles identiﬁed four novel metabolites, merely by manual inspection of the metabolite proﬁles. Three of
the metabolites, designated Unknown 6, Unknown 22, and Unknown 26, have been detected in A. nidulans
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Figure 6.6: ESI+ chromatogram of six selected strains cultivated on 1.0 µg/ml DOX with a NID3 reference.
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Figure 6.7: ESI- chromatogram of six selected strains cultivated on 1.0 µg/ml DOX with a NID3 reference.
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Figure 6.8: DAD chromatogram of six selected strains cultivated on 1.0 µg/ml DOX with a NID3 reference.
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Figure 6.9: Selection of known A. nidulans compounds.
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Figure 6.10: UV spectra of four compunds which were not identiﬁed by dereplication.
before (personal communication, Kristian F. Nielsen), but their structures are unknown. The compound
designated 781.5432 indicates the monoisotopic mass of a compound, which has not been detected before.
Inspection of the UV spectra of the unknown compounds (Figure 6.10) revealed that Unknown 6, Unknown
22, and Unknown 26 have similar UV spectra, why they may be analogues of the same compound. Based
on the modest ability to absorb light, the compounds are most likely not polyketides, as these tend to be
highly conjugated systems. Rather, these three compounds may be alkaloids/NRPs, and perhaps they are
novel compounds with a potential use as pharmaceuticals.
Dereplication of 781.5432 did not identify any known metabolites why this compound may be a novel
compound. Intriguingly, the UV spectrum of this compound is characteristic for ergosterol, a component
of fungal cell walls, but the monoisotopic mass is almost twice that of ergosterol. Very recently, Miao and
co-workers reported a steroid-xanthone heterodimer (asperversin A) from A. versicolor, which is the ﬁrst of
its kind [Miao et al., 2012]. Asperversin A is a heterodimer of 5α,8α-epidioxyergosta-6,22-dien-3β-ol and
5-methoxysterigmatocystin, joined by an ether bond (Figure 6.11). Although this compound only diﬀers
from 781.5432 by 1 Dalton, the UV spectrum dismisses this compound as a candidate, as asperversin A has
far greater UV absorbance due to the xanthone monomer (personal communication, Jens C. Frisvad). In
fact, based on the hypothesis that the UV spectrum of ergosterol or derivatives will not be greatly inﬂuenced
by formation of a heterodimer, the counterpart of such a compound would necessarily have very poor UV
absorbance e.g. a NRP.
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Figure 6.11: Structure of the recently reported asperversin A; a heterodimer of 5α,8α-epidioxyergosta-6,22-
dien-3β-ol and 5-methoxysterigmatocystin.
None of the six examined strains seem to be part of a secondary metabolite gene cluster i.e. there are no
putative PKSs, NRPSs, terpene synthases, prenyltransferases, or cytochrome P450s up- and downstream of
these genes (± 10 genes). There is a putative PKS located 11 genes from AN6420 (AN6431), however, the
AN6420 over-expression strain seem to only upregulate NRP and the 781.5432 compounds, which is also not
likely a polyketide.
The two phosphatases are both characterized proteins. Protein phosphatase Z (AN3793, ppzA) is involved
in oxidative stress response and belongs to a group of proteins that are speciﬁc to fungi [Leiter et al., 2012].
Over-expression of ppzA upregulates production of desferritriacetylfusigen and sterigmatocystin, the latter
in a manner that may exceed the capacity of tailoring enzymes, as the known intermediates averantin and
averuﬁn accumulate in high amounts. The link between these metabolites and Protein phosphatase Z is not
obvious.
cnaA (AN8820) encodes a calmodulin-dependent protein phosphatase catalytic subunit, which is an es-
sential protein involved in cell cycle regulation [Rasmussen et al., 1994, Nanthakumar et al., 1996, Son
and Osmani, 2009, Hernández-Ortiz and Espeso, 2013]. Over-expression of cnaA results in up-regulation of
shamixanthone production, however, a possible link between shamixanthones and cell cycle regulation is also
not obvious.
areB (AN6221) encodes a characterized transcription factor AreB, which is involved in nitrogen metabolism
[Conlon et al., 2001, Wong et al., 2009]. It has previously been shown that AreB is pleiotropic and that over-
expression of areB results in severe growth inhibition and aberrant cell morphology [Wong et al., 2009]. Wong
and co-workers over-expressed the areB gene under control of a xylose-inducible promoter, and integrated
the construct into the yA locus. Interestingly, in the areB over-expression strain, there is a substantial up-
regulation of Unknown 26, which appears to be a NRP, which is a product of the nitrogen metabolism. At
this point it is impossible to propose the exact connection, and the fact that areB encodes at least three
diﬀerent proteins [Conlon et al., 2001] illustrates the complexity of this regulation.
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6.3 Concluding remarks
In this study I successfully applied the HTP setup that I have developed, for over-expression of A. nidulans
phosphatases and transcription factors. The HTP setup proved very eﬃcient and strain construction was
very fast and only little manual work was required. Due to problems with protoplasting and initial PCR
ampliﬁcation not all intended strain were constructed. Also, eight of the constructed strains were not analyzed
by UHPLC-DAD-TOFMS due to technical problems with the TOFMS. However, 52 strains were obtained
and several of them did show an altered metabolite proﬁle, resulting in either overall down-regulation of
secondary metabolite production, or up-regulation of single or a few metabolites which are normally not
produced under the speciﬁc circumstances. Furthermore, examination of six selected strain identiﬁed four
possible novel compounds. As this experiment was the last one I carried out during my PhD, I did not have
suﬃcient time for construction of the missing strains or in-depth analysis of all analytical data.
At this point in time the aspects of regulation is apparently too complex for researchers to elucidate
the remaining parts of fungal secondary metabolism, why I predict that random HTP approaches can be
very helpful in uncovering some of the mechanisms involved with regulation of secondary metabolism, and
this study conﬁrms that regulation by transcriptional control and/or protein prosphorylation is part of this
regulation. Additionally, these libraries may be of use to the entire fungal research community for studies
within cell cycle regulation, cell diﬀerentiation etc.
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6.4 Experimental procedures
6.4.1 Fungal strains
The A. nidulans strain NID1 (IBT 29539) (argB2 pyrG89 veA1 nkuA∆) [Nielsen et al., 2008] was used as
a reference and for insertion of all genes. The recipient strain (NIDX) for background-free integration was
constructed by integration of a wA::pyrG cassette into IS1, as described in Chapter 3.
Table 6.3: Fungal strains used and constructed in this study. hph* contains a silent point mutation eliminating
an AsiSI restriction site. oriR* contains a point mutation eliminating a Nb.BtsI nicking site.
Strain Genotype Source
NIDX argB2 pyrG89 veA1 nkuA∆ IS1::PgpdA0.5kb::wA::TtrpC ::pyrG Chapter 3
RFP argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::rfp::TtrpC ::argB This study
GFP argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::gfp::TtrpC ::argB This study
Phosphatase strains
AN0129 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN0129::TtrpC ::argB This study
AN0164 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN0164::TtrpC ::argB This study
AN0914 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN0914::TtrpC ::argB This study
AN3793 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN3793::TtrpC ::argB This study
AN3810 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN3810::TtrpC ::argB This study
AN3941 (nimT) argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN3941::TtrpC ::argB This study
AN4426 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN4426::TtrpC ::argB This study
AN5057 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN5057::TtrpC ::argB This study
AN6892 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6892::TtrpC ::argB This study
AN8820 (cnaA) argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN8820::TtrpC ::argB This study
AN10138 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN10138::TtrpC ::argB This study
AN10281 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN10281::TtrpC ::argB This study
AN10570 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN10570::TtrpC ::argB This study
TF strains
AN5859 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN5859::TtrpC ::argB This study
AN5894 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN5894::TtrpC ::argB This study
AN5955 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN5955::TtrpC ::argB This study
AN5966 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN5966::TtrpC ::argB This study
AN6030 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6030::TtrpC ::argB This study
AN6062 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6062::TtrpC ::argB This study
Continued on Next Page
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Table 6.3  Continued
Strain Genotype Source
AN6091 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6091::TtrpC ::argB This study
AN6166 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6166::TtrpC ::argB This study
AN6178 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6178::TtrpC ::argB This study
AN6195 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6195::TtrpC ::argB This study
AN6221 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6221::TtrpC ::argB This study
AN6223 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6223::TtrpC ::argB This study
AN6293 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6293::TtrpC ::argB This study
AN6295 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6295::TtrpC ::argB This study
AN6325 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6325::TtrpC ::argB This study
AN6385 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6385::TtrpC ::argB This study
AN6420 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6420::TtrpC ::argB This study
AN6492 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6492::TtrpC ::argB This study
AN6508 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6508::TtrpC ::argB This study
AN6536 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6536::TtrpC ::argB This study
AN6549 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6549::TtrpC ::argB This study
AN6569 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6569::TtrpC ::argB This study
AN6575 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6575::TtrpC ::argB This study
AN6650 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6650::TtrpC ::argB This study
AN6687 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6687::TtrpC ::argB This study
AN6696 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6696::TtrpC ::argB This study
AN6715 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6715::TtrpC ::argB This study
AN6733 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6733::TtrpC ::argB This study
AN6762 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6762::TtrpC ::argB This study
AN6788 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6788::TtrpC ::argB This study
AN6814 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6814::TtrpC ::argB This study
AN6828 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6828::TtrpC ::argB This study
AN6849 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6849::TtrpC ::argB This study
AN6900 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN6900::TtrpC ::argB This study
AN10763 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN10763::TtrpC ::argB This study
AN10789 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN10789::TtrpC ::argB This study
AN10809 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN10809::TtrpC ::argB This study
AN11918 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN11918::TtrpC ::argB This study
AN12045 argB2 pyrG89 veA1 nkuA∆ IS1::PO7 ::AN12045::TtrpC ::argB This study
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6.4.2 Media
Minimal medium for A. nidulans was made as described in [Cove, 1966] but with 1% glucose, 10 mM
NaNO3 and 2% agar. Minimal medium for A. niger was prepared as described in [Chiang et al., 2011].
YES, MEA and CYA media were prepared as described by Frisvad and Samson [Samson et al.]. When
necessary, media were supplemented with 4 mM L-arginine, 10 mM uridine, 10 mM uracil. Furthermore,
media were supplemented with 0.1-20 µg/ml doxycycline hyclate (doxycycline hydrochloride hemiethanolate
hemihydrate) (Sigma-Aldrich).
6.4.3 PCR, cloning and transformation
All primers are listed in Table 3.3.3. All PCR reactions were carried out using the PfuX7 polymerase
[Nørholm, 2010], and either HF or Phire PCR buﬀer (Finnzymes/Thermo Scientiﬁc). For phosphatases,
primer pairs named ANxxxx-Fw and ANxxxx-Rv were used for ampliﬁcation of ORFs, and for transcription
factors primer pairs named F-xxxx and R-xxxx were used for ampliﬁcaition of ORFs from A. nidulans genomic
DNA (gDNA). All primers are listed in Table 6.4.3. The PCR program was: 98◦C for 1 min, 98◦C for 15
s, 60◦C for 30 s, 72◦C for 30s/kb, and 72◦C for 5 min. Normally, I performed 35 cycles of ampliﬁcation.
Diagnostic (conidial) PCR was performed as a regular PCR reaction, except initial denaturation step was 20
min. PCR reactions were mixed in a Hamilton STAR liquid handler in a total volume of 50 µl.
Length and quality of the PCR fragments was assessed via capillary electrophoresis on a Lab-Chip GX
(Caliper LifeSciences) and compared to the calculated lengths of PCR products, which was calculated using
the novel program VirtualPCR, developed for this study by Ali Altintas, Center for Biological Sequence
Analysis, DTU.
Unpuriﬁed PCR fragments were assembled via uracil-excision fusion [Geu-Flores et al., 2007] into the
compatible vector pDH124. The background-free cloning vector pDH124 was constructed by insertion of
ccdB::camR into the UEC of pDCA-Tet (kindly provided by Diana C. Anyaogu) as described in Section
3.1.5. Cloning reactions were carried out in microtiter PCR plates, and one reaction (10 µl) contained 1 µl
USER enzyme, 0.5 µl New England Biolabs buﬀer 4 (NEB4), 0.5 µl 10x bovine serum albumin (BSA), 2
µl unpuriﬁed PCR fragment in HF buﬀer, and 6 µl MQ water. Correct clones were veriﬁed by restriction
digestion. Plasmids were linearized by digestion with NotI, heat inactivated, and transformed directly into
A. nidulans. Protoplasting and gene-targeting procedures were performed as described previously [Johnstone
et al., 1985, Nielsen et al., 2006]. All plasmids are listed in Table 6.4.3.
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Table 6.4: Primers used in this study. All primers are shown in 5'-3' direction.
Primer name Sequence
mRFP-ORF-Fw AGAGCGAUATGGCCTCCTCCGAGGAC
mRFP-ORF-Rv TCTGCGAUTTAGGCGCCGGTGGAGT
GFP-ORF-Fw AGAGCGAUATGGTGAGCAAGGGCGAG
GFP-ORF-Rv TCTGCGAUTTACTTGTACAGCTCGTCCATGC
GFP-fw1 AGCTGGUGCAGGCGCTGGAGCC
Stag-rv1 TCTGCGAUTTAAGCACCGCTGTCCATGT
AN0103-fw AGAGCGAUATGAGTGATCTGGATAGGTACCGT
AN0129-fw AGAGCGAUATGGCAACCGTTGTGGTG
AN0164-fw AGAGCGAUATGCCTGGTTTACCAGGTACGT
AN0410-fw AGAGCGAUATGGCCGATCAGGACGTG
AN0504-fw AGAGCGAUATGACTGATAGCAAGGTCCCTC
AN0914-fw AGAGCGAUATGACTCTGGCTCCGTCGAA
AN1343-fw AGAGCGAUATGAACTCGCTGAATATCCTATCG
AN1358-fw AGAGCGAUATGGGCCAGACTCTGTCAGAG
AN1467-fw AGAGCGAUATGATCTTATCGGTCAGGCCC
AN2472-fw AGAGCGAUATGGACAGATCGAATACAGTGGA
AN2902-fw AGAGCGAUATGCTTCTTCGTTTACCGCCA
AN3793-fw AGAGCGAUATGGGTCAGTCTCATTCCAAGG
AN3810-fw AGAGCGAUATGGCCTACGACCCGCGA
AN3941-fw AGAGCGAUATGGAACATTCCTCGCCTTT
AN4419-fw AGAGCGAUATGGCTATGAACAAGGTTCCC
AN4426-fw AGAGCGAUATGACTTACCCTTTGACGAAGAAA
AN4544-fw AGAGCGAUATGCCCGTTCAAACCAGC
AN4896-fw AGAGCGAUATGGCGCATCCCACCATT
AN5057-fw AGAGCGAUATGGCCGGATCTACTGCTG
AN5722-fw AGAGCGAUATGCGTCGTGCAGCCCT
AN6391-fw AGAGCGAUATGGATAACAATATGGAGATCGATG
AN6892-fw AGAGCGAUATGTTCAGTGGCTCCTCGAG
AN6982-fw AGAGCGAUATGTCTGCGATGACAGGCC
AN8820-fw AGAGCGAUATGGATCGGAATCTAGCGC
AN10077-fw AGAGCGAUATGTTCGGCAAGAGTCCAGAAC
AN10138-fw AGAGCGAUATGGAACCTACAGCTTCAGGCT
Continued on Next Page
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Table 6.4  Continued
Primer name Sequence
AN10281-fw AGAGCGAUATGGCCTCCCAAGATGTTGA
AN10570-fw AGAGCGAUATGTACTGGGTATACTTCGTGATGG
AN0103-rv ACCAGCUCCTTAGACGGAGAAGATTTGAGGG
AN0129-rv ACCAGCUCCTTATCTCGAATAAGGCTTGTTCAT
AN0164-rv ACCAGCUCCTCACAGAAAGTAGTCGATCACAGGA
AN0410-rv ACCAGCUCCTTACTTCTTTTGCTTTCGCGGA
AN0504-rv ACCAGCUCCTTACAAAAAGTACTCGCTGCG
AN0914-rv ACCAGCUCCTCATCTCCGTGACCTGCG
AN1343-rv ACCAGCUCCTCATAGAGCGTCTGCTTCTCCT
AN1358-rv ACCAGCUCCCTACGAAGAGGCGGGTTTCT
AN1467-rv ACCAGCUCCTACTCCTCCACAGCAATTATAACCA
AN2472-rv ACCAGCUCCTTAGGCCAACCTCGCCTC
AN2902-rv ACCAGCUCCTCAGCCTTTATCCTCGCCAA
AN3793-rv ACCAGCUCCCTAAAAGCTTTGGGCCGAAAC
AN3810-rv ACCAGCUCCCTACAACCAAGCCAAAGTCCATA
AN3941-rv ACCAGCUCCTTAGTATGAAAGCATGCGACG
AN4419-rv ACCAGCUCCCTAATGATCAAAGCTGTACAAGACGTAC
AN4426-rv ACCAGCUCCTCATGAAGCGACGCGAATC
AN4544-rv ACCAGCUCCTCACAGAAACTCATCAATGCTTCT
AN4896-rv ACCAGCUCCTCAATCAGTATCAGAGTGCTCAGG
AN5057-rv ACCAGCUCCTCATGCTTGGGCCTTTACAC
AN5722-rv ACCAGCUCCTTAAAGCTTAGCTTTGATGTTATCTTC
AN6391-rv ACCAGCUCCTCACAGGAAGTAGTCTGGGGTAC
AN6892-rv ACCAGCUCCTCATGTACTGTCGCTCGAACC
AN6982-rv ACCAGCUCCTTATCCCGGGCTCTCCCT
AN8820-rv ACCAGCUCCCTACCGTCTCGTTGTCGACG
AN10077-rv ACCAGCUCCTCATAGTGTGATGTCGAGAACCAG
AN10138-rv ACCAGCUCCTTATGCCCAGCGATCCTGA
AN10281-rv ACCAGCUCCTCAACGAATTTTGCGCATAG
AN10570-rv ACCAGCUCCCTAATTCTGATTCTTCTTCTCCAAGTACT
F-5836 AGAGCGAUATGGCCAGCATGAATCAACCT
F-5859 AGAGCGAUATGGCTCCATCTTCTCGTCCT
F-5894 AGAGCGAUCCTCGAACCGCTGCCG
Continued on Next Page
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Table 6.4  Continued
Primer name Sequence
F-5929 AGAGCGAUATGGACAACAGGCCTGCTTC
F-5955 AGAGCGAUATGGCCTCCAACAGCAAAG
F-5966 AGAGCGAUATGGATCCTAGAAACCATCCCT
F-6010 AGAGCGAUTCTTTCTCTCTCCATCCTCCATC
F-6030 AGAGCGAUATGGACGGATCACATAAGGAGA
F-6062 AGAGCGAUATGCCCCAGTTCAACTGCC
F-6091 AGAGCGAUCCTTCCCCTCTCGTGCAG
F-6166 TCTGCGAUGAGATGATTTCACATATTTCGATT
F-6173 AGAGCGAUATGAACCCTTCTGACTTGGCT
F-6178 AGAGCGAUATGTCGCCCCCGACCTTA
F-6195 AGAGCGAUATTCCCTCGACTTCATACATCC
F-6221 AGAGCGAUATGGCTAGCACGACCTACG
F-6223 AGAGCGAUATGGCCGACATCCTCACC
F-6293 AGAGCGAUATGACGGAGAAAAACACTACGCA
F-6295 AGAGCGAUATGAGCATCAATCCCCCAAAT
F-6325 AGAGCGAUATGACGGACACTCGTCCAGTC
F-6385 AGAGCGAUATGAGCATCTTAGGTATTATAACA
F-6396 AGAGCGAUATGAGTGACACCTTATCCACC
F-6420 AGAGCGAUATGAGCAAGCCCCTTACA
F-6492 AGAGCGAUCAGATCCTGCTTGTATTGCGT
F-6503 AGAGCGAUATGGAGACCGCAGAGCCT
F-6508 AGAGCGAUCTTCTTCACGTTGTCCGC
F-6536 AGAGCGAUATGCCCCTTCCTGCCCG
F-6549 AGAGCGAUATGGCAGGCACTCAGGAC
F-6566 AGAGCGAUATGGAGCAGCCTAATGAACCG
F-6569 AGAGCGAUATGATTGCCATCGGTCTTGAAG
F-6575 AGAGCGAUATGACAACGACGACGGCA
F-6650 AGAGCGAUTTCCTCATTGATTCACATTCTTCAGTTC
F-6687 AGAGCGAUATGTGTGCTTCACCGAATTCG
F-6696 AGAGCGAUATGGAGTCGTCTCCCCCGA
F-6715 AGAGCGAUATGACTACCAGCAATCACCATCAA
F-6733 AGAGCGAUATGGCCTTTGCGGTGACG
F-6747 AGAGCGAUATGCCCGCTGAAGAGAGG
Continued on Next Page
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Table 6.4  Continued
Primer name Sequence
F-6762 AGAGCGAUATGCCCCTTCGACGAGCA
F-6788 AGAGCGAUATGCCGCAGAAAGCCCAG
F-6814 AGAGCGAUATGTTTGAACTGGAGACTCCGTC
F-6828 AGAGCGAUATGCTGTGTCACTTCTCGATG
F-6832 AGAGCGAUATGTTCATCGCCTTCGAAGCTACC
F-6849 AGAGCGAUAATTCCATCAATCCTATCTATCCTGATCAT
F-6861 AGAGCGAUATGGCACCGGACATAGAG
F-6884 AGAGCGAUATGGATCTGGAGTGCCGG
F-6889 AGAGCGAUATGGCGACACACGACGG
F-6900 AGAGCGAUATGCCTCGCAAATTTTTCGTTGG
F-6960 AGAGCGAUATGACGAGTGACTCCTACGATCA
F-10763 AGAGCGAUTCCCTTTATCTGGGTATTATCTGC
F-10789 AGAGCGAUATGTCGTCTCTGCCCAGGA
F-10809 AGAGCGAUATGACAGAGCAAGACAACTCCTATC
F-11918 AGAGCGAUATGATCTCCGCTCCGGGT
F-12045 AGAGCGAUATGTCAGCTAGTCCATCTCCGTC
R-5836 TCTGCGAUTTAACGACGAGCACTTATCAGACT
R-5859 TCTGCGAUTCATCCTGCAAACGGCG
R-5894 TCTGCGAUTTACTTGGATCCCCATCCG
R-5929 TCTGCGAUCTATTGCGGGTAGCTGGTCG
R-5955 TCTGCGAUTCATTTGCGAGCAACTGAAAC
R-5966 TCTGCGAUATAGTTGGACGCCGGATAAAC
R-6010 TCTGCGAUGTTAAATCGAGAGGAGAATTTCCTAT
R-6030 TCTGCGAUTCACCAGATCTGATTCTCAGTAACTG
R-6062 TCTGCGAUTTAAGACAGGCATAGAACCTCTTTG
R-6091 TCTGCGAUGGGCAAGTGATCTACATTATGTGTT
R-6166 AGAGCGAUGCAACCTGCCATCTCACT
R-6173 TCTGCGAUCTACAGCGGGTTGAATGCC
R-6178 TCTGCGAUTCAGTTCACCTTCTTCTTTTTCG
R-6195 TCTGCGAUGTACAGTGTTCCGATTCAAGGAA
R-6221 TCTGCGAUCTAGATACTCTTAGGCGATTTGGCT
R-6223 TCTGCGAUCTAGTATGAGCTCCCCCCATAGATA
R-6293 TCTGCGAUCTAGAAGAGGAGTTTTTGAATCGC
Continued on Next Page
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Primer name Sequence
R-6295 TCTGCGAUCATCAAGACATTATAATTTACTTAGTGGA
R-6325 TCTGCGAUGTAATAATTTAGATCAATGATTCGATTC
R-6385 TCTGCGAUTCATGTCTGTTGTGAGTG
R-6396 TCTGCGAUTCAGTATAGATGGCTGGGAACG
R-6420 TCTGCGAUCTAGTCACTATCCAAGACAATAAC
R-6492 TCTGCGAUACGCAAAGAAGTAAATAATCAAAATGGGTA
R-6503 TCTGCGAUTTACTCGTCACCGCGCTT
R-6508 TCTGCGAUTCAGTCAAGGTGTGCCAT
R-6536 TCTGCGAUGAGTGGCGTGTCATCGC
R-6549 TCTGCGAUCTAACTCGCCGGTTTGCTCTTTTTC
R-6566 TCTGCGAUTTAAATTTGGTCTAATATCGCCGCATG
R-6569 TCTGCGAUCTAATCTCTCCATTGCACAAATACATCAT
R-6575 TCTGCGAUCAATGTGCAAATGACTAGGTTTGC
R-6650 TCTGCGAUTAGCGCAAATATAGACTCTATGTCTAG
R-6687 TCTGCGAUTTACTTCCCAGTCTTCGACTTC
R-6696 TCTGCGAUTCAATAACCCAGCATCGCAGAAAGC
R-6715 TCTGCGAUTCACCAGTCCTGGCCAC
R-6733 TCTGCGAUTTATTGAGAGACTTCCCTCAATTTATCAAT
R-6747 TCTGCGAUCTACTGCTTATCACTGTCCGG
R-6762 TCTGCGAUCTATAGGAAACGATACAGAAACTCCAGG
R-6788 TCTGCGAUCTAACCCGCAGTCCCACTTAC
R-6814 TCTGCGAUTTATCGCCGTGTCGAATGC
R-6828 TCTGCGAUCTAAACCTGTTCCGTGTTTGTGG
R-6832 TCTGCGAUCTAAGCGGGGTTCGGCCC
R-6849 TCTGCGAUTCATGCCGTCGGTGGG
R-6861 TCTGCGAUTTATTTCGCATCCTCCCCAAAC
R-6884 TCTGCGAUTCATGGAGGCAGATTCCAAATG
R-6889 TCTGCGAUCTAAGGCTGTATAAACTGCGATGGCAGG
R-6900 TCTGCGAUTTACAGGCGGGCATTGAC
R-6960 TCTGCGAUCTATCCGTCGCTTTCGTATCC
R-10763 TCTGCGAUTTATCCCTTGTTAATCCAACCG
R-10789 TCTGCGAUCTATTCACCTAACAAGGGCAAAC
R-10809 TCTGCGAUCAGGTAAAAAGCCAAATTGATG
Continued on Next Page
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Primer name Sequence
R-11918 TCTGCGAUTCATCTAAAGGCTGTTGGCATAG
R-12045 TCTGCGAUCTAGGACGTCGAATCGCATG
Table 6.5: Plasmids used and constructed in this study. All plasmids are oriR∗ ampR. hph* contains a silent
point mutation eliminating an AsiSI restriction site. oriR* contains a point mutation eliminating a Nb.BtsI
nicking site. UEC = AsiSI/Nb.BtsI uracil excision cassette
Plasmid Genotype Source
AN0103 TS1::PO7 ::AN0103::GFP-Stag::TtrpC ::argB ::TS2 This study
AN0129 TS1::PO7 ::AN0129::GFP-Stag::TtrpC ::argB ::TS2 This study
AN0164 TS1::PO7 ::AN0164::GFP-Stag::TtrpC ::argB ::TS2 This study
AN0410 (bimG) TS1::PO7 ::AN0410::GFP-Stag::TtrpC ::argB ::TS2 This study
AN0504 (sitA) TS1::PO7 ::AN0504::GFP-Stag::TtrpC ::argB ::TS2 This study
AN0914 TS1::PO7 ::AN0914::GFP-Stag::TtrpC ::argB ::TS2 This study
AN1343 TS1::PO7 ::AN1343::GFP-Stag::TtrpC ::argB ::TS2 This study
AN1358 TS1::PO7 ::AN1358::GFP-Stag::TtrpC ::argB ::TS2 This study
AN1467 TS1::PO7 ::AN1467::GFP-Stag::TtrpC ::argB ::TS2 This study
AN2472 TS1::PO7 ::AN2472::GFP-Stag::TtrpC ::argB ::TS2 This study
AN2902 TS1::PO7 ::AN2902::GFP-Stag::TtrpC ::argB ::TS2 This study
AN3793 TS1::PO7 ::AN3793::GFP-Stag::TtrpC ::argB ::TS2 This study
AN3810 TS1::PO7 ::AN3810::GFP-Stag::TtrpC ::argB ::TS2 This study
AN3941 (nimT) TS1::PO7 ::AN3941::GFP-Stag::TtrpC ::argB ::TS2 This study
AN4419 TS1::PO7 ::AN4419::GFP-Stag::TtrpC ::argB ::TS2 This study
AN4426 TS1::PO7 ::AN4426::GFP-Stag::TtrpC ::argB ::TS2 This study
AN4544 TS1::PO7 ::AN4544::GFP-Stag::TtrpC ::argB ::TS2 This study
AN4896 TS1::PO7 ::AN4896::GFP-Stag::TtrpC ::argB ::TS2 This study
AN5057 TS1::PO7 ::AN5057::GFP-Stag::TtrpC ::argB ::TS2 This study
AN5722 TS1::PO7 ::AN5722::GFP-Stag::TtrpC ::argB ::TS2 This study
AN6391 (pphA) TS1::PO7 ::AN6391::GFP-Stag::TtrpC ::argB ::TS2 This study
AN6892 TS1::PO7 ::AN6892::GFP-Stag::TtrpC ::argB ::TS2 This study
AN6982 TS1::PO7 ::AN6982::GFP-Stag::TtrpC ::argB ::TS2 This study
AN8820 (cnaA) TS1::PO7 ::AN8820::GFP-Stag::TtrpC ::argB ::TS2 This study
Continued on Next Page
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Plasmid Genotype Source
AN10077 TS1::PO7 ::AN10077::GFP-Stag::TtrpC ::argB ::TS2 This study
AN10138 TS1::PO7 ::AN10138::GFP-Stag::TtrpC ::argB ::TS2 This study
AN10281 TS1::PO7 ::AN10281::GFP-Stag::TtrpC ::argB ::TS2 This study
AN10570 TS1::PO7 ::AN10570::GFP-Stag::TtrpC ::argB ::TS2 This study
RFP TS1::PO7 ::rfp::TtrpC ::argB ::TS2 This study
GFP TS1::PO7 ::gfp::TtrpC ::argB ::TS2 This study
AN5859 TS1::PO7 ::AN5859::TtrpC ::argB ::TS2 This study
AN5894 TS1::PO7 ::AN5894::TtrpC ::argB ::TS2 This study
AN5955 TS1::PO7 ::AN5955::TtrpC ::argB ::TS2 This study
AN5966 TS1::PO7 ::AN5966::TtrpC ::argB ::TS2 This study
AN6030 TS1::PO7 ::AN6030::TtrpC ::argB ::TS2 This study
AN6062 TS1::PO7 ::AN6062::TtrpC ::argB ::TS2 This study
AN6091 TS1::PO7 ::AN6091::TtrpC ::argB ::TS2 This study
AN6166 TS1::PO7 ::AN6166::TtrpC ::argB ::TS2 This study
AN6178 TS1::PO7 ::AN6178::TtrpC ::argB ::TS2 This study
AN6195 TS1::PO7 ::AN6195::TtrpC ::argB ::TS2 This study
AN6221 TS1::PO7 ::AN6221::TtrpC ::argB ::TS2 This study
AN6223 TS1::PO7 ::AN6223::TtrpC ::argB ::TS2 This study
AN6293 TS1::PO7 ::AN6293::TtrpC ::argB ::TS2 This study
AN6295 TS1::PO7 ::AN6295::TtrpC ::argB ::TS2 This study
AN6325 TS1::PO7 ::AN6325::TtrpC ::argB ::TS2 This study
AN6385 TS1::PO7 ::AN6385::TtrpC ::argB ::TS2 This study
AN6420 TS1::PO7 ::AN6420::TtrpC ::argB ::TS2 This study
AN6492 TS1::PO7 ::AN6492::TtrpC ::argB ::TS2 This study
AN6508 TS1::PO7 ::AN6508::TtrpC ::argB ::TS2 This study
AN6536 TS1::PO7 ::AN6536::TtrpC ::argB ::TS2 This study
AN6549 TS1::PO7 ::AN6549::TtrpC ::argB ::TS2 This study
AN6569 TS1::PO7 ::AN6569::TtrpC ::argB ::TS2 This study
AN6575 TS1::PO7 ::AN6575::TtrpC ::argB ::TS2 This study
AN6650 TS1::PO7 ::AN6650::TtrpC ::argB ::TS2 This study
AN6687 TS1::PO7 ::AN6687::TtrpC ::argB ::TS2 This study
AN6696 TS1::PO7 ::AN6696::TtrpC ::argB ::TS2 This study
AN6715 TS1::PO7 ::AN6715::TtrpC ::argB ::TS2 This study
Continued on Next Page
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Plasmid Genotype Source
AN6733 TS1::PO7 ::AN6733::TtrpC ::argB ::TS2 This study
AN6762 TS1::PO7 ::AN6762::TtrpC ::argB ::TS2 This study
AN6788 TS1::PO7 ::AN6788::TtrpC ::argB ::TS2 This study
AN6814 TS1::PO7 ::AN6814::TtrpC ::argB ::TS2 This study
AN6828 TS1::PO7 ::AN6828::TtrpC ::argB ::TS2 This study
AN6849 TS1::PO7 ::AN6849::TtrpC ::argB ::TS2 This study
AN6900 TS1::PO7 ::AN6900::TtrpC ::argB ::TS2 This study
AN10763 TS1::PO7 ::AN10763::TtrpC ::argB ::TS2 This study
AN10789 TS1::PO7 ::AN10789::TtrpC ::argB ::TS2 This study
AN10809 TS1::PO7 ::AN10809::TtrpC ::argB ::TS2 This study
AN11918 TS1::PO7 ::AN11918::TtrpC ::argB ::TS2 This study
AN12045 TS1::PO7 ::AN12045::TtrpC ::argB ::TS2 This study
6.5 Chemical analysis of strains
Analysis was performed using UPHLC-DAD-TOFMS. The equipment used was an Agilent 6550 iFunnel Q-
TOF LC/MS system (Agilent Technologies, Torrence, CA, USA). This system comprised an Agilent 6550
orthogonal acceleration quadrupole time of ﬂight mass spectrometer (TOFMS) equipped with an iFunnel
ESI source, connected to an Agilent 1290 inﬁnity UHPLC. The column used was an Agilent Poroshell 120
phenyl hexyl 2.7 µm, 250 mm x 2.1 mm, and the column was maintained at 60 ◦C. A linear water-acetonitrile
(LCMS-grade) gradient was used (both solvents were buﬀered with 20 mM formic acid) starting from 10 %
(vol/vol) acetonitrile and increased to 100 % in 15 min, maintaining this ratio for 2.5 min before returning
to starting conditions in 0.1 min and staying there for 2.4 min before the next run. A ﬂow rate of 0.35
ml/min was used. TOFMS was performed in ESI+ with a data acquisition rate of 10 scans per second at
m/z 30-1700. The TOFMS was calibrated before each run sequence using a proprietary Agilent calibration,
using the Agilent ESI-L tuning mix. During analysis the lockmass solution, containing compounds forming
ions with m/z 186.2216 and m/z 922.0100, was constantly infused into the spray chamber using the IFunnel.
UV/VIS spectra were collected at wavelengths from 190 to 640 nm. Data processing was performed using
Agilent MassHunter B06.00. Tandem MS was performed with a fragmentation energy of 10, 20, and 40 eV,
respectively.
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Chapter 7
PHUSER (Primer Help for USER)
This chapter contains the published paper PHUSER (Primer Help for USER): a novel tool for USER fusion
primer design, published in Nucleic Acids Research, of which I am a co-author.
In this study we have developed a web-based program for designing primers that are compatible with the
uracil-excision (UE) cloning method. This program helps design primers for constructs to be inserted into
any UE-cassette, fusion of diﬀerent sequences with subsequent insertion into any UE-cassette, or fusion of
several sequences by UE-compatible overhangs but without inserting the sequence into a vector.
I have used this program to design primers for ampliﬁcation of A. niger PKS genes (see Chapter 8)
for heterologous expression in A. nidulans, some of which were used for testing the PHUSER program.
Furthermore, I have used the program to design primers for ampliﬁcation of A. nidulans phosphatases and
transcription factors, used for tunable over-expression at IS1 in A. nidulans (see Chapter 6).
My contribution to this study included assessment of program contents and user-friendliness, testing
usability of the PHUSER program, and experimental validation of primer ﬁtness. Supporting information is
included in Appendix C.
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ABSTRACT
Uracil-Specific Exision Reagent (USER) fusion is
a recently developed technique that allows for
assembly of multiple DNA fragments in a few
simple steps. However, designing primers for
USER fusion is both tedious and time consuming.
Here, we present the Primer Help for USER
(PHUSER) software, a novel tool for designing
primers specifically for USER fusion and USER
cloning applications. We also present proof-of-
concept experimental validation of its functionality.
PHUSER offers quick and easy design of PCR
optimized primers ensuring directionally correct
fusion of fragments into a plasmid containing a
customizable USER cassette. Designing primers
using PHUSER ensures that the primers have
similar annealing temperature (Tm), which is essen-
tial for efficient PCR. PHUSER also avoids identical
overhangs, thereby ensuring correct order of
assembly of DNA fragments. All possible primers
are individually analysed in terms of GC content,
presence of GC clamp at 30-end, the risk of primer
dimer formation, the risk of intra-primer comple-
mentarity (secondary structures) and the presence
of polyN stretches. Furthermore, PHUSER offers the
option to insert linkers between DNA fragments, as
well as highly flexible cassette options. PHUSER
is publicly available at http://www.cbs.dtu.dk/
services/phuser/.
INTRODUCTION
The assembly of several DNA fragments is a common
task in molecular biology and traditionally this has been
achieved by merging matching ends generated by restric-
tion endonucleases. However, this rarely allows for a
seamless fusion of two fragments, which is often desirable.
Moreover, the need for unique restriction sites at the site
of desired fusion can render the process practically unfeas-
ible for large DNA segments; and if possible, the process is
time consuming and tedious. A popular way to bypass
these obstacles is to merge DNA fragments by fusion
PCR (also known as overlapping PCR or overlap
extension PCR) (1). While this technique is suitable for
achieving seamless fusion, it requires PCR optimization
and the ampliﬁcation rate drops dramatically with an
increase in the number of fragments to be fused and/or
when the ﬁnal product size is >4 kb (2,3). USER fusion,
which allows rapid and efﬁcient assembly of multiple PCR
fragments in a one-step approach (4,5), offers a number of
advantages over traditional cloning procedures and fusion
PCR: (i) it is independent of restriction sites; (ii) it does
not require DNA ligase; (iii) it eliminates the need for
amplifying very large fragments and (iv) the ﬁnal chimer-
ical DNA fragment, which is inserted into the destination
vector, is generated from sequences that have only been
PCR ampliﬁed once, hence, reducing the amounts of PCR
generated errors that often compromise fragments fused
by PCR. The only requirement of USER fusion is
the presence of an A and a T separated by 8–20 bp’s in
the region that one wishes to fuse (see Figure 1 for an
overview of the process). This region is hereafter
referred to as segment. The design of the primers for
*To whom correspondence should be addressed. Tel: +1 617 582 7951; Fax: +1 617 632 3351; Email: lronn@bio.dtu.dk
Correspondence may also be addressed to Uffe Mortensen. Tel: +45 45252701; Fax: +45 45884148; Email: um@bio.dtu.dk
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PCR ampliﬁcation of the DNA fragments is based on
these segments, and after PCR ampliﬁcation the DNA
fragments are treated with USERTM reagent and will
self-assemble in a pretreated plasmid containing a USER
cassette. The independence from restriction sites, along
with the fact that USER fusion does not require
subsequent rounds of PCR (as fusion PCR does), makes
the method particularly favourable.
Given that USER fusion is based on a single-step
cloning approach, the design of good primers is essential
for ensuring correct and efﬁcient fusions. Designing
primers for USER applications is a tedious and time
consuming task to perform manually, due to the number
of factors (e.g. deﬁning the USER tails, making compat-
ible ends that can be joined in an orderly fashion, ensuring
uniform Tm, avoiding hairpins and primer dimer forma-
tion), which must be taken into account. To address this
problem, we have developed the PHUSER (Primer Help
for USER) primer design software that employs a simple,
yet powerful algorithm to determine the best primers for
D
C
B
A
Figure 1. Overview of the USER fusion process. (A) PCR ampliﬁcation of target DNA using uracil containing primers and a proofreading
polymerase which does stall at uracil during PCR. (B) The PCR products are treated with the uracil DNA glycosylase and DNA glycosylase–
lyase Endo VIII enzyme mix (USERTM), creating 30 extensions. The primer design allows complementary hybridization of overhangs between
fragments. (C) The overhangs (purple) match extensions of a prepared USER compatible vector. Complementary base paring facilitates self-assembly
of the fragments and the vector. The construct is now ready for transformation in E. coli. (D) Preparation of USER compatible vector is done
by digestion of the USER cassette with restriction and nicking enzymes.
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USER fusion, evaluated based on a number of parameters
described in the ‘Results page’ section of this article.
PHUSER is user friendly and signiﬁcantly simpliﬁes the
primer design step of USER fusion of multiple DNA
fragments.
SOFTWARE FEATURES
PHUSER is available as an easy-to-use web server aimed
at molecular biologists, as well as a downloadable UNIX
command-line tool aimed at more technically oriented
users to whom a scriptable interface to the program is
desirable. The web server has been tested in Internet
Explorer, Firefox and Safari on Mac OSX, Linux and
Windows. The command-line tool is written in Perl with
a Python wrapper, and will thus be compatible with most
existing computer platforms.
Primer design
The input data for the program are any number of DNA
fragments in FASTA format, and a USER cassette con-
sisting of a restriction site and a nicking site, which
matches the cassette to be used in the destination vector.
Based on this input, PHUSER will identify all segments in
proximity of the joining region [i.e. the junction between
two DNA fragments (4)] of the DNA fragments
containing a dTTP located 8–20 bases downstream of an
dATP. This typically gives rise to a number of joining
regions, which will produce overhang in the length of
8–20 bases, also called fusion tails. When fusing more
than two DNA fragments, unique fusion tails must be
used to ensure that the fusion of fragments occurs in the
correct order. There is no computational limit as to how
many fragments can be processed using PHUSER,
although the number of unique fusion tails may be
exhausted if multiple fragments are submitted. Six frag-
ments have been reported successfully fused in a single
process (6), but the practical experimental limitations
have yet to be established.
The part of the primer that binds to the target DNA is
here referred to as the binding region. The desired length
of a primer binding region is 18–24 bp (7), leading to seven
potential primer lengths for both the forward and reverse
strand. The selection of the pair of primers is based
on matching the annealing temperature, Tm; the Tm is
calculated for the binding region part of the primer
only. For a given primer pair, the primers’ Tm should be
within 2C of each other, in order to achieve efﬁcient PCR
ampliﬁcation (8). The Tm for every possible forward and
reverse primer is calculated using the nearest neighbor
method (9), and pairs that obey the 2C rule are stored.
If no primers obey the rule, the pairs that have the lowest
Tm difference are processed further. In the event that
fusion tails are identical, PHUSER compares all the
primer pairs, disqualiﬁes pairs with identical fusion tails
and selects the next best Tm match as the best primer pair.
Cassette options
PHUSER features a choice of ﬁve predeﬁned USER
cassettes: (i) PacI/Nt.BbvCI (10); (ii) XbaI(2)/Nt.
BbvCI (http://www.neb.com/nebecomm/ManualFiles/
manualE5500.pdf) (11); (iii) AsiSI/Nb.BsmI (12); (iv)
PmeI/Nb.BbvCI; and (v) AsiSI/Nb.BtsI (12). Linear
assembly (12) is also supported, when PHUSER is used
without selecting a USER cassette. Furthermore, users
have the option to tailor their own cassettes (see
‘Query page’ section).
Linker insertion
Lastly, PHUSER enables the insertion of linkers between
the DNA fragments. This is done simply by including
a FASTA entry between the fragments with the header
‘>linker’.
WEB INTERFACE FOR PHUSER 1.0
Query page
The PHUSER query page is designed to be simple and
intuitive with a tabbed-based interface separating basic
from advanced options. DNA sequences can be submitted
in FASTA format either by copy/pasting or uploading
a text ﬁle containing the sequences. PHUSER has a
built-in feature to divide large fragments into several
shorter fragments for PCR. The desired maximum
length of the PCR products can be adjusted in the drop-
down menu titled ‘Automatic adjustment of maximum
PCR product length’. If this option is used, PHUSER
will automatically split the input sequence into a number
of subsequences each below the deﬁned threshold
and design fusion primers for them all. This makes it
possible to input a single large sequence (which would
be considered too long for efﬁcient PCR) and let the
program take care of the entire process of designing
primers for USER fusion for this particular sequence.
PHUSER offers three options for cassette selection,
one basic and two advanced. The tab titled (i) ‘Basic:
Predeﬁned fusion cassettes’ allows for selection of one of
the ﬁve predeﬁned cassettes described above. The tab
titled (ii) ‘Advanced: Select restriction/nicking pair’
allows users to custom design a cassette by selecting
restriction and nicking enzymes, and entering directional
bases. The tab titled (iii) ‘Advanced: User designed cas-
settes’ allows users to enter a custom cassette with the
format:
50-GCTGAGGGTTTAAT.TAAGACC.TCAGC-30
The ﬁrst period indicates the position of the restriction site
and the second period indicates the position of the nicking
site. This needs to be entered for both the forward and
the reverse strand of the custom cassette.
Results page
Once the desired inputs are submitted, the user will be
presented with the results page (Figure 2). The results
report is divided into four sections:
(i) Overview of the primers (50–30),
(ii) Graphic overview of the DNA fragments, primers
and their interaction,
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(iii) Primer details including assessment of the param-
eters presented in the ‘Primer design’ section and
(iv) The ﬁnal construct after USER fusion.
The quick overview of the primers is written in 50 to 30
direction and includes the dUTP. The graphical overview
of DNA fragments and primers provides a visual presen-
tation of where the primers anneal to the template se-
quences. This is followed by the primer details, showing
more speciﬁc information regarding each primer. Apart
from Tm, this section includes assessment of the following
parameters.
Figure 2. Result page of the PHUSER web-server. Here a detailed colour-coded report summarizing the main ﬁnding of the primer design is shown,
and the user has the option of downloading the primers in FASTA format as well.
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GC content. The GC content (number of dGTP plus
dCTP as a percentage of the total number of nucleic
acid residues) should ideally be between 40% and 60%,
to keep annealing temperature within a favourable
range (9).
Presence of 30-end GC clamp. Due to the stronger anneal-
ing of guanine and cytosine with complementary bases,
speciﬁc binding is promoted by the presence of at least
one of either of these bases in the last ﬁve bases of the
30-end (GC-clamp). However, if more than three out of the
last ﬁve bases at the 30-end are guanine or cytosine,
the binding to the DNA fragment may be too strong (8).
Risk of Inter- and intra-primer complementarity. Stretches
of more than ﬁve complimentary bases between different
primers used in the same PCR can lead to primer dimer
formation, which can interfere with the desired hybridiza-
tion. Similarly, stretches of more than three compli-
mentary bases within a primer can lead to formation of
intra-primer secondary structures, resulting in reduced
PCR efﬁciency. With PHUSER the risk of inter- and
intra-primer complementarity is assessed based on the
relationship between the Tm of the primer and the com-
plimentary bases potentially leading to undesirable
dimerization or intra-primer secondary structures.
If the Tm of the potential inter-primer dimerization or
intra-primer secondary structure formation is at least
10C smaller than that of the annealing temperature
used in the PCR cycle, the risk of complementarity is
considered theoretical, since most of the DNA which
could undesirably hybridize is denatured at this higher
temperature.
Presence of polyN stretches. Sequences consisting of four
or more consecutive identical nucleotides within the
primer are known as polyN stretches; polyG or polyC
stretches promote non-speciﬁc annealing (8), whereas
polyA or polyT can cause the ‘opening’ of stretches of
the primer template complex, referred to as ‘breathing’(8).
The assessment of each parameter is highlighted in
either green (signifying a positive assessment) or red
(signifying a negative assessment)—see Figure 3 for an
example. Note that the primer parameters used for
primer design are supplied only to evaluate the efﬁciency
of a speciﬁc ampliﬁcation and not the competence of the
ampliﬁcation. Therefore, the lack of positive assessment in
any parameter (or all parameters) does not preclude a
useful PCR outcome.
The last section shows the ﬁnal product, which will be
the result of assembling the sequences into the cassette
using USER fusion. The user also has the option to
download text ﬁles of the report as shown on the screen,
or only the best primers in FASTA format, which can be
directly used to order the primers.
PROOF OF CONCEPT
Polyketide synthases (PKSs) are complex enzymes
encoded by large genes (10 kb), and PCR ampliﬁcation
of genes of such lengths is very challenging. One way to
overcome this problem is to amplify sections of PCR
friendly sizes, followed by fragment reassembly to attain
the original gene. USER fusion is a powerful method for
assembly of such large genes. In this study, USER fusion
was applied for the cloning of six genes encoding putative
PKSs of known sequence from Aspergillus niger (Table 1).
As proof of concept of PHUSER, the software was
used for the design of primers (Supplementary Table S1).
According to size, the six PKS genes were ampliﬁed as
2, 3, 4 or 5 fragments generating a total of 21 PCR
Figure 3. Primer details from the PHUSER report. The desired properties are colour-coded in green and undesired properties are encoded in red.
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products. Prior to transformation into chemically compe-
tent E. coli, the fragments of the individual genes (ﬁve
fragments at the most) were puriﬁed and mixed in equal
quantities with the prepared cloning vector pU1111-1 and
treated with USERTM mix. pU1111-1 is a 12 kb expres-
sion vector for Aspergillus nidulans, including a gpdA
promoter, an AsiSI/Nb.BtsI USER cassette, TrpC
terminator and an argB marker ﬂanked by UP- and
DOWN-stream sequences for targeted insertion (12).
Transformants were selected on LB media containing
100mg/ml ampicillin, and the plasmids were puriﬁed and
tested by restriction analysis. Despite the complexity of
the six vector construction reactions, we found that in
all cases, 50% or more of the transformants tested con-
tained a plasmid with the correct conﬁguration of inserts
(Table 1). Furthermore, a selection of these plasmids was
sequenced (StarSeq, Germany) conﬁrming error-free
sequence and assembly of all six genes. The false positives
observed contained no insert and were therefore caused by
incompletely digested pU1111-1. In other USER cloning
experiments, we have shown that such false positives can
be avoided by prolonged digestion with AsiSI/Nb.BtsI.
For further details, please see Supplementary Data.
The experiment demonstrates that the use of PHUSER
for primer design results in a highly efﬁcient cloning
procedure.
Experimental details of the proof of concept study are
found in the Supplementary Data.
CONCLUSION
USER fusion is considered an attractive alternative to
classical restriction–ligation-based cloning, since it offers
simplicity, speed and high efﬁciency. However, the
laborious nature of manually designing good primers is
a bottleneck in creating fusion constructs (10,13–15).
PHUSER makes the design of good primers quick and
easy, and will reduce the time needed to get from
strategy to result signiﬁcantly. Consequently, PHUSER
in combination with USER fusion offer means to
advance high-throughput generation of constructs. This
allows for, e.g. simple construction of gene expression
libraries and for vectors expressing genes encoding
proteins that are fused to an epitope-tag, a puriﬁcation-tag
or to a ﬂuorescent protein-like GFP. We have shown that
PHUSER can be used to design primers that have been
experimentally shown to be efﬁcient, by successful
assembly of up to ﬁve PCR fragments in a single
reaction with a success rate of 50% or higher for the six
genes tested. PHUSER also supports different usages of
the USER based cloning method, such as homologous
recombination for library construction (13) and linear
template construction (14). All these features render
PHUSER not only an efﬁcient, but also a very ﬂexible
tool for designing primers for USER fusion.
SUPPLEMENTARY DATA
Supplementary data are available at NAR Online.
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Chapter 8
Heterologous expression of polyketide
synthases in A. nidulans
This study was the ﬁrst study I conducted during my Ph.D., and it formed the basis for some of the other
studies presented in this thesis. This study provided insights into A. niger secondary metabolism, which I
have used for subsequent in-depth investigation of selected biosyntheses. Additionally, the study was used to
assess the use of A. nidulans as a host for heterologous gene expression and reveal the obstacles in semi-HTP
or HTP strain construction.
8.1 Introduction
The genome sequence and annotation of A. niger ATCC1015 was released to the public in 2006 [Baker, 2006],
and is available from the DOE Joint Genome Institute database1. Investigation of the genome had shown
that the A. niger genome encoded no less than 37 putative PKS and PKS-like enzymes [Fisch et al., 2009],
which was a number that greatly exceeded the number of known polyketide compounds from this species
[Nielsen et al., 2009]. A very important observation was that the A. niger genome contained a gene cluster
that was very similar to the fumonisin gene cluster in Gibberella moniliformis [Pel et al., 2007, Andersen
et al., 2011, Proctor et al., 2003]. Further investigation of the metabolite proﬁles of diﬀerent A. niger strains
indeed veriﬁed that some strains of A. niger do produce the carcinogenic fumonisin compounds [Frisvad
et al., 2007, 2013].
Fumonisins are produced by some industrial strains of A. niger [Frisvad et al., 2013], but the fact that
A. niger has been used in industrial fermentations for many years without anyone reporting the presence of
fumonisin, raises the question of whether or not this important workhorse is capable of producing any other
harmful compounds that have not yet been reported. On the other hand, A. niger might be able to produce
1http://genome.jgi-psf.org/Aspni5/Aspni5.home.html
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new compounds that could be exploited for commercial purposes e.g. pigments or pharmaceuticals.
As many gene clusters are silenced under certain circumstances, it is very likely that some of these genes,
if intact, are not expressed under standard laboratory or industrial cultivations. Based on this hypothesis,
it should be possible to identify new compounds by heterologously expressing the putative PKS encoding
genes under control of a constitutive promoter. In this study, I heterologously expressed the 37 putative
PKS, PKS-like, and hybrid PKS/NRPS genes from A. niger. The PKSs were expressed in the model fungus
A. nidulans using the characterized expression system developed by Hansen and co-workers [Hansen et al.,
2011]. Using this system, the genes were placed under control of the strong, constitutive promoter PgpdA
[Punt et al., 1990, 1991], and expressed from a constitutively expressed integration site, IS1 [Hansen et al.,
2011].
A. niger is very well-studied with regard to production of secondary metabolites. Strains of A. niger
primarily produces compounds that belong to the groups: fumonisins (PKs), naphtho-γ-pyrones (PKs),
bicoumarins (PKs), malformins (NRPs), and asperazines (alkaloids) (selected compounds are shown in Figure
8.1) (reviewed by Nielsen et al. [2009]). A. niger produces very few terpenoid compounds, however compounds
of the yanuthone family are produced in high amounts in the strain used in this study (see datails in Chapter
10). During the past three years there have been a lot of advances within the ﬁeld of linking genes to their
corresponding metabolite(s) in A. niger. The metabolites that have been linked to genes are shown in Table
8.2.3, and the applied approaches have been discussed in Chapter 2.
8.2 Results and discussion
8.2.1 Heterologous expression of 37 putative PKSs links three PKSs to a com-
pound
PKSs were chosen based on the genomic mining study performed by Fisch and co-workers [Fisch et al., 2009],
an overview is shown in table 8.2.3. The genes were PCR ampliﬁed from KB1001 in one or two pieces,
depending on the size of the gene. Generally, genes longer than 8 kb were split in two. The genes were
inserted into the CMBU1111 plasmid [Hansen et al., 2011] which contains the constitutively active promoter
PgpdA, terminator TtrpC and the argB marker, ﬂanked by upstream (TS1) and downstream (TS2) targeting
sequences for insertion into IS1 (Figure 8.2).
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Figure 8.1: Selected A. niger secondary metabolites.
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Figure 8.2: Cloning vector pCMBU1111.
All plasmids were veriﬁed by restriction analysis, linearized, and transformed into A. nidulans strain
NID3 (contains a transient disruption of nkuA). Two of the resulting strains (ASPNIDRAFT_56896 (56896)
and ASPNIDRAFT_191422 (191422)) had visible new phenotypes: 56896 produced vast amounts of a yellow
compound and 191422 produced a slightly yellow pigment which was vaguely visible to the eye when looking
at the fungus (see Figure 8.3). Moreover, it seemed that expression of both 191422 and 56896 resulted in
darker conidia, which made the fungus appear larger compared to the reference where the outermost part of
the colony is whitish transparent due to lack of conidial pigmentation.
Figure 8.3: Phenotypes ofA. nidulans expressing the ASPNIDRAFT_191422 and ASPNIDRAFT_56896
genes.
The metabolite proﬁles of all transformants were analyzed by HPLC-DAD-TOFMS. The results showed
that two of the strains, expressing ASPNIDRAFT_44965 (44965) and 56896, produced a new compound
compared to the reference (Figure 8.4). Interestingly, there was no detection of a new compound in the
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strain expressing 191422, which displayed an altered phenotype (Figure 8.4).
Dereplication of the compound produced by 44965, and comparison to an authentic standard, conﬁrmed
that this PKS produced the small aromatic compound 6-methylsalicylic acid (6-MSA) (data shown in Chapter
10). The discovery of this compound was the beginning of uncovering the entire biosynthetic pathway towards
the antibiotic and antifungal compound yanuthone D, which is described in chapter 10.
Dereplication of the compound produced by 56896 identiﬁed YWA1 as the PKS product. This compound
was previously described for A. nidulans as the building block for green melanin, which is the green conidial
pigment that gives A. nidulans its characteristic green color [Watanabe et al., 1999]. Examination of 56896
and 191422 later revealed that both of these PKSs produce YWA1, which is the precursor to naphtho-γ-
pyrones and black melanin in A. niger. These ﬁndings are presented in detail in chapter 9.
8.2.2 Co-expression with discrete thioesterases did not provide any new com-
pounds
An interesting observation for the PKSs that provided a product was that they all contained a release domain,
and the remaining PKSs did not contain an obvious release domain (see Table 8.2.3). This domain is essential
for release of the ﬁnal compound from the PKS. Although it is not obvious, it was recently shown that the
6-MSA synthase contains a thiohydrolase (TH) domain rather than a dehydrogenase (DH) domain, and this
TH domain is responsible for release of 6-MSA from the PKS [Moriguchi et al., 2010].
Analysis of the gene clusters revealed that three of the PKSs contained a discrete thioesterase domain
within the proposed cluster: ASPNIDRAFT_44005 (44005), ASPNIDRAFT_179079, and ASPNIDRAFT_
179585. The three thioesterases were co-expressed from a plasmid (pDHX2) in the strains harboring the
respective PKSs. The strains were analyzed by HPLC-DAD-TOFMS but no new compounds were detected
for any of the strains (data not shown).
8.2.3 Gene deletion links 44005 to asperrubrol
Puzzled, and intrigued, by the lack of new compounds I set out to investigate why no other compounds were
produced. As a test case, I chose to delete 44005 in A. niger and examine the metabolite proﬁle. Surprisingly,
the 44005∆ strain failed to produce asperrubrol - a compound which has so far been reported as a terpene
(Figure 8.5) [Rabache et al., 1974, Nielsen et al., 2009].
Besides the thioesterase, examination of the genes surrounding 44005 revealed several activities including
an NRPS. The presense of a putative NRPS in the proposed cluster was surprising, as asperrubrol does not
contain any nitrogen atoms. Therefore, I also deleted the NRPS gene, but I did not detect any changes in
the metabolite proﬁle for the NRPS∆ strain (Figure 8.5).
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Figure 8.4: Dereplication of new compounds. A. DAD chromatogram of the strains expressing 44965, 56896,
and 191422 in comparison to a reference. B. Mass spectra of the compound produced by 44965 (TOP) and of
the compound produced by 56896 (BOTTOM). C. UV spectra of the compound produced by 44965 (TOP)
and of the compound produced by 56896 (BOTTOM).
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Figure 8.5: BPC and EIC chromatograms of the 44005∆ and the NRPS∆ strains. [M+H]+ (asperrubrol) =
337.1798
I investigated the remainder of proposed cluster genes, and via BLAST analysis I found that 190482 had
homology to amino acid permeases, which are enzymes involved in transport of amino acids into the cell.
Furthermore, the BLAST analysis showed that 50432 is homologous to phenylalanine ammonia lyases (PALs),
which convert phenylalanine into cinnamic acid. 44006 is homologous to 4-coumarate-CoA ligases, catalyzing
attachment of Coenzyme A (CoA) to 4-coumarate, which is a compound that is identical to cinnamic acid,
but with a hydroxyl on the aromatic ring.
Based on the enzyme activities encoded by the proposed gene cluster, I have suggested a model for
biosynthesis of asperrubrol in A. niger (Figure 8.6). In this model I propose that the role of the putative
amino acid permease (190482) is to transport phenylalanine across a plasmamembrane, be it into the cell
or into a speciﬁc compartment of the cell. Next, phenylalanine is converted into cinnamic acid by the PAL
(50432) and the cinnamic acid is attached to a CoA, catalyzed by a cinnamic acid ligase (44006). Cinnamic
acid-CoA then serves as a starter unit to the PKS (44005), which performs ﬁve rounds of elongation while
reducing three ketides to double bonds and attaching two methyl groups. The demethylasperrubrol compound
is then released from the PKS by the thioesterase (44004). As there are no reports of O-methyl transferase
activity within a PKS the ﬁnal methyl group must be attached post synthesis, however this activity is
not obviously encoded by any gene in the proposed cluster. The asperrubrol compound was identiﬁed by
dereplication, and has not been compared to an authentic standard or investigated by NMR. Thus, it is
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possible and even likely that the ﬁnal methyl group is not an O-methyl group, but a C-methyl group that has
been attached somewhere else on the PK chain by the PKS. There are many diﬀerent reports on the structure
of asperrubrol and the similar structure asperenone/aspergellone when comparing data from Antibase2010,
Nielsen et al. [2009], and original litterature e.g. [Rabache et al., 1974]. Thus I suspect that there are many
diﬀerent analogues of these compounds, and that they are strain speciﬁc within the group of black Aspergilli.
Figure 8.6: Proposed biosynthesis of asperrubrol in A. niger.
In order to test my model, I heterologously expressed the PAL (50432) in A. nidulans to verify that it
did produce cinnamic acid. Inspection of the resulting metabolite proﬁle and comparison to an authentic
cinnamic acid standard conﬁrmed that cinnamic acid was indeed the product of the PAL (Figure 8.7). As
expected, the A. nidulans reference strain did not produce detectable amounts of cinnamic acid.
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Figure 8.7: EIC chromatograms of IS1-50432 and reference compared to a cinnamic acid standard. [M+H]+
(cinnamic acid) = 149.0598 Da.
Investigation of this gene cluster indeed clariﬁed why heterologous expression of the PKS, and even in
combination with the TE, did not provide any products. I have shown that the 44005 PKS is dependent on
an alternative starter unit, cinnamic acid, which is not produced in A. nidulans. Additionally, I have linked
a PKS to a known A. niger compound and importantly, I have found that a compound that was originally
proposed to be of terpenoid origin, is in fact a PK that uses cinnamic acid (phenylalanine-derived) as a
precursor.
This study is not representative of all the PKSs that did not produce a compound by heterologous
expression, however, it does provide a valuable insight into the complexity of PK synthesis. It also indicates
that some of the partly or highly reducing PKSs may in fact produce known compounds that have previously
been regarded as terpenoids. Table 8.2.3 shows the putative and characterized PKSs in A. niger, and the
compounds that have been linked to them as per August 2013 (including unpublished data obtained in this
study).
Table 8.1: A. niger PKSs. *ASPNIDRAFT_#, 1[Gil Girol et al., 2012]**, 2[Zabala et al., 2012], 3[Li et al.,
2011b], 4[Pel et al., 2007, Frisvad et al., 2007, Khaldi and Wolfe, 2011]
.
Model ID* Length (bp/aa) Exons Domains (CDD) PKS product
37260 7823/2463 9 KS AT DH ER  MT  ACP KR
39026 7405/2122 12 KR AT DH - ER KR ACP
41618 11394/3538 14 KS AT DH MT  KR ACP C A ACP
41846 5565/1855 1 A ACP KS AT ACP
43495 8213/2314 19 KS AT DH MT ER KR ACP
44005 7444/2474 2 KS AT DH MT  KR ACP Asperrubrol (this study)
Continued on Next Page
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Table 8.1  Continued
Model ID* Length (bp/aa) Exons Domains (CDD) PKS product
44965 5340/1780 1 KS AT DH(TH) KR ACP 6-MSA (this study)
47991 7612/2433 6 KS AT DH MT ER KR ACP
51499 5419/1718 5 KS AT  ACP Coumarins1
56896 6755/2129 6 AT KS AT  ACP TE YWA1 (this study)
56946 7915/2600 3 KS AT  ACP TE Azaphilones2
118581 11427/3760 5 KS AT DH KR KR ACP C A ACP TR
118598 8422/2441 15 KS AT DH MT ER KR ACP
118617 8542/2472 19 KS AT DH  ER KR ACP
118624 11791/3645 7 KS AT DH MT KR C A ACP TR
118629 7409/2442 3 KS AT DH  KR ACP
118644 11948/3706 7 KS AT DH  KR ACP C A ACP TR
118666 6733/2199 4 KS AT ACP  ER KR ACP
118744 7394/2347 5 KS AT DH MT ER KR ACP
128601 11657/3779 3 KS AT DH MT KR C A ACP (TR)
128638 6984/2202 6 KS AT DH  ER KR ACP
138585 7869/2421 11 KS AT DH MT ER KR ACP
171221 8222/2358 10 KS AT DH MT ER KR
176722 12144/3942 6 KS AT DH MT  ACP C A ACP TR
179079 8683/2668 10 KS AT DH MT ER KR ACP
(179462) SAT KS AT PT ACP Tetracyclins3
179585 7090/2347 2 KS AT DH KR ER ACP
181803 8305/2591 9 KS AT DH MT ER KR ACP
187099 7099/2211 3 KR AT DH  ER KR ACP
188697 8178/2469 14 KS AT DH  ER KR ACP
188817 8248/2534 11 KS AT DH MT ER KR ACP
190014 7760/2517 4 KS AT ACP MT TR
191422 6664/2122 7  KS AT  ACP TE YWA1 (this study)
191702 8153/2494 13 KS AT DH MT ER KR
194381 6957/2104 3 KS AT DH ACP MT
210217 8194/2560 8 KS AT DH MT ER KR ACP
211885 7996/2443 10 KS AT DH MT KR ACP
225574 8010/2527 7 KS AT DH MT ER KR ACP Fumonisin4
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8.3 Assessment of A. nidulans as a host for heterologous PKS ex-
pression
8.3.1 Only three compounds were linked to a PKS
As only three compound were produced (and only two detected by metabolite proﬁle analysis) from heterol-
ogous expression of 37 genes, the success rate was indeed low (8.1 %). Although, there are many possible
explanations for this result, some are more likely than others.
Were the genes correctly transcribed? The main question here is whether or not the ORFs of the genes
were correctly predicted. I have used the automated FGeneSH gene prediction applied on the Joint Genome
Institute (JGI) database. With only little knowledge of PKSs, it is quite possible that some of the predictions
are wrong. Curiously, this was in fact the case when it was ﬁrst discovered that YWA1 was the product of WA
in A. nidulans; Watanabe and co-workers ﬁrst reported that WA produced the polyketide citreoisocoumarin,
which is a bicyclic compound with a C5 side chain [Watanabe et al., 1998]. Later they realized that they had
used a C-terminal truncated version, which lacked part of the TE domain. Expression of the correct ORF
resulted in production of YWA1, which is the true polyketide product of WA [Watanabe et al., 1999].
Are the genes correctly translated and functional? All the PKSs, except one, contain introns. There is, to
the best of my knowledge, no studies on the evolution of introns or splicing of introns, why it is possible that
A. nidulans is unable to correctly splice some of the introns from A. niger leading to wrong translation of
the mRNA. Moreover, even if the mRNA is translated correcly the huge enzyme may not be able to fold in
a correct manner. The PKS may depend on co-factors for proper allostery, or on other proteins for protein-
protein interactions. This may be with respect to formation of an active enzyme complex, or delivery or
reception of the PK compound from another enzyme: The PKS may depend on the delivery of a starter unit
before synthesis can occur, or it may be dependent on another enzyme to receive or release the PK compound
once the PKS has ﬁnished synthesis. When assessing the research that has been done on fungal PKSs within
the past ﬁve years, it seems as there are only few PKSs that are not dependent on alternative starter units
or external release mechanisms. Some of the PKSs that are independent of such comprise mostly 6-MSA
synthases and non-reducing PKSs e.g. YWA1 synthases and orsellinic acid synthases. Some gene clusters
comprise two synthases which must both be expressed in order to synthesize the ﬁnal compound, which is the
case for e.g. lovastatin and the recently described azanigerones [Zabala et al., 2012]. Furthermore, alternative
starter unit are emplyed by several PKSs: the sterigmatocystin/aﬂatoxin PKS uses a hexanoyl-CoA starter
unit that is produced by a fatty acid synthase embedded in the gene cluster [Crawford et al., 2006], and the
asperrubrol PKS from A. niger is dependent on a cinnamic acid starter unit (this study).
In my personal opinion, the latter option seems the most probable as the synthesis of PK compounds is
very complex, and has a high degree of variability. However, I would assume that problems with wrong gene
prediction and maybe even wrong intron splicing may be the case for a few of the PKSs.
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Based on the fact that there was so many parameters to assess in order to fully understand the outcome
of this study, I decided not to submit this study for publication. Rather, I used the results of the study to
perform in-depth studies on the PKSs that did provide new compounds. Additionally, I used this semi-high
throughput (semi-HTP) study to locate bottlenecks and assess current tools available for strain construction.
8.3.2 There are obvious bottlenecks in HTP strain construction
As brieﬂy mentioned above, this semi-HTP study also served as a test-case for performing HTP strain
construction. Doing so, I identiﬁed several bottlenecks which preferrably should be assessed and resolved
before initiating a HTP strain construction study.
Screening of clones could be tedious, and the cloning eﬃciency varied from batch to batch. Generally,
the uracil-excision cloning system is very robust and has a high eﬃciency, but it does have one disadvantage:
digestion of the cassette. Recall that a uracil-excision cassette contains a restriction site ﬂanked by two
nicking sites. When digested the vector is linearized by the restriction enzyme, and the ends are processed by
the nicking enzyme to form 6-8 nt single-stranded overhangs. If not fully digested, the reaction will contain
both correctly digested vector, partially digested vector and intact vector. The two latter variants will result
in false positive clones, increasing the work load for screening of clones. One way to address this issue is
by elimination of the UE cassette, and merely fuse PCR fragments. This is indeed possible, however, the
cloning eﬃciency decreases as the number of fragments increases. Therefore this approach is not suitable for
a HTP study. Another way to address the problem is by inserting a reporter gene or a killer gene into the
UE cassette, which will be disrupted if the fragment is inserted into the vector. This was the principle of the
old-fashioned pBluescript vectors which contain a lacZ gene with a multiple cloning site, resulting in a color
change of the colony from blue to white when exposed to X-gal if the gene was inserted into the multiple
cloning site.
Screening of fungal transformants is a hazzle. The quick and dirty solution for screening fungal trans-
formant is spore PCR, the fungal equivalent of colony PCR. However easy, this method is not very robust,
and often it does not work. Therefore it may be necessary to extract genomic DNA, and subject it to PCR
analysis e.g. in combination with southern blot analysis. This approach works well, and is not considered
laborious when constructing a single strain. However, when constructing several strains, this step becomes
extremely tedious and time consuming.
I have addressed the above mentioned obstacles in HTP strain construction by developing a background-
free cloning vector that contains the ccdB suicide gene in between two identical UE cassettes. This allowed
for background-free insertion of genes into the vector, and is highly suitable for HTP plasmid construction.
Furthermore, I have developed a background-free transformation system for heterologous or ectopic gene ex-
pression in A. nidulans, which exploits use of a color marker for eﬃcient veriﬁcation of correct transformants.
These tools are described in Chapter 3, and have been applied throughout this study.
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8.4 Experimental
8.4.1 Fungal strains
The A. nidulans strain NID3 (argB2 pyrG89 veA1 nkuA-trS ) [Nielsen et al., 2008] was used as a reference
and for insertion of all genes. For A. niger, KB1001 (pyrG∆ kusA::AFpyrG) [Chiang et al., 2011] was used as
a reference and for gene deletions. A. niger deletion strains comprised a 44005∆ strain (pyrG∆ kusA::AFpyrG
ASPNIDRAFT_44005∆::hph) and a NRPS∆ strain (pyrG∆ kusA::AFpyrG ASPNIDRAFT_190891∆::hph).
Table 8.2: A. nidulans strains used and constructed in this study. oriR* contains a point mutation eliminating
a Nb.BtsI nicking site.
Strain Genotype Source
Strain Genotype Source
NID3 argB2 pyrG89 veA1 nkuA-trS [Nielsen
et al., 2008]
37260 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_37260::TtrpC ::argB This study
39026 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_39026::TtrpC ::argB This study
41618 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_41618::TtrpC ::argB This study
41846 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_41846::TtrpC ::argB This study
43495 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_43495::TtrpC ::argB This study
44005 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_44005::TtrpC ::argB This study
44005+TE argB2 pyrG89 veA1 IS1::PgpdA::ASPNIDRAFT_44005::TtrpC ::argB pDH121 This study
44965 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_44965::TtrpC ::argB This study
47991 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_47991::TtrpC ::argB This study
51499 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_51499::TtrpC ::argB This study
56896 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_56896::TtrpC ::argB This study
56946 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_56946::TtrpC ::argB This study
118581 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_118581::TtrpC ::argB This study
118598 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_118598::TtrpC ::argB This study
118617 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_118617::TtrpC ::argB This study
118624 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_118624::TtrpC ::argB This study
118629 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_118629::TtrpC ::argB This study
118644 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_118644::TtrpC ::argB This study
118666 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_118666::TtrpC ::argB This study
118744 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_118744::TtrpC ::argB This study
128601 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_128601::TtrpC ::argB This study
Continued on Next Page
161
Table 8.2  Continued
Strain Genotype Source
128638 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_128638::TtrpC ::argB This study
138585 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_138585::TtrpC ::argB This study
171221 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_171221::TtrpC ::argB This study
176722 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_176722::TtrpC ::argB This study
179079 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_179079::TtrpC ::argB This study
179079+TE argB2 pyrG89 veA1 IS1::PgpdA::ASPNIDRAFT_179079::TtrpC ::argB pDH123 This study
179585 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_179585::TtrpC ::argB This study
179585+TE argB2 pyrG89 veA1 IS1::PgpdA::ASPNIDRAFT_179585::TtrpC ::argB pDH122 This study
181803 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_181803::TtrpC ::argB This study
187099 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_187099::TtrpC ::argB This study
188697 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_188697::TtrpC ::argB This study
188817 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_188817::TtrpC ::argB This study
190014 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_190014::TtrpC ::argB This study
191422 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_191422::TtrpC ::argB This study
191702 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_191702::TtrpC ::argB This study
194381 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_194381::TtrpC ::argB This study
210217 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_210217::TtrpC ::argB This study
211885 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_211885::TtrpC ::argB This study
225574 argB2 pyrG89 veA1 nkuA-trS IS1::PgpdA::ASPNIDRAFT_225574::TtrpC ::argB This study
8.4.2 Media
Minimal medium for A. nidulans was made as described in [Cove, 1966] but with 1% glucose, 10 mM NaNO3
and 2% agar. Minimal medium for A. niger was prepared as described in [Chiang et al., 2011]. YES, MEA
and CYA media were prepared as described by Frisvad and Samson [Samson et al.]. When necessary, media
were supplemented with 4 mM L-arginine, 10 mM uridine, 10 mM uracil, and/or 100 µg/ml Hygromycin B
(Invivogen, San Diego, CA, USA).
8.4.3 PCR, cloning and transformation
Primers for ampliﬁcation of genes were designed using the Primer Help for USER software (PHUSER) [Olsen
et al., 2011]. All primers are listed in Table 8.4.3. All PCR reactions were carried out using the PfuX7
polymerase [Nørholm, 2010], and either HF or Phire PCR buﬀer (Finnzymes/Thermo Scientiﬁc). The PCR
program was: 98◦C for 1 min, 98◦C for 15 s, 60◦C for 30 s, 72◦C for 30s/kb, and 72◦C for 5 min. Normally,
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I performed 35 cycles of ampliﬁcation. Diagnostic (conidial) PCR was performed as a regular PCR reaction,
except initial denaturation step was 20 min.
ASPNIDRAFT_44965 was ampliﬁed with BGHA582-585 (2 fragments), 56896 with BGHA586-591 (3
fragments), 128601 with BGHA592-607 (5 fragments), 194381 with BGHA608-613 (3 fragments), 211885
with BGHA614-621 (4 fragments), and 225574 with BGHA622-629 (4 fragments). 41618 (primers 47-50),
118581 (primers 63-66), 118624 (primers 71-74), 118644 (primers 77-80), and 176722 (primers 91-94) were
ampliﬁed as two fragments, otherwise the genes were ampliﬁed as a single fragment (Table 8.4.3 lists the
pairwise primer sets).
Fragments were assembled via uracil-excision fusion [Geu-Flores et al., 2007] into a compatible vector,
and correct clones were veriﬁed by restriction digestion (plasmids are listed in Table 8.4.3). Protoplasting
and gene-targeting procedures were performed as described previously [Johnstone et al., 1985, Nielsen et al.,
2006].
Table 8.3: Primers used in this study. All primers are shown in 5'-3' direction
Primer number Primer name Sequence
1 BGHA582 AGAGCGAUATGCCAGGCCTTGTACAC
2 BGHA583 ACGGGGTCCUCGGTACATTCCCCCATAGTTT
3 BGHA584 AGGACCCCGUTCTCGTCACCCCTACCAT
4 BGHA585 TCTGCGAUTTAAGCATCCAGCTCCTTTGT
5 BGHA586 AGAGCGAUATGGAGGGTCCATCTCGTGTGT
6 BGHA587 AGAACCGAUATGAAGCGATTGACCGGGAC
7 BGHA588 ATCGGTTCUGCCAAGGCAAACATTGGAC
8 BGHA589 AAAGAAUCGGACAGTGCAAGTTGCG
9 BGHA590 ATTCTTUGACTGCGCTGCTGCGGAG
10 BGHA591 TCTGCGAUTTAATTGGCCATGGCGTTGCCA
11 BGHA592 AGAGCGAUATGTCTTCTTCACCCAAAGAGCCC
12 BGHA593 AGTGGCGCUAAAGAAGCCGGCGGCGTA
13 BGHA594 AGCGCCACUGATGCCATCCGCATTGCCTTCT
14 BGHA595 AGTGTCUCCAGGAGAGGCTTGGTAGCG
15 BGHA596 AGACACUCGGTGCCTTGTACTCCGCCTACAC
16 BGHA597 ACCGTCGAUCTTGGGGCCCAGAGCCTCGTTCA
17 BGHA598 ATCGACGGUACCATCTACCTGGACGAACTGTTT
18 BGHA599 ACCGCAAGUGGCCGCAAGACGGGGCAG
19 BGHA606 ACTTGCGGUGTTGTCGAGCCCAGCTCC
Continued on Next Page
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20 BGHA607 TCTGCGAUCCGGCAATCTTGGCCTTGC
21 BGHA608 AGAGCGAUATGGCAATCATGGAACAG
22 BGHA609 ACCGGCGCUGTTATTGACGTTCCGTACT
23 BGHA610 AGCGCCGGUGTCCAAGTCTCAGCAATCCCTCTA
24 BGHA611 ATCTTGCAUGATTCCGGCAGCGGCCAC
25 BGHA612 ATGCAAGAUTCTGTATACGATCCTCTA
26 BGHA613 TCTGCGAUTTATTATCAAGCGGAGCT
27 BGHA614 AGAGCGAUATGAGTCCCAGCAAGAAT
28 BGHA615 ACGCCGAGCAAUGAAGCAGTTCCATGCAGT
29 BGHA616 ATTGCTCGGCGUTTTCACCGGCCAGGGAGC
30 BGHA617 ATAGCCGCUCAGCATTCTTGAGCAAAGCCTGT
31 BGHA618 AGCGGCTAUTCCATACTGTCAATGACGG
32 BGHA619 AGCATTUGTAATACCCACTGGACTGT
33 BGHA620 AAATGCUCCCACCCACGGGGACTGT
34 BGHA621 TCTGCGAUTCAGACCACCTCCTGTGTACTGAT
35 BGHA622 AGAGCGAUATGGATAGTCAAGACTCGTCTCCC
36 BGHA623 AGCTTTCTUTTAGGGATGCCGGGTGTGC
37 BGHA624 AAGAAAGCUTAGTCGAGCATGAACGATACATCA
38 BGHA625 AGAATCAAUATGCGAGCTATCGCTGGC
39 BGHA626 ATTGATTCUCTTGAGCTCGAGCTCGTC
40 BGHA627 ATCGTGGCCGCUTCTTCGTATGAGAGGAACGATG
41 BGHA628 AGCGGCCACGAUGCCATGTGTTTACGCTACT
42 BGHA629 TCTGCGAUTCACGGGGCCTTCATTTC
43 FW-37260 AGAGCGAUATGTCTGCCAGCGAGACT
44 RV-37260 TCTGCGAUTCACTCCTTCACCCCATATCT
45 FW-39026 AGAGCGAUATGGAAGAGCACGTCAGAGA
46 RV-39026 TCTGCGAUCGGCTGTGCCCCGATAAAC
47 FW-41618-f1 AGAGCGAUATGAACGTCCCCAATGAG
48 RV-41618-f1 ATCAACCUCATGCACTATAGACCGGC
49 FW-41618-f2 AGGTTGAUCCGTCCACAGCGGCCCTA
50 RV-41618-f2 TCTGCGAUCTAGGCATGAGCCCCTTTGCTTTC
51 FW-41846 AGAGCGAUATGGTACCAGAGGACGACCAA
52 RV-41846 TCTGCGAUCTACTGACCTTCTACCTGCTTCT
Continued on Next Page
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53 FW-43495 AGAGCGAUATGACTACTCCGATGAACG
54 RV-43495 TCTGCGAUTCACTCACCCACATTACC
55 FW-44005 AGAGCGAUATGACACGAACGGAGCCAAT
56 RV-44005 TCTGCGAUTTATGCCTGCAGCTGCGG
57 FW-47991 AGAGCGAUATGGCCCTTCGTCTTCCC
58 RV-47991 TCTGCGAUTCACTCGATCCCCAACAAC
59 FW-51499 AGAGCGAUATGAGGCTCTTCTTCTTTAGTA
60 RV-51499 TCTGCGAUTTACCAAGACGCAGTGAG
61 FW-56946 AGAGCGAUATGGTCACAACGACAAGG
62 RV-56946 TCTGCGAUTCAAGGATTCAAAAATCCCATCT
63 FW-118581-1 AGAGCGAUATGGTTTCTGAATATGTCCC
64 RV-118581-1 ACCGCAGACUGGAGTGATGACTCAAACG
65 FW-118581-2 AGTCTGCGGUTCGGCATGTTGAGTCTTT
66 RV-118581-2 TCTGCGAUCTAAACTAGTAATGACCTCAGACT
67 FW-118598 AGAGCGAUATGTCTTTGAAGTTTCCGGAAGA
68 RV-118598 TCTGCGAUTCATCGTCGGTATTCGCTCTT
69 FW-118617 AGAGCGAUATGGAAGGGAAGCATTTAGAACCC
70 RV-118617 TCTGCGAUTCAGGACCAACCACGAGG
71 FW-118624-f1 AGAGCGAUAATATGGCATACCCACAAG
72 RV-118624-f1 AAGATGCAUCGTCGTCAACCATCAAGG
73 FW-118624-f2 ATGCATCTUACTTTCTCTGCTTGGGGAAGGC
74 RV-118624-f2 TCTGCGAUCGTGGAACGAGTGGTGGTGAT
75 FW-118629 AGAGCGAUATGTCAGTCCCTGAACCC
76 RV-118629 TCTGCGAUTAGCCAGCTCTTGGATTG
77 FW-118644-f1 AGAGCGAUGACATCATGGCAACGGAACGA
78 RV-118644-f1 ATTCTGUGGCTTTGAAGGAGGCCTAAGTC
79 FW-118644-f2 ACAGAAUCGGTGTCCCTGAATTATT
80 RV-118644-f2 TCTGCGAUTTCCAAATAAGCAGCAAC
81 FW-118666 AGAGCGAUATGAATAGGTCACAGTCTGCG
82 RV-118666 TCTGCGAUTTACATCCCCGACTTACC
83 FW-118744 AGAGCGAUATAGGCTGTCGCCTACCG
84 RV-118744 TCTGCGAUCATCCTCGCATCCATCAACT
85 FW-128638 AGAGCGAUCCGATTGCAATTGTAGGCATGT
Continued on Next Page
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86 RV-128638 TCTGCGAUCTCCAAACTCGACTTCTTCAAC
87 FW-138585 AGAGCGAUATGGGAATGAGACTCCCT
88 RV-138585 TCTGCGAUGCGTAAGCTCATCCAGCT
89 FW-171221 AGAGCGAUATGTCTACACGTCCCCAAT
90 RV-171221 TCTGCGAUCTGCTCACCCTCCTTCAC
91 FW-176722-f1 AGAGCGAUATGGCCCCTCATCCACAA
92 RV-176722-f1 AATTGAUGCGGCGAGAAGGTGATTGG
93 FW-176722-f2 ATCAATUCTGGCTTCCATCCCCGCC
94 RV-176722-f2 TCTGCGAUTCACCGTCGGGATTCCAACC
95 FW-179079 AGAGCGAUATGGCTTTCGACAATTCGCACAA
96 RV-179079 TCTGCGAUTCAAACCCACCCCTTCTTCAAC
97 FW-179585 AGAGCGAUATGGACACACCCCTCTCA
98 RV-179585 TCTGCGAUGTCGTTGCTTGTGGTGATC
99 FW-181803 AGAGCGAUATGGAGGACCCTACTACT
100 RV-181803 TCTGCGAUCTAATTCTGTGACTGAAACTG
101 FW-187099 AGAGCGAUATGGCTGGAGACTTAAGGG
102 RV-187099 TCTGCGAUCACAGCCTTCTCAACCAA
103 FW-188697 AGAGCGAUATGAGTAACAATGAGGAGC
104 RV-188697 TCTGCGAUTCACTGCTTGCTATACTT
105 FW-188817 AGAGCGAUATGGCCGGAGAGTATTCAACG
106 RV-188817 TCTGCGAUCTACGTCCGCTTCGTTGC
107 FW-190014 AGAGCGAUATGCCCGCCAATACTCCA
108 RV-190014 TCTGCGAUCAGAAAACCAGTTTGCCTCC
109 FW-191422 AGAGCGAUATGGAGACAGTCGCCGAGGTA
110 RV-191422 TCTGCGAUCTACAACAAAGCCCGGCGAAGGA
111 FW-191702 AGAGCGAUATGGCCATAAACAATGGA
112 RV-191702 TCTGCGAUCTCAGCACTAATGCCATA
113 FW-210217 AGAGCGAUATGCAACTACTAACGACT
114 RV-210217 TCTGCGAUTTACAAATGACAGGTATTCT
115 44004-fw AGAGCGAUATGGACATTGGTGTAGGCGTC
116 44004-rv TCTGCGAUTCATTCGGGATTTGGCTGTT
117 142878-fw AGAGCGAUATGGCCTCTTCCACTGTTGTC
118 142878-rv TCTGCGAUTCACGGGGCATGCTTAAAAAAAG
Continued on Next Page
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119 179510-fw AGAGCGAUATGTCCAGCGAAAATTTCACTATAAC
120 179510-rv TCTGCGAUTTACAGCTTGTCCTTCCTGGCT
121 50432-bi1-fw AGAGCGAUATGCTTGATAAACACATACCAGATG
122 50432-bi1-rv TCTGCGAUTCATTGTCGAAAAGAATTAAGGATT
123 179510-rv TCTGCGAUTTACAGCTTGTCCTTCCTGGCT
124 179510-rv TCTGCGAUTTACAGCTTGTCCTTCCTGGCT
125 179510-rv TCTGCGAUTTACAGCTTGTCCTTCCTGGCT
126 179510-rv TCTGCGAUTTACAGCTTGTCCTTCCTGGCT
Table 8.4: Plasmids used and constructed in this study. All plasmids are oriR ampR. hph* contains a silent
point mutation eliminating an AsiSI restriction site. oriR* contains a point mutation eliminating a Nb.BtsI
nicking site. UEC = AsiSI/Nb.BtsI uracil excision cassette
Plasmid Genotype Source
pCMBU1111 TS1::PgpdA::UEC::TtrpC ::argB ::TS2 [Hansen et al., 2011]
pDHX2 AMA1 PgpdA0.5kb::UEC::TtrpC ::pyrG This study
pCMBU0020 UEC [Hansen et al., 2011]
pCMBU0020 US-44005::hph::DS-44005 [Hansen et al., 2011]
pCMBU0020 US-190891::hph::DS-190891 [Hansen et al., 2011]
pDH15 TS1::PgpdA::ASPNIDRAFT_37260::TtrpC ::argB ::TS2 This study
pDH16 TS1::PgpdA::ASPNIDRAFT_39026::TtrpC ::argB ::TS2 This study
pDH17 TS1::PgpdA::ASPNIDRAFT_41618::TtrpC ::argB ::TS2 This study
pDH18 TS1::PgpdA::ASPNIDRAFT_41846::TtrpC ::argB ::TS2 This study
pDH19 TS1::PgpdA::ASPNIDRAFT_43495::TtrpC ::argB ::TS2 This study
pDH20 TS1::PgpdA::ASPNIDRAFT_44005::TtrpC ::argB ::TS2 This study
pDH25 TS1::PgpdA::ASPNIDRAFT_44965::TtrpC ::argB ::TS2 This study
pDH26 TS1::PgpdA::ASPNIDRAFT_47991::TtrpC ::argB ::TS2 This study
pDH27 TS1::PgpdA::ASPNIDRAFT_51499::TtrpC ::argB ::TS2 This study
pDH28 TS1::PgpdA::ASPNIDRAFT_56896::TtrpC ::argB ::TS2 This study
pDH29 TS1::PgpdA::ASPNIDRAFT_56946::TtrpC ::argB ::TS2 This study
pDH30 TS1::PgpdA::ASPNIDRAFT_118581::TtrpC ::argB ::TS2 This study
pDH31 TS1::PgpdA::ASPNIDRAFT_118598::TtrpC ::argB ::TS2 This study
Continued on Next Page
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pDH32 TS1::PgpdA::ASPNIDRAFT_118617::TtrpC ::argB ::TS2 This study
pDH33 TS1::PgpdA::ASPNIDRAFT_118624::TtrpC ::argB ::TS2 This study
pDH34 TS1::PgpdA::ASPNIDRAFT_118629::TtrpC ::argB ::TS2 This study
pDH35 TS1::PgpdA::ASPNIDRAFT_118644::TtrpC ::argB ::TS2 This study
pDH36 TS1::PgpdA::ASPNIDRAFT_118666::TtrpC ::argB ::TS2 This study
pDH37 TS1::PgpdA::ASPNIDRAFT_118744::TtrpC ::argB ::TS2 This study
pDH38 TS1::PgpdA::ASPNIDRAFT_128601::TtrpC ::argB ::TS2 This study
pDH39 TS1::PgpdA::ASPNIDRAFT_128638::TtrpC ::argB ::TS2 This study
pDH40 TS1::PgpdA::ASPNIDRAFT_138585::TtrpC ::argB ::TS2 This study
pDH41 TS1::PgpdA::ASPNIDRAFT_171221::TtrpC ::argB ::TS2 This study
pDH42 TS1::PgpdA::ASPNIDRAFT_176722::TtrpC ::argB ::TS2 This study
pDH43 TS1::PgpdA::ASPNIDRAFT_179079::TtrpC ::argB ::TS2 This study
pDH44 TS1::PgpdA::ASPNIDRAFT_179585::TtrpC ::argB ::TS2 This study
pDH45 TS1::PgpdA::ASPNIDRAFT_181803::TtrpC ::argB ::TS2 This study
pDH46 TS1::PgpdA::ASPNIDRAFT_187099::TtrpC ::argB ::TS2 This study
pDH47 TS1::PgpdA::ASPNIDRAFT_188697::TtrpC ::argB ::TS2 This study
pDH48 TS1::PgpdA::ASPNIDRAFT_188817::TtrpC ::argB ::TS2 This study
pDH49 TS1::PgpdA::ASPNIDRAFT_190014::TtrpC ::argB ::TS2 This study
pDH50 TS1::PgpdA::ASPNIDRAFT_191422::TtrpC ::argB ::TS2 This study
pDH51 TS1::PgpdA::ASPNIDRAFT_191702::TtrpC ::argB ::TS2 This study
pDH52 TS1::PgpdA::ASPNIDRAFT_194381::TtrpC ::argB ::TS2 This study
pDH53 TS1::PgpdA::ASPNIDRAFT_210217::TtrpC ::argB ::TS2 This study
pDH54 TS1::PgpdA::ASPNIDRAFT_211885::TtrpC ::argB ::TS2 This study
pDH55 TS1::PgpdA::ASPNIDRAFT_225574::TtrpC ::argB ::TS2 This study
pDH121 AMA1 PgpdA0.5kb::44004::TtrpC ::pyrG This study
pDH122 AMA1 PgpdA0.5kb::142878::TtrpC ::pyrG This study
pDH123 AMA1 PgpdA0.5kb::179510::TtrpC ::pyrG This study
pDH124 TS1::PgpdA::ASPNIDRAFT_50432::TtrpC ::argB ::TS2 This study
8.4.4 Chemical analysis of strains
Metabolites were extracted in small-scale as described in [Smedsgaard, 1997]. Analytical LC-DAD-MS ex-
periments were performed on an Agilent HP 1100 liquid chromatograph with auto sampler, with a DAD
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detector system (Wald-brom, Germany) coupled to a liquid chromatography time-of-ﬂight (LCT) oaTOF
mass spectrometer (Micromass, Manchester, UK) with a Z-spray source and a Lock Spray probe. 1 µl of the
extracts were injected on a Luna II (C18 (50 x 2 mm, 3 µm), Phenomenex, Torrance, CA, USA) column. The
analysis was performed with a ﬂow rate of 0.3 ml/min with an acetonitrile:water gradient starting at 15:85
and ending at 100:0 in 20 min, hereafter maintaining 100 % acetonitrile for 5 minutes and then returning
to the start conditions in 8 minutes. 45 ppm formic acid was added to the solvents before use. The DAD
collected UV/VIS spectra from 200-700 nm with a resolution of 4 nm.
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Chapter 9
Identiﬁcation of the naphtho-γ-pyrone
gene cluster in Aspergillus niger
This chapter contains a manuscript in preparation, intended for submission to Fungal Genetics and Biology,
of which I am ﬁrst author.
In this study I have investigated the polyketide product of the A. niger PKS encoded by 191422, see
details in Chapter 8. The development of an expression system for A. niger made possible this investigation,
that resulted in the discovery that A. niger possesses two PKSs that produce WYA1, which is the precurser
to naphtho-γ-pyrones and black melanin. The gene cluster deﬁned by 191422 contains all activities for pro-
duction of naphtho-γ-pyrones, although the production of naphtho-γ-pyrones was previously solely assigned
to AlbA [Jørgensen et al., 2011, Chiang et al., 2011].
I have carried out all experimental work in this study, including conception of the idea based on results
from Chapter 8, experimental design, interpretation of results and writing of manuscript. To complete this
study I need to construct two additional strains: a 191422 cluster deletion strain, and a 191422∆ albA∆
double deletion strain. Hopefully, the cluster deletion strain will verify that AlbA is dependent on this gene
cluster for production of naphtho-γ-pyrones. The 191422∆ albA∆ double deletion strain will be used to
investigate whether or not the fawn, and not completely white, appearance of the albA∆ strain is caused
by very little production of YWA by 191422. Supporting information is included in Appendix D.
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Abstract 
Aspergillus niger is a filamentous fungus of great importance with respect to enzyme and secondary 
metabolite production. Since the genome sequence of A. niger was released, several secondary metabolites 
have been linked to a gene, including naphtho-γ-pyrones, which were linked to albA/fwnA. In this study we 
have shown that a silent copy of albA/fwnA exists in A. niger, and that this gene is embedded within a typical 
secondary metabolite gene cluster, containing all necessary activities for formation of naphtho-γ-pyrones. 
We have shown that both AlbA/FwnA and the homologue, which we have named NapA, both produce 
YWA1, however NapA does not seem to be involved in 1,8-dihydroxynaphthalene (DHN) melanin 
formation. We therefore propose that these two genes were originally intended for separate and 
compartmentalized processes, but the high activity of AlbA/FwnA may have caused a shift in this regulation. 
This result is intriguing as it provides an insight into evolution of secondary metabolism, and may form a 
basis for studying evolution within black Aspergilli. 
 
Keywords 
Secondary metabolism, naphtho-γ-pyrone, polyketide, biosynthesis, genomics, Aspergillus niger. 
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1. Introduction 
Aspergillus niger is an important filamentous fungus, widely used for production of organic acids and 
enzymes. A. niger is able to produce a wide array of secondary metabolites, reviewed in (Nielsen et al., 
2009), some of which are harmful to human health e.g. the carcinogenic fumonisins. Recently, Fisch and co-
workers performed genomic mining on the full-genome sequenced A .niger ATCC1015, and it revealed no 
less than 33 putative polyketide synthase (PKS) clusters, 15 non-ribosomal peptide synthase (NRPS) clusters 
and 9 hybrid PKS/NRPS clusters (Fisch et al., 2009). This number greatly exceeds the number of known 
metabolites from A. niger, why it is hypothesized that the remaining gene clusters are non-functional or 
silenced under standard laboratory conditions. Many different approaches have been successfully carried out 
in order to scrutinize the biosynthetic potential of filamentous fungi by e.g. expression of local transcription 
factors (Bergmann et al., 2007, Chiang et al., 2009), targeting general sumyolation and histone methylation 
mechanisms (Szewczyk et al., 2008, Bok et al., 2009, Chiang et al., 2010), and co-cultivation with other 
organisms (Schroeckh et al., 2009).  
In A. niger the AlbA/FwnA PKS (encoded by albA/fwnA) is required for production of naphtho-γ-pyrones 
and in addition, AlbA/FwnA is required for production of the conidial black pigment which is characteristic 
for the group of black Aspergilli (Chiang et al., 2011; Jørgensen et al., 2011a). Neither the biosynthesis of 
naphtho-γ-pyrones nor DHN- melanin has been shown for A. niger, however it has been shown for other 
Aspergilli that DHN-melanin can be produced from a YWA1 precursor via chain shortening and subsequent 
polymerization, reviewed by Langfelder and co-workers (2003). 
A. niger contains a PKS (termed PKS44 in (Fisch et al., 2009)) that have a high sequence similarity to AlbA, 
but the function of this PKS has not been reported. Another black Aspergillus, A. carbonarius, contains 
homologues of both AlbA and PKS44. 
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 Figure 1. Selected naphtho-γ-pyrone  structures from A. niger. 
 
2. Materials and methods 
2.1. Strains and media 
The strain IBT 29539 (argB2, pyrG89, veA1, nkuAΔ) was used for strain constructions in A. nidulans. 
ATCC1015-derived strain KB1001 (pyrGΔ kusA::AFpyrG) was used for all strain construction in A. niger.  
All fungal strains constructed in the present work (Appendix, Table A1) have been deposited in the IBT 
Culture Collection at Department of Systems Biology, DTU, Kgs. Lyngby, Denmark. Escherichia coli strain 
DH5α was used for propagating all plasmids, except E. coli ccdB survival2 cells (Invitrogen) were used to 
propagate plasmids carrying the ccdB gene. Minimal medium for A. nidulans was made as described in 
(Cove, 1966) but with 1% glucose, 10 mM NaNO3 and 2% agar. Minimal medium for A. niger was prepared 
as described in (Chiang et al., 2011). YES media were prepared as described by Frisvad and Samson 
(Frisvad and Samson, 2004). When necessary, media were supplemented with 4 mM L-arginine, 10mM 
uridine, 10mM uracil and/or 100 μg/ml Hygromycin B (Invivogen, San Diego, CA, USA).  
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2.2. PCR, cloning and transformation 
Primers for amplification of genes were designed using the Primer Help for USER software (PHUSER) 
(Olsen et al., 2011). All primers are listed in Appendix (Table A2). The PfuX7 polymerase (Nørholm, 2010) 
was used in all PCR reactions. Fragments were assembled via uracil-excision fusion (Geu-Flores et al., 
2007) into a compatible vector. Correct clones were verified by restriction digestion (data not shown). 
Protoplasting and gene-targeting procedures were performed as described previously (Johnstone et al.,1985; 
Nielsen et al.,  2006). Diagnostic (conidial) PCR was performed as a regular PCR reaction, except initial 
denaturation step was 20 min.  
 
2.3. Construction of the pDHU1 and pDHU2 vectors for integration into A. niger IS1 and IS2  
The pDHU1 and pDHU2 vectors were constructed by USER fusion of 5 fragments 1) E. coli origin of 
replication (oriR) and the E. coli ampicillin resistance gene (ampR) carrying a silent point mutation omitting a 
Nb.BtsI nicking site, 2) upstream targeting sequence, 3) a PCR fragment containing 0.5 kb of the PgpdA 
promoter, an AsiSI/Nb.BtsI USER cassette containing ccdB and cmR, and the TtrpC terminator , 4) 
downstream targeting sequence  5) selection marker: E. coli hph. Fragments 1and 3 were amplified from 
pDH57 (Holm et al., in review) (primers 1+2 and primers 3+4), fragment 2 and 4 were amplified from 
KB1001 genomic DNA (primers 5+6 and 7+8 for pDHU1,  primers 11+12 and 13+14 for pDHU2) , 
fragment 5 was amplified from pCB1003 (primers 17+18) (McCluskey et al., 2010). Fragments were 
assembled as described in (Geu-Flores et al., 2007), using equal concentrations of purified PCR product, and 
correct clones were verified by restriction digestion (data not shown).  
 
2.4. Heterologous expression of PKSs from A. nidulans IS1 
The PKS genes PKS44 (ASPNIDRAFT_191422) AlbA (ASPNIDRAFT_56896), and Acar44 (JGI protein 
ID: 56260) were amplified by PCR (primers 19+20, 21+22, and 23+24, respectively) and inserted into 
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pDH57 (argB marker). Transformation substrate was excised by NotI digestion and transformed into IBT 
29539, and transformants were selected on medium without arginine. Transformants were verified by 
diagnostic PCR according to (Hansen et al., 2011). 
 
2.5. Construction of deletion strains  
All deletions in A. niger was done in KB1001: upstream (US) and downstream (DS) fragment were 
generated by PCR from KB1001 genomic DNA and inserted into the CMBU0020 vector (Hansen et al., 
2011) along with the hph marker. US and DS fragments for PKS44Δ were generated using primers 25-28. 
hph was generated using primers 17+18. After insertion of targeting sequences and hph into CMBU0020, 
bipartite transformation substrates were amplified by PCR, using primers 191422_US-FW+29 and 
30+191422_DS-RV. Deletion strains were selected on 100 μg/ml Hygromycin B (Invivogen),  
 
2.6. Ectopic expression of napA in A. niger 
albA (ASPNIDRAFT_191422) was amplified by PCR (primers 19+20) from KB1001 genomic DNA and 
inserted into pDHU1 or pDHU2. Transformation substrate was excised by NotI digestion and transformed 
into KB1001and transformants were selected on medium with 100 μg/ml hygromycin B (Invivogen), and 
verified by diagnostic PCR. 
 
 
2.7. Strain construction by sexual crossing  
Complementation of WA in A. nidulans was investigated by sexual crossing. This was performed by plating 
each parental strain in a line, <5 mm from each other, on plate containing solid MM plus supplements to 
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complement all auxotrophies. After three days cultivation at 37 °C, a 5x5 mm square (containing both 
strains) were transferred to MM without supplements. Since the two haploid strains used in a cross contained 
complementary marker gene combinations, none of the parental strains are able to grow. After 2-3 days 
incubation at 37 °C, in order to induce meiosis, the plates were sealed with two layers of Parafilm to omit 
oxygen supply, and wrapped in aluminum foil to omit light, and incubated for two weeks. Plates were then 
examined for number and size of formed cleistothecia. Ascospores were plated on MM, and correct progeny 
was verified by diagnostic PCR. 
 
2.8. Chemical analysis of strains  
Unless otherwise stated strains were inoculated as a three point inoculation on solid MM media and 
incubated at 37 °C for 5 days. Extraction of metabolites was performed as described in (Smedsgaard, 1997). 
6-MSA was purchased from (Apin Chemicals, Oxon, UK). Analysis was performed using ultra-high-
performance liquid chromatography (UPHLC) UV/Vis diode array detector (DAD) high-resolution MS 
(TOFMS) on a maXis G3 orthogonal acceleration (OA) hexapole–quadrupole time of flight (hQ- TOF) mass 
spectrometer (Bruker Daltonics, Bremen) equipped with an electrospray injection (ESI) source and 
connected to an Ultimate 3000 UHPLC system (Dionex, Sunnyvale). The column used was a reverse-phase 
Kinetex 2.6-μmC18, 100 mm × 2.1mm (Phenomenex), and the column temperature was maintained at 40 °C. 
A linear water- acetonitrile (LCMS-grade) gradient was used (both solvents were buffered with 20 mM 
formic acid) starting from 10% (vol/vol) acetonitrile and increased to 100% in 10min, maintaining this rate 
for 3 min before returning to the starting conditions in 0.1 min and staying there for 2.4 min before the 
following run. A flow rate of 0.4 mL·min−1 was used. TOFMS was performed in ESI+ with a data 
acquisition range of 10 scans per second at m/z 100–1000. The TOFMS was calibrated using Bruker 
Daltonics high precision calibration alorithm (HPC) by means of the use of the internal standard sodium 
formate, which was automatically infused before each run. This provided a mass accuracy of better than 1.5 
ppm in MS mode. UV/VIS spectra were collected at wavelengths from 200 to 700 nm. Data processing was 
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performed using DataAnalysis 1.2 and Target Analysis4.0 software (Bruker Daltonics). Tandem MS was 
performed in with fragmentation energy was varied from 18 to 55 eV. 
 
3. Results and discussion 
3.1. PKS44, which has a homologue in A. carbonarius, is similar to AlbA 
PKS44 (ASPNIDRAFT_191422) is a non-reducing PKS, which has not been linked to production of a 
compound. In order to investigate the possible polyketide (PK) product of PKS44, a BLAST search was 
performed on all sequenced Aspergilli in the Aspergillus Genome Database (AspGD). Interestingly, PKS44 
had homologues in three other Aspergilli: A. acidus (Aspfo1_0143182), A. brasiliensis (Aspbr1_0199700), 
and A. carbonarius (Acar5010_056260), which all belong to the group of black Aspergilli. Furthermore, we 
found that PKS44 was similar to the A. niger PKS AlbA (62.3 % similarity/45.5 % identity), and contained 
the same domain organization SAT-KS-AT-ACP-ACP-TE (Fisch et al., 2009). As AlbA is responsible for 
production of naphtho-γ-pyrones we speculated that PKS44 might produce a PK similar to the AlbA PK 
product. 
 
3.2. Heterologous production of three PKSs in A. nidulans results in production of a yellow pigment  
It has been shown previously that the non-reducing PKS44 contains a thioesterase (TE) domain for product 
release. As PKSs containing such a TE domain is known to release their polyketide (PK) products without 
the need for additional enzymes, we expressed the PKS44 gene, its A. carbonarius homologue (Acar44), and 
albA heterologously in the model fungus A. nidulans, for which a system for heterologous expression has 
been developed and tested for expression of PKS genes (Hansen et al., 2011, Holm et al., submitted for 
publication). The PKS genes were expressed from IS1 under regulation of the strong constitutive promoter 
PgpdA. The resulting strains had visibly altered phenotypes: IS1-PKS44 and IS1-Acar44 had slightly yellow 
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colors, which were visible to the eye when looking at the colonies and IS1-albA produced vast amounts of 
yellow pigment, which was secreted into the medium (Figure 2A).  
 
Figure 2. A. Morphologies of A. nidulans strains expressing albA, PKS44, and Acar44. B. Conidial pigment pathway in 
A. nidulans. WA synthesizes the yellow pigment YWA1, which is polymerized into green DHN-based melanin by the 
YA laccase. 
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The strains were subjected to metabolite profile analysis by UHPLC-DAD-TOFMS and the chromatograms 
were examined for production of new compounds. Surprisingly, no new compound could be detected in IS1-
PKS44 or IS1-Acar44, but IS1-albA did produce a new compound (RT = 4.65 min, m/z = 277.0709) relative 
to the A. nidulans reference strain NID1 (Figure 3).  
 
 
Figure 3. A. BPC of A. nidulans strains expressing PKS genes. B. EIC of the pseudomolecular ion of YWA (1) 
(277.0709±0.005). Chromatograms are to scale. 
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Dereplication identified the compound as being YWA1, which has been characterized in A. nidulans as the 
yellow conidial pigment that polymerizes into green DHN-based melanin (Watanabe et al., 1999). The fact 
that YWA1 can be converted into black DHN-based melanin via chain shortening and subsequent 
polymerization, combined with the fact that YWA1 is the product of AlbA, led us to conclude that in A. 
niger black melanin is formed from a YWA1 precursor in a similar manner as shown for A. fumigatus (Fujii 
et al., 2004).  
Based on the similarity between AlbA and PKS44, we hypothesized that the yellow compound produced by 
PKS44 in A. nidulans might also be a conidial pigment. However, AlbA produced vast amounts of YWA1, 
which did not seem to be the case for the pale yellow IS1-PKS44 strain. Thus, either the PKS44 product is 
different from YWA1, or the PKS44 had a much lower activity than AlbA. If the compound was bound to 
insoluble cell materiel e.g. the cell wall it would certainly explain why it was not detectable by analytical 
chemistry. To substantiate this hypothesis we analyzed a yellow strain of A. nidulans (yAΔ) and indeed we 
detected only trace amounts of YWA1 (Figure 3) although the yellow color was clearly visible to the eye 
(Figure 2B), showing that the vast majority of the produced YWA1 is impossible to extract. 
 
3.3. Deletion of PKS44 in A. niger does not produce a detectable change in the metabolite profile 
As heterologous expression of the PKSs did not reveal the PK product(s), we deleted the PKS44 in A. niger 
by replacing the ORF with the hph selectable marker. The conidial produced by the PKS44Δ were still black 
(Figure 4A), suggesting that PKS44 is not required for production of conidial pigments. Therefore the strain 
was cultivated on solid YES medium, which is known to support production of many compounds in A. niger, 
and subsequently subjected to metabolite profile analysis by UHPLC-DAD-TOFMS (Figure 4B). The 
resulting data were minutely examined for compounds that were produced by the reference strain, and not in 
the PKS44Δ strain, but no such compound was detected. This result suggests that the gene may be silenced, 
why a gene deletion would not reveal the identity of the PKS product.  
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Figure 4. A. Morphologies of A. niger strains. B. BPC of A. niger strains. C. EIC of A. niger strains. A = m/z 
589.1704±0.005, B = m/z 571.1599±0.005. 
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3.4. Over-expression of PKS44 in A. niger albAΔ results in production of naphtho-γ-pyrones  
As the PKS44 seemed to be silent, we over-expressed the PKS44 gene from a specific locus in A. niger, IS-
NIG1, similar to the expression system developed for A. nidulans (Hansen et al., 2011). The strain was 
verified by diagnostic PCR and subjected to metabolite profile analysis by UHPLC-DAD-TOFMS. Still, 
there was no detectable change in the metabolite profile (Figure 4C). Based on the fact that deletion of 
PKS44 and over-expression of PKS44 in A. niger did not provide any clues about the identity of the PKS 
product, it was indeed possible that the PKS44 gene and the gene cluster might not be functional at all.  
The fact that albA produces the yellow YWA1 pigment, which is a precursor to all the naphtho-γ-pyrones in 
A. niger, might result in a masking effect of the compound produced by PKS44, especially if it is produced 
in small amounts, and/or the activity of the enzyme is low. We therefore over-expressed the PKS44 gene in 
an albAΔ strain to eliminate production of naphtho-γ-pyrones. With only one available marker (AFpyrG had 
been inserted into the kusA locus for transient disruption) this was accomplished by integrating the PKS44 
gene directly into the albA locus, thus looping out albA. Correct albA::PKS44 strains were easily 
recognizable by the lack of black pigmentation (see Figure 4A), and correct insertion was verified by 
diagnostic PCR. The strain was subjected to metabolite profile analysis, but there was still no change in the 
metabolite profile (Figure 4B). This result was extraordinary, as it has been reported twice by different 
research groups that abolishment of albA resulted in the lack of naphtho-γ-pyrones, however, they were still 
present in this white strain. As the white reference strain (albA::rfp) indeed did not produce any naphtho-γ-
pyrones (Figure 4C) it only leaves the explanation that PKS44 and AlbA produce the same compound: 
YWA1.  
  
3.5. The PKS44 product is a substrate to the YA laccase in A. nidulans 
To test if YWA1 was indeed the product of PKS44, without being able to detect the compound by chemical 
analysis, we examined the possibility of the PKS44 product being a substrate to the YA laccase, which 
catalyzes the polymerization of YWA1 into green melanin in A. nidulans (see Figure 1B). In order to 
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examine this possibility we would remove the native YWA1 PKS in A. nidulans, WA, and express each of 
the three putative homologous PKSs in its place. The resulting strains wAΔ IS1-PKS44, wAΔ IS1-Acar44, 
and wAΔ IS1-albA were prepared by sexual crossing with a wAΔ yAΔ double deletion strain of A. nidulans. 
The strains were examined visually (Figure 1A) and it was clear that the compounds produced by PKS44 and 
Acar44 were indeed converted into green melanin by the YA laccase, however in a lower concentration than 
in the reference. As expected, albA complemented the wA gene completely. These results clearly show that 
YWA1 is the product of PKS44, why we have named it NapA (Naphtho-γ-pyrone producing), and the 
corresponding gene napA. These results are further substantiated by the fact that Jørgensen and co-workers 
previously have reported trace amounts of aurasperone B in liquid cultivations of an albAΔ strain (Jørgensen 
et al., 2011b).  
 
3.6. The putative PKS44 gene cluster is identical to the A. carbonarius Acar44 gene cluster  
Examination of the genes surrounding the PKS44 gene in A. niger and Acar44 in A. carbonarius showed the 
presence of two putative transcription factors (TFs), along with several activities, which are typically found 
in a secondary metabolite cluster: a CYP450, a monooxygenase, two O-methyltransferases, and a 
dehydrogenase (Figure 5)(Marchler-Bauer et al., 2011). Additionally, the putative cluster in A. niger 
contained two genes with no characterized homologues. Interestingly, the Acar44 gene cluster in A. 
carbonarius was identical to the PKS44 cluster in A. niger, although with only one of the genes with no 
characterized homologues (identities and similaries are shown in Appendix, Table A3). Gene prediction was 
analyzed using FGeneSH (Softberry), which proposed that the 56024 ORF in A. carbonarius was in fact two 
different ORFs, and a pairwise alignment verified that the two ORFs (termed 56024A and 56024B) were in 
fact homologues of the two ORFs in A. niger (ASPNI_DRAFT191165 and ASPNIDRAFT_191711), 
respectively. Interestingly, the cluster seems to contain two transcription factors (ASPNIDRAFT_50739 and 
ASPNIDRAFT_44533), which is also the case for the aurofusarin cluster. 
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Figure 5. nap clusters in A. carbonarius and A. niger. 
 
The presence of two O-methyltransferases in the gene cluster account for addition of two methyl groups. 
Both of the O-methyltransferases have homology to AurJ in Fusarium graminearum (Frandsen et al., 2006). 
Furthermore, the enzyme encoded by ASPNIDRAFT_191165 is a homologue of the AurZ dehydrogenase in 
F. graminearum (Frandsen et al., 2011), which catalyzes the dehydration of YWA1 to form nor-rubrofusarin 
(Figure 6). In F. graminearum, nor-rubrofusarin is proposedly oxidized to form 9-hydroxyrubrofusarin, 
however, this configuration has not been observed in A. niger KB1001 (Chiang et al., 2011). In F. 
graminearum, dimerization into aurofusarin is catalyzed by an extracellular complex comprising Gip1 
(laccase), AurF, AurO, and AurS. BLAST analysis suggests that these enzymes have no apparent 
homologues in A. niger (ATCC1015), however, a PFAM search (PF00394) revealed that A. niger contains 
no less than 15 putative laccases, none of which are located in the vicinity of albA or napA. As only O-
methylation and dimerization activities are required for formation of the naphtho-γ-pyrones produced in A. 
niger, it is possible that dimerization is catalyzed by all or some of the remaining enzymes encoded by this 
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cluster, in a manner that is different from aurofusarin formation in F. graminearum. For instance, monomers 
may be joined by oxidative phenol coupling catalyzed by a cytochrome P450, as was recently shown for 
kotanin formation in A. niger (Gil Girol et al., 2012). Based on these findings, we have proposed the 
biosynthesis of naphtho-γ-pyrones in A. niger (Figure 6). 
  
Figure 6. Proposed biosynthesis of naphtho-γ-pyrones in A. niger. 
 
3.7. AlbA “borrows” tailoring enzymes from NapA  
In A. nidulans, the two genes encoding the enzymes that are responsible for production of the green melanin, 
wA and yA, are located on different chromosomes (ChrII and ChrI, respectively) even though genes that 
produce a secondary metabolite are often clustered together in the genome. Similarly, albA in A. niger does 
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not seem to be surrounded by any cluster genes (Chiang et al., 2011), although several genes are involved in 
chain shortening and modifications of YWA1 into melanin, reviewed in (Langfelder et al., 2003).  
However, napA is located in a typical gene cluster, containing all the enzymatic activities that are required 
for modification of YWA1 into naphtho-γ-pyrones. Thus, the albA and  napA genes may originally have 
been involved in separate processes in different compartments. As the AlbA enzyme has much higher 
activity than NapA, it may have been energetically favorable to shift to metabolism in a way that allows 
AlbA to produce YWA1 for feeding into both pathways.  The similarity of the two PKS genes suggest that 
they have have arisen via divergent evolution, however, it is not obvious to predict the origin of the two 
biosyntheses. 
Several of the genes encoded by the napA gene cluster are similar to genes that have been characterized in 
the aurofusarin gene cluster in F. graminearum. The evolutionary relationship between the two types of 
clusters is further strengthened by the similarity in products, which both have a YWA1 core that is O-
methylated and dimerized via a carbon-carbon bond. Other compounds with similar features include 
parasperone A from Aspergillus parasiticus (Salvo, 1994), ustilaginoidin from Ustilaginoidea virens, and 
chaetochromin from Chaetomium spp. (Koyama et al., 1988), which likely encode similar biosynthetic gene 
clusters.   
 
3.8. Conclusions 
In this study we have shown that A. niger contains two copies of the same gene, albA and napA, encoding 
PKSs responsible for production of DHN-melanin and naphtho-γ-pyrones. One of the genes, napA, is located 
in a typical secondary metabolite gene cluster responsible for naphtho-γ-pyrone, but not DHN-melanin, 
formation. Interestingly, deletion of albA abolishes production of naphtho-γ-pyrones, suggesting that napA is 
silenced under laboratory conditions, however, over-expression studies have confirmed that NapA is a 
functional enzyme and expression of NapA restores naphtho-γ-pyrone production in an albAΔ strain. Based 
on bioinformatics, we have suggested a biosynthetic route towards naphtho-γ-pyrones comprising 
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dehydration and O-methylation, and we propose that naphtho-γ-pyrones are not formed via laccase-catalyzed 
dimerization as is the case for aurofusarin in F. graminearum, but rather via oxidative phenol coupling as 
shown for dimerization of bicoumarins in A. niger. 
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Chapter 10
Molecular and chemical characterization
of the biosynthesis of the 6-MSA derived
meroterpenoid yanuthone D in
Aspergillus niger
This chapter contains the manuscript Molecular and chemical characterization of the biosynthesis of the
6-MSA derived meroterpenoid yanuthone D in Aspergillus niger , submitted to JACS, of which I am joint
ﬁrst author.
In this interdisciplinary study I have dissected the biosynthetic pathway towards yanuthone D in A.
niger by combining several disciplines within molecular biology, preparative chemistry and analytical chem-
istry including gene deletions, gene expressions using the newly developed AMA1-based expression platform
(described in Section 3.1.4), structure elucidation by NMR spectroscopy, in-house production of fully la-
beled 6-methylsalicylic acid using one of the newly developed integration sites (described in Section 3.1.2),
identiﬁcation of compounds by MS/MS, and feeding studies with both labeled and unlabeled compounds.
My contribution to this study was conception of the idea based on results from Chapter 8, preparation
of strains in collaboration with Z.D.J., planning and execution of feeding studies and analysis thereof, and
writing of the manuscript in collaboration with L.M.P. and the entire team. Supporting information is
included in Appendix E.
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ABSTRACT: Meroterpenoids are produced by several genera of filamentous fungi. In this study we show that 
the antibiotic yanuthone D from Aspergillus niger is a meroterpenoid derived from the polyketide 6-
methylsalicylic acid (6-MSA). Formation of yanuthone D depends on a cluster composed of 10 genes including 
yanA encoding the polyketide synthase (PKS) responsible for production of 6-MSA. All genes in this cluster 
were individually deleted and analyses of the resulting strains uncovered three intermediates towards yanuthone 
D. These findings have allowed us to deduce the genetic and biosynthetic pathway from 6-MSA to yanuthone D 
including linking one of the genes, yanI, to a novel enzymatic activity. In addition, several branching points in 
the pathway were discovered, revealing five novel yanuthones (F, G, H, I, and J) that are all likely the result of 
detoxification processes. Identification of another novel compound (yanuthone X1) revealed a structure similar to 
the other yanuthones, however, despite the striking similarity to the yanuthones, both gene deletions and 
13
C8-6-
MSA feeding experiments showed that yanuthone X1 does not originate from 6-MSA. Rather it is synthesized 
via a different precursor, which is nevertheless modified in a process that is dependent on several genes in the 
yan cluster, thus defining a novel class of yanuthones. 
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INTRODUCTION 
 
Fungal polyketides (PKs) comprise a large and complex group of metabolites with a wide range 
of bioactivities. Hence, the group includes compounds that are used by fungi as pigments for UV-light 
protection, in intra- and inter species signalling and in chemical warfare against competitors
1
. Many PKs are 
mycotoxins that are harmful to human health e.g. patulin and the highly carcinogenic aflatoxins
2
. On the other 
hand, several PKs have a great medical potential e.g. cholesterol-lowering statins
3
, the antimicrobial and 
immunosuppressive mycophenolic acid
4
, the ACAT inhibiting pyripyropenes
5
, and the farnesyltransferase 
inhibiting andrastins
6
. Although more than 6000 different PKs have been isolated and characterized (Antibase 
2012), these compounds are likely only the tip of the iceberg. For example, for each fungus analyzed, only a 
small part of its full repertoire of PKs genes appears to be produced under laboratory conditions
7,8
. In agreement 
with this view, genome sequencing of several fungal species have uncovered far more genes for PKs production 
than can be accounted for by the number of compounds that they are actually known to produce. Hence, the 
chemical space of PKs is far from fully known and many new drugs and mycotoxins await discovery. 
The fungal genome sequencing projects have demonstrated that genes necessary for production of 
individual PKs often cluster around the gene encoding the polyketide synthase (PKS), which delivers the first 
intermediate in a given PK pathway. Although, this is helpful for pathway elucidation, compounds produced by 
orphan gene clusters
9
 can still not be easily predicted by bioinformatic tools, reviewed in
10,11
. This is because 
most fungal PKs are produced by type I iterative PKSs whose products are notoriously difficult to predict. 
Moreover, the specificities and the order of actions of the tailoring enzymes that modify the PK released from 
the PKS further complicate prediction of the end products.  To elucidate the biochemical pathway of an orphan 
gene cluster it is therefore necessary to create gene cluster mutations and/or genetically reconstitute the pathway 
in a heterologous host. Subsequent analytical and structural chemistry analyses of the compounds that are 
present in the reference strain, but not in the mutant strains; and of compounds that accumulate in the mutant 
197
strains, but are absent or present in minute amounts in the reference strain, may deliver insights that can be used 
for pathway elucidation.  
Aspergillus niger is an industrially important filamentous fungus, which has obtained GRAS 
status for use in several industrial processes and is used for production of organic acids and enzymes. 
Importantly, when the full genome sequence of A. niger was examined, a gene cluster resembling the fumonisin 
gene cluster from Gibberella moniliformis was surprisingly identified, suggesting that this well characterized 
fungus had the genetic potential to produce the carcinogenic fumonisins
12
. This possibility was later confirmed 
by genetic and chemical analyses
7,13
. The fact that the A. niger genome contains several orphan gene clusters for 
production of secondary metabolites
14
 raises the question, whether it can produce other bioactive PKs that could 
be harmful, or perhaps beneficial, to human health. To this end, it is interesting to note that among the 33 
predicted PKS and PKS-like genes in A. niger, one encodes a putative PKS, which is phylogenetically close to 
fungal 6-methylsalicylic acid (6-MSA) synthases
14
. Importantly, the model PK 6-MSA
15
 (Figure 1A)
 
is known to 
be the precursor to e.g. the mycotoxin patulin
16 
produced by many Aspergillus and Penicillium species 
substantiating the possibility that this gene could be the source of yet another unknown bioactive PK in A. niger. 
We therefore investigated whether A. niger has the potential to produce 6-MSA or 6-MSA derived compounds.  
Yanuthones constitute a group of compounds that comprise a six-membered methylated ring (the 
C7 core scaffold) with two side chains; one sesquiterpene and varying side chain (-R) (Figure 1B). In this study 
we demonstrate that in A. niger, 6-MSA is the precursor for formation of yanuthone D, which is an antibiotic 
against Candida albicans, methicillin resistant Staphylococcus aureus (MRSA) and vancomycin resistant 
Enterococcus
17
. We also show that yanuthone D is in fact a complex meroterpenoid synthesized by a pathway 
where 6-MSA is decarboxylated, heavily oxidized and fused to a sesquiterpene and a mevalon moiety. This is 
surprising as yanuthones have so far been thought to origin from the shikimate pathway
17
.   
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 Figure 1. Chemical structures of (A) 6-methylsalicylic acid (6-MSA) and (B) previously described yanuthones: 
yanuthones A-E, 7-deacetoxyyanuthone A and 22-deacetylyanuthone A
17,18
. 
 
RESULTS  
 
A. niger PKS48 encodes a 6-MSA synthase. To investigate the possibility that the A. niger gene 
PKS48/ASPNIDRAFT_44965 encodes a 6-MSA synthase, we transferred the gene to A. nidulans, which has not 
199
been shown to produce 6-MSA, and which does not contain a close homologue to known 6-MSA PKSs. To 
ensure a high expression level on a defined medium, the PKS48 gene was integrated into a well characterized 
integration site, IS1
19
, under control of the strong constitutive promoter PgpdA. As expected, the metabolite 
profile obtained with an A. nidulans reference strain did not show any indications of 6-MSA when analyzed by 
HPLC-DAD-TOFMS (Figure 2A). In contrast, the metabolite profile of the strain expressing PKS48 showed the 
presence of a prominent new peak, which had the same retention time as an authentic 6-MSA standard and 
displayed the same adducts and monoisotopic mass for the pseudomolecular ion. We therefore conclude that 
PKS48 encodes a 6-MSA synthase. 
 
Figure 2. (A) Extracted ion chromatogram (EIC) showing production of 6-MSA (m/z 153.0546±0.005) in A. 
nidulans. (B) Base peak chromatograms (BPC) m/z 100-1000 of the reference, yanAΔ, and yanRΔ strain, and (C) 
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EICs of yanuthone D (1) 503.2640±0.005 (red) and yanuthone E (2) 505.2791±0.005 (black) for the reference, 
yanAΔ, and yanRΔ. All chromatograms are to scale. 
 
Production of yanuthones D and E is eliminated by deletion of PKS48. The fact that 6-MSA has not 
previously been reported from A. niger prompted us to investigate whether this compound could be a precursor 
to a known secondary metabolite produced by this fungus. We therefore cultivated a reference and a PKS48Δ A. 
niger strain on four different solid media (MM, CYA, YES and MEA) that are known to trigger the production 
of a wide range of metabolites
20
. The resulting UHPLC-DAD-TOFMS metabolite profiles were almost identical 
(see Figure S1) showing that the PKS48Δ mutation did not induce a global response on the secondary 
metabolism. However, on YES and MM media, we identified two compounds that were produced by the 
reference strain, but not by the PKS48Δ strain (Figure 2B and C, Table S1). UHPLC separation with UV/Vis and 
high-resolution MS detection as well as MS/MS suggested that the two compounds were yanuthones D and E. 
This was confirmed by isolation of the compounds, NMR spectroscopy and circular dichroism (CD) 
(Supplemental Tables S2, S3 and S4). Hence, production of yanuthones D and E appears to be based on the use 
of 6-MSA as a key precursor. In this scenario, one carbon must be eliminated from C8-based 6-MSA to form the 
C7 core scaffold of yanuthones D and E. 
 
Yanuthones constitute a complex group of compounds that appear to origin from different precursors. In 
addition to yanuthones D and E, A. niger has previously been reported to produce yanuthones A, B, and C, 1-
hydroxyyanuthone A, 1-hydroxyyanuthone C, and 22-deacetylyanuthone A
17
 and 7-deacetoxyyanuthone A has 
been reported from the genus Penicillium
18
 (Figure 1B). We thus examined the extracted ion chromatograms 
from the UHPLC-DAD-TOFMS profiles obtained by the reference strain for the presence of these metabolites. 
In extracts obtained after cultivation on MM, YES, and CYA media, this analysis identified trace amounts of a 
compound (yanuthone X1) with a mass and elemental composition corresponding to the yanuthone isomers A 
and C. The nature of this compound was further investigated by MS/MS and its fragmentation pattern was 
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similar to the pattern of other yanuthones, showing characteristics such as loss of a sesquiterpene chain. 
Moreover, the UV/VIS spectrum of the compound was similar to spectra obtained for yanuthones D and E 
substantiating that this compound was a yanuthone. Surprisingly, when the UHPLC-DAD-TOFMS metabolite 
profiles obtained with the PKS48Δ strain were examined for the presence of this yanuthone, it was still present. 
This observation strongly suggested that some yanuthones, are produced independently of PKS48. 
 
Fully labeled 
13
C8-6-MSA is incorporated into yanuthones D and E in vivo.  The fact that some yanuthones 
could be produced independently of PKS48 combined with the fact that yanuthones have been proposed to origin 
from the shikimate pathway, raised the possibility that the absence of yanuthones D and E in the PKS48 deletion 
strain potentially could be the result of an indirect effect. To investigate this possibility, we fed fully labeled 
13
C8-6-MSA to a reference strain and the PKS48Δ strain at different time points during growth (24 h, 48 h and 
72 h), see Experimental Section. The addition of 
13
C8-6-MSA did not seem to adversely affect the growth rate, 
and the morphologies of the colonies of the two strains were identical (Figure S2). This indicates that the 
amounts of 
13
C8-6-MSA added (2-10 μg/ml) did not significantly influence strain fitness. Metabolites were then 
extracted from the plates and analyzed by UHPLC-DAD-TOFMS. For both strains, 
13
C8-6-MSA was 
incorporated into yanuthones D and E resulting in a mass shift of 7.023 Da. This is in agreement with the 
scenario described above where one carbon atom must be eliminated from 6-MSA in the biosynthetic processing 
towards yanuthones D and E. Moreover, the MS-based metabolite profiles also showed that 
13
C8-6-MSA was 
exclusively incorporated into compounds related to yanuthones.  These compounds are only present in tiny 
amounts, and are likely intermediates or analogues of yanuthone D or E as they share the same UV 
chromophore, and as their masses corresponded to water loss(es) or gain from yanuthone D or E. Based on these 
results, we named the 6-MSA synthase (encoded by PKS48/ASPNIDRAFT_44965) YanA (yanuthone) and the 
corresponding gene yanA. On the other hand, no labeled yanuthone X1 was observed in the reference strain as 
well as in the PKS48 deletion strain after addition of 
13
C8-6-MSA (mass spectra are shown in Figure S3), 
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confirming our finding that yanuthone X1 is formed in the absence of PKS48. Hence, we conclude that 6-MSA is 
not the precursor of yanuthone X1.  
 
The yan gene cluster comprises ten genes. To determine whether yanA defines a gene cluster for a biosynthetic 
pathway towards yanuthones D and E, ten genes up- and downstream of yanA were annotated using FGeneSH 
(Softberry) and AUGUSTUS software
21
. Subsequently, these twenty putative genes were examined using the 
NCBI Conserved Domain Database (CDD)
22
 for ORFs encoding activities that are typically employed for the 
modification of PKs. Based on these analyses, additional eight genes could potentially belong to the yanA 
cluster, including genes encoding a transcription factor (TF), a prenyl transferase, an O-acyl transferase, a 
decarboxylase, two oxidases, two cytochrome P450s (CYP450s), and a dehydrogenase (Table 1 and Figure 3). 
Together with yanA and 192604 (a gene with no known homologs), these eight genes form a cluster of ten genes 
that are not interrupted by any of the remaining eleven genes included in the analysis. The fact that one of the ten 
genes in this cluster putatively encodes a TF (44961) raised the possibility that expression of the genes involved 
in yanuthones D and E production is controlled by this TF. In agreement with this view, deletion of 44961 
resulted in a strain that did not produce these two yanuthones (Figure 2B and C). To further delineate the yanA 
gene cluster, we determined the expression levels of the ten cluster genes as well as of four flanking genes by 
RT-qPCR in a 44961Δ strain and a reference strain. When the two datasets were compared, we found, as 
expected, that expression from 44961 is eliminated in the 44961Δ strain where the entire gene is deleted (see 
Figure S4). More importantly, the analysis demonstrated that expression from the other nine genes in the cluster 
was significantly down-regulated in the 44961Δ strain as compared to the reference strain (p-value < 0.05). 
Specifically, the expression was reduced more than 10-fold for seven of the genes, including yanA. Expression 
of the remaining two genes: 54844 and 44964 were expressed at a level corresponding to 20 % and 11 %, 
respectively, of the level obtained with the reference strain. In contrast, expression levels from the four flanking 
genes were not significantly different from the reference (Figure S4). Next, we individually deleted the 
remaining eight genes in the proposed yan gene cluster, which encode putative activities for PK modification. 
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None of the resulting strains, including 192604Δ, produced yanuthone D indicating that all genes belong to the 
yan cluster (Table S1).  As a control, the four additional genes flanking this cluster were also individually 
deleted, but all these four strains produced yanuthone D.  Based on these analyses and the results from the RT-
qPCR, we propose that the yan gene cluster is composed by 10 genes yanA-I, and yanR, where yanR encodes a 
TF that regulates the gene cluster (Figure 3, Table 1). Finally, all ten genes were simultaneously deleted in one 
strain. When 
13
C8-6-MSA was fed to this strain, no labeled metabolites were detected showing that all 6-MSA 
derived yanuthones depend on this gene cluster (see above). 
 
Figure 3. The proposed yan cluster. The yanA 6-MSA synthase encoding gene is flanked by 9 cluster genes 
(yanB-yanI, yanR) whose products contain all necessary activities for conversion of 6-MSA into yanuthone D.  
 
Table 1. Overview of genes and proposed activities of the yan cluster. 
Locus 
(ASPNIDRAFT_) 
Gene name Predicted functional domains 
(CDD) 
Proposed activity 
44959 - No conservation - 
44960 - Glyoxalase - 
44961  yanR Fungal transcription factor Transcription factor  
54844  yanC CYP450 m-Cresol hydroxylase 
44963  yanB Amidohydrolase, decarboxylase 6-MSA decarboxylase  
44964  yanG UbiA-like prenyltransferase Prenyltransferase  
44965  yanA Polyketide synthase 6-MSA synthase  
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193092  yanH CYP450 Cytochrome P450  
44967  yanI Membrane bound O-acyl transferase O-Mevalon transferase 
127904  yanD Short-chain dehydrogenase Dehydrogenase 
192604  yanE No conservation - 
44970  yanF FAD/FMN-containing 
dehydrogenases 
Oxidase 
44971  - No conservation -  
44972 - No conservation - 
 
 
YanF converts yanuthone E into yanuthone D. As the first step towards elucidating the order of reaction steps 
in the pathway towards yanuthones D and E, we asked whether yanuthones D and E are two different end 
products, or whether one is an intermediate in the pathway towards production of the other. To this end, we note 
that individual deletion of genes in the yan gene cluster generally resulted in loss of production of both 
yanuthones D and E on YES medium. The only exception is the yanFΔ strain, which produced substantial 
amounts of yanuthone E (2), but no yanuthone D (1), see Figure 4. These finding suggest that YanF converts 
yanuthone E into yanuthone D, which is the true end product of the pathway. Interestingly, the yanFΔ strain 
produced a new and unknown compound, which was not detected in the reference strain. Elucidation of its 
structure revealed a yanuthone E analog with a hydroxylation at C-2 at the expense of the first double bond 
(between C-2 and C-3) in the sesquiterpene moiety (Table S5). This compound was named yanuthone J (9). 
205
 Figure 4. BPC m/z 100-1000 of reference strain (KB1001), yanHΔ, yanIΔ, and yanFΔ. All NMR-elucidated 
compounds are shown for comparison of intensity and relative retention times. Below are structures of the novel 
yanuthones identified in this study. Structures of yanuthone D (1), yanuthone E (2), 7-deacetoxyyanuthone A 
(3), and 22-deacetylyanuthone A (6) are shown in Figure 1. 
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m-cresol and toluquinol are intermediates of the yanuthone D biosynthesis. Deletion of yanB, yanC, yanD, 
yanE, and yanG, did not produce any detectable intermediates and the phenotype of these mutations do therefore 
not link any of the genes to specific reaction steps in the pathway towards formation of yanuthone D. However, 
one of the five putative enzymes, YanC, has a defined homologue, PatI, in the Aspergillus clavatus patulin 
biosynthesis pathway
23
 where it catalyzes the oxidation of m-cresol into toluquinol, suggesting that toluquinol 
and m-cresol are also likely intermediates in the yanuthone biosynthesis. To test this hypothesis we fed m-cresol 
and toluquinol to the yanAΔ strain. Analysis of the metabolite profiles of the two strains indeed showed that 
addition of m-cresol or toluquinol restored production of yanuthones D and E in the yanAΔ strain (Figure 5). 
  
Figure 5. Feeding with unlabeled m-cresol and toluquinol. EICs of yanuthone D (1) 503.2640±0.005 (red) and 
yanuthone E (2) 505.2791±0.005 (black) for the wildtype and the yanAΔ strain with and without feeding. 
Chromatograms are to scale. 
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In an attempt to further elucidate the role of the five enzymes, the corresponding genes were inserted into 
plasmid pDHX2 (Figure S5) and individually expressed in the A. nidulans strain harboring the yanA gene. No 
new compounds were produced in these IS1-yanA strains expressing yanC, yanD, yanE, and yanG, despite that 
6-MSA was produced in high amounts (Figure S6). Similarly, in the strain expressing yanB, no new product was 
observed, but in this case 6-MSA was absent indicating that 6-MSA is a substrate for YanB.  
 
Deletion of yanI and yanH reveals key intermediates in the biosynthesis of yanuthone D. In contrast to the 
yanBΔ-EΔ, and yanGΔ strains, new products were observed in the yanHΔ and yanIΔ strains. Deletion of yanH  
resulted in a strain where the most prominent compound accumulating is 7-deacetoxyyanuthone A (3) (NMR 
data in Table S6). Interestingly, we also identified two novel compounds in this strain, see Figure 4. Isolation 
and structure elucidation revealed two C-1 oxidized yanuthone derivatives, which we named yanuthone F (4) 
and yanuthone G (5) (NMR data in Tables S7 and S8). Yanuthone G (5) is a glycosylated version of yanuthone F 
(4), which can also be detected in trace amounts in the reference strain (see Table S1). Deletion of yanI resulted 
in a strain producing the known compounds 7-deacetoxyyanuthone A (3) and 22-deacetylyanuthone A (6) (NMR 
data in Table S9), see Figure 1B. Importantly, the latter compound corresponds to yanuthone E (2) without the 
mevalon moiety. In addition, two novel compounds were produced. The structures were elucidated by NMR 
spectroscopy revealing that one, which we named yanuthone H (7), is very similar to 22-deacetylyanuthone A 
(6), but with a hydroxyl group at C-1 (Figure 4, Table S10). The other novel compound, which we name 
Yanuthone I (8), is a modification of 22-deacetylyanutone A (6) with an oxidative cleavage between C4 and C5 
of the sesquiterpene chain (NMR data in Table S11).  We note that yanuthone I (8) was also detected in trace 
amounts in the reference strain (see Table S1). 
 
Determination of the yanuthone X1 structure. As mentioned above yanuthone X1 (12) has an elemental 
composition corresponding to yanuthone A and C, but was biosynthesized from another precursor than 
yanuthone D and E.  Since the structures of yanuthones A, C, D and E are similar (Figure 1B), it seemed 
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unlikely that yanuthone X1 (12) was either yanuthone A or C. We therefore isolated and elucidated the structure 
(see Figure 4 and Table S12). This analysis confirmed that yanuthone X1 (12) does not have the same C7 core 
scaffold, but instead a C6 core with  a methoxygroup directly attached to the six-membered ring at the expense of 
a methyl group (See Figure 4). Despite that yanuthone X1 (12) and yanuthones D and E employ different 
precursors, they share common features like the epoxide and the sesquiterpene side chain, and we therefore 
hypothesized that they share common enzymatic steps during their biosynthesis. In agreement with this, 
examination of the metabolite profiles obtained with the yan gene deletion strains revealed that yanuthone X1 
(12) was absent in the yanC, yanD, yanE, and yanG deletion strains (Table S1). In contrast, yanuthone X1 (12) is 
produced in larger amounts in the yanAΔ strain, which cannot produce 6-MSA. 
 
DISCUSSION 
 
Elucidation of the biosynthetic route from 6-MSA towards yanuthone D. We have used a combination of 
bioinformatics, genetic tools, chemical analyses and feeding experiments to investigate whether 6-MSA is 
produced and if it is used for production of toxic secondary metabolites in A. niger. Our work demonstrates that 
6-MSA is synthesized by the YanA PKS and then subsequently modified into the antimicrobial end product 
Yanuthone D, which is surprising as yanuthones have previously been suggested to origin from shikimic acid
17
. 
We have also shown that yanA defines a gene cluster of ten members, yanA-I and yanR, which is regulated by 
YanR, a putative transcription factor with homology to Zn2Cys6 TF types that are commonly involved in 
regulation of secondary metabolite production. The fact that deletion of yanR completely abolished production 
of yanuthone D suggests that YanR acts as an activator of the yan cluster. Additionally, analyses of strains where 
the remaining genes in the yan cluster were individually deleted have allowed us to isolate and characterize the 
full structures of three intermediates. Based on these compounds we propose the entire pathway for yanuthone D 
formation including addition of a sesquiterpene and a mevalon to the core polyketide moiety at different stages 
of the biosynthesis (see Figure 6). 
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 Figure 6. Proposed biosynthesis of yanuthone D (1). Structures and enzymatic activities in brackets are 
hypothesized, activities in plain text have been proposed from bioinformatics, and activities in bold have been 
experimentally verified. 
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In our model, the last intermediate in the pathway is yanuthone E (2), which is converted into the 
end product yanuthone D (1) by oxidation of the hydroxyl group at C-15 in a process catalysed by YanF. The 
fact that yanuthone E (2) is present in the reference strain indicates that it may act as a reservoir for rapid 
conversion into the more potent antibiotic compound yanuthone D. Yanuthone E (2) is likely formed from 22-
deacetylyanuthone A (6) by attachment of mevalon to the hydroxyl group at C-22. Since 22-deacetylyanuthone 
A (6), but not yanuthone E (2), accumulates in the yanIΔ strain we propose that YanI, a putative O-acyl 
transferase catalyses this step. Intriguingly, YanI therefore appears to be an O-mevalon transferase, an activity, 
which, to the best of our knowledge, has not previously been described in the literature. Next, we propose that 
22-deacetylyanuthone A (6) is formed by hydroxylation of C-22 of 7-deacetylyanuthone A (3). In agreement 
with this view, 7-deacetylyanuthone A (3), but not 22-deacetoxyyanuthone A (6), accumulates in the absence of 
YanH.  
Unfortunately we did not detect any intermediates leading from 6-MSA to 7-deacetoxyyanuthone 
A (3) in any of the deletion strains in A. niger. The remaining tentative steps in the pathway were therefore 
deduced from bioinformatics and feeding experiments. First, analyses of patulin formation in Aspergillus 
floccosus (as A. terreus, Jens C. Frisvad personal communication) and A. clavatus have shown that it requires 
decarboxylation of 6-MSA into m-cresol
23,24
. This step is catalyzed by 6-MSA decarboxylase
25
, which has been 
proposed to be encoded by patG
24
. m-cresol is then converted into gentisyl alcohol in two consecutive 
hydroxylation steps catalyzed by the two P450s, CYP619C3 (PatH) and CYP619C2 (PatI). However, 
CYP619C2 may also act directly on m-cresol to form the co-metabolite toluquinol, which is not an intermediate 
towards patulin. When we inspected the yan gene cluster for similar activities we found a putative 6-MSA 
decarboxylase (yanB) and CYP619C2 (YanC), but not of CYP619C3. These observations suggest that m-cresol 
and toluquinol are intermediates in yanuthone D formation. We present two lines of evidence in support of this 
view. First, our feeding experiments demonstrate that both compounds can be converted into yanuthone D.  
Secondly, heterologous expression of yanA in A. nidulans lead to production of 6-MSA. This compound 
disappears if the strain also expresses yanB indicating that 6-MSA is a substrate for the putative 6-MSA 
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decarboxylase YanB. Together these results strongly suggest to that m-cresol is formed directly from 6-MSA by 
a decarboxylation reaction, which is most likely catalyzed by YanB. This reaction explains how C8 based 6-
MSA can serve as the building block for the C7 based core unit of yanuthones. Moreover, the analyses show that 
toluquinol is an intermediate in the production of yanuthone D and that it is formed from m-cresol in a process 
most likely catalyzed by the putative cytochrome P450 encoded by yanC. Conversion of toluquinol into 7-
deacetylyanuthone A (3) requires epoxydation and prenylation. Based on the fact that prenylated toluquinol is 
never observed in the reference or mutant strains, we propose that epoxidation precedes prenylation. In this 
scenario, toluquinol is epoxidated into (10), which is in equilibrium with the tautomer (11). This compound (11) 
is then prenylated to form 7-deacetylyanuthone A (3) as a sesquiterpene moiety is attached to C-13 of (11). The 
latter reaction is likely catalyzed by YanG, a putative prenyltransferase. This is supported by the observation that 
yanuthone D (1) and all detectable intermediates, including 7-deacetoxyyanuthone A (3), were absent in the 
yanGΔ strain. The identity of the gene products(s) responsible for epoxidation of toluquinol is less clear. 
Amongst the putative activities encoded by the genes in the yan cluster, which have not been assigned to any 
reaction step during the analyses above, we note the presence of a putative dehydrogenase (YanD) and one with 
an unknown activity (YanE). We hypothesize that one or both of these enzymes catalyze epoxidation. The fact 
that neither 6-MSA, m-cresol, toluquinol, nor any other intermediates were detected in the yanBΔ, yanCΔ, 
yanDΔ, and yanEΔ strains suggests that these small, aromatic compounds must be rapidly degraded, converted 
into other compound(s), or they may be incorporated into insoluble material e.g. the cell wall.  
 
Accumulation of intermediates in the yanuthone D pathway may trigger detoxification reactions. 
Disruption of the biosynthetic pathway towards yanuthone D results in formation of three branch points in the 
pathway towards yanuthone D: at yanuthone E (2), at 7-deacetoxyyanuthone A (3), and at 22-deacetylyanuthone 
A (6). In addition to yanuthone E (2), yanuthone J (9) accumulates in the yanFΔ strain. Similarly, yanuthone F 
(4) accumulates in addition to 7-deacetoxyyanuthone A (3) in the yanHΔ strain and Yanuthone H (7) 
accumulates in addition to 22-deacetylyanuthone A (6) in the yanIΔ strain. In all cases, the sesquiterpenes of the 
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accumulated intermediates in the main pathway are oxidized at C-1 or C-2. As hydroxylation is a known 
detoxification mode we therefore hypothesize that the abnormally high amount of potentially toxic intermediates 
7-deacetoxyyanuthone A (3), 22-deacetylyanuthone A (6)  and yanuthone E (2) triggers the cell to initiate phase 
I type of detoxification processes in which the toxic intermediates are hydroxylated. This hypothesis is supported 
by the fact that there is no obvious assignment of an enzyme with this activity, encoded by the yan gene cluster. 
An additional variant of yanuthone F (4) was identified in the yanHΔ strain, in which yanuthone F (4) is 
glycosylated at the hydroxyl group at C-15 to form yanuthone G (5).  The glucose moiety of yanuthone G (5) is 
intriguing as sugar moieties are rare in fungal secondary metabolites, and the fact that yanuthone G (5) is 
detected in the reference strain shows that it is a naturally occurring compound (see Figure 4 and Table S1). As 
yanuthone G (5) production is up-regulated in yanHΔ we suggest that glycosylation poses a second (phase II 
conjugation) type of mechanism for further detoxification of possible toxic intermediates.   
The branch point at 22-deacetylyanuthone A (6) revealed a novel compound yanuthone I (8), 
which is identical to 22-deacetylyanuthone A (6) and yanuthone H (7) but with an oxidative cleavage of the 
sesquiterpene chain. A similar enzymatic modification has also been proposed for the mycophenolic acid 
biosynthesis
26
. 
 
Yanuthone X1 defines a novel class of yanuthones. Since yanuthones are based on a C7 scaffold, they were 
previously proposed to originate from shikimic acid
17
. However, in our study we demonstrate that yanuthone D 
and E origin from the C8 polyketide precursor 6-MSA, which is decarboxylated to form the C7 core of the 
yanuthone structure. In contrast, the novel yanuthone X1 (12) has a C6 core scaffold that does not origin from 6-
MSA and does not require decarboxylation by YanB. Based on this we define two classes of yanuthones, those 
that are based on the polyketide 6-MSA, class I, and those that are based on the yet unknown precursor leading 
to the formation of yanuthone X1 (12), class II. The two classes of yanuthones share several enzymatic steps. 
First we note that the sesquiterpene side chain in yanuthone X1 (12) is likely attached by YanG, as it is the case 
for yanuthone D. Secondly it depends on enzyme activities of YanC, YanD and YanE, but not of YanB. 
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Together this suggests that the precursor is a small aromatic compound similar to 6-MSA but lacking the 
carboxylic acid. Importantly, the main difference between yanuthone D and yanuthone X1 (12) are the groups 
attached to C-16. In the case of yanuthone X1 (12) this position is oxidized whereas in yanuthones D and E there 
is a carbon-carbon bond that originates from the methyl group of 6-MSA. Consequently, yanuthone X1 (12) 
cannot be mevalonated by YanH. 
 
CONCLUSION 
 
This study has identified a cluster of 10 genes, which is responsible for production of antimicrobial yanuthone D 
in A. niger. We show that yanuthone D is based on the polyketide 6-MSA, and not on shikimic acid as 
previously suggested, and we have proposed a detailed genetic and biochemical pathway for converting 6-MSA 
into yanuthone D. Interestingly, we have revealed that the novel yanuthone X1, though similar in structure, is not 
derived from 6-MSA, but the unknown precursor to yanuthone X1 does employ several enzymes encoded by the 
yan cluster. An important finding in the elucidation of the biosynthesis is the identification of yanI encoding an 
O-mevalon transferase, which represents a novel enzymatic activity. We have discovered that the pathway 
towards yanuthone D branches when intermediates accumulate, as three intermediates are hydroxylated. Two of 
the hydroxylated compounds are further modified by oxidative cleavage of the sesquiterpene and glycosylation, 
respectively, resulting in five novel yanuthones. The discovery of a glycosylated compound, yanuthone G, is 
intriguing as glycosylated compounds are very rare in fungal secondary metabolism. With great success, we 
have employed an interdisciplinary approach for solving the biosynthetic pathway; applying gene deletions, 
heterologous gene expression, UHPLC-DAD-MS, MS/MS, structural elucidation by NMR spectroscopy and 
CD, and feeding experiments with labeled and unlabeled metabolites. Together our analyses have cast new 
insights into understanding the complexity of fungal secondary metabolism.  
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EXPERIMENTAL SECTION 
 
Strains and media. The strain IBT 29539 (argB2, pyrG89, veA1, nkuAΔ) was used for strain constructions in A. 
nidulans. ATCC1015-derived strain KB1001 (pyrGΔ kusA::AFpyrG) was used for all strain construction in A. 
niger.  All fungal strains prepared in the present work (Table S13) have been deposited in the IBT Culture 
Collection at Department of Systems Biology, DTU, Kgs. Lyngby, Denmark. Escherichia coli strain DH5α was 
used for propagating all plasmids, except E. coli ccdB survival2 cells (Invitrogen) were used to propagate 
plasmids carrying the ccdB gene. 
Minimal medium for A. nidulans was made as described by Cove
27
 but with 1% glucose, 10 mM 
NaNO3 and 2% agar. Minimal medium for A. niger was prepared as described by Chiang and co-workers
28
. 
YES, MEA and CYA media were prepared as described by Frisvad and Samson
29
. When necessary, media were 
supplemented with 4 mM L-arginine, 10 mM uridine, 10 mM uracil and/or 100 μg/ml hygromycin B (Invivogen, 
San Diego, CA, USA).  Luria-Bertani (LB) medium was used for cultivation of E. coli strains, and consisted of 
10 g/l Tryptone (Bacto), 5 g/l yeast extract (Bacto), and 10 g/l NaCl, pH adjusted to 7.0 prior to autoclavation. 
When necessary, LB was supplemented with 100 μg/ml ampicillin and/or 25 μg/ml chloramphenicol. 
 
Construction of basic vectors for strain construction. All primers are listed in Table S14. The PfuX7 
polymerase
30 
was used in all PCR reactions. Fragments were assembled via uracil-excision fusion
31
 into a 
compatible vector.  
pDH56 and pDH57 are designed for integration of novel genes into the IS1 site of A. nidulans. In 
pDH56, the AsiSI/Nb.BtsI uracil-excision cassette of CMBU1111
19
 is modified into a ccdB-cm
R
 AsiSI/Nb.BtsI 
uracil-excision cassette. Unlike with CMBU1111, new fragments can be introduced into this cassette and cloned 
in ccdA deficient E. coli strains like DH5α without generating background as false positives resulting from 
incomplete digestion of the USER cassette are eliminated
32
. Specifically, the suicide gene ccdB and the 
chloramphenicol resistance gene cm
R
 (ccdB-cm
R
) construct was PCR amplified (using primers 84 and 85) from 
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pDONR (Invitrogen) and inserted into CMBU1111 by uracil-excision cloning in a manner that reconstituted the 
original uracil excision cassette on either side of the insert. Plasmids with the AsiSI/Nb.BtsI uracil-excision 
cassette are maintained in ccdB survival2 cells (Invitrogen). The pDH57 vector was constructed from pDH56 by 
removing an undesirable Nb.BtsI nicking site located in the amp
R
 gene. pDH56 was PCR amplified in two 
pieces, using primers 81+76 and 75+ 80. 75 and 76 have complementary uracil-containing overhangs, which 
were designed to introduce a silent mutation into the Nb.BtsI recognition site. The two PCR fragments were 
assembled via uracil-excision cloning, and correct clones were verified by sequencing. The gene targeting 
substrate for insertion of the 6-MSA synthase gene yanA was made by amplifying the synthase gene yanA 
(PKS48/ASPNIDRAFT_44965) from IBT29539 genomic DNA by PCR (primers 1+2) and inserted into pDH57, 
yielding pDH57-yanA. 
The pDHX2 vector is AMA1-based and designed for episomal gene expression. pDHX2 was 
constructed by USER fusion of 5 fragments 1) E. coli origin of replication (ori
R
) and the E. coli ampicillin 
resistance gene (amp
R
) carrying a silent point mutation omitting a Nb.BtsI nicking site, 2) the 5’ half of AMA1, 
3) the 3’ half of AMA1, and 4) 0.5 kb of the PgpdA promoter, an AsiSI/Nb.BtsI USER cassette containing ccdB 
and cm
R
, and the TtrpC terminator, and 5) the A. fumigatus pyrG selection marker (Figure S5). Fragment 1 was 
amplified from pDH57 (primers 77+78), fragment 2, 3, and 5 were amplified from pDEL2 (primers 86+89, 
87+88, and 82+83)
33
, fragment 4 was amplified from pDH57 (primers 79+80). Fragments were assembled as 
described by Geu-Flores and coworkers
31
 using equal molar amounts of purified PCR product, and correct 
clones were verified by restriction digestion. Plasmids for episomal heterologous expression of cluster genes 
were constructed by PCR amplification of ORFs using primers 3-12 pairwise. Genes were inserted into 
AsiSI/Nb.BtsI digested pDHX2 as described by Nour-Eldin and co-workers
34
, resulting in pDHX2-yanB, 
pDHX2-yanC, pDHX2-yanD, and pDHX2-yanE. Plasmids were verified by sequencing. 
Plasmids carrying gene targeting substrates for gene deletion in A. niger were constructed by  
PCR amplification of upstream (US) and downstream (DS) targeting sequences along with the hph marker, 
comferring resistance to hygromycin B. US and DS targeting sequences were generated using the primers 17-72, 
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hph was amplified from pCB1003
35 
using primers 13+14. The three fragments were assembled into the 
CMBU0020 vector
19
.  
 
Strain construction. Protoplasting and gene-targeting procedures were performed as described previously for A. 
nidulans
36,37
 and A. niger
28
. Gene targeting substrate for insertion of the 6-MSA synthase (yanA) was excised 
from pDH57-yanA by NotI digestion and transformed into IBT29539. Transformants, with yanA integrated into 
IS1, were verified by diagnostic PCR as described by Hansen and co-workers
19
. 
Strains for episomal expression of cluster genes were constructed by transforming the IS1-yanA 
strain with circular plasmids (pDHX2-yanB, pDHX2-yanC, pDHX2-yanD, and pDHX2-yanE) using pyrG as a 
selectable marker. 
A. niger deletion strains were constructed by transforming KB1001 with bipartite gene targeting 
substrates. The substrates were generated by PCR amplification of the US::hph::DS cassettes of the  
CMBU0020-based plasmids using primers GENE_US-FW+73 and 74+GENE_DS-RV. Deletion strains were 
selected on 100 μg/ml hygromycin B, and verified by diagnostic PCR. 
 
RNA extraction and RT-qPCR. RNA isolation from the A. niger strains and subsequent quantitative RT-PCR 
reactions were done as previously described by Hansen and co-workers
19
 except that biomass for RNA isolation 
was prepared with a Tissue-Lyser LT (Qiagen) by treating samples for 1 min at 45 MHz. The A. niger histone 3 
encoding gene, hhtA (ASPNIDRAFT_52637) and gamma-actin encoding gene actA (ASPNIDRAFT_200483) 
were used as internal standards for normalization of expression levels. All primers used for quantitative RT-PCR 
are shown in Table S14 (primers 90-121). 
 
Chemical analysis of strains. Unless otherwise stated strains were inoculated as a three point inoculation on 
solid MM media and incubated at 37 °C for 5 days. Extraction of metabolites was performed as described by 
Smedsgaard
38
. 6-MSA was purchased from (Apin Chemicals, Oxon, UK). Analysis was performed using ultra-
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high-performance liquid chromatography (UPHLC) UV/Vis diode array detector (DAD) high-resolution MS 
(TOFMS) on a maXis 3G orthogonal acceleration quadrupole time of flight mass spectrometer (Bruker 
Daltonics, Bremen, Germany) equipped with an electrospray ionization (ESI) source and connected to an 
Ultimate 3000 UHPLC system (Dionex, Sunnyvale, USA). The column used was a reverse-phase Kinetex 2.6-
μm C18, 100 mm × 2.1mm (Phenomenex, Torrance, CA), and the column temperature was maintained at 40 °C. 
A linear water- acetonitrile (LCMS-grade) gradient was used (both solvents were buffered with 20 mM formic 
acid) starting from 10% (vol/vol) acetonitrile and increased to 100% in 10 min, maintaining this rate for 3 min 
before returning to the starting conditions in 0.1 min and staying there for 2.4 min before the following run. A 
flow rate of 0.4 mL·min
−1
 was used. TOFMS was performed in ESI+ with a data acquisition range of 10 scans 
per second at m/z 100–1000. The TOFMS was calibrated using Bruker Daltonics high precision calibration 
algorithm (HPC) by means of the use of the internal standard sodium formate, which was automatically infused 
before each run. This provided a mass accuracy of better than 1.5 ppm in MS mode. UV/VIS spectra were 
collected at wavelengths from 200 to 700 nm. Data processing was performed using DataAnalysis 4.0 and Target 
Analysis 1.2 software (Bruker Daltonics). Tandem MS was performed with fragmentation energy was varied 
from 18 to 55 eV. 
 
Preparative isolation of selected metabolites. The fungal strains was inoculated as three point inoculations on 
10-200 plates of YES medium and incubated at 30 °C for 5 days. The plates were harvested and extracted twice 
overnight with ethyl acetate (EtOAc) with or without 1 % formic acid. For specific details about each extract see 
supplementary Table S2. The extracts were filtered and concentrated in vacuo. The combined extract was 
dissolved in methanol (MeOH) and H2O (9:1), and an equal amount of heptane was added where after the phases 
were separated. To the MeOH/H2O phase H2O was added to a ratio of 1:1, and metabolites were then extracted 
with dichlormethane (DCM). The phases were then concentrated separately in vacuo. The DCM phase was 
adsorbed onto diol column material and dried before packing into a SNAP column (Biotage, Uppsala, Sweden) 
with diol material. The extract was then fractionated on an Isolera flash purification system (Biotage) using 
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seven steps of heptane-DCM-EtOAc-MeOH. Solvents used were of HPLC grade and H2O was purified and 
deionized by a Millipore system through a 0.22 μm membrane filter (milliQ-water). For flow rate, column sizes 
and fractionation see Table S2.  
The Isolera fractions were subjected to further purification on a semi-preparative HPLC  which 
was either a Waters 600 Controller with a 996 photodiode array detector (Waters, Milford, MA, USA) or a 
Gilson 322 Controller connected to a 215 Liquid Handler, 819 Injection Module and a 172 DAD (Gilson, 
Middleton, WI, USA). This was achieved using a Luna II C18 column (250 x 10 mm, 5 μm, Phenomenex) or a 
Gemini C6-Phenyl 110A column (250 x 10.00 mm, 5 μm, Phenomenex). 50 ppm TFA was added to acetonitrile 
of HPLC grade and milliQ-water. For choice of system, flow rate, column, gradients and yields see Table S2.  
 
NMR and structural elucidation. The 1D and 2D spectra were recorded on a Unity Inova-500 MHz 
spectrometer (Varian, Palo Alto, CA, USA). Spectra were acquired using standard pulse sequences and 
1
H 
spectra as well as DQF-COSY, NOESY, HSQC and HMBC spectra were acquired. The deuterated solvent was 
acetonitrile-d3 and signals were referenced by solvent signals for acetonitrile-d3 at δH = 1.94 ppm and δC = 
1.32/118.26 ppm. The NMR data was processed in Bruker Topspin 3.1 or ACD NMR Workbook. Chemical 
shifts are reported in ppm (δ) and scalar couplings in hertz (Hz). The sizes of the J coupling constants reported in 
the tables are the experimentally measured values from the spectra. There are minor variations in the 
measurements which may be explained by the uncertainty of J. The description of the structural elucidation of 
the yanuthones can be found in the supplementary material and NMR data for all compounds are listed in Tables 
S3-S12. 
Circular dichroism (CD) spectra were obtained using a J-710 spectropolarimeter (Jasco, Cremella, 
Italy). The samples were dissolved in methanol to a concentration of 1 mg/3 mL and analysed in 0.2 cm optical 
path length cells. The temperature was 20 °C and the spectra were recorded from 200 – 500 nm. Optical rotation 
was measured on a Perkin Elmer 321 Polarimeter. 
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Production and purification of fully labeled 
13
C-6-MSA. As fully labeled 
13
C8-6-MSA was not commercially 
available it was produced in-house from the 6-MSA producing strain by batch cultivation using a Sartorious 1L 
bioreactor (Satorious, Stedim Biotech, Germany) with a working volume of 0.8 L equipped with 2 Rushton six-
blade disc turbines. The pH electrode (Mettler Toledo, OH, USA) was calibrated according to manufacture 
standard procedures.  The bioreactor was sparged with sterile atmospheric air and off-gas concentrations of 
oxygen and carbon dioxide were measured with a Prima Pro Process Mass Spectrometer (Thermo-Fischer 
Scientific, MA). Temperature was maintained at 30°C throughout the cultivation and pH controlled by automatic 
addition of 2M NaOH and H2SO4. Start culture conditions were pH: 3.0, stir rate: 100 rpm and air flow: 0.1 
volume of air per volume of liquid per minute (vvm). Following inoculation these conditions were changed in a 
linear fashion over a period of 720 min. to pH: 5.0, stir rate: 800 rpm and air flow: 1 vvm. The strain was 
cultivated until glucose was depleted, measured by glucose test strips (Machery-Nagel, Germany) and the culture 
had entered stationary phase as monitored by off-gas CO2 concentration. 
When glucose was depleted the entire volume of the reactor was harvested and the biomass 
removed by filtration through a Whatman 1 qualitative paper filter followed by centrifugation at 8000 g for 20 
min. to remove fine sediments. The 6-MSA was then recovered from the supernatant by liquid-liquid extraction 
using ethyl acetate containing 0.5 % formic acid.  
The organic extract then completely dried in vacuo to give a crude extract that was redissolved in 
20 mL ethyl acetate and dry loaded onto 3 g Sepra ZT C18 (Phenomenex) resin  prior packing into a 25 g SNAP 
column (Biotage, Uppsala, Sweden) with 22 g pure resin in the base. The crude extract was then fractionated on 
an Isolera flask purification system (Biotage, Uppsala, Sweden) using an water-acetonitrile gradient starting at 
15:85 going to 100 % acetonitrile in 23 min at a flow rate of 25 mL min
-1
 and kept at that level for an additional 
4 min. Fractions were automatically collected using UV detection at 210 and 254 nm resulting in a total of 15 
fractions of which 3 were pooled and analysed. 6-MSA concentration was assessed using a Dionex Ultimate 
3000 UHPLC coupled with a ultimate 3000 RS diode array detector (Dionex, Germering, Germany) equipped 
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with a Poroshell 120 phenyl hexyl 2.1x100 mm, 2.7µm (Agilent, Little River, DE) column. Finally, purity (98.7 
%) was analyzed by UHPLC-TOFMS (Figure S3A). 
 
Feeding experiments. Solid YES plates were prepared for each strain using a 6 mm plug drill to make a well in 
the middle of the agar. The well should act as a feeding container. Water, 25-100 μl, was added to the well and 
spores of the appropriate strains were inoculated into the water and the plates were incubated at 30 °C for 5 days. 
100 μg 13C-6-MSA, m-cresol, toluquinol (=ortoluquinol) (in 25-100 μl 1:4 ethanol:water)  was added to the three 
plates after 24h, 48h and 72h of incubation, respectively. Control plates without feed were included. Agar plugs 
were taken both as reported previously
38
, and also separately from the center of the colony, the middle ring of the 
colony, and the rim of the colony, respectively, to verify diffusion and absorption of the 6-MSA and the location 
of yanuthone production.  Metabolites were analyzed as described in the section “Chemical analysis of strains”. 
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Chapter 11
Heterologous Reconstitution of the
Intact Geodin Gene Cluster in
Aspergillus nidulans Through a Simple
and Versatile PCR Based Approach
This chapter contains the paper Heterologous Reconstitution of the Intact Geodin Gene Cluster in Aspergillus
nidulans Through a Simple and Versatile PCR Based Approach, published in PLoS ONE, of which I am
co-author.
In this study we have used A. nidulans as a host for heterologous expression of the entire (+)-geodin cluster
from A. terreus. After successful transfer to A. nidulans, selected steps in the patway were investigated using
gene deletion and gene expression approaches.
My contribution to this study was development of Integration Site 3 (IS3), and preparation of strains for
testing autoregulation of the transcriptional regulator. Supporting information is included in Appendix F.
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Introduction
Fungal natural products constitute a rich resource for bioactive
secondary metabolites [1,2]. To fully exploit this potential, it is
essential to identify the genes required for the biosynthesis of these
compounds. This process is becoming progressively easier due to
the rapidly increasing number of fungal genomes that have been
fully sequenced; and since the genes involved in the production of
a given secondary metabolite often cluster together in the same
region of a chromosome [1–3]. Importantly, the genome
sequencing projects have revealed that the number of putative
gene clusters for secondary metabolite production greatly exceeds
the number of known natural products in a given fungus, hence,
indicating that most fungal compounds are yet to be discovered.
The prerequisite for genetic exploration of the huge reservoir of
undiscovered biosynthetic pathways is solid methodologies for
cultivating, propagating and genetically manipulating the produc-
ing species. However, the vast majority of newly sequenced
organisms fail to meet these requirements, hence, hampering
pathway elucidation and exploitation. An attractive solution to this
problem is to transfer pathways into another fungus where the
methodology is well established. This approach has been used
successfully to investigate several gene clusters [4–6]. All of these
studies apply a strategy where individual genes in a cluster are
PCR amplified, cloned, and integrated sequentially into either a
random or defined locus. One advantage of this strategy is that it
allows easy engineering of individual genes prior to integration in
the host strain. In addition, it is possible to insert the foreign
gene(s) into a well characterized locus that supports high
expression levels [7]. Inserting the genes into a known locus also
simplifies strain validation. In a recent example of this strategy,
Itoh et al. [6] transferred five genes from Aspergillus fumigatus to A.
oryzae allowing the authors to deduce the biosynthetic route for the
meroterpenoid pyropyripene A. However, the strategy may be
limited to reconstitution of simple pathways depending on only a
small number of genes since assembly of multistep pathways will
require several rounds of tedious iterative integration steps or
enough genetic markers.
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For multistep pathways it is therefore desirable to transfer entire
gene clusters from the natural producer to the expression host in
one or a few steps. This requires a host, which can efficiently
express all genes in the cluster and correctly splice the resulting
transcripts. Assembly of multiple genes and PCR fragments can
efficiently be performed in Saccharomyces cerevisiae by recombination
based methods [8]. However, the demand for splicing disfavors S.
cerevisiae as expression host for this gene transfer strategy as only
little splicing occurs in yeast. In contrast, correct and efficient
splicing of heterologous transcripts by another filamentous fungus
is likely. Activation of the cluster in the new host requires as a
minimum that the chromatin structure at the insertion site is in an
open configuration and that transcription factors exist that
recognize the individual promoters in the cluster. The latter may
be facilitated by the fact that many clusters appear to contain one
or more genes that encode transcription factors. In a pioneering
study, Bergmann et al. showed that expression of such a gene
activated the entire aspyridone gene cluster in A. nidulans [9]. The
potential of transferring entire clusters to an expression host has
been demonstrated by Sakai et al. who managed to produce
citrinin in A. oryzae [10]. To obtain this feat, they isolated and
transformed a cosmid from a Monascus purpureus library containing
all six genes required for production of citrinin into this production
host. Here constitutive expression of the citrinin pathway regulator
encoded by ctnA dramatically increased citrinin production in the
heterologous host. However, construction and screening of cosmid
libraries is not simple and a versatile PCR based method that
facilitates the transfer of entire gene clusters from the natural
producer to the expression host is desirable.
We have previously developed a versatile PCR based expression
platform that can be used for heterologous expression in A. nidulans
of one or a pair of genes from the defined locus IS1, which
supports a high level of gene expression [4,7]. Here, we
demonstrate how this platform can be expanded to allow transfer
of an entire gene cluster from another fungus into IS1.
Results and Discussion
2.1 Method for PCR based reconstruction of fungal gene
clusters in a heterologous host
Our method for transfer of large DNA fragments relies on
successive gene targeting events that introduce ,15 kb fragments
into a defined locus. In the example of the method presented here,
we transfer a gene cluster into IS1 taking advantage of a vector set
we have previously developed for this purpose [7]. In our method,
fragments covering the entire gene cluster are PCR amplified,
combined via USER fusion into ,15 kb fragments, and inserted
into the integration vector by USER cloning (Figure 1A) [11,12].
The first fragment to be integrated is assembled in the vector and
integrated into IS1 as we have described previously for integration
of single genes [7]. The following fragments are integrated as an
extension of the previous one by using one of two different
markers, argB and pyrG, for selection. In principle, an indefinite
number of integrations can be done, since the marker from the
previous integration is excised as the new fragment with the other
marker integrates (Figure 1B). This principle is referred to as re-
iterative gene targeting [13]. Importantly, marker replacements
allows for a simple selection scheme for identification of correctly
targeted strains. If, as in our case, the pyrG marker is flanked by a
direct repeat, we recommend to use the pyrG marker in the last
integration step, as the pyrG marker subsequently can be removed
by direct repeat recombination if desirable [14]. In this manner
both markers are available in the finalized strain providing a
marker repertoire for additional genetic engineering.
In the present study we demonstrate the potential of our method
by transferring the geodin gene cluster from A. terreus to A. nidulans.
This cluster was chosen, firstly, because it contains a gene
encoding a putative transcription factor, which potentially could
facilitate activation of the other genes in the cluster. Secondly, the
biosynthetic pathway for geodin production is partially character-
ized (Figure 2) [15–21], which simplifies the delineation of the
cluster size. Thirdly, the geodin pathway shares several steps with
the monodictyphenone pathway including production of several
common intermediates/products e.g. emodin [22]. We therefore
envisioned, that the chance of producing geodin in A. nidulans
would be increased, as the corresponding endogenous enzymes
could complement geodin enzymes that might not be functional.
Moreover, shared intermediates would likely be non-toxic to the
host.
2.2 Delineation of the putative geodin producing gene
cluster in A. terreus
Three enzymes involved in geodin production have previously
been linked to genes. Specifically, dihydrogeodin oxidase, a
polyketide synthase, and a thioesterase are encoded by
ATEG_08458 [18], ATEG_08451 [19–21], and ATEG_08450
[20], respectively, see Aspergillus Comparative Sequencing Project
database (Broad Institute of Harvard and MIT, http://www.
broadinstitute.org/). As indicated by the gene numbers these genes
localize in close proximity to each other strongly suggesting that a
gene cluster responsible for production of geodin exists. Three
additional enzymes required for geodin biosynthesis have been
characterized biochemically in vitro: emodin anthrone oxygenase
[15], emodin O-methyltransferase [16] and questin oxygenase
[17]. Moreover, the occurrence of chlorine atoms in geodin
suggests the involvement of a halogenase.
To explore the possibility that genes encoding these four
enzymatic activities were also present in this region, we examined
all annotated open reading frames (ORFs) positioned between
ATEG_08458 and ATEG_08450, as well as 20 kb upstream of
ATEG_08458 and downstream of ATEG_08450. Among the
ORFs in this region, none had a functional annotation
corresponding to these enzymatic activities. We therefore subject-
ed all annotated ORFs in this regions to a functional prediction
using the BLAST algorithm [23] from NCBI and the HHpred
software [24]. This analysis uncovered three genes that could
encode putative methyltransferases (ATEG_08449, ATEG_08452
and ATEG_08456), one ORF that may encode an oxygenase
carrying out a Baeyer-Villiger oxidation (ATEG_08459), and a
putative halogenase (ATEG _08460), see Table 1.
Unexpectedly, none of the annotated ORFs were found to
encode the emodin anthrone oxygenase (Figure 2). To investigate
this apparent dilemma, we searched the literature for other
oxygenases catalyzing a similar reaction. Via this effort, we found
an oxygenase that catalyzes conversion of norsolorinic acid
anthrone to norsolorinic acid, a step towards aflatoxin production
in A. flavus [25]. This recently identified enzyme is encoded by the
gene hypC. Inspired by these findings, we used the sequence of
HypC to conduct pair-wise alignments to putative proteins
encoded by alternative ORFs in the proposed geodin gene cluster.
One short putative ORF encodes a protein of 150 amino acid
residues with an overall identity of 34% with the 210 residues of
HypC. Moreover, the conserved amino acid residues were
primarily positioned in catalytic regions or conserved domains
(Figure S1, [25]). Interestingly, the putative ORF is oriented in the
opposite direction of ATEG_08457. This strongly indicates that
the region at ATEG_08457 is wrongly annotated and contains two
separate ORFs that we now denote ATEG_08457-1 (the originally
Gene Cluster Reconstitution in A. nidulans
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Figure 1. Schematic overview of the PCR based USER cloning strategy for transfer of entire gene clusters from one fungus to
another. In the illustrated case, the geodin gene cluster in A. terreus is PCR amplified, cloned, and integrated into the IS1 locus in A. nidulans. A) ORFs
GedA-GedL are depicted as arrows. The yellow and green arrows represent the ORFs encoding the transcription factor and the PKS, respectively.
Remaining ORFs are represented by red arrows. Arrow size is proportional to ORF length and arrow direction indicates genomic orientation. Numbers
above the gene cluster specify sequence in base pairs. Genomic DNA fragments and cloning vectors are amplified as PCR products using primers
extended with uracil-containing tails. The tails contain matching sequences (indicated by identical colors) allowing for PCR product assembly in a
single USER Fusion reaction. For the geodin cluster, all putative ORFs are fused into two fragments, which are individually inserted into a vector
prepared for gene targeting. Blue boxes labeled up (upstream) and dw (downstream) represent targeting sequences for homologous recombination
into IS1 in the first gene-targeting event. The targeting sequences in the second integration event are represented in gray and blue and consist of the
overlapping region between Fragment 1 and 2 and the downstream part of IS1, respectively. Genetic markers used for selection are depicted in
orange (argB) and purple (AFpyrG). The sizes of uracil-containing tails, vector elements and PgpdA fragment are not drawn to scale. B) The first gene-
targeting event introduces the first fragment into IS1 by homologous recombination between IS1 up and down-sequences as indicated. The second
gene-targeting event introduces the second fragment using the overlapping region of the Fragment 1 and 2 (gray) and the downstream section of
IS1 as targeting sequences. Note that additional DNA can be inserted in subsequent gene-targeting events. For example, a third fragment can be
inserted by using the downstream end of fragment 2 and the downstream region of IS1 as targeting sequences. See text for details concerning use
and recycling of markers.
doi:10.1371/journal.pone.0072871.g001
Figure 2. Proposed pathway for geodin production. The PKS (ACTS, [20]), thioesterase (ACTE, [20]) and dihydrogeodin oxidase previously
linked to genes as well as the sulochrin halogenase identified in this study (highlighted in bold) are denoted by their ged-annotation. Enzymatic
reactions for which the enzyme has been characterized but the gene not identified are marked in bold as EOX = emodin anthrone oxygenase, EOM
= emodin-O-methyltransferase and QO = questin oxygenase. Reactions involving compounds 8-10 shown in brackets are inferred reactions
proposed by Henry and Townsend based on a similar intra-molecular rearrangement in aflatoxin biosynthesis [26,27].
doi:10.1371/journal.pone.0072871.g002
Gene Cluster Reconstitution in A. nidulans
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annotated ATEG_08457.1) and ATEG_08457-2 (the new puta-
tive HypC homolog). Specifically, we suggest that ATEG_08457-2
and ATEG_08457-1 are positioned on A. terreus supercontig 12,
base pairs 1307175-1307627 and 1308053-1308540, respectively.
Finally, we inspected the remaining ORFs in the region for
activities relevant for production of geodin. Among these, one
(ATEG_08454) was functionally annotated as a gluthatione-S-
transferase and two ORFs (ATEG_08455 and ATEG_08457-1)
uncovered by the BLAST analysis displayed similarity to
oxidoreductases and MdpH, respectively. The latter is a protein
of unknown function required for emodin synthesis in A. nidulans
[22]. To substantiate our predictions of the involvement of these
putative genes, we conferred literature on similar biosynthetic
pathways. The requirement for an oxidoreductase in geodin
biosynthesis has previously been proposed by Henry and Town-
send [26,27], while Simpson suggested the involvement of both a
glutathione-S-transferase and an oxidoreductase in the biosynthe-
sis of xanthones in A. nidulans [28].
In addition to genes involved in the biosynthetic steps towards
geodin, we noticed the presence of a gene, ATEG_08453, which
encodes a putative transcription factor. The position of this gene
within the putative geodin gene cluster suggests that it could
regulate the activity of all genes in the cluster. In summary, our
analysis suggests that the geodin gene cluster spans 25 kb and
contains 13 putative ORFs (Figure 1A). Gene numbers, functional
predictions and published data resulting from the entire analysis
are presented in Table 1.
2.3 Strategy for transferring the geodin cluster from A.
terreus into A. nidulans
Two vectors, containing 12 kb (Fragment 1) and 15 kb
(Fragment 2) of the putative geodin gene cluster, respectively,
were constructed by USER fusion by merging four individual
PCR fragments in the first vector and seven PCR fragments in the
second (Figure 1A). Assembling the geodin pathway from PCR
fragments offers the possibility of introducing defined changes in
the DNA sequence prior to integration via the many tools and
methods for PCR based genetic engineering. In the present case,
we inserted the strong constitutive promoter, PgpdA, of A. nidulans
upstream of ATEG_08453, which encodes the putative transcrip-
tion factor described above, with the intention that this
modification would activate transcription of all genes in the
geodin cluster after its integration into IS1. Importantly, a
fragment of the geodin cluster (2 kb) is included in both constructs
to serve as the upstream targeting sequence for the second gene-
targeting event as illustrated in Figure 1B.
2.4 Production of geodin in A. nidulans
Using the two vectors constructed above, the putative geodin
gene cluster (ged) was successfully transferred to an A. nidulans
reference strain as well as to a strain where the entire
monodictyphenone gene cluster (mdpA-LD) had been deleted.
Geodin production in the mdpA-LD strains would indicate that all
genes in the geodin cluster are functionally expressed, while geodin
formation in the reference strain could be mediated via
metabolites produced in the monodictyphenone pathway. The
ability of the recombinant strains to produce geodin on minimal
medium was analyzed by UHPLC-HRMS. The presence of
geodin in fungal extracts was identified by comparison of retention
time, accurate mass spectra, and isotope ratio to an authentic
geodin standard. These analyses demonstrated that both ged+ and
ged+ mdpA-LD produced geodin (Figure 3A). Consequently, we
suggest that the putative transcription factor, ATEG_08453, is
renamed gedR and that the enzymes in the cluster (ATEG_08449-
08452 + ATEG_08454-08460) are renamed gedA-L. In different
experiments, we observed that the amount of geodin is reproduc-
ibly higher in the ged+ strain (40–70 mg/plate) as compared to the
amount in the ged+ mdpA-LD strain (2–4 mg/plate), which does not
produce emodin via the mdp cluster. We therefore speculate that
natively produced emodin, or other intermediates towards emodin
production, could be converted into geodin in the ged+-strains.
2.5 Genetic characterization of the geodin cluster in A.
nidulans
One reason for transferring a gene cluster into a host with a
well-developed genetic toolbox is the possibility for further
Table 1. Summary of characterized and putative ORFs in the A. terreus geodin gene cluster.
BROAD
annotation
Proposed
annotation Enzyme class Validation Reference
ATEG_08449 GedA Putative O-methyl transferase* BLAST, Hhpred This study
ATEG_08450 GedB b-lactamase type thioesterase Heterologous expression, in vitro assays [20]
ATEG_08451 GedC Polyketide synthase Deletion mutants, heterologous expression, in vitro assays [19–21]
ATEG_08452 GedD Putative O-methyl transferase* BLAST, Hhpred This study
ATEG_08453 GedR Putative transcription factor Deletion mutant, quantitative RT-PCR This study
ATEG_08454 GedE Putative gluthathione-S-transferase Annotation from BROAD, BLAST, Hhpred This study
ATEG_08455 GedF Putative oxidoreductase BLAST, Hhpred This study
ATEG_08456 GedG Putative SAM-dependent-methyltransferase* BLAST, Hhpred This study
ATEG_08457-2 GedH Putative emodin anthrone oxidase, similar to HypC BLAST, 34% amino acid identity This study
ATEG_08457-1 GedI Putative mdpH homolog BLAST, 46% amino acid identity This study
ATEG_08458 GedJ Dihydrogeodin oxidase Enzymatic assays, protein sequencing [18]
ATEG_08459 GedK Putative Bayer Villiger-type oxidase Enzymatic assays, Identity inferred in this study [17]
ATEG_08460 GedL Sulochrin halogenase Deletion mutant, functional complementation This study
All similarity percentages indicate identities at the amino acid level.
*One of these three putative ORFs is likely to encode the emodin O-methyltransferase described by Chen et al [16].
doi:10.1371/journal.pone.0072871.t001
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Figure 3. Production of geodin in A. nidulans ged+ strains. A) Left panels depict extracted ion chromatograms (ESI-) of geodin m/z 396.9876 6
0.005 amu from fungal extracts of ged+, ged+ mdpA-LD and reference strains (Bruker maXis system). An authentic geodin standard is included for
comparison. The mass spectra of the putative geodin peak in ged+ and the authentic geodin standard are depicted in panels to the right. B) and C)
ESI2 chromatograms of geodin m/z 396.9876 6 0.005 amu (B)) and sulochrin m/z 331.08126 0.005 amu (C)) extracted from ged+ mdpA-LD (grey),
ged+ mdpA-LD gedLD, (blue), ged+ mdpA-LD gedCD (purple) and ged+ mdpA-LD gedRD (red).
doi:10.1371/journal.pone.0072871.g003
Gene Cluster Reconstitution in A. nidulans
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characterization of the cluster. To demonstrate this possibility, we
decided to investigate the functionality of three key genes in the
cluster, gedC, gedR and gedL encoding the PKS, the putative
regulator, and the putative halogenase, respectively. We focused
our efforts on the ged+ mdpA-LD strains, as they provide a genetic
background with no risk of complementation by mdp enzymes.
UHPLC-HRMS analysis of strains grown on minimal medium
revealed that all three deletion strains were unable to synthesize
geodin (Figure 3B), thereby confirming that geodin is indeed
produced from the reconstituted cluster and that the correspond-
ing proteins of all three genes were functional in A. nidulans and
play a role in geodin biosynthesis. We note the presence of a co-
eluting isobaric compound, seen as the broad peak (6.7–7.3 min) in
Figure 3B. However, this compound is not geodin as it does not
contain a chlorine isotopic pattern. In agreement with previous
analyses [19–21], no intermediates of the proposed geodin
pathway (Figure 2) accumulated in the ged+ gedCD mdpA-LD strain,
which is expected, as the PKS responsible for geodin formation is
absent.
According to the proposed biosynthetic route for geodin
production, the halogenase accepts sulochrin as substrate and
adds two chlorine atoms to form dihydrogeodin (Figure 2).
Consistent with the hypothesis that gedL encodes the sulochrin
halogenase, sulochrin accumulated significantly in the ged+ gedLD
mdpA-LD strain (1.2 – 1.8 mg/plate), but was undetectable in the
gedR or gedC deletion strains (Figure 3C). To confirm that this lack
of halogenase activity was due to the gedL deletion we reintroduced
the gedLORF at another ectopic site, IS3, which is a site located on
a chromosome different from the one harboring IS1, see Figure
S2. Surprisingly, no production of geodin was observed in this
strain (Figure S3A). This prompted us to perform a BLAST search
of the GenBank database [23] using the amino acid sequence of
the current ATEG_08460.1 gene model as query. Strikingly, the
majority of the best hits were enzymes that contain additional 49
amino acid residues in their N-terminus, including a conserved
MSIP/MSVP motif at the very N-terminal end, see Figure S4A.
Interestingly, intron prediction based on Augustus [29] predicts an
intron just upstream of the AUG proposed by the current gene
model (ATEG_08460.1). Taking this into account and by using an
ATG further upstream in the gedL gene, a very similar extension
can be generated for GedL, see Figure S4B and C. We therefore
inserted a larger fragment of the gedL locus that includes this new
ATG as well as its native UTR sequence into IS2 [4] in the ged+
gedLD mdpA-LD strain. In this strain, geodin was produced in
ample amounts (4.0 – 6.8 mg/plate) strongly suggesting that gedL
indeed encodes the sulochrin halogenase. Interestingly, in this
strain, targeted analysis of the UHPLC-HRMS data and
comparison to an in-house metabolite database [30], revealed
0.04 – 0.06 mg/plate of sulochrin and trace amounts of
monochlor-sulochrin indicating that chlorine is added in two
discrete catalytic steps, see Figure S3B.
To investigate whether GedR regulates the genes of the geodin
cluster in A. nidulans, we performed a gene specific mRNA
transcript analysis by quantitative RT-PCR in the ged+ mdpA-LD
and ged+ gedRD mdpA-LD strains for all genes in the geodin gene
cluster where a putative homolog is present in the monodictyphe-
none cluster (Table 1). This analysis demonstrated that transcrip-
tion of all seven selected genes was down regulated in the absence
of GedR. Most prominently transcription from four of the genes
(gedF, G, H, and K) was reduced to less than 10% of the level
obtained in the ged+ mdpA-LD strain (Figure 4). We note that the de
novo annotated candidate gene for the emodin anthrone oxidase,
gedH (ATEG_08457-2), is transcribed in both the ged+ mdpA-LD
and ged+ mdp+ strains. In addition, its expression levels in the two
strains were different from those obtained for gedI (ATEG_08457-
1). Together, these observations strongly indicate that gedR
encodes a transcription factor, which activates the expression of
the genes that are involved in geodin synthesis and that gedH is a
genuine ORF.
Inspired by these results, we next tested whether GedR would
activate the gedR promoter. To this end we inserted a lacZ reporter
gene under the control of the native gedR promoter into IS3, in ged+
mdpA-LD and ged+ gedRD mdpA-LD strains. On MM medium
containing 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-
gal), colonies formed by the PgpdA-lacZ positive control strain were
strongly blue, see Figure S5. The center of the colonies formed by
ged+ mdpA-LD PgedR-lacZ strain exhibited slightly blue color.
However, this level of blue represents background as it did not
differ from the amount and location of blue color produced by the
negative control strain ged+ mdpA-LD, see Figure S5. In agreement
with this, a quantitative RT-PCR analysis showed that the lacZ
mRNA level was only modestly increased (1.5 fold) in the ged+
mdpA-LD PgedR-lacZ strain as compared to a ged+gedRD mdpA-LD
PgedR-lacZ strain, but this difference was not statistically significant
(p = 0.08). Thus, GedR is not sufficient to induce expression from
gedR in A. nidulans.
The fact that geodin production was significantly higher in the
ged+ than in the ged+ mdpA-LD strains prompted us to investigate
whether GedR could also activate transcription of the mdp cluster.
Specifically, we compared transcription from mdpG, encoding the
monodictyphenone PKS, in the ged+ and the reference strains. In
agreement with our hypothesis the mdpG transcript was easily
detectable in the ged+ strain, but undetectable in the reference, see
Figure S6.
2.6 Conservation of gene clusters resembling the geodin
cluster in other fungal species
Finally, we speculated whether gene clusters of a similar
organization could be found in other sequenced fungal species as
emodin is well-known to serve as precursor to a wide range of
natural products [31–34]. Comparison of the geodin gene cluster
to all Aspergillus genomes available at the Aspergillus Comparative
Sequencing Project database (Broad Institute of Harvard and
MIT, http://www.broadinstitute.org/) revealed the presence of
putative gene clusters in A. fumigatus and A. fischerianus containing
putative homologs of 12 of the 13 annotated ORFs in the geodin
Figure 4. The A. terreus transcription factor GedR is important
for gene expression in the geodin gene cluster in A. nidulans.
Transcription levels of selected ged-genes in ged+ mdpA-LD, gedRD
strains relative to the corresponding levels in ged+ mdpA-LD strains.
doi:10.1371/journal.pone.0072871.g004
Gene Cluster Reconstitution in A. nidulans
PLOS ONE | www.plosone.org 6 August 2013 | Volume 8 | Issue 8 | e72871
232
cluster (the halogenase, gedL, is absent). The internal organiza-
tion of the putative clusters in A. fumigatus (Afu4g14450-14580)
and A. fischerianus (101790-101920) were identical to the geodin
cluster with the exception of an inversion affecting the five
ORFs gedG- gedK. Moreover, the amino acid identities between
biosynthetic enzymes in A. terreus and A. fumigatus/A. fischerianus
were in average 58% and 60%, respectively. The conservancy
across these three species further substantiates our delineation of
the geodin cluster and hints that the putative clusters in A.
fumigatus and A. fischerianus may encode the biosynthesis for a
similar compound. Both species are known to produce
trypacidin [35], which differs from geodin only by the absence
of chlorines and the presence of an additional methyl group
[36]. In agreement with the structural differences between
geodin and trypacidin, the putative A. fumigatus and A. fischerianus
gene clusters contain one additional putative methyltransferase,
but lack the putative halogenase. Thus, the two putative clusters
are candidates for trypacidin gene clusters.
Materials and Methods
Strains and media
Escherichia coli strain DH5a was used to propagate all plasmids.
Genomic DNA from the geodin producing A. terreus IBT15722
strain was used as template for PCR amplification of the geodin
cluster. A. nidulans strains are shown in Table S1. A. nidulans strains
were grown on solid glucose minimal medium (MM) prepared as
described by Cove [37], but with 1 % glucose, 10 mM NaNO
and 2 % agar. MM was supplemented with 10 mM uridine (Uri),
10 mM uracil (Ura), and/or 4 mM L-arginine (Arg) when
required. Solid plates containing 5-fluoroorotic acid (5-FOA) were
made as MM+Uri+Ura medium supplemented with filter steril-
ized 5-FOA (Sigma-Aldrich) to a final concentration of 1.3 mg/ml.
Vector construction
All vectors were made by USER cloning and USER fusion
[7,11]. All PCR products were amplified in 35 cycles using proof-
reading PfuX7 polymerase [38]. Next USER fusions of vector and
inserts were performed as previously described [12]. Reactions
were incubated for 20 min at 37 uC, followed by 20 min at 25 uC
before transformation into E. coli.
The pU2111-3 vector was constructed by USER fusion of 5
PCR amplified fragments: 1) vector backbone for propagation in
E. coli (amplified with primers DH110/DH111), 2) US
(upstream) targeting sequence for insertion in IS3 (DH112/
DH113), 3) PgpdA-S::UEC::TtrpC (DH114/DH115), 4) A.
fumigatus pyrG (marker) (DH116/DH117) and 5) DS (downstream)
targeting sequence for insertion in IS3 (DH118-DH119). UEC:
uracil excision cassette. Template for fragments 1 and 3:
pU1111, for fragments 2 and 5: A. nidulans genomic DNA, and
for fragment 4: pDEL2 [13]. p2110-3-lacZ was constructed by
combing an AsiSI and Nb.BtsI pU2111-3 vector fragment with
a PCR product containing the E. coli lacZ gene (amplified from
pU2110-1-lacZ using motni136/motni137 [7] as primers) by
USER cloning. The plasmid p2010-3-PgedR-lacZ was con-
structed by USER fusion of 5 PCR amplified fragments: 1) gedR
promoter sequence (DH120/DH121, template: NID677 geno-
mic DNA with), 2) lacZ::TtrpC::AFpyrG (motni136/DH122,
template: p2111-3), 3) vector backbone for propagation in E.
coli (DH110/DH111 template: pU1111), 4) DS targeting
sequence for insertion in IS3 (DH123/DH119 template:
pU2111-3) and 5) US targeting sequence for insertion in IS3
(DH112/DH113). The vectors pU2110-3-ATEG_08460.1 and
pU2110-2-gedL were constructed by combining the PCR
fragments generated with the primers JBN K35/K36 and JBN
W77/W78 with pU2111-3 and pU2111-2 [4] vector fragments,
respectively, by USER fusion. Prior to USER fusion both
plasmids were digested with AsiSI and Nb.BtsI to create the
vector fragments.
The two integration vectors containing the geodin gene
cluster, pU1110-1-ged1 (containing Fragment 1) and pU2000-
ged2 (containing Fragment 2), were made as follows. Primers for
generating all PCR fragments for Fragment 1 and 2 assemblies
are shown in Table S2. pU1110-1-ged1 was constructed by
combining all relevant fragments for Fragment 1 assembly into
an AsiSI and Nb.BtsI pU1111-1 vector fragment by USER
fusion. The vector fragment of pU2000-ged2 is based on two
PCR fragments generated by using primers 77/422 and 421/70
as well as pJ204 [7] and pU2111-1, respectively, as templates.
These two PCR products and all relevant fragments for
Fragment 2 assembly were then combined by USER fusion.
The inserts in the two integration vectors were fully sequenced
(StarSEQ, Germany).
Construction of A. nidulans strains
Protoplastation and gene-targeting procedures were per-
formed as described by Nielsen et al [14] using either argB or
AFpyrG as marker. All strains were verified by PCR analysis
using spores as the source of DNA. Prior to PCR, the samples
were incubated for 25 min at 98uC to liberate genomic DNA.
This treatment was followed by touch-down PCR programs
with annealing temperatures ranging from 64–56uC. Reactions
were carried out in 35 cycles using 40 mL volume with less
than 1000 spore (one light stab in the colony with a pipette
tip).
The ged+ (NID677) and ged+ mdpA-LD (NID695) strains were
obtained by transformation of the relevant gene targeting
substrates into NID74 [39] or NID356, respectively. The gene
targeting substrates containing Fragment 1 and Fragment 2 were
liberated from pU1111 (NotI) and pU2052 (SwaI), respectively,
and gel purified (GFXTM, GE Healthcare) prior to transformation.
The resulting strains, NID677 and NID695, were subjected to
counter selection on 5-FOA, generating NID802 and NID823, in
order to recycle the AFpyrG marker, hence, allowing the use of this
marker for subsequent gene deletions of gedC, gedL and gedR. These
deletions were made as described in [14] using the primers listed in
Table S2.
The strains NID1291 and NID1297, expressing lacZ under
the control of ATEG_08453 promoter was made by transform-
ing a gene targeting substrate liberated from pU2010-3-PgedR-
lacZ by digestion with SwaI into NID823 and NID925,
respectively. A control strain expressing lacZ under the
constitutive promoter PgpdA¸ NID1278, was constructed by
integrating the gene-targeting substrate liberated from pU2110-
3-lacZ by SwaI. Both gene-targeting substrates integrate into IS3
located between genes AN4770 and AN4769 on chromosome
III, at position 1047840-1051735, by homologous recombina-
tion (See Figure S2).
The halogenase complementation strains, ATEG_08460.1 and
gedL, were made in the NID1279 background, a pop-out
recombinant strain from NID843. Digestion of vector pU2110-
3-ATEG_08460.1 and pU2110-2-gedL liberated gene-targeting
constructs for transformation and integration in IS3 and IS2,
respectively.
Chemical characterization of A. nidulans strains
All strains were grown as three point stab inoculations for 7 days
at 37uC in the dark on solid MM-media. Extraction and analysis of
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metabolites were performed by 2 methods: i) The agar plug
extraction method described by Smedsgaard [40], using a total of
1 cm2 of a colony, followed by analysis using reversed phase
separation UHPLC- UV/VIS -HRMS on a maXis G3 quadru-
pole time of flight (qTOF) mass spectrometer (Bruker Daltonics,
Bremen, Germany) connected to an Ultimate 3000 UHPLC
system (Dionex, Sunnyvale, CA), and equipped with a 10 cm
Kinetex C18 column (Phenomenex Torrance, Ca, USA) running
a 10–100% acetonitrile gradient system in 10 min at 40uC; ii)
more concentrated samples were made by extracting metabo-
lites from a total of 15 cm2 of a colony using 12 ml solvent (ethyl
acetate-dichloromethane-methanol-formic acid 60:30:15:1 v/v/
v) in a 16-ml vial. The extract was evaporated to dryness with
N2 flow and redissolved in 0.5 ml methanol and analyzed by
reversed phase separation an Agilent 1290 UHPLC coupled to
an Agilent 6550 qTOF (Santa Clara, CA, USA) equipped with a
electrospray source, and equipped with a 25 cm Agilent
Poroshell phenyl hexyl running a 10–100% acetonitrile gradient
system in 15 min 60uC. Both MS instruments were mainly
operated in ESI2 as geodin and related compounds ionizes best
here in this mode [30]. Identification and quantification of
geodin and sulochrin (BioAustralis, Smithfield, NSW, Australia)
were based on comparison of peak area, retention time,
accurate mass (61.5 ppm), isotope pattern and adduct pattern
to quantitative authentic standards. Non quantitative standards
representing 5-O-methylsulochrin; sulochrin-2’-methylether;
isosulochrin; 3-O-demethylsulochrin; trypacidin; and emodin
were also included in the analyses. Other intermediates were
identified by comparison to an internal reference standard
database (,1500 compounds) [30]. For the identification of
geodin in NID695, high resolution MS (50 000 FWHM) and
mass accuracy (, 1.5 ppm) of the maXis G3 was needed to
exclude a non chlorine containing co-eluting isobaric com-
pound, seen as the broad peak in Figure 3 (6.7–7.3 min) that
impaired the identification of geodin. In the following strains
geodin was further verified by better chromatographic separa-
tion on a 25 cm phenyl-hexyl column on the Agilent UHPLC-
qTOF.
RNA isolation and quantitative RT-PCR
RNA isolation from the A. nidulans strains and subsequent
quantitative RT-PCR reactions were done as previously described
in [7] except that biomass for RNA isolation was prepared with a
Tissue-Lyser LT (Qiagen) by treating samples for 1 min at
45 MHz. The A. nidulans histone 3 encoding gene, hhtA (AN0733)
was used as an internal standard for normalization of expression
levels. All primers used for quantitative RT-PCR are shown in
Table S2.
Bioinformatic analysis of gedL (ATEG_08460.1)
Alignment illustrations and sequence were made in CLC Main
Workbench 6.8.4.; Alignment parameters Gap open costs = 10,
Gap extension cost = 1. All sequences in the alignments can be
retrieved from Genbank, by the following references for the
putative halogenases: Aspergillus oryzae ref|XP_001818590.1|,
Aspergillus terreus ref|XP_001217599.1| and the A. terreus genome
sequence resource at the Broad Institute, Bipolaris sorokiniana
gb|EMD66881.1|, Chaetomium chiversii (RadH) gb|ACM42402.1|,
Chaetomium globosum ref|XP_001227515.1|, Pochonia chlamydosporia
(Rdc2) gb|ADM86580.1| [39] and Talaromyces stipitatus
ref|XP_002486044.1|. Intron prediction of the A. terreus
ATEG_08460.1 locus was done based on the Augustus gene
prediction resource [29].
Concluding Remarks
We have described the complete and targeted transfer of all 13
genes of the geodin gene cluster from A. terreus to A. nidulans
through a sequential integration approach enabling A. nidulans to
synthesize geodin. In principle, this strategy can be used to
reconstitute gene clusters of any size as the sequential integrations
are based on marker recycling. In addition, defined promoters can
easily be introduced in front of relevant genes in the cluster of
interest. Importantly, we demonstrate that the cluster can be
genetically dissected for clarification of its biochemical potential.
We therefore envision that our method will significantly speed up
the uncovering of biochemical pathways in fungi where the
genome has been sequenced.
Supporting Information
Figure S1 Identification of putative HypC homolog
encoded by gedH (ATEG_08457-2) in the A. terreus
geodin gene cluster. Pairwise alignment of putative emodin
anthrone oxidase, GedH (ATEG_08457-2), from A. terreus and
norsolinic anthrone oxidase, HypC, from A. flavus. The conserved
DUF-1772 domain and putative catalytic regions proposed by
Ehrlich et al [25] are highlighted in green and blue, respectively.
(TIF)
Figure S2 Schematic overview of the integration of a
gene-expression cassette into the integration site, IS3,
by homologous recombination. IS3 is located between genes
AN4770 and AN4769 on chromosome III. The cassette consists of
six parts: upstream targeting sequence (US), promoter (P, in this
case 0.5 kb PgpdA), your favorite gene (YFG), terminator (T,
TtrpC), marker (in this case AFpyrG flanked by direct), and the
downstream targeting sequence (DS). The orientations of the
genes AN4770 and AN4769 are indicated by green arrows. The
sizes of US, DS and the intergenic region are 1984 bp, 1911 bp,
and 3007 bp, respectively.
(TIF)
Figure S3 Complementation of halogenase deficiency.
A) Left panel: detection of sulochrin (-ESI, EIC(m/z 331.0812));
right panel: detection of geodin (-ESI, EIC(m/z 396.9876)). Strains
for halogenase analysis, from top to bottom: NID843 (gedLD);
NID1280 (gedLD, IS3::PgpdA-ATEG_08460.1); and NID1306
(gedLD, IS2::gedL). B) Ratio of geodin, monochlor-sulochrin, and
sulochrin in the NID1306 strain, including ESI2-MS spectrum of
monochlor-sulochrin showing the isotopic pattern and the mass
deviations relative to the theoretical masses. Reference standards
of geodin and sulochrin were included in all runs (data not shown).
(TIF)
Figure S4 Identification of the likely start codon of
gedL. A) Alignment of the top hits in a BLAST search for
ATEG_08460.1 homologs shows that they contain a very
conserved 48 amino acid residue addition in the N-terminus.
Amongst the homologs, Rdc2, has been characterized as a
halogenase by [39] MLAS is the predicted N-terminus of
ATEG_08460.1. Drawing is not to scale. B) The position of
putative exons and intron in the 5’end of gedL as predicted by the
Augustus software [29]. The predicted protein sequence encoded
by exon 1 and by the first section of exon 2 is indicated. C) Full
alignment of the halogenase homologs and GedL based on the
GedL sequence derived from the new start codon.
(TIF)
Figure S5 Expression of lacZ under the control of the
gedR promoter (PgedR). Left panel: the positions of the strains
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on the plate are shown in the right panel. NID823 (ged+ mdpA-LD)
is the reference strain without the lacZ gene. NID1278 is a control
strain containing the PgpdA-lacZ construct in IS3. The NID1291
(ged+ mdpA-LD PgedR-lacZ) strain carries PgedR-lacZ in IS3. The
strains were stabbed on MM containing X-gal and incubated three
days at 37 uC in the dark before photography.
(TIF)
Figure S6 Constitutive expression of gedR induces
transcription of the A. nidulans gene mdpG. mdpG mRNA
levels in reference (NID1) and in the ged+ strain (NID677) were
evaluated by quantitative RT-PCR. For each strain, RNA was
extracted as described in Materials and Method and the RNA
samples analyzed in triplicate by quantitative RT-PCR. The
samples were loaded and analyzed by 1% agarose gel-electropho-
resis as indicated in the figure.
(TIF)
Table S1 Strain genotypes. * = For reference see Nielsen et
al ([13]).
(XLSX)
Table S2 Primers list. The sequence of PCR products # 1-3
corresponds to supercontig 12: 1302695-1315163 (ATEG_08454-
08460) in the genome sequenced isolate NIH2624 (IBT28053).
Similarly, PCR products # 4-6 and 8 corresponds to supercontig
12: 1289727-1304484 (ATEG_08449-08454) in NIH2624
(IBT28053). * = For reference see Hansen et al ([7]).
(XLSX)
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Chapter 12
Over-expression of Transcription Factor
in Aspergillus aculeatus Activates
Biosynthetic Pathway and Reveals Novel
Compounds Acurin A and B
This chapter contains a manuscript in preparation, Over-expression of Transcription Factor in Aspergillus
aculeatus Activates Biosynthetic Pathway and Reveals Novel Compounds Acurin A and B, of which I am
joint ﬁrst author. The chapter describes the investigation of a putative 6-MSA synthase in A. aculeatus,
and the products to which 6-MSA is a precursor. I conceived the idea for this study based on an analysis
of all synthases identiﬁed from the genome sequence of A. aculeatus ATCC16872, which is publicly available
from the DOE Joint Genome Institute1. Using a combination of BLAST analyses with known PKS as query
sequences, and keyword searches for speciﬁc enzymatic activities, I identiﬁed a total of 57 synthases: 24
PKSs, 19 NRPSs, nine terpenoid synthases and ﬁve hybrids. Details of this study is presented in Appendix
H. The PKSs comprised ﬁve NR-PKSs, 17 partly or fully reducing PKSs, three non-ordinary PKSs, and
interestingly: a putative 6-MSA synthase.
Heterologous expression of the gene veriﬁed that it encoded a 6-MSAS synthase. The AMA1-based
expression platform (described in Section 3.1.4) was applied for over-expression of the PKS gene and a TF
located upstream of the 6-MSA synthase, resulting in production of two novel compounds. A total of ﬁve
compounds were linked to this gene cluster, and feeding studies with fully 13C labeled 6-MSA veriﬁed that
6-MSA was incorporated into three of the compounds.
1http://genome.jgi-psf.org/Aspac1/Aspac1.home.html
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At present time, we have not elucidated the structures of the three compounds that incorporate 6-MSA.
Thus, we aim to solve the structures before submission, enabling a discussion about biosynthetic routes and
origins and possible relationships to the novel compounds acurin A and B.
My contribution to this study was conception of the idea, experimental design of genetic work and feeding
studies, supervision of and execution of genetic work, execution of feeding studies, and analysis of data from
feeding studies. The manuscript was written in collaboration with L.M.P. Supporting information is included
in Appendix G.
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ABSTRACT 
Aspergillus aculeatus is a filamentous fungus, belonging to the Aspergillus clade Nigri, which is an 
industrial workhorse for enzyme production. Only a few secondary metabolites have been reported for 
this fungus, however, its genetic potential for production of secondary metabolites is vast. In this study 
we have identified a 6-methylsalicylic acid (6-MSA) synthase from A. aculeatus, and verified its 
functionality by episomal expression in A. aculeatus and heterologous expression in A. nidulans. 
Furthermore, we have over-expressed a transcription factor, embedded in the gene cluster, and found 
that it activated a biosynthetic cluster and produced two novel compounds, which we have named 
acurin A and B. Feeding studies with fully 13C-labeled 6-MSA dismisses that 6-MSA is incorporated 
into acurin A and B, however, 6-MSA is incorporated into three other novel, and perhaps related, 
compounds. 
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INTRODUCTION 
Aspergillus aculeatus is a filamentous fungus belonging to the group of black Aspergilli. A. aculeatus 
was recently sequenced by the DOE Joint Genome Institute (JGI), but no genes have yet been linked to 
production of metabolites. A. aculeatus is a known producer of several important secondary 
metabolites including okaramines [1], the toxic secalonic acids [2] and recently we have reported 
production of the antifungal compounds calbistrins as well as several novel compounds with yet 
unknown activities[3]. The latter include acu-morpholine and a group of related compounds of mixed 
biosynthetic origin, the aculenes. 
Analysis of the published genome sequence revealed that A. aculeatus contains a gene with high 
similarity to 6-MSA synthases, however, the gene cluster containing the putative 6-MSA synthase does 
not resemble any reported gene clusters containing a 6-MSAS synthase e.g. the yde cluster in A. niger 
[4] and the pat cluster in A. terreus [5]. No 6-MSA or obvious 6-MSA-derived compounds are detected 
in wildtype extracts of A. aculeatus, so it is possible that 6-MSA is highly modified into the final 
metabolite as it is the case for both yanuthone D [4] and patulin [5].  
As no genetic techniques exist for A. aculeatus, we have used an AMA1-based expression platform for 
gene expression. AMA1-containing plasmids allow for autonomous replication in many different 
Aspergilli [6,7] why this is a quick and efficient tool for expressing genes in organisms that do not have 
available genetic techniques. Furthermore, the transformation efficiency with autonomous plasmids is 
much higher than integrating linear substrates [6] why it is also an efficient mean for gene expression 
in organisms that protoplast or transform very poorly. 
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In this study we have shown that the putative 6-MSA synthase is in fact a 6-MSA synthase, by 
heterologous expression of the gene in the model fungus Aspergillus nidulans. Furthermore, we have 
used the AMA1-based expression platform in A. aculeatus for expression of a transcription factor 
embedded in the 6-MSA gene cluster. This approach activated a biosynthetic cluster, which is 
responsible for production of five novel compounds, including acurin A and B, which we report for the 
first time in this study.  
 
RESULTS AND DISCUSSION 
 
Heterologous expression of putative 6-MSA synthase verifies production of 6-MSA. A BLAST 
analysis of the 1904397 gene on all genomes in the Aspergillus Genome Database (AspGD) revealed a 
high similarity to fungal 6-methylsalicylic acid (6-MSA) synthases. To verify that the gene encodes a 
6-MSA synthase the gene was integrated into the defined and characterized locus IS1 of A. nidulans, 
which is a site that was previously used for successful expression of PKS genes [4, 8]. This approach is 
useful in this study, as A. nidulans is known to not produce 6-MSA. The metabolite profile of the strain 
was analyzed by UHPLC-DAD-TOFMS, and a new compound was produced compared to the 
reference (Figure 1). Dereplication of the compound and comparison to an authentic standard of 6-
MSA verified that 6-MSA (1) was indeed produced, confirming that 1904397 encodes a 6-MSA 
synthase.  
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Figure 1. BPC of the A. nidulans strain expressing the putative 6-MSA synthase 1904397 compared to 
an A. nidulans reference. 
 
Expression of 6-MSA synthase in A. aculeatus results in accumulation of 6-MSA. 6-MSA was not 
detected in wildtype extracts of A. aculeatus, why we hypothesized that over-expression of the 6-MSA 
synthase could result in production of a new compound, or in higher amounts of a known compound, 
thus identifying the end product of the biosynthetic pathway. Accordingly, the 6-MSA synthase was 
expressed in A. aculeatus from the plasmid pDHX3, carrying the hph selection marker. Correct 
transformants were cultivated on solid minimal medium with hygromycin B and subjected to 
metabolite profile analysis by UHPLC-DAD-TOFMS. Data analysis verified that the strain produced 6-
MSA (Figure 2). However, there was no significant change in the rest of the metabolite profile (Figure 
2). The fact that the A. aculeatus pDHX3-6-MSAS strain produced 6-MSA rather than a biosynthetic 
end product, indicated that any tailoring enzymes in the biosynthetic pathway are not expressed. Thus, 
the entire 6-MSA cluster may be silent under the applied laboratory conditions. 
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Figure 2. BPC and EIC (153.055±0.005) for A. aculeatus reference and pDHX3-6-MSAS over-
expression strain. 
 
Over-expression of transcription factor from putative 6-MSA cluster results in up-regulation of 
three compounds. Examination of the gene cluster revealed that a putative transcription factor (TF) 
was located downstream of the 6-MSA synthase gene, why this could possibly be a regulator of the 
gene cluster. The TF was expressed from the expression platform pDHX2, cultivated on minimal and 
YES media, and analyzed by UHPLC-DAD-TOFMS. Examination of the metabolite profiles revealed 
up-regulation of two compounds on minimal medium, (2) and (3), which were not present in the 
reference (Figure 3). 
The two compounds, (2) and (3), were produced by both the reference strain and pDHX2-TF when 
cultivated on YES, indicating that the biosynthesis of these compounds is normally active when 
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cultivated on YES medium, but not on minimal medium. In general, cultivation on YES medium did 
not result in a detectable change in the metabolite profile (Figure 3). An obvious explanation for this 
result is that the plasmid is lost when proper selection is not maintained; YES provides all nutrients, 
including uracil and uridine, whereas minimal medium does not. Another explanation is that the TF is 
already highly expressed during cultivation on YES, why over-expression does not affect production of 
the compounds.  
 
Figure 3. BPC of A. aculeatus expressing putative transcription factor from plasmid (pDHX2-TF) 
compared to a reference, cultivated on minimal medium (A) and YES (B). 
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Purification and structural elucidation reveals two novel, related compounds. Importantly, 
dereplication of the two compounds did not result in identification of any known compounds. (2) and 
(3) (C21H27NO5) were isolated and structure elucidated by 2D NMR spectroscopy, revealing two 
analogous compounds, which have never been described before (Figure 4), NMR data can be found in 
supplementary Table S1 and Table S2.  
O
OO
NH
O
OH
*
*
 
Figure 4. Structure of the novel compounds (2)/(3) only differing by their stereochemistry. 
Stereocenters are marked with *. 
 
The compounds (2) and (3) differ only by their stereochemistry. The structures of (2) and (3) are 
surprising, as it is not obvious how they are derived from 6-MSA, if at all. The backbone of the novel 
compounds have previously been observed e.g. in lucilactaene produced by a Fusarium sp. [9], 
epolactaene from a marine Penicilium sp. [10] and fusarin C from Fusarium moniliforme [11]. All of 
these compounds contain the long chain observed in compound (2) and (3) but differs in the attached 
moiety. Lucilactaene contains to fused five-membered rings, epolactaene a single five-membered 
lactam entailing an epoxide, and the fusarins display different structures. The novel compounds (2) and 
(3) are the first to entail a six-membered ring. The biosynthesis of the backbone chain has been 
investigated by labeling studies for the fusarins, which verified that it was of polyketide origin [12]. 
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Furthermore, labeling and genetic studies [13] showed that the final part originates from a C4-unit. 
Assuming that (2) and (3) have the same polyketide chain, the final part must consist of a nitrogen-
containing C3 unit e.g. serine. 
 
Fully labeled 6-MSA is incorporated into three compounds. To test whether 6-MSA was indeed 
incorporated into these compounds we fed fully labeled 6-MSA (13C8-6-MSA) to the strain. Careful 
inspection of the metabolite profile revealed a mass shift of 7.023 Da for three compounds: (4), (5), and 
(6) (Figure 5).  
 
Figure 5. A. BPC (black) of pDHX2-TF on YES+13C8-6-MSA, EIC 374.1963±0.005 (green), EIC 
472.2333±0.005 (pink), EIC 474.2484±0.005 (purple). B. Mass spectra of compounds (4), (5), and (6). 
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The fact that a mass shift equivalent of seven 13C atoms, and not the eight 13C atoms that are present in 
13C8-6-MSA, suggests that one carbon atom is eliminated from 6-MSA during modification into the 
end products. A mass shift of 7.023 Da was also observed in feeding studies of the yanuthone D 
biosynthesis, where one carbon atom is eliminated from 6-MSA by decarboxylation [4]. Interestingly, 
(2) and (3), whose production appeared to be activated by expression of the TF, did not appear to 
incorporate 6-MSA (Figure S1). Based on the structures of (2) and (3), it is not surprising that 6-MSA 
is not incorporated into the compounds. In contrast, it is very surprising that a putative TF, located 
immediately downstream of a 6-MSA synthase, controls expression of two compounds, which does not 
depend on 6-MSA. Similarly, the three compounds that do contain 6-MSA, are not positively 
controlled by the putative TF in a simple manner, if at all. Thus, the mode of action for the putative TF 
is not clear. 
At this point, we have not been able to produce compounds (4), (5), and (6) in large scale cultivations, 
why their structures remain unsolved.   
 
Acurin A is not bioactive against cancer cells. Some of the compounds that are structurally similar to 
(2) and (3) have been reported as bioactive; Lucilactaene as a cell cycle inhibitor in p53-transfected 
cancer cell [9], epolactaene as a neuritogenic compound in human neuroblastoma cells [10], and fusarin 
C as a mutagen [11]. This prompted us to investigate the bioactivity of acurin A. The compound was 
tested in a CellTiter-Glo® assay [14] (Figure S2), but was found to be inactive.    
 
 
248
Over-expression of TF in A. aculeatus reveals novel compounds acurin A and B 
ACKNOWLEDGMENTS 
We kindly acknowledge Kenneth S. Bruno (Pacific Northwest National Laboratory, Richland, WA) for 
providing the KB1042 strain, and Kristian F. Nielsen (Technical University of Denmark) for providing 
fully labeled 6-MSA. This study was supported by grant 09-064967 from the Danish Council for 
Independent Research, Technology, and Production Sciences. 
 
MATERIALS AND METHODS 
Strains and media. The A. nidulans strain IBT29539 (argB2, pyrG89, veA1, nkuAΔ) [15] was used for 
heterologous expression of 6-MSAS. A. aculeatus ATCC16872-derived strain KB1042 (pyr-) was used 
as reference and for expression of 6-MSAS and TF. KB1042 was kindly provided by Kenneth S. Bruno 
(Pacific Northwest National Laboratory, Richland, WA, USA). Escherichia coli strain DH5α was used 
for cloning. Minimal media (MM) contained 1% glucose, 10 mM NaNO3, 1· salt solution[16] and 2% 
agar for solid media. MM was supplemented with 10 mM uridine, 10 mM uracil, 4 mM L-arginine, 100 
µg/ml hygromycin B (Invivogen, San Diego, CA, USA) when necessary. 
 
Heterologous expression of 6-MSAS in A. nidulans. 6-MSAS from A. aculeatus ATCC16872 
(ASPACDRAFT_1904397) was expressed heterologously in A. nidulans, using the expression 
platform developed in [8].  The 6-MSAS gene was PCR amplified using primers 6MSAS_ORF_FW 
(5’-AGAGCGAUATGCCTCACTTCTCCTCTGCC-3’) and 6MSAS_ORF_RV (5’-
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TCTGCGAUGGTTAGAGATCTGATTAGCGGG-3’). Protoplasting, gene-targeting procedures and 
verification of strains were as described previously [4][17]. 
 
Expression of 6-MSAS and TF in A. aculeatus. 6-MSAS (ASPACDRAFT_1904397) and TF 
(ASPACDRAFT_123491) were expressed in A. aculeatus, using the AMA1-based expression 
platforms pDHX2 and pDHX3. pDHX2 is described in [4]. pDHX3 was constructed exactly as 
pDHX2, except hph was PCR amplified from pCB1003[18] using primers hph-pX-Fw (5’- 
ACTAGGTAAUGCTAGTGGAGGTCAACACATCA-3’) and hph-pX-Rv (5’- 
AGTGGGGAUCGGTCGGCATCTACTCTATT -3’) and inserted instead of pyrG. The 6-MSAS gene 
was PCR amplified as descrived above, and the TF was PCR amplified using primers TF_ORF_FW 
(5’-AGAGCGAUAAGCCATGTTCTCCACCTTCTC-3’) and TF_ORF_RV (5’-
TCTGCGAUTGTGACGGGACCCTAGATGAC-3’).  Protoplasting and transformation procedures 
were carried out as described previously [17]. Transformants were selected on MM without uracil and 
uridine (for strains carrying pDHX2) or MM with hygromycin B (for strains carrying pDHX3). 
 
Chemical analysis of strains. Unless otherwise stated strains were inoculated as a three point 
inoculation on solid MM media and incubated at 37 °C for 5 days. Extraction of metabolites was 
performed as described in [Smedsgaard, 1997]. 6-MSA was purchased from (Apin Chemicals, Oxon, 
UK). Analysis was performed using ultra-high-performance liquid chromatography (UPHLC) UV/Vis 
diode array detector (DAD) high-resolution MS (TOFMS) on a maXis 3G orthogonal acceleration 
quadrupole time of flight mass spectrometer (Bruker Daltonics, Bremen, Germany) equipped with an 
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electrospray ionization (ESI) source and connected to an Ultimate 3000 UHPLC system (Dionex, 
Sunnyvale, USA). The column used was a reverse-phase Kinetex 2.6-μmC18, 100 mm × 2.1mm 
(Phenomenex, Torrance, CA), and the column temperature was maintained at 40 °C. A linear water- 
acetonitrile (LCMS-grade) gradient was used (both solvents were buffered with 20 mM formic acid) 
starting from 10% (vol/vol) acetonitrile and increased to 100% in 10min, maintaining this rate for 3 
min before returning to the starting conditions in 0.1 min and staying there for 2.4 min before the 
following run. A flow rate of 0.4 mL·min−1 was used. TOFMS was performed in ESI+ with a data 
acquisition range of 10 scans per second at m/z 100–1000. The TOFMS was calibrated using Bruker 
Daltonics high precision calibration algorithm (HPC) by means of the use of the internal standard 
sodium formate, which was automatically infused before each run. This provided a mass accuracy of 
better than 1.5 ppm in MS mode. UV/VIS spectra were collected at wavelengths from 200 to 700 nm. 
Data processing was performed using DataAnalysis 1.2 and Target Analysis4.0 software (Bruker 
Daltonics). Tandem MS was performed with fragmentation energy was varied from 18 to 55 eV. 
 
Feeding experiments. Feeding experiments were carried out exactly as described in [4] on solid YES 
plates. Fully labeled 6-MSA (13C8-6-MSA) was kindly provided by Kristian F. Nielsen (Technical 
University of Denmark), described in [4]. 
 
Preparative isolation of selected metabolites. A. aculeatus OeX-TF2 was cultivated on solid MM and 
incubated at 30°C for five days. The plates were harvested and extracted twice overnight with ethyl 
acetate (EtOAc) with 1 % formic acid. The extract was filtered and concentrated in vacuo. The 
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combined extract was dissolved in methanol (MeOH) and H2O (9:1), and an equal amount of heptane 
was added where after the phases were separated. To the MeOH/H2O phase H2O was added to a ratio 
of 1:1, and metabolites were then extracted with dichlormethane (DCM). The phases were then 
concentrated separately in vacuo.  
The DCM phase was subjected to further purification on a semi-preparative HPLC, a Waters 600 
Controller with a 996 photodiode array detector (Waters, Milford, MA, USA). This was achieved using 
a Luna II C18 column (250 x 10 mm, 5 μm, Phenomenex), a flowrate of 4 mL/min and a isocratic run at 
40 % acetonitrile for 18 minutes. 50 ppm TFA was added to acetonitrile of HPLC grade and milliQ-
water. This yielded 4.4 mg of acurin A and 5.0 mg of acurin B. 
 
NMR and structural elucidation. The 1D and 2D spectra were recorded on a Unity Inova-500 MHz 
spectrometer (Varian, Palo Alto, CA, USA). Spectra were acquired using standard pulse sequences and 
1H spectra as well as DQF-COSY, NOESY, HSQC and HMBC spectra were acquired. The deuterated 
solvent was DMSO-d6 and signals were referenced by solvent signals for DMSO-d6 at δH = 2.49 ppm 
and δC = 39.5 ppm. The NMR data was processed in Bruker Topspin 3.1. Chemical shifts are reported 
in ppm (δ) and scalar couplings in hertz (Hz). The sizes of the J coupling constants reported in the 
tables are the experimentally measured values from the spectra. There are minor variations in the 
measurements which may be explained by the uncertainty of J. The structural elucidation can be found 
in supplementary and NMR data for acurin A and B compounds are listed in Tables S1 and S2, 
respectively.  
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Supporting Information  Figures 
 1 
Fig. S1. Eight known metabolites that have been linked to specific PKS genes in A. nidulans. 2 
Aspyridone (adpA), asperfuranone (afoE/G), asperthecin (aptA), YWA1 (wA), (1) 3 
monodictypheonone (mdpG), (2) orsellinic acid (orsA), (3) emericellamide (A) (easB) and (4) 4 
sterigmatocystin (stcA). 5 
 6 
7 
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 8 
 9 
Fig. S2. A graphical illustration of the procedure employed to make the gene targeting fragments 10 
for the PKS deletions. Genomic DNA serves as template for two separate PCR reactions (A) that 11 
amplify the UP-stream and DOWN-stream regions of the PKS gene targeted for deletion. The 12 
oligonucleotide pairs contain approx. 20 nucleotide attB sequences that allow BP-recombination 13 
according to the Gateway cloning system (Invitrogen). (B) The PCR products with the specific attB 14 
sequences are incorporated into donor vectors (C) that contain A. fumigatus pyrG flanked by a 15 
sequence (DR) that serves as a direct repeat in the final mutant. The resulting plasmids (D) are 16 
purified from E. coli, and used as template to amplify gene-targeting substrates by PCR. Universal 17 
oligonucleotides U1 & U2 are used to amplify the UP-stream targeting fragments; and D1 and D2 18 
are used to amplify DOWN-stream targeting fragments. The final targeting substrates (E) are co-19 
transformed as bipartite gene-targeting substrates. 20 
21 
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 22 
 23 
Fig. S3. Illustration of the diagnostic PCR procedure. A standard repertoire of PCR reactions were 24 
used in the analysis of PKS deletion mutant strains. (A) shows PCR check of a targeting event for a 25 
given PKS locus. Up and Dw depicts the up- and downstream flanks of the PKS, respectively. The 26 
forward primer, P1, anneals outside the targeting sequence and the reverse primer, P2, is placed 27 
within the A. fumigatus pyrG (AFpyrG) marker gene. (B) the marker gene has been excised from 28 
the locus and the primer pair, P1 or P3 with P4, binds on either side of the remaining direct repeat 29 
sequence. The reaction can also occur on reference strain genomic DNA template, but in this case to 30 
produce a significantly larger fragment as illustrated in (C). In addition to this, a PCR reaction (C) 31 
using P1 or P3 with P5 positioned inside the PKS gene, identifies false positives. The PKS gene is 32 
shown as a blue arrow, the marker gene as a light grey arrow and the direct repeat as black squares. 33 
Drawing is not to scale. A control PCR reaction with reference strain genomic DNA as template is 34 
always included. (D) shows a typical agarose gel result for the PCR verification of a deletion strain 35 
(AN0150 (mdpG) in this case). Lanes are indicated by numbers 1-8 below the wells. Lane 1 & 8, 1 36 
kb ladder from New England Biolabs. Lane 2 shows the test for correct replacement of mdpG with 37 
the AFpyrG marker by P1 & P2 (test A) in the deletion strain candidate giving the 3.5 kb band, and 38 
the expected absence of a band in the WT control reaction in lane 3. Lanes 4 and 5, confirms 39 
marker loss after counter-selecting on 5-FOA via primers P1 and P4 (test B), the pop-out event is 40 
verified by the 2.9 kb band in lane 4 whereas WT gave the expected larger 7.9 kb band. Lane 6 and 41 
7 with primers P1 & P5 confirm that the deletion strain is pure and does not contain WT nuclei 42 
(intact mdpG sequence). All spore PCR reactions were run in triplicates. 43 
  44 
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 45 
Fig. S4. Chromosome map showing the position of the 32 PKS genes on the eight chromosomes of 46 
A. nidulans. The map was generated based mainly on information from the Aspergillus Genome 47 
Database at Stanford. The approximate location of the centromere is shown for each of the eight 48 
chromosomes. Telomeres are indicated as black tips and are not to scale. PKS genes that have 49 
previously been linked to polyketide compounds have been marked in red with the corresponding 50 
gene names. The scale bar on the left indicates size in mega bases (Mb). a In the present study, we 51 
name the PKS gene AN8383, ausA, (marked in green) due to its role in the biosynthesis of 52 
austinols. b These ORFs have been removed from the genome annotation of the Aspergillus 53 
Genome Database at Stanford during preparation of Version 5. We have made the deletions 54 
according to Version 4 of annotation. c The annotation of this gene was taken from the genome 55 
databases at the Broad Institute of Harvard and MIT. 56 
57 
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 58 
 59 
Fig. S5. Verification that the polyketide is absent in selected deletion mutants by either positive or 60 
negative mode extracted ion chromatograms. The mdpGΔ, orsAΔ, easBΔ and stcAΔ mutants are 61 
compared to the reference strain for the mass corresponding to the metabolites these genes are 62 
known to be involved in.  (A) Monodictyphenone m/z 287 [M-H]-, (B) orsellinic acid m/z 167 [M-63 
H]-, (C) sterigmatocystin m/z 325 [M+H]+ and (D) emericellamide A m/z 610 [M+H]+, 64 
emericellamide C/D m/z 596 [M+H]+,  emericellamide E/F m/z 624 [M+H]+. * Chiang et al, 65 
(Chiang et al. 2008) also observed a minor compound with the same mass.66 
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 68 
Fig. S6. Positive mode extracted ion chromatograms for the mdpGΔ strain cultivated on RTO, 69 
identifying arugosin A m/z 425 [M+H]+. 70 
71 
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 73 
Fig. S7. Additional polyketides that were detected in metabolite extracts in this study. 74 
75 
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 76 
 77 
Fig. S8. (A) UHPLC profiles (UV 210 nm) of orsAΔ, AN7903Δ compared to the reference strain. 78 
The peaks are numbered as follows: orsellinic acid (2), ω-hydroxyemodin (8), violaceol I (13), 79 
violaceol II (14), lecanoric acid (15), F9775A (16), F9775B (17), austinol (18), dehydroaustinol 80 
(19). (B) UV-spectra of violaceol I (left panel) and II (right panel) standard are shown in black, with 81 
an overlay shown in red of the UV-spectra of the sample representing peak 14 (left panel) and peak 82 
13 (right panel). There is agreement between standards and samples. 83 
84 
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B.2 Chromatograms of phosphatase and TF strains
This section contains ESI-, ESI+, and DAD chromatograms of phosphatase and TF strains, respectively.
Black chromatograms are ESI- base peak chromatograms (BPC) for all ions, in a m/z 100-1700 range. Blue
chromatograms are ESI+ base peak chromatograms (BPC) for all ions except m/z = 186.2 ± 0.05, in a m/z
100-1000 range. The ion corresponding to m/z = 186.2 represents the ion pair reagent tetrapropylammonium
(TPA), which was used in a sample run previous to these analyses. DAD chromatograms (measured at 280
nm) are shown in green.
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Supplementary materials for: 
PHUSER (Primer Help for USER):  A novel tool for USER fusion primer design 
Olsen et al. 2011 
 
PROOF OF CONCEPT 
MATERIALS AND METHODS 
Sequence retrieval: The genome of Aspergillus niger strains ATCC1015 was recently 
sequenced and annotated (1). DNA sequences were retrieved from the DOE Joint Genome Institute 
database (http://genome.jgi-psf.org/Aspni5/Aspni5.home.html). The whole coding sequence including 
introns was amplified from start codon to stop codon, promoter and terminator were present in the cloning 
vector. 
Primer design: The sequence of each gene was divided into PCR-friendly sizes ranging from 
1.7 – 2.7 kb. The sequences were submitted to PHUSER in FASTA format, and the tab “1) Basic: Predefined 
fusion cassettes” was selected to choose the AsiSI/Nb.BtsI cassette, which was held by the target cloning 
vector, pU1111-1 (2).  
PCR amplification: PCR fragments for USER fusion were produced by PCR using PfuX7 
polymerase (3), and the primers were designed by PHUSER (table S1). Genomic DNA from A. niger strain 
ATCC1015 was purified with the FastDNA® SPIN Kit for Soil (Q-BIOgene). For amplification of genes from 
genomic DNA the reaction conditions were: initial denaturation (98˚C; 30s) followed by 32 PCR cycles (98˚C; 
10s, Tm (lowest in primer-pair)+5˚C; 30s, 72˚C; 30s/kb DNA) and a final extension step (72˚C; 5 min). PCR 
products were purified using the IllustraTM GFX PCR DNA and Gel Band Purification kit (GE Healthcare). 
Cloning and transformation: The pU1111-1 vector was prepared for cloning by digestion with 
AsiSI and subsequent nicking with Nb.BtsI (both from New England Biolabs). 2 μg of pU1111-1 was digested 
in 40 U of AsiSI overnight at 37˚ C in 100 μL total volume. Subsequently, another 10 U of AsiSI and 10 U of 
Nb.BtsI was added and the mixture incubated at 37˚ C for 2 h. The digested vector was purified with 
IllustraTM GFX PCR DNA and Gel Band Purification kit (GE Healthcare). USER cloning was performed using 
0.01 pmol of linearized pU1111-1 plasmid, equal amounts of insert fragments and 1 U USERTM enzyme mix 
(New England Biolabs) in 13 μL total volume. The mixture incubated for 20 min. at 37˚ C followed by 20 
335
  
min. at 25˚ C. All of the cloning mixture was transformed into chemically competent Escherichia coli DH5α 
cells. Purified plasmid from the resulting clones were digested with NruI endonuclease and a clone was 
selected based on the predicted band pattern; a pattern distinctive of PKS insertion. The plasmid 
originating from the selected clone was sequenced (StarSeq, Germany). The CLC software was used for all 
computational handling of sequence. 
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TABLES 
Table S1. Primers designed by PHUSER. 
Name Sequence 5’-3’ Product size 
Gene ID: 44965 
FW-44965-1 AGAGCGAUATGCCAGGCCTTGTACAC 2624 
RV-44965-1 ACGGGGTCCUCGGTACATTCCCCCATAGTTT 
FW-44965-2 AGGACCCCGUTCTCGTCACCCCTACCAT 2740 
RV-44965-2 TCTGCGAUTTAAGCATCCAGCTCCTTTGT 
Gene ID: 55896 
FW-55896-1 AGAGCGAUATGGAGGGTCCATCTCGTGTGT 2250 
RV-55896-1 AGAACCGAUATGAAGCGATTGACCGGGAC 
FW-55896-2 ATCGGTTCUGCCAAGGCAAACATTGGAC 2170 
RV-55896-2 AAAGAAUCGGACAGTGCAAGTTGCG 
FW-55896-3 ATTCTTUGACTGCGCTGCTGCGGAG 2260 
RV-55896-3 TCTGCGAUTTAATTGGCCATGGCGTTGCCA 
Gene ID: 128601 
FW-128601-1 AGAGCGAUATGTCTTCTTCACCCAAAGAGCCC 2040 
RV-128601-1 AGTGGCGCUAAAGAAGCCGGCGGCGTA 
FW-128601-2 AGCGCCACUGATGCCATCCGCATTGCCTTCT 2240 
RV-128601-2 AGTGTCUCCAGGAGAGGCTTGGTAGCG 
FW-128601-3 AGACACUCGGTGCCTTGTACTCCGCCTACAC 2310 
RV-128601-3 ACCGTCGAUCTTGGGGCCCAGAGCCTCGTTCA 
FW-128601-4 ATCGACGGUACCATCTACCTGGACGAACTGTTT 2730 
RV-128601-4 ACCGCAAGUGGCCGCAAGACGGGGCAG 
FW-128601-5 ACTTGCGGUGTTGTCGAGCCCAGCTCC 2537 
RV-128601-15 TCTGCGAUCCGGCAATCTTGGCCTTGC 
Gene ID: 194381 
FW-194381-1 AGAGCGAUATGGCAATCATGGAACAG 2259 
RV-194381-1 ACCGGCGCUGTTATTGACGTTCCGTACT 
FW-194381-2 AGCGCCGGUGTCCAAGTCTCAGCAATCCCTCTA 2450 
RV-194381-2 ATCTTGCAUGATTCCGGCAGCGGCCAC 
FW-194381-3 ATGCAAGAUTCTGTATACGATCCTCTA 2255 
RV-194381-3 TCTGCGAUTTATTATCAAGCGGAGCT 
Gene ID: 211885 
FW-211885-1 AGAGCGAUATGAGTCCCAGCAAGAAT 1776 
RV-211885-1 ACGCCGAGCAAUGAAGCAGTTCCATGCAGT 
FW-211885-2 ATTGCTCGGCGUTTTCACCGGCCAGGGAGC 2310 
RV-211885-2 ATAGCCGCUCAGCATTCTTGAGCAAAGCCTGT 
FW-211885-3 AGCGGCTAUTCCATACTGTCAATGACGG 1820 
RV-211885-3 AGCATTUGTAATACCCACTGGACTGT 
FW-211885-4 AAATGCUCCCACCCACGGGGACTGT 2112 
RV-211885-4 TCTGCGAUTCAGACCACCTCCTGTGTACTGAT 
Gene ID: 225574 
FW-225574-1 AGAGCGAUATGGATAGTCAAGACTCGTCTCCC 1620 
RV-225574-1 AGCTTTCTUTTAGGGATGCCGGGTGTGC 
FW-225574-2 AAGAAAGCUTAGTCGAGCATGAACGATACATCA 2310 
RV-225574-2 AGAATCAAUATGCGAGCTATCGCTGGC 
FW-225574-3 ATTGATTCUCTTGAGCTCGAGCTCGTC 2030 
RV-225574-3 ATCGTGGCCGCUTCTTCGTATGAGAGGAACGATG 
FW-225574-4 AGCGGCCACGAUGCCATGTGTTTACGCTACT 2027 
RV-225574-4 TCTGCGAUTCACGGGGCCTTCATTTC 
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Table A1. Fungal strains used and constructed in this study. Strains in red are intended but have not yet 
been constructed. 
Name Organism Genotype 
IBT 29539 [Nielsen et al., 2006] A. nidulans argB2, pyrG89, veA1, nkuAΔ 
IS1-PKS44 A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1-PKS44 
IS1-Acar44 A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1-Acar44 
IS1-albA A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1-albA 
IS1-wA A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1-wA 
yAΔ A. nidulans argB2, pyrG89, veA1, nkuAΔ yAΔ 
wAΔ  yAΔ A. nidulans argB2, pyrG89, veA1, nkuAΔ wAΔ yAΔ 
IS1-PKS44w A. nidulans argB2, pyrG89, veA1, nkuAΔ wAΔ IS1-PKS44 
IS1-Acar44w A. nidulans argB2, pyrG89, veA1, nkuAΔ wAΔ IS1-Acar44 
IS1-albAw A. nidulans argB2, pyrG89, veA1, nkuAΔ wAΔ IS1-albA 
IS1-PKS44wy A. nidulans argB2, pyrG89, veA1, nkuAΔ wAΔ yAΔ IS1-
PKS44 
IS1-Acar44wy A. nidulans argB2, pyrG89, veA1, nkuAΔ wAΔ yAΔ IS1-
Acar44 
IS1-albAwy A. nidulans argB2, pyrG89, veA1, nkuAΔ wAΔ yAΔ IS1-
albA 
KB1001 [Chiang et al., 2011] A. niger pyrGΔ kusA::AFpyrG 
napAΔ A. niger pyrGΔ kusA::AFpyrG napAΔ 
albAΔ-napA A. niger pyrGΔ kusA::AFpyrG albAΔ::napA::hph 
albAΔ-rfp A. niger pyrGΔ kusA::AFpyrG albAΔ::rfp::hph 
IS-NIG1-napA A. niger pyrGΔ kusA::AFpyrG IS-NIG1::napA::hph 
napΔ (cluster) A. niger pyrGΔ kusA::AFpyrG napΔ 
albAΔ napAΔ A. niger pyrGΔ kusA::AFpyrG albAΔ napAΔ 
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Table A2. Primers used in the study. See details in experimental section. 
# Primer name Sequence 5’→ 3’ 
1 ori_coli_FW ATCCCCACUACCGCATTAAGACCTCAGCG 
2 ampR_RV AGCTGCTUCGTCGATTAAACCCTCAGCG 
3 p71_prom-
ter_short_usF AGCCCAATAUTAAGCTCCCTAATTGGCCC 
4 p71_prom-ter_dsR ATTACCTAGUGGGCGCTTACACAGTACA 
5 ASN-IS1-US-Fw AAGCAGCUACGCTTGGATAAGAAGTGAGAAGT 
6 ASN-IS1-US-Rv ATATTGGGCUTCTACACCGATATGGAGCTCTTT 
7 ASN-IS1-DS-Fw ACTAGGTAAUAAGTAAGCGTGCGTGAAACAG 
8 ASN-IS1-DS-Rv AGTGGGGAUTAATTATAACTGGTCAGCCACTGAC 
9 Chk-IS1-US-Fw GGAGTTTCGGTGGAGTCTACGGAG 
10 Chk-IS1-DS-Rv TGGGTTACATACCTCTTCTGGGT 
11 AlbA_US_FW AAGCAGCUATCCGTCGGTCAGGCTGCT 
12 AlbA_US_RV ATATTGGGCUCACACGAGATGGACCCTCCAT 
13 AlbA_DS_FW ACTAGGTAAUTCCCGCTAGGACTGACAACA 
14 AlbA_DS_RV AGTGGGGAUCTCCCTCGTATTCGCCTCCT 
15 Chk-IS2-US-Fw ACTCAGCATGTTGGTTATATATTCGAG 
16 Chk-IS2-DS-Rv TGGTTCATCGCTTGCAGGTC 
17 hph-1003-Fw AGCCCAATAUGCTAGTGGAGGTCAACACATCA 
18 hph-1003-Rv ATTACCTAGUCGGTCGGCATCTACTCTATT 
19 FW_191422 AGAGCGAUATGGAGACAGTCGCCGAGGTA 
20 RV_191422 TCTGCGAUCTACAACAAAGCCCGGCGAAGGA 
21 BGHA586 AGAGCGAUATGGAGGGTCCATCTCGTGTGT 
22 BGHA591 TCTGCGAUTTAATTGGCCATGGCGTTGCCA 
23 399441_FW AGAGCGAUATGGTCCTTAGGACGAGGTTG 
24 399441_RV TCTGCGAUCTACAGCAATGCACGACGCA 
25 191422_US_FW GGGTTTAAUTGACTGACCCCATGGCTATGA 
26 191422_US_RV ATATTGGGCUCTTGCTAGTTGCTGAGGTACCC 
27 191422_DS_FW ACTAGGTAAUCTTGAACCTCATAGGAGTAGATAGGC 
28 191422_DS_RV GGTCTTAAUCCAATGCACCTAATCATGTCCA 
29 Upst-HygR-N CTGCTGCTCCATACAAGCCAACC  
30 Dwst-1003HygF-N GACATTGGGGAGTTCAGCGAGAG  
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Molecular and chemical characterization of the biosynthesis of the 6-MSA derived 
meroterpenoid yanuthone D in Aspergillus niger 
 
Dorte K. Holm, Lene M. Petersen, Andreas Klitgaard, Peter B. Knudsen, Zofia D. Jarczynska, Kristian F. 
Nielsen, Charlotte H. Gotfredsen, Thomas O. Larsen, Uffe H. Mortensen. 
 
SUPPORTING INFORMATION 
 
Figures: 
Figure S1.  BPC of yanAΔ strain relative to the reference KB1001 
Figure S2. The morphology of the reference strain is identical with and without addition of 
13
C8-6-
MSA 
Figure S3. Positive electrospray (ESI+) mass spectra of labeled compounds 
Figure S4. RT-qPCR expression analysis 
Figure S5. (A) Gene deletion in A. niger and pDHX2 
Figure S6. Base peak chromatogram (ESI+) of the five strains that express putative cluster genes yanB, 
yanC, yanD, yanE, and yanG in the A. nidulans IS1-yanA strain (Reference) 
 
Tables: 
Table S1. Detection of metabolites in the deletion and overexpression strains 
Table S2. Purification of metabolites 
Table S3. NMR data for yanuthone D 
Table S4. NMR data for yanuthone E 
Table S5. NMR data for yanuthone J 
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Table S6. NMR data for 7-deacetoxyyanuthone A 
Table S7. NMR data for yanuthone F 
Table S8. NMR data for yanuthone G 
Table S9. NMR data for 22-deacetylyanuthone A 
Table S10. NMR data for yanuthone H 
Table S11. NMR data for yanuthone I 
Table S12. NMR data for yanuthone X1 
Table S13. Fungal strains 
Table S14. Primers used in the study 
Table S15. 
13
C NMR chemical shift in ppm for compound 1-9 and 12 
Table S16. 
1
H NMR chemical shift in ppm for compound 1-9 and 12  
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Figure S1. BPC of yanAΔ strain relative to the reference KB1001, cultivated on MM (A), YES (B), 
CYA (C), and MEA (D) for 5 days at 30°C.  
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Figure S2. The morphology of the reference strain is identical with and without addition of 
13
C8-6-
MSA. The figure shows the top and bottom of KB1001 cultivated on YES medium for 5 days at 30 °C.  
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Figure S3. Positive electrospray (ESI+) mass spectrum of: (A) uniformly labeled 
13
C8-6-
methylsalicylic acid, (B) unlabeled and labeled yanuthone D, (C) unlabeled and labeled yanuthone E, 
and (D) unlabelled yanuthone X1. The calculated shift from 
12
C7 to 
13
C7 is 7.0234 Da.  
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Figure S4. RT-qPCR expression analysis of yanA and 13 flanking genes in a yanRΔ (44961Δ) strain 
and a reference strain.  A. Absolute expression levels ((Δc(t))-1 values) in the reference strain (grey bar) 
compared to the TFΔ strain (blue/red bar). Red bars indicate significant down-regulation (p-value 
<0.05), blue bars indicate non-significant changes (p-value >0.05).  Values are normalized to 
expression of hhtA. B.  Relative expression levels (fold change, 2
ΔΔc(t)
 values) of yan cluster genes 
(except yanR, which is deleted) in the TFΔ strain relative to the reference strain. Expression levels are 
individually normalized to expression of actA and hhtA, as indicated.  
349
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Figure S5. (A) Gene deletion in A. niger. The ORF is replaced by the selectable hygromycin B 
phosphatase (hph) gene. Not to scale. (B) pDHX2 vector used for expression of all cluster genes in the 
A. nidulans IS1-yanA strain. The vector contains the AMA1 sequence for autonomous replication in 
Aspergillus and the pyrG gene for selection. 
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Figure S6. Base peak chromatogram (ESI+) of the five strains that express putative cluster genes yanB, 
yanC, yanD, yanE, and yanG in the A. nidulans IS1-yanA strain (Reference). All strains, except Oex-
yanB still produce 6-MSA. IS = internal standard: chloroamphenicol, A = austinol, DHA = 
dehydroaustinol. Chromatograms are to scale.  
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Table S1. Detection of metabolites in the deletion and overexpression strains using extracted ion 
chromatograms of [M+H]
+
 ± 0.005. 
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e A
 (6
) 
Y
an
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n
e H
 (7
) 
Y
an
u
th
o
n
e I (8
) 
Y
an
u
th
o
n
e J (9
) 
Y
an
u
th
o
n
e X
1  (1
2
) 
WT - + + - - + - - + - + 
OE-yanA + - - - - - - - - - - 
yanA∆ - - - - - - - - - - + 
yanB∆ - - - - - + - - + - + 
yanC∆ - - - - - - - - - - - 
yanD∆ - - - - - - - - - - - 
yanE∆ - - - - - - - - - - - 
yanF∆ - - + + - - - - + + + 
yanG∆ - - - - - - - - - - - 
yanH∆ - - - + + + - - - - + 
yanI∆ - - - + - - + + + - + 
yanR∆ - - - + - + - - - - + 
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Structural elucidation.  
The structural elucidation of the compounds showed several similar features in the 
1
H as well as 2D spectra 
comparable to those reported for the known yanuthones.[Bugni et al., 2000; Li et al., 2003] All compounds 
except yanuthone I displayed 8H overlapping resonances at δH 1.93-2.11 ppm in the 
1
H spectrum corresponding 
to the four methylene groups H4, H5, H8 and H9 in the sesquiterpene moiety. Other common resonances were 
from the diastereotopic pair H-12/H-12’ and 3 methyl groups (H-19, H-20 and H-21) around δH 1.60 ppm, 
whereof H-20 and H-21 were overlapping. In the HMBC spectrum a correlation to the quaternary C-18 around 
δC 194 ppm was seen and all compounds also had two carbons around 60 ppm (one quaternary, one methine) 
being the carbons in the epoxide ring.   
The compounds however differed greatly in the moiety attached to C-16. Yanuthone D, yanuthone E and 
yanuthone J all displayed two methylene groups around δC 45 ppm, a methyl group around δC 28 ppm, two 
carbonyls around δC 171 ppm and another quaternary carbon around δC 70 ppm for the mevalonic acid part. 7-
deacetoxyanuthone A, yanuthone F and yanuthone G all had a methyl group attached at C-16 while yanuthone 
H, yanuthone I and 22-deacetylyanuthone A had a further hydroxy group at C-22. The hydroxylation in this 
position was indicated by a significant shift downfield of H-22/C-22.  
Some structures had a further modification being a hydroxy group at either C-1 or C-2. The compounds 
yanuthone F, G and H all had a hydroxy group at C-1, shifting C-1 and H-1 significantly downfield. Yanuthone J 
had the hydroxy group attached at C-2 which shifted the resonances for C-2 and H-2 downfield, and due to the 
lack of the double bond in those structures, the resonance for H-3 was no longer observed in the double bond 
area but at δH 1.35 ppm. Yanuthone I differed in this part of the structure with fewer resonances due to the 
shorter terpene chain. 
The 
1
H NMR spectrum for yanuthone G stood out from the rest due to several resonances between 3-5 ppm. 
Elucidation of the structure revealed a sugar moiety attached to the hydroxy group at C-15. The presence of this 
hexose unit gave rise to the additional resonances observed. 
The NMR data for yanuthone X1 displayed the same resonances for the sesquiterpene part of the molecule, but 
the methoxy group attached to C-16 is different for all other reported yanuthones, and was obvious from the 
chemical shift of C-16 which gave rise to a resonance at δC 168.3 ppm, which is considerable further downfield 
than in the other structures. Furthermore C-17 was affected shifting upfield to δC 100.3 ppm. 
NMR data for all compounds can be found in Tables S3-S12 and a combined overview of the chemical shifts in 
Tables S15 and S16.  
The stereochemistry of the compounds was investigated by circular dichroism (CD) and optical rotation. The CD 
data for yanuthone D, E and 7-deacetoxyyanuthone A showed that the positive and negative cotton effects were 
identical to those previously reported for these compounds [Bugni et al., 2000].  
 
  
354
S12 
 
Table S2. Purification of metabolites 
Compound 
name 
Strain Number 
of plates 
Extraction Isolera fractionation Purification Yield 
Yanuthone D 
(1) 
A. niger 
KB1001 
200 EtOAc  
+ 1 % FA 
50g diol, 40 mL·min
-1
, 
CV = 66 mL, auto 
fractionation, 15 fractions 
Waters, Luna II C18, 4 
mL·min
-1
, 40-100% 
ACN over 20 min. 
4.5 mg 
Yanuthone E 
(2) 
A. niger 
KB1001 
200 EtOAc  
+ 1 % FA 
50g diol, 40 mL·min
-1
, 
CV = 66 mL, auto 
fractionation, 15 fractions 
Gilson, Luna II C18, 5 
mL·min
-1
, 40-100% 
ACN over 20 min. 
2.9 mg 
7-deacetoxy 
Yanuthone A 
(3) 
A. niger 
KB1001 
200 EtOAc  
+ 1 % FA 
50g diol, 40 mL·min
-1
, 
CV = 66 mL, auto 
fractionation, 15 fractions 
Waters, Luna II C18, 4 
mL·min
-1
, 40-100% 
ACN over 20 min. 
9.3 mg 
Yanuthone F 
(4) 
yanHΔ  100 EtOAc 25g diol, 25 mL·min
-1
, 
CV = 33 mL, auto 
fractionation, 10 fractions 
Gilson, Luna II C18, 5 
mL·min
-1
, 30-80% 
ACN over 18 min. 
Waters, gemini, 5 
mL·min
-1
, 40-65% 
ACN over 20 min 
1.8 mg 
Yanuthone G 
(5) 
yanHΔ 100 EtOAc 25g diol, 25 mL·min
-1
, 
CV = 33 mL, auto 
fractionation, 10 fractions 
Gilson, Luna II C18, 5 
mL·min
-1
, 30-80% 
ACN over 18 min. 
Waters, gemini, 5 
mL·min
-1
, 30-40% 
ACN over 20 min, to 
45% for 2 min. 
4.0 mg 
22-
deacetylyanuth
one A (6) 
yanIΔ  100 EtOAc  25g diol, 25 mL·min
-1
, 
CV = 33 mL, auto 
fractionation, 12 fractions 
Gilson, Luna II C18, 5 
mL·min
-1
, 20-90% 
ACN over 17 min.  
Waters, Luna II C18, 5 
mL·min
-1
, 30-100% 
ACN over 20 min. 
7.3 mg 
Yanuthone H 
(7) 
yanIΔ 100 EtOAc  25g diol, 25 mL·min
-1
, 
CV = 33 mL, auto 
fractionation, 12 fractions 
Gilson, Luna II C18, 5 
mL·min
-1
, 30-60% 
ACN over 16 min. 
9.8 mg 
Yanuthone I 
(8) 
yanIΔ 100 EtOAc 25g diol, 25 mL·min
-1
, 
CV = 33 mL, auto 
fractionation, 12 fractions 
Waters, Luna II C18, 5 
mL·min
-1
, 30-60% 
ACN over 16 min. 
4.7 mg 
Yanuthone J 
(9) 
yanFΔ  
 
 
150 EtOAc  
+ 1 % FA 
25g diol, 25 mL·min
-1
, 
CV = 33 mL, auto 
fractionation, 15 fractions 
Waters, Luna II C18, 4 
mL·min
-1
, 20-100% 
ACN over 20 min. 
1.5 mg 
Yanuthone X1 
(12) 
A. niger 
KB1001 
200 EtOAc  
+ 1 % FA 
50g diol, 40 mL·min
-1
, 
CV = 66 mL, auto 
fractionation, 15 fractions 
Waters, gemini, 4 
mL·min
-1
, 90 % ACN 
isocratic for 15 min, 
then to 100 % ACN for 
5 min. 
1.5 mg 
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Yanuthone D 
HRESIMS: m/z = 503.2640 [M + H]
+
, calculated for [C28H38O8+H]
+
: 503.2639.       
         
CDMeOH: [θ]213 = 12.4263, [θ]230 = -7.8722, [θ]240 = 1.1769, [θ]260 = -4.0282, [θ]298 = 0.7690 
 
 Table S3. NMR data for yanuthone D 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 1.59 (3H, s) 17.1 2, 19 - 
2 - 132.1 - - 
3 5.10 (1H, m) 125.0 1, 19 19 
4 2.06 (2H, m) 27.3 2, 3, 5/9 20 
5 1.97 (2H, m) 40.2 3/7, 6, 4/8,20 20 
6 - 136.4 - - 
7 5.09 (1H, m) 124.9 5/9, 8, 20  9 
8 2.09 (2H, m) 27.0 5/9, 6, 7, 10  20, 21 
9 1.99 (2H, m) 40.1 7, 8, 10, 11, 21 7, 11 
10 - 141.0 - - 
11 5.03 (1H, t, 1.5) 116.4 9, 12, 21 9, 12, 12’, 14 
12 2.66 (1H, m) 25.6 10, 11, 13, 14, 15/18 11, 12’, 14, 21 
12’ 2.76 (1H, m) 25.6 10, 11, 13, 14, 15/18 11, 12, 14, 21 
13 - 63.0 - - 
14 3.68 (1H, s) 58.6 12, 13, 15/18, 16, 22  11, 12, 12’, 21 
15 - 193.2 - - 
16 - 143.9 - - 
17 6.58 (1H, t, 1.5) 133.1 13, 15/18, 22 22, 22’, 24, 28 
18 - 193.2 - - 
19 1.66 (3H, s) 25.7 1, 2, 3 3, 4 
20 1.591 (3H, s) 16.1 5, 6, 7 5, 8 
21 1.63 (3H, s) 16.2 9, 10, 11 8, 12, 12’, 14 
22 4.84 (1H, dd, 16.1, 1.5) 60.2 15/18, 16, 17, 23 17 
22’ 4.89 (1H, dd, 16.1, 1.5) 60.2 15/18, 16, 17, 23 17 
23 - 171.2 - - 
24 2.69 (2H, m) 45.6 23, 26 17, 28 
25 - 70.0 - - 
26 2.64 (1H, m) 45.1 24, 25, 28 28 
26’ 2.57 (1H, m) 45.1 27 - 
27 - 173.1 - - 
28 1.33 (3H, s) 27.6 24, 25  17, 24, 26 
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Yanuthone E 
HRESIMS: m/z = 505.2791 [M + H]
+
, calculated for [C28H40O8+H]
+
: 505.2789.       
         
CDMeOH: [θ]209 = 2.1815, [θ]241 = -12.3941, [θ]340 = 7.4622 
 
Table S4. NMR data for yanuthone E 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 1.58 (3H, s) 17.7 2, 3, 19 - 
2 - 131.8 - - 
3 5.07 (1H, m) 124.9 1, 4, 5, 19 4, 5, 19 
4 2.02 (2H, m) 27.2 2, 6 3 
5 1.96 (2H, m) 40.3 3/7, 4, 6, 20,   3, 7 
6 - 135.8 - - 
7 5.06 (1H, t, 6.4) 124.9 5/9, 8, 20 5, 9, 20 
8 2.06 (2H, m) 27.2 5/9, 6, 7, 10 - 
9 1.99 (2H, m) 40.3 6, 7, 8, 11, 21 7, 11 
10 - 139.9 - - 
11 5.04 (1H, t, 7.2) 117.7 9, 12, 13, 21 9, 12, 12’, 14 
12 2.67 (1H, m) 26.6 10, 11, 13, 14, 18 11, 12’, 14 
12’ 2.42 (1H, m) 26.6 10, 11, 13, 14, 18 11, 12, 14 
13 - 61.3 - - 
14 3.64 (1H, d, 2.8) 60.1 12/12’, 13, 15, 16, 22/22’,  11, 12, 12’ 15 
15 4.68 (1H, br. s) 65.8 16, 17 14 
16 - 154.6 - - 
17 5.86 (1H, q, 1.4) 121.6 13, 15, 16, 22, 22’ 22, 22’, 24 
18 - 194.8 - - 
19 1.66 (3H, s) 25.6 1, 2, 3 3 
20 1.581 (3H, s) 16.0 5, 6, 7 7 
21 1.62 (3H, s) 16.3 9, 10, 11 - 
22 4.82 (1H, d, 16.1) 63.6 15, 16, 17, 18, 23 17, 22’ 
22’ 4.76 (1H, d, 16.1) 63.6 15, 16, 17, 18, 23 17, 22 
23 - 171.4 - - 
24 2.69 (2H, m) 45.8 23, 25, 26, 28 17 
25 - 70.2 - - 
26 2.59 (2H, m) 45.4 24, 25, 27, 28 - 
27 - 173.5 - - 
28 1.33 (3H, s) 27.7 25, 26 - 
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Yanuthone J 
HRESIMS: m/z = 523.2907 [M + H]
+
, calculated for [C28H42O9+H]
+
: 523.2901       
        
 
 
Table S5. NMR data for yanuthone J 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
1 1.28 (3H, m) 29.7 - 
2 - 70.9 - 
3 1.35 (2H, m) 44.0 4, 19 
4 1.43 (2H, m) 23.1 - 
5 1.93 (2H, m) 40.5 3, 4, 6, 7, 11, 
20 
6 - 136.3 - 
7 5.08 (1H, tq, 6.3, 1.0) 124.4 - 
8 2.09 (2H, m) 26.7 6, 7, 9, 10 
9 2.02 (2H, m) 40.3 7, 8, 10, 11, 21 
10 - 139.6 - 
11 5.03 (1H, tq, 6.3, 1.0) 117.5 - 
12 2.45 (1H, m) 26.5 10, 11, 13, (18) 
12’ 2.68 (1H, m) 26.5 10, 11, 13 
13 - 61.1 - 
14 3.63 (1H, d, 2.8) 59.9 13, 15, 16 
15 4.69 (1H, m) 65.7 - 
16 - 154.7 - 
17 5.86 (1H, q, 1.5) 121.5 13, 15, 22 
18 - (194.2) - 
19 1.12 (3H, s) 29.2 1, 2, 3 
20 1.58 (3H, s) 15.9 5, 6, 7 
21 1.62 (3H, s) 16.2 9, 10, 11 
22 4.83 (1H, d, 16.0)  63.6 16, 17, 23 
22’ 4.76 (1H, d, 16.0) 63.6 16, 17, 23 
23 - 171.2 - 
24 2.681 (2H, m) 43.7 23, 25, 26, 28  
25 - 70.9 - 
26 2.61 (2H, m) 45.1 24, 25, 27, 28  
27 - 173.6 - 
28 1.33 (3H, s) 27.5 25, 26 
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7-deacetoxyyanuthone A 
HRESIMS: m/z = 345.2434 [M + H]
+
, calculated for [C22H32O3+H]
+
: 345.2424       
         
CDMeOH: [θ]206 = -13.6324, [θ]242 = -25.0218, [θ]335 = 16.7472 
 
 
 
Table S6. NMR data for 7-deacetoxyyanuthone A 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
1 1.67 (3H, d 1.0) 
2 - 
3 5.10 (1H, m) 
4 2.07-1.90 (2H, m) 
5 2.07-1.90 (2H, m) 
6 - 
7 5.09 (1H, m) 
8 2.07-1.90 (2H, m) 
9 2.07-1.90 (2H, m) 
10 - 
11 5.05 (1H, m) 
12 2.72 (1H, dd, 15.2, 7.9) 
12’ 2.39 (1H, dd, 15.2, 6.7) 
13 - 
14 3.62 (1H, d, 2.89) 
15 4.49 (1H, br. s) 
16 - 
17 5.70 (1H, p, 1.5) 
18 - 
19 1.60 (3H, s) 
20 1.59 (3H, s) 
21 1.64 (3H, s) 
22 2.07-1.90 (3H, m)  
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Yanuthone F 
HRESIMS: m/z = 361.2373 [M + H]
+
, calculated for [C22H32O4+H]
+
: 361.2373       
         
 
 
Table S7. NMR data for yanuthone F 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 3.84 (2H, br. s) 68.3 2, 3, 19 3, 5 
2 - 136.2 - - 
3 5.33 (1H, tq, 7.4, 1.5) 125.3 1, 19 1, 4, 5 
4 2.11 (2H, m) 26.8 2, 5, 6 3, 7 
5 1.99 (2H, m) 40.1 2/6, 4/8, 20 1, 3, 7 
6 - 136.2 - - 
7 5.09 (1H, tq, 6.9, 1.1) 124.9 4/8, 5/9, 20 4, 5, 8, 9 
8 2.07 (2H, m) 26.8 6, 5/9, 10 7 
9 2.01 (2H, m) 40.1 6, 8/12, 10, 21 7, 11, 14 
10 - 139.7 - - 
11 5.04 (1H, tq, 7.3, 1.2) 118.0 8/12, 9, 21 9, 12, 12', 14 
12 2.70 (1H, dd, 15.1, 8.1) 27.0 10, 11, 13 11, 12', 14 
12' 2.37 (1H, m) 27.0 10, 11, 13, 18 11, 12, 14 
13 - 61.4 - - 
14 3.60 (1H, d, 2.7) 60.2 13, 15, 16 9, 11, 12, 12', 15 
15 4.48 (1H, m) 67.6 16, 17 14, 22 
16 - 158.8 - - 
17 5.68 (1H, m) 123.2 13, 15, 22 22 
18 - 194.9 - - 
19 1.59 (3H, s) 13.5 1, 2, 3, 4 - 
20 1.591 (3H, s) 16.1 5, 6, 7 - 
21 1.62 (3H, s) 16.1 6, 10, 11, 13 - 
22 1.92 (2H, br. s) 20.0 15, 16 15, 17 
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Yanuthone G 
HRESIMS: m/z = 523.2917 [M + H]
+
, calculated for [C28H42O9+H]
+
: 523.2901.       
         
 
 
Table S8. NMR data for yanuthone G 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 3.86 (2H, s) 68.2 2, 3, 19 3, 19 
2 - 135.9 - - 
3 5.34 (1H, t, 6.3) 125.2 1, 4, 5, 19 1 
4 2.10 (2H, m) 26.8 2/6, 3, 5 5, 20 
5 1.99 (2H, m) 40.0 2/6, 4/8, 7, 20 4, 7 
6 - 135.9 - - 
7 5.10 (1H, t, 6.3) 124.9 4/8, 5/9, 20 5, 9 
8 2.06 (2H, m) 26.9 5/9, 6, 10 9, 20, 21  
9 2.02 (2H, m) 40.0 6, 8/12, 10, 11, 21 7, 8, 11, 14 
10 - 139.7 - - 
11 5.04 (1H, t, 6.7) 117.9 8/12, 9, 21 9, 12, 12’, 14, 15 
12 2.67 (1H, m) 26.9 10, 11, 13, 18 11, 14, 21 
12' 2.37 (1H, dd, 14.8, 6.2) 26.9 10, 11, 13, 18 11, 14, 21 
13 - 61.3 - - 
14 3.82 (1H, br. s) 59.7 15, 16 9, 11, 12, 12’, 15, 17, 21 
15 4.59 (1H, m) 76.2 23 11, 14, 17 
16 - 157.0 - - 
17  5.71 (1H, br. s) 123.9 13, 15, 22 14, 15, 27 
18 - 194.4 - - 
19 1.591 (3H, s) 13.7 1, 2, 3 1 
20 1.59 (3H, s) 15.9 5, 6, 7  4, 8 
21 1.62 (3H, s) 16.3 9, 10, 11 8, 12, 12’, 14 
22 1.97 (3H, m) 20.1 15, 16 26, 27 
23 4.56 (1H, m) 105.7 16 24, 25, 26, 27, 28, 28’ 
24 3.25 (1H, br. s) 74.6 23, 26/27 23, 25, 26, 27 
25 3.37 (1H, m) 77.2 - 23, 24, 26, 27, 28, 28’ 
26 3.35 (1H, m) 71.2 - 22, 23, 24, 25, 27, 28, 28’ 
27 3.35 (1H, m) 77.2 - 17, 22, 23, 24, 25, 26, 28, 28’ 
28 6.77 (1H, d, 10.7) 62.6 - 23, 25, 26, 27, 28’ 
28’ 3.66 (1H, d, 10.7) 62.6 - 23, 25, 26, 27, 28 
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22-deacetylyanuthone A 
HRESIMS: m/z = 361.2372 [M + H]
+
, calculated for [C22H32O4+H]
+
: 361.2373       
         
 
 
Table S9. NMR data for 22-deacetylyanuthone A 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 1.66 (3H, s) 25.8 2, 3, 19 - 
2 - 132.0 - - 
3 5.10 (1H, m) 124.9 1, 4, 5, 19 4, 5, 19 
4 2.07 (2H, m) 26.8 2, 5, 6 3, 5, 19, 20 
5 1.98 (2H, m) 40.1 4/8, 6, 3/7, 20 3, 4, 7 
6 - 136.0 -  
7 5.10 (1H, m) 124.9 4/8, 5/9, 20 8, 5/9, 20 
8 2.09 (2H, m) 26.8 5/9, 6, 7, 10 7, 9, 20, 21  
9 2.03 (2H, m) 40.1 7, 10, 11, 13, 8/12, 21 7, 8, 11 
10 - 140.2 - - 
11 5.05 (1H, ddd, 7.93, 6.71, 1.22) 118.0 9, 8/12, 13, 21 9, 12, 12’, 14, 21 
12 2.70 (1H, dd, 15.3, 7.9) 26.8 10, 13, 17, 18 11, 12’, 14, 21 
12' 2.42 (1H, dd, 15.3, 6.7) 26.8 10, 13, 17, 18 11, 12, 14, 21 
13 - 61.6 - - 
14 3.62 (1H, d, 2.8) 60.2 12,15, 16, 22 11, 12, 12’, 15 
15 4.64 (1H, m) 66.2 13, 16, 17, 18 14, 22, 22’ 
16 - 160.8 - - 
17 5.87 (1H, q, 1.73) 119.7 15, 16, 22 22, 22’ 
18 - 195.1 - - 
19 1.601 (3H, s) 17.7 1, 2, 3 3, 4 
20 1.60 (3H, s) 15.9 5, 6, 7 4, 7, 8 
21 1.63 (3H, s) 16.2 8/12, 9, 10, 11, 13 8, 11, 12, 12’ 
22 4.27 (1H, m) 62.0 15 15, 17 
22' 4.21 (1H, m) 62.0 - 15, 17 
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Yanuthone H 
HRESIMS: m/z = 377.2332 [M + H]
+
, calculated for [C22H32O5+H]
+
: 377.2322.       
         
 
 
Table S10. NMR data for yanuthone H 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
1 3.85 (2H, s) 68.3 2, 3, 4, 19 3 
2 - 136.0 - - 
3 5.34 (1H, m) 125.4 1, 4, 5, 19 1, 5 
4 2.11 (2H, m) 26.8 3, 5, 6 - 
5 1.99 (2H, m) 40.1 4/8, 6, 7, 12, 20 3 
6 - 135.9 - - 
7 5.10 (1H, t, 6.4) 124.9 4/8, 5/9, 20 9 
8 2.07 (2H, m) 26.8 5/9, 7, 10 - 
9 2.02 (2H, m) 40.1 7, 10, 11, 8/12, 21 7, 11 
10 - 139.8 - - 
11 5.05 (1H, t, 6.8) 118.0 8/12, 21 9, 12, 12’, 14 
12 2.71 (1H, dd, 15.1, 8.3) 26.8 10, 11, 13, 18 11, 12’, 14 
12' 2.40 (1H, dd, 15.1, 6.8) 26.8 20, 11, 13, 18 11, 12, 14 
13 - 60.9 - - 
14 3.62 (1H, d, 2.9) 60.4 12, 13, 15, 16 11, 12, 12’ 15 
15 4.64 (1H, br. s) 66.1 16, 17 14, 16, 17 
16 - 160.6 - 15 
17 5.87 (1H, d, 1.5) 119.7 13, 15, 16 15, 22, 22’ 
18 - 194.9 - - 
19 1.601 (3H, s) 13.5 1, 2 - 
20 1.60 (3H, s) 16.1 5/8, 7 - 
21 1.63 (3H, s) 16.2 8/12, 10, 11 - 
22 4.27 (1H, d, 17.6) 62.0 15, 16, 17, 18 17, 22’ 
22' 4.21 (1H, m) 62.0 15, 16, 17, 18 17, 22 
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Yanuthone I 
HRESIMS: m/z = 325.1635 [M + H]
+
, calculated for [C17H24O6+H]
+
: 325.1646.       
         
  
 
Table S11. NMR data for yanuthone I 
Atom 
assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
connectivities 
5 - 177.4 - - 
6 2.28 (1H, m) 38.2 5, 7/7', 8, 20 7, 7', 8, 20 
7 1.48 (1H, m) 32.5 5, 6, 8, 20 6, 7', 8, 9, 20 
7' 1.26 (1H, m) 32.5 5, 6, 8, 20 6, 7, 8, 9, 21 
8 1.32 (2H, m) 24.5 7/7', 9, 10 6, 7, 7', 9, 11, 20 
9 1.92 (2H, t, 7.1) 38.7 7/7', 8, 10, 11, 21 7, 7', 8, 11, 14 
10 - 137.9 - - 
11 5.00 (1H, t, 7.1) 116.9 9, 12/12', 13, 21 8, 9, 12, 12', 14 
12 2.63 (1H, dd, 15.1, 7.9) 25.7 10, 11, 13, 14, 17, 18 12', 14, 17, 21 
12' 2.32 (1H, m) 25.7 9, 10, 11, 13, 14, 17, 18 12, 14, 17, 21 
13 - 60.0 - - 
14 3.59 (1H, d, 2.4) 59.1 12/12', 13/22/22', 15, 16 9, 11, 12, 12', 15, 17, 21 
15 4.61 (1H, br. S) 64.3 16, 17 14, 22' 
16 - 162.2 - - 
17 5.82 (1H, d, 1.6) 117.4 13/22/22', 14, 15, 16, 18 22' 
18 - 193.7 - - 
20 1.02 (3H, d, 6.7) 16.7 5, 6, 7 6, 7, 7', 8  
21 1.56 (3H, s) 15.6 9, 10, 11, 12/12', 13 7', 9, 12, 12', 14 
22 4.21 (1H, d, 18.5) 60.0 15, 16, 17, 18 22' 
22' 4.09 (1H, d, 18.5) 60.0 15, 16, 17, 18 15, 17, 22 
-COOH 12.01 (1H, br. s) -   
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Yanuthone X1 
HRESIMS: m/z = 403.2482 [M + H]
+
, calculated for [C17H24O6+H]
+
: 403.2479       
        
 
 
Table S12. NMR data for yanuthone X1 
Atom assignment 
1
H-chemical shift [ppm]/  
J coupling constants [Hz] 
13
C-chemical 
shift [ppm] 
HMBC 
correlations 
NOESY 
correlations 
1 1.66 (3H, s) 25.6 2, 3, 19 3 
2 - 132.2 - - 
3 5.08 (1H, m) 125.0 5 1, 4/5 
4 2.05 (2H, m) 27.6 3, 5, 6  3, 5 
5 2.00 (2H, m) 40.3 6, 4/8, 7, 11 3, 4 
6 - 135.6 - - 
7 5.08 (1H, m) 125.0 5/9, 20 - 
8 2.07 (2H, m) 27.6 5/9, 6, 7 9 
9 1.95 (2H, m) 40.3 7, 8, 10, 11, 21 8, 11 
10 - 139.8 - - 
11 5.01 (1H, t, 7.3) 117.5 9, 21 9, 12, 12’ 
12 2.78 (1H, dd, 15.3, 8.2) 26.2 10, 11, 13, 14 11, 12’ 
12’ 2.45 (1H, dd, 15.3, 6.7) 26.2 10, 11, 13, 14, 18 11, 12 
13 - 60.5 - - 
14 3.59 (1H, d, 3.1) 56.3 15, 16 15 
15 5.95 (1H, d, 3.1) 66.6 16 14 
16 - 168.3 - - 
17 5.30 (1H, s) 100.3 13, 15, 16 22 
18 - 193.7 - - 
19 1.57 (3H, s) 17.6 1, 2, 3 - 
20 1.571 (3H, s) 15.8 5, 6 - 
21 1.61 (3H, s) 16.3 9, 10, 11 - 
22 3.67 (3H, s)  57.4 16 17 
23 - 170.7 - - 
24 2.14 (3H, s) 20.6 23 - 
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Table S13. Fungal strains. 
Name Organism Genotype 
IBT 29539 A. nidulans argB2, pyrG89, veA1, nkuAΔ 
OE-yanA A. nidulans argB2, pyrG89, veA1, nkuAΔ S1::PgpdA::yanA::TtrpC::argB 
OE-yanG A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1::PgpdA::yanA::TtrpC::argB, pDHX2::yanG 
OE-yanC A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1::PgpdA::yanA::TtrpC::argB, pDHX2::yanC 
OE-yanB A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1::PgpdA::yanA::TtrpC::argB, pDHX2::yanB 
OE-yanD A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1::PgpdA::yanA::TtrpC::argB, pDHX2::yanD 
OE-yanE A. nidulans argB2, pyrG89, veA1, nkuAΔ IS1::PgpdA::yanA::TtrpC::argB, pDHX2::yanE 
KB1001 A. niger pyrGΔ kusA::AFpyrG 
yanAΔ A. niger pyrGΔ kusA::AFpyrG yanAΔ 
yanGΔ A. niger pyrGΔ kusA::AFpyrG yanGΔ 
yanIΔ A. niger pyrGΔ kusA::AFpyrG yanIΔ 
yanCΔ A. niger pyrGΔ kusA::AFpyrG yanCΔ 
yanBΔ A. niger pyrGΔ kusA::AFpyrG yanBΔ 
yanHΔ A. niger pyrGΔ kusA::AFpyrG yanHΔ 
yanDΔ A. niger pyrGΔ kusA::AFpyrG yanDΔ 
yanEΔ A. niger pyrGΔ kusA::AFpyrG yanEΔ 
yanFΔ A. niger pyrGΔ kusA::AFpyrG yanFΔ 
yanRΔ A. niger pyrGΔ kusA::AFpyrG yanRΔ 
44959Δ A. niger pyrGΔ kusA::AFpyrG ASPNI_DRAFT44959Δ 
44960Δ A. niger pyrGΔ kusA::AFpyrG ASPNI_DRAFT44960Δ 
44971Δ A. niger pyrGΔ kusA::AFpyrG ASPNI_DRAFT44971Δ 
44972Δ A. niger pyrGΔ kusA::AFpyrG ASPNI_DRAFT44972Δ 
ClusterΔ A. niger pyrGΔ kusA::AFpyrG ASPNI_DRAFT44958-44972Δ 
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Table S14. Primers used in the study. See details in experimental section. 
# Primer name Sequence 5’→ 3’ 
1 44965-fw AGAGCGAUATGCCAGGCCTTGTACAC 
2 44965-rv TCTGCGAUTTAAGCATCCAGCTCCTTTGT 
3 44963_ORF_FW AGAGCGAUATGGACCGTATCGACGTACACC 
4 44963_ORF_RV TCTGCGAUCTAGGTACTATAAGTATGAACACGAGACTG 
5 44964_ORF_FW AGAGCGAUATGTCTACTACTAAGCGCTCGGTAAC 
6 44964_ORF_RV TCTGCGAUCTAGTATACTTTCATGGGTGCGTGA 
7 54844_ORF_FW AGAGCGAUCGGGCTAGACTTTCTCTTCCTAAG 
8 54844_ORF_RV TCTGCGAUATGGCGCTTGTTCATCTGACT 
9 127904_ORF_FW AGAGCGAUATGGTCAAGTTTTTTCAGCCCA 
10 127904_ORF_RV TCTGCGAUCTAACGGAACTGGGGAGGAA 
11 192604_ORF_FW AGAGCGAUTACTTTGCGACTACCTGCCATG 
12 192604_ORF_RV TCTGCGAUCTACTCCGACTTTTCACCTTTGG 
13 hph-1003-Fw AGCCCAATAUGCTAGTGGAGGTCAACACATCA 
14 hph-1003-Rv ATTACCTAGUCGGTCGGCATCTACTCTATT 
15 44965-chk-usF CAGTTGACTAGACTAGGAACGGTCA 
16 44965-chk-dsR AACGACCATGATGCTTGTTCAG 
17 44965_US-FW GGGTTTAAUATGACTCCACATCATCTTCCACAC 
18 44965_US-RV ATATTGGGCUGATGGTGTGTACAAGGCCTGG 
19 44965_DS-FW ACTAGGTAAUGACTGTTATGCATTGAATTTGAGC 
20 44965_DS-RV GGTCTTAAUAGATCCTGACGCTCATATCTGCT 
21 44964_US-FW GGGTTTAAUGGTCTTTCCGACACGTAAGTCTG 
22 44964_US-RV ATATTGGGCUTGGACCTCAATGGCCGCT 
23 44964_DS-FW ACTAGGTAAUGCGAGTATGAAGAAGGTGGATGA 
24 44964_DS-RV GGTCTTAAUATTCAGGGTCTTGAGATTGGC 
25 44963_US-FW GGGTTTAAUAAGTCCTCCCACGTCGGAG 
26 44963_US-RV ATATTGGGCUAGAATCTAAACCTTGTCTCTTCGCT 
27 44963_DS-FW ACTAGGTAAUGAACGTTTGATTGGTAATGGATGT 
28 44963_DS-RV GGTCTTAAUTCATCCACCTTCTTCATACTCGC 
29 54844_US-FW GGGTTTAAUGTAGAATAACAGCTACCTCGAATTTGA 
30 54844_US-RV ATATTGGGCUACGTGGTGCGTAAGCAGACAT 
31 54844_DS-FW ACTAGGTAAUCCTGCTGAATAAACACGAAGG 
32 54844_DS-RV GGTCTTAAUATGGACCGTATCGACGTACACC 
33 44960_US-FW GGGTTTAAUTGAGTACCTATCCACTCTTCCTGG 
34 44960_US-RV ATATTGGGCUGATGGAGTGTGAAGCCAATGAG 
35 44960_DS-FW ACTAGGTAAUTCATTCTAAAATTGGCGTCTTCA 
36 44960_DS-RV GGTCTTAAUCTACTGCCGCCGTCACTATCTA 
37 193092_US-FW GGGTTTAAUCATCGACATCTCTCTGCCCAT 
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38 193092_US-RV ATATTGGGCUGAAAGCTGGTTGGAAGTATAAGTGG 
39 193092_DS-FW ACTAGGTAAUTGTGCAGCGGTATTGACTTCA 
40 193092_DS-RV GGTCTTAAUCACGGAGTTATTTTCCACGCT 
41 44967_US-FW GGGTTTAAUCGTTGGCATGACAGTCTTCAA 
42 44967_US-RV ATATTGGGCUGTCTGCCATCACAACCAGTTTG 
43 44967_DS-FW ACTAGGTAAUAGCCATGTTGCCAGACACAGT 
44 44967_DS-RV GGTCTTAAUACTACCATCTCGTAACCGTCCTAG 
45 127904_US-FW GGGTTTAAUGACCGACTCTACACTACCGTTCC 
46 127904_US-RV ATATTGGGCUATTGAACTGGTAAACATGCCATG 
47 127904_DS-FW ACTAGGTAAUTAGCCCTAGGACGGTTACGAG 
48 127904_DS-RV GGTCTTAAUAACCAACTTTGTTCCATTCTATCG 
49 192604_US-FW GGGTTTAAUGACACATCGTATTGATGACGACC 
50 192604_US-RV ATATTGGGCUCATGGCAGGTAGTCGCAAAG 
51 192604_DS-FW ACTAGGTAAUAAGAGAATACGGAACACATTGACC 
52 192604_DS-RV GGTCTTAAUCGGTCCAACAGTGAGGGTCT 
53 44970_US-FW GGGTTTAAUCGTTGATAATTCCAATTCCAATTC 
54 44970_US-RV ATATTGGGCUCGTCGAAGATGACCTGATTTG 
55 44970_DS-FW ACTAGGTAAUCGGGTTATCACTGTATCAATATCG 
56 44970_DS-RV GGTCTTAAUGCTACTACTATGCCGACTGCGT 
57 44971_US-FW GGGTTTAAUGGCCACACCTCAAGTTTGTATG 
58 44971_US-RV ATATTGGGCUCGGGATTGGAGTGCTCTAGTT 
59 44971_DS-FW ACTAGGTAAUGTTGGCTGAGAGTCAGGGTTAG 
60 44971_DS-RV GGTCTTAAUCCATTAGCTTCGGAACACTGG 
61 44959_US-FW GGGTTTAAUCCTTGTATTCATATCAATTGCGA 
62 44959_US-RV ATATTGGGCUATGTGACAATGAAGAATGGTACG 
63 44959_DS-FW ACTAGGTAAUGGAAAGGATGTTCCAAACAGTT 
64 44959_DS-RV GGTCTTAAUCTTTGTTGATTACTAGTCGTAATCATATG 
65 44961_US-FW GGGTTTAAUTGTCATGTTGTATCGGAGTGTTTAG 
66 44961_US-RV ATATTGGGCUTGTAGCACAAGTGTCTCACTAGTAAATAG 
67 44961_DS-FW ACTAGGTAAUGATTGGAAGTATCCCACAGTCTG 
68 44961_DS-RV GGTCTTAAUGAGAACACCGATCTCCGACGTGGGA 
69 44972_US-FW GGGTTTAAUGACGCAGTCGGCATAGTAGTAG 
70 44972_US-RV ATATTGGGCUGGAGAAGTGGTCAAACTTGTTTCA 
71 44972_DS-FW ACTAGGTAAUACAGGTGATTAAGATGCAAGGCT 
72 44972_DS-RV GGTCTTAAUCTTGCATCATCCGTAATTATGCT 
73 Upst-HygR-N CTGCTGCTCCATACAAGCCAACC  
74 Dwst-1003HygF-N GACATTGGGGAGTTCAGCGAGAG  
75 ampR_PM_FW AGCGCTACAUAATTCTCTTACTGTCATGCCATCC 
76 ampR_PM_RV ATGTAGCGCUGCCATAACCATGAGTGATAACACTG 
77 ori_coli_FW ATCCCCACUACCGCATTAAGACCTCAGCG 
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78 ampR_RV AGCTGCTUCGTCGATTAAACCCTCAGCG 
79 p71_prom-
ter_short_usF 
AGCCCAATAUTAAGCTCCCTAATTGGCCC 
80 p71_prom-ter_dsR ATTACCTAGUGGGCGCTTACACAGTACA 
81 argB_FW ACTAGGTAAUATCGCGTGCATTCCGCGGT 
82 pyrG_FW_C1 ACTAGGTAAUATGACATGATTACGAATTCGAGCT 
83 pyrG_RV_G16 AGTGGGGAUGCCTCAATTGTGCTAGCTGC 
84 ccdB-camR-fw AGAGCGAUCGCAGAAGCCTACTCGCTATTGTCCTCA 
85 ccdB-camR-rv TCTGCGAUCGCTCTTGCGCCGAATAAATACCTGT 
86 AMA1_FW AAGCAGCUGACGGCCAGTGCCAAGCT 
87 AMA1_RV ATATTGGGCUGGAAACAGCTATGACCATGAGATCT 
88 AMA-3'-Fw ACCCCAAUGGAAACGGTGAGAGTCCAGTG 
89 AMA-5'-Rv ATTGGGGUACTAACATAGCCATCAAATGCC 
90 ANIG-actA-qFw GTATGCAGAAGGAGATCACTGCTCT 
91 ANIG-actA-qRv GAGGGACCGCTCTCGTCGT 
92 ANIG-hhtA-qFw CTTCCAGCGTCTTGTCCGTG 
93 ANIG-hhtA-qRv GCTGGATGTCCTTGGACTGGAT 
94 44959-qFw GGCAAAGTTCTAGTCATCGACGA 
95 44959-qRv CATATATCCCAGAGGCGGACAC 
96 44960-qFw GATAGAGGAGATGAGGAAGAGAGGCT 
97 44960-qRv CCTTGGGTACCATTCACAGTCAG 
98 44961-qFw ACATGGACCACCGAGTAGCGT 
99 44961-qRv TAGGGTGTGCGAGAATATCACTTG 
100 54844-qFw CGATGAAGATGGCAATCCCAT 
101 54844-qRv CTATGGCATCGCATACTGAGAAAGA 
102 44963-qFw GCGAGGAGGTAGAAAAGGCAAT 
103 44963-qRv TGAACACGAGACTGGAGTACGGA 
104 44964-qFw TCTTCTGGATACTGGGAATTGGAG 
105 44964-qRv GCGTGATGCACCCTCAACA 
106 44965-qFw TTGTCTGTCAAGGAGGACGAGATT 
107 44965-qRv CTTCACCAAATGCTGCACAGTC 
108 193092-qFw ATCACGGCAAAGAGAGCCAAGT 
109 193092-qRv GAACTGTGGCACGACCATGTC 
110 44967-qFw TGCTGGCTGCTAAGGATTGATG 
111 44967-qRv ATGTTCCAACGCAATGAACAAC 
112 127904-qFw ATGAGCAACATGCTCCCACTACAT 
113 127904-qRv CAGTGATGGTCTTATCCGCCAG 
114 192604-qFw GCCTAATCCTGGGCATCGTG 
115 192604-qRv CTGTGCTCCCCGATCTGCA 
116 44970-qFw TCTCAGGGTGTCCATCTTCCGT 
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117 44970-qRv CGACACGAAATAGGCATCATTCT 
118 44971-qFw ATCTACTCCGGCTCCTGCGAT 
119 44971-qRv ACTCGCAAACAACTTCATTGCTC 
120 44972-qFw AGGTGACTCGAACTGGTATGCTG 
121 44972-qRv CAGAATATACTCGATATGATCGCCTC 
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Table S15. 
13
C NMR chemical shift in ppm for compound 1-9 and 12.  
Atom # 1 2 4 5 6 7 8 9 12 
1 17.1 17.7 68.3 68.2 25.8 68.3 29.7  25.6 
2 132.1 131.8 136.2 135.9 132.0 136.0 70.9  132.2 
3 125.0 124.9 125.3 125.2 124.9 125.4 44.0  125.0 
4 27.3 27.2 26.8 26.8 26.8 26.8 23.1  27.6 
5 40.2 40.3 40.1 40.0 40.1 40.1 40.5 177.4 40.3 
6 136.4 135.8 136.2 135.9 136.0 135.9 136.3 38.2 135.6 
7 124.9 124.9 124.9 124.9 124.9 124.9 124.4 32.5 125.0 
8 27.0 27.2 26.8 26.9 26.8 26.8 26.7 24.5 27.6 
9 40.1 40.3 40.1 40.0 40.1 40.1 40.3 38.7 40.3 
10 141.0 139.9 139.7 139.7 140.2 139.8 139.6 137.9 139.8 
11 116.4 117.7 118.0 117.9 118.0 118.0 117.5 116.9 117.5 
12 25.6 26.6 27.0 26.9 26.8 26.8 26.5 25.7 26.2 
13 63.0 61.3 61.4 61.3 61.6 60.9 61.1 60.0 60.5 
14 58.6 60.1 60.2 59.7 60.2 60.4 59.9 59.1 56.3 
15 193.2 65.8 67.6 76.2 66.2 66.1 65.7 64.3 66.6 
16 143.9 154.6 158.8 157.0 160.8 160.6 154.7 162.2 168.3 
17 133.1 121.6 123.2 123.9 119.7 119.7 121.5 117.4 100.3 
18 193.2 194.8 194.9 194.4 195.1 194.9 194.2 193.7 193.7 
19 25.7 25.6 13.5 13.7 17.7 13.5 29.2  17.6 
20 16.1 16.0 16.1 15.9 15.9 16.1 15.9 16.7 15.8 
21 16.2 16.3 16.1 16.3 16.2 16.2 16.2 15.6 16.3 
22 60.2 63.6 20.0 20.1 62.0 62.0 63.6 60.0 57.4 
23 171.2 171.4  105.7   171.2  170.7 
24 45.6 45.8  74.6   43.7  20.6 
25 70.0 70.2  77.2   70.9   
26 45.1 45.4  71.2   45.1   
27 173.1 173.5  77.2   173.6   
28 27.6 27.7  62.6   27.5   
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Table S16. 
1
H NMR chemical shift in ppm for compound 1-9 and 12.  
Atom 
# 
1 2 4 5 6 7 8 9 12 
1 1.59 (3H, s) 1.58 (3H, s) 3.84 (2H, br. s) 3.86 (2H, s) 1.66 (3H, s) 3.85 (2H, s) 1.28 (3H, m)  1.66 (3H, s) 
2 - - - - - - -  - 
3 5.10 (1H, m) 5.07 (1H, m) 5.33 (1H, tq, 7.4, 
1.5) 
5.34 (1H, t, 6.3) 5.10 (1H, m) 5.34 (1H, m) 1.35 (2H, m)  5.08 (1H, m) 
4 2.06 (2H, m) 2.02 (2H, m) 2.11 (2H, m) 2.10 (2H, m) 2.07 (2H, m) 2.11 (2H, m) 1.43 (2H, m)  2.05 (2H, m) 
5 1.97 (2H, m) 1.96 (2H, m) 1.99 (2H, m) 1.99 (2H, m) 1.98 (2H, m) 1.99 (2H, m) 1.93 (2H, m) - 2.00 (2H, m) 
6 - - - - - - - 2.28 (1H, m) - 
7 5.09 (1H, m) 5.06 (1H, t, 
6.4) 
5.09 (1H, tq, 6.9, 
1.1) 
5.10 (1H, t, 6.3) 5.10 (1H, m) 5.10 (1H, t, 6.4) 5.08 (1H, tq, 6.3, 
1.0) 
1.48 (1H, m) 5.08 (1H, m) 
7’ - - - - - - - 1.26 (1H, m)  
8 2.09 (2H, m) 2.06 (2H, m) 2.07 (2H, m) 2.06 (2H, m) 2.09 (2H, m) 2.07 (2H, m) 2.09 (2H, m) 1.32 (2H, m) 2.07 (2H, m) 
9 1.99 (2H, m) 1.99 (2H, m) 2.01 (2H, m) 2.02 (2H, m) 2.03 (2H, m) 2.02 (2H, m) 2.02 (2H, m) 1.92 (2H, t, 7.1) 1.95 (2H, m) 
10 - - - - - - - - - 
11 5.03 (1H, t, 1.5) 5.04 (1H, t, 
7.2) 
5.04 (1H, tq, 7.3, 
1.2) 
5.04 (1H, t, 6.7) 5.05 (1H, ddd, 7.93, 6.71, 
1.22) 
5.05 (1H, t, 6.8) 5.03 (1H, tq, 6.3, 
1.0) 
5.00 (1H, t, 7.1) 5.01 (1H, t, 7.3) 
12 2.66 (1H, m) 2.67 (1H, m) 2.70 (1H, dd, 15.1, 
8.1) 
2.67 (1H, m) 2.70 (1H, dd, 15.3, 7.9) 2.71 (1H, dd, 15.1, 
8.3) 
2.45 (1H, m) 2.63 (1H, dd, 15.1, 
7.9) 
2.78 (1H, dd, 15.3, 
8.2) 
12’ 2.76 (1H, m) 2.42 (1H, m) 2.37 (1H, m) 2.37 (1H, dd, 14.8, 
6.2) 
2.42 (1H, dd, 15.3, 6.7) 2.40 (1H, dd, 15.1, 
6.8) 
2.68 (1H, m) 2.32 (1H, m) 2.45 (1H, dd, 15.3, 
6.7) 
13 - - - - - - - - - 
14 3.68 (1H, s) 3.64 (1H, d, 
2.8) 
3.60 (1H, d, 2.7) 3.82 (1H, br. s) 3.62 (1H, d, 2.8) 3.62 (1H, d, 2.9) 3.63 (1H, d, 2.8) 3.59 (1H, d, 2.4) 3.59 (1H, d, 3.1) 
15 - 4.68 (1H, br. s) 4.48 (1H, m) 4.59 (1H, m) 4.64 (1H, m) 4.64 (1H, br. s) 4.69 (1H, m) 4.61 (1H, br. S) 5.95 (1H, d, 3.1) 
16 - - - - - - - - - 
17 6.58 (1H, t, 1.5) 5.86 (1H, q, 
1.4) 
5.68 (1H, m) 5.71 (1H, br. s) 5.87 (1H, q, 1.73) 5.87 (1H, d, 1.5) 5.86 (1H, q, 1.5) 5.82 (1H, d, 1.6) 5.30 (1H, s) 
18 - - - - - - - - - 
19 1.66 (3H, s) 1.66 (3H, s) 1.59 (3H, s) 1.591 (3H, s) 1.601 (3H, s) 1.601 (3H, s) 1.12 (3H, s)  1.57 (3H, s) 
20 1.591 (3H, s) 1.581 (3H, s) 1.591 (3H, s) 1.59 (3H, s) 1.60 (3H, s) 1.60 (3H, s) 1.58 (3H, s) 1.02 (3H, d, 6.7) 1.571 (3H, s) 
21 1.63 (3H, s) 1.62 (3H, s) 1.62 (3H, s) 1.62 (3H, s) 1.63 (3H, s) 1.63 (3H, s) 1.62 (3H, s) 1.56 (3H, s) 1.61 (3H, s) 
22 4.84 (1H, dd, 16.1, 
1.5) 
4.82 (1H, d, 
16.1) 
1.92 (2H, br. s) 1.97 (3H, m) 4.27 (1H, m) 4.27 (1H, d, 17.6) 4.83 (1H, d, 16.0) 4.21 (1H, d, 18.5) 3.67 (3H, s)  
22’ 4.89 (1H, dd, 16.1, 
1.5) 
4.76 (1H, d, 
16.1) 
  4.21 (1H, m) 4.21 (1H, m) 4.76 (1H, d, 16.0) 4.09 (1H, d, 18.5)  
23 - -  4.56 (1H, m)   -  - 
24 2.69 (2H, m) 2.69 (2H, m)  3.25 (1H, br. s)   2.681 (2H, m)  2.14 (3H, s) 
25 - -  3.37 (1H, m)   -   
26 2.64 (1H, m) 2.59 (2H, m)  3.35 (1H, m)   2.61 (2H, m)   
26’ 2.57 (1H, m)         
27 - -  3.35 (1H, m)   -   
28 1.33 (3H, s) 1.33 (3H, s)  6.77 (1H, d, 10.7)   1.33 (3H, s)   
28’    3.66 (1H, d, 10.7)      
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Figure S1.  
 
Identification of putative HypC homolog encoded by gedH (ATEG_08457-2) in the A. terreus 
geodin gene cluster. Pairwise alignment of putative emodin anthrone oxidase, GedH (ATEG_08457-
2), from A. terreus and norsolinic anthrone oxidase, HypC, from A. flavus. The conserved DUF-1772 
domain and putative catalytic regions proposed by Ehrlich et al [25] are highlighted in green and blue, 
respectively. 
doi:10.1371/journal.pone.0072871.s001 
 
   
374
Figure S2.  
 
Schematic overview of the integration of a gene-expression cassette into the integration site, IS3, 
by homologous recombination. IS3 is located between genes AN4770 and AN4769 on chromosome 
III. The cassette consists of six parts: upstream targeting sequence (US), promoter (P, in this case 0.5 
kb PgpdA), your favorite gene (YFG), terminator (T, TtrpC), marker (in this case AFpyrG flanked by 
direct), and the downstream targeting sequence (DS). The orientations of the genes AN4770 and 
AN4769 are indicated by green arrows. The sizes of US, DS and the intergenic region are 1984 bp, 
1911 bp, and 3007 bp, respectively. 
doi:10.1371/journal.pone.0072871.s002 
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Figure S3.  
 
Complementation of halogenase deficiency. A) Left panel: detection of sulochrin (-ESI, EIC(m/z 
331.0812)); right panel: detection of geodin (-ESI, EIC(m/z 396.9876)). Strains for halogenase analysis, 
from top to bottom: NID843 (gedLΔ); NID1280 (gedLΔ, IS3::PgpdA-ATEG_08460.1); and NID1306 
(gedLΔ, IS2::gedL). B) Ratio of geodin, monochlor-sulochrin, and sulochrin in the NID1306 strain, 
including ESI−-MS spectrum of monochlor-sulochrin showing the isotopic pattern and the mass 
deviations relative to the theoretical masses. Reference standards of geodin and sulochrin were 
included in all runs (data not shown). 
doi:10.1371/journal.pone.0072871.s003 
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Figure S4.  
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Identification of the likely start codon of gedL. A) Alignment of the top hits in a BLAST search for 
ATEG_08460.1 homologs shows that they contain a very conserved 48 amino acid residue addition in 
the N-terminus. Amongst the homologs, Rdc2, has been characterized as a halogenase by [39] MLAS 
is the predicted N-terminus of ATEG_08460.1. Drawing is not to scale. B) The position of putative 
exons and intron in the 5’end of gedL as predicted by the Augustus software [29]. The predicted protein 
sequence encoded by exon 1 and by the first section of exon 2 is indicated. C) Full alignment of the 
halogenase homologs and GedL based on the GedL sequence derived from the new start codon. 
doi:10.1371/journal.pone.0072871.s004 
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Figure S5.  
 
Expression of lacZ under the control of the gedR promoter (PgedR). Left panel: the positions of the 
strains on the plate are shown in the right panel. NID823 (ged+ mdpA-LΔ) is the reference strain 
without the lacZ gene. NID1278 is a control strain containing the PgpdA-lacZ construct in IS3. The 
NID1291 (ged+ mdpA-LΔ PgedR-lacZ) strain carries PgedR-lacZ in IS3. The strains were stabbed on 
MM containing X-gal and incubated three days at 37 °C in the dark before photography. 
doi:10.1371/journal.pone.0072871.s005 
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Figure S6.  
 
Constitutive expression of gedR induces transcription of the A. nidulans gene mdpG. mdpG mRNA 
levels in reference (NID1) and in the ged+ strain (NID677) were evaluated by quantitative RT-PCR. 
For each strain, RNA was extracted as described in Materials and Method and the RNA samples 
analyzed in triplicate by quantitative RT-PCR. The samples were loaded and analyzed by 1% agarose 
gel-electrophoresis as indicated in the figure. 
doi:10.1371/journal.pone.0072871.s006 
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Table S1.  
Strain genotypes. * = For reference see Nielsen et al ([13]). 
doi:10.1371/journal.pone.0072871.s007 
Strain  Genotype
NID1  argB2, pyrG89, veA1, nkuAΔ 
NID3  argB2, pyrG89, veA1, nkuA‐trS::AFpyrG 
NID74  argBΔ, pyrG89, veA1, nkuAΔ 
NID356  argBΔ, pyrG89, veA1, nkuA∆, mdpA‐L∆
NID675  argBΔ, pyrG89, veA1, nkuA∆, IS1::ATgedE‐L::argB 
NID676  argBΔ, pyrG89, veA1, nkuA∆, mdpA‐L∆, IS1::ATgedE‐L::argB 
NID677  argBΔ, pyrG89, veA1, nkuA∆, IS1::ATgedA‐L::PgpdA‐gedR::AFpyrG 
NID695  argBΔ, pyrG89, veA1, nkuA∆, mdpA‐L∆, IS1::ATgedA‐L::PgpdA‐gedR::AFpyrG 
NID761  argBΔ, pyrG89, veA1, nkuA∆, mdpA‐L∆ IS1::ATgedA‐L, gedR∆:AFpyrG 
NID802  argBΔ, pyrG89, veA1, nkuA∆, IS1::ATgedA‐L::PgpdA‐gedR 
NID823  argBΔ, pyrG89, veA1, nkuA∆, mdpA‐L∆, IS1::ATgedA‐L::PgpdA‐gedR 
NID842  argBΔ, pyrG89, veA1, nkuA∆, mdpA‐L∆, IS1::ATgedA‐B::gedD‐gedL::PgpdA‐gedR, gedC∆:AFpyrG
NID843  argBΔ, pyrG89, veA1, nkuA∆, mdpA‐L∆, IS1::ATgedA‐K::PgpdA‐gedR, gedL∆:AFpyrG 
NID925  argBΔ, pyrG89, veA1, nkuA∆, mdpA‐L∆, IS1::ATgedA‐L, gedR∆ 
NID1278  argB2, pyrG89, veA1, nkuA∆, IS3::PgpdA‐lacZ 
NID1279  argBΔ, pyrG89, veA1, nkuA∆, mdpA‐L∆, IS1::ATgedA‐K::PgpdA‐gedR, gedL∆ 
NID1280  argB2, pyrG89, veA1, nkuA∆, IS1::ATgedA‐K::PgpdA‐gedR, gedL∆, IS3::PgpdA‐ATEG_08460.1::AFpyrG 
NID1291  argBΔ, pyrG89, veA1, nkuA∆, mdpA‐L∆ IS1::ATgedA‐L, IS3::0.9 kb PgedR‐lacZ 
NID1297  argBΔ, pyrG89, veA1, nkuA∆, mdpA‐L∆ IS1::ATgedA‐L, gedR∆, IS3::0.9 kb PgedR‐lacZ 
NID1306  argBΔ, pyrG89, veA1, nkuA∆, mdpA‐L∆, IS1::ATgedA‐K::PgpdA‐gedR, gedL∆:AFpyrG, IS2::gedL 
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Table S2.  
Primers list. The sequence of PCR products # 1-3 corresponds to supercontig 12: 1302695-1315163 
(ATEG_08454-08460) in the genome sequenced isolate NIH2624 (IBT28053). Similarly, PCR 
products # 4-6 and 8 corresponds to supercontig 12: 1289727-1304484 (ATEG_08449-08454) in 
NIH2624 (IBT28053). * = For reference see Hansen et al ([7]). 
doi:10.1371/journal.pone.0072871.s008 
PCR 
prod
uct # 
Prime
r pair 
(fw/rv
) 
Forward primer  Reverse Primer Description 
1  455/45
6 
agctcacuCCAGATCA
ACCAGCAGACGA 
aggcccagguGACGTTT
GCGATTCCGCCCA 
4.072 bp of A.terreus IBT15722 gDNA 
spanning putative ORFs ATEG_8454‐8456 
including 1788 bp overlap with 521/464 PCR 
product 
2  457/17
7 
acctgggccuCGTGAG
TTGGGATGGAATG
A 
aacacaauGAAGGCTG
TGTGATGCCCGG 
4.382 bp of A.terreus IBT15722 gDNA 
spanning putative ORFs ATEG_8457‐8458 
3  178/50
8 
attgtgtuAGATACCG
CCAGAACTGCCTA 
actggagauCGAGGAT
ATGGAAGGACACTA 
3.993 bp of A.terreus  IBT15722 gDNA 
spanning putative ORFs ATEG_8459‐8460 
4  459/46
0 
agctcacuTTAGAACC
CAGCAGCAAGGCG 
agcggacacuCCTGTCG
CTGCAGTTCAGTT 
4.430 bp of A.terreus  IBT15722 gDNA 
spanning putative ORFs ATEG_8449‐8451 (5') 
5  461/46
2 
agtgtccgcuAACGCT
TAGAGGCAGCTACT 
atctgcagacuGGATGA
CTAGATGGCACTGG 
5.382 bp of A.terreus  IBT15722 gDNA 
spanning the 3´ end of the Geodin PKS 
(ATEG_8451) 
6  463/52
2 
agtctgcagauAATGA
GGTTACAATGCATC
C 
agcttacuTGTGATGCT
CCCTGGTGACT 
2.397 bp of A.terreus  IBT15722 gDNA 
spanning putative ORF ATEG_8452 
7  405/40
6 
agtaagcuCCCTAATT
GGCCCATCCG 
atctgaaaauGCGGTAG
TGATGTCTGCTCA 
500 bp of A. nidulans PgpdA promoter 
amplified from pU1111 (20) 
8  521/46
4 
attttcagauGTCTGC
AGAAGGACACAAG
C 
actggagauCATGGATT
TGCGGCAGTACT 
2.533 bp of A.terreus  IBT15722 gDNA 
spanning putative ORFs ATEG_8453‐8454 
including 1788 bp overlap with 455/456 PCR 
product 
9  84/71  atctccaguTTACACA
GACCAGCAATCAT 
agtgagcuCGCGGTTTT
TTGGGGTAGTCATC 
 A. nidulans cloning vector pU1111 (Hansen et 
al, 2011) 
10  77/422  atctccaguAGCGCG
GCCGCATTTAAATC 
acagagttcuTGAAGTG
GTGGGCTAACTAC 
1,6 kb of basic cloning vector PJ204 (DNA 2.0) 
including the ampR marker gene 
382
11  421/70  agaactctguAGCACC
GCCTACATACCTCG 
agtgagcuTGGATAAC
CGTATTACCGCCTTTG
5,3 kb of A. nidulans cloning vector pU2000 
(nomenclature from (20)) including A. 
fumigatus pyrG marker gene flanked by direct 
repeats and IS1 downstream targeting region 
12  BGHA1
63/568 
GGTCTACTCCCCTG
CGTCTA 
CTCATCCAGCCTGTTA
TCCA 
Analytical PCR for verification of insertion of 
fragment1 in IS1 upstream targeting site 
13  BGHA9
8/162 
GGTTTCGTTGTCAA
TAAGGGAA 
GTTCAGGGTGACGGT
GAGAG 
Analytical PCR for verification of insertion of 
fragment1 in IS1 downstream targeting site 
14  112/10
8 
gggtttaauATGTCTG
CAGAAGGACACAA
GC 
gggtttaauATGACTAC
GACCTATGCAGT 
Analytical PCR for verification of insertion of 
fragment2 in the overlap with the fragment1 
15  BGHA 
182/16
2 
CACACATCGACATC
CTCACC 
GTTCAGGGTGACGGT
GAGAG 
Analytical PCR for verification of insertion of 
fragment2 in IS1 downstream targeting site 
16  569/57
0 
TCTGATCTGTCTGG
AGCCT 
gatccccgggaattgccatg
CCGGACTAGACGGTT
GGATT 
Deletion of the geodin polyketide synthase, 
ATEG_8451. Amplifies 2,0 kb of A.terreus  
IBT15722 gDNA upstream of the putativeORF. 
Specific tail for use of A. fumigatus pyrG as 
selective marker 
17  571/57
2 
aattccagctgaccacca
tgACTGGTATCAGAT
TGGTCCG 
CTTCAGGTGCGAGTA
ATCTT 
As above, but 2,0 kb downstream of the 
putative ORF 
18  573/57
4 
CACGGACGAGCAT
AGAATAG 
gatccccgggaattgccatg
ACAGTCAGTCTTGGT
CTGCG 
Deletion of the putative sulochrin halogenase, 
ATEG_8460. Amplifies 2,0 kb of A.terreus  
IBT15722 gDNA upstream of the putativeORF. 
Specific tail for use of A. fumigatus pyrG as 
selective marker 
19  J58/57
6 
aattccagctgaccaccatg
TTACACAGACCAGCA
ATCATC 
AGAAGAGGTCTGTGA
TGCTGA 
As above, but 2,0 kb downstream of the 
putative ORF 
20  JBN 
5A/2K 
catggcaattcccgggga
tcTGGATAACCGTAT
TACCGCC 
GGAAGAGAGGTTCA
CACC 
Amplification of 1455 bp A. fumigatus PyrG 5' 
region for fusion PCR deletion substrates. 
21  JBN 
4Q/5B 
TGATACAGGTCTCG
GTCCC 
catggtggtcagctggaatt
tGCCAAGCTTAACGC
GTACC 
Amplification of 1217 bp A. fumigatus PyrG 3' 
region for fusion PCR deletion substrates. 
22  327/32
8 
GAATCACTTGCCAT
CTTGCT 
gatccccgggaattgccatg
ATTTCGGACATAGCT
CGTTG 
Deletion of A. nidulans mdp gene cluster 
(mdpA‐L) ‐ upstream fragment 
23  329/33
0 
aattccagctgaccacca
tgTGCTGTATATGG
GTCTTGG 
CTGTTTTGAGGCGGT
TCC 
Deletion of A. nidulans mdp gene cluster 
(mdpA‐L) ‐ downstream fragment 
24  BGHA 
192/23
TCGTCAAGGTTTTC
CCTTTGT 
ACGCTATTGATGTGG
TGAAT 
Analytical PCR for verification of mdpA‐L 
deletion 
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Over-expression of Transcription Factor in Aspergillus aculeatus Activates Biosynthetic Pathway 
and Reveals Novel Compounds Acurin A and B. 
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Supporting information 
Figure S1. Mass spectra of compounds (2), (3), (4), (5), and (6), cultivated on YES or YES + 13C-6-
MSA. 
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Supporting information 
Figure S2. Effect of increasing concentrations of acurin A on CLL cell viability in a CellTiter-Glo® 
assay. The relative cell viability is compared to DMSO control (1 %).  
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Table S1. NMR Data for acurin A in DMSO-d6. 1H NMR spectrum and all 2D spectra were recorded at 
the Varian Unity Inova-500 spectrometer at DTU. Signals were referenced by solvent signals for 
DMSO-d6 at δH = 2.49 ppm and δC = 39.5 ppm.  
1
2
3
4
5
6
7
8
9
10
11
12 13
14
O
22
OO23
15 19
17
NH
18
16
O
20
OH
21  
Atom  1H-chemical shift [ppm]/  
J coupling constants [Hz] 
13C-chemical 
shift [ppm] 
HMBC 
correlations 
H2BC 
correlations 
NOE 
connectivities 
1 1.71 (dd 7.2, 1.0) 15.4 2, 3, 22 2 2, 4 
2 6.88 (m) 139.9 1, 4, 22 1 1 
3 - 129.8 - -  
4 6.22 (s) 126.8 6, 12, 22 - 1, 6, 12 
5 - 137.5 - -  
6 6.69 (d 15.4) 140.0 4, 5, 8, 9, 12  7 4, 7 
7 6.60 (m) 128.8 5, 8 6 6, 12 
8 6.83 141.0 10 7/9 6, 7 
9 6.831 (m) 128.9 7 8  
10 7.38 (m) 141.3 8, 13, 14 9 9, 15 
11 - 134.4 - -  
12 1.64 (s) 13.8 4, 5 4 4, 7 
13 1.85 (s) 11.6 10, 11, 14 10, 11  
14 - 197.8 - -  
15 4.39 (m) 47.5 14, 16/16’, 19 16/16’ 16’ 
16 2.33 (m) 27.3 14, 15, 17, 20/20’ 15, 20/20’ 16’, 20 
16’ 1.92 (m) 27.3 - 15, 20/20’ 15, 16, 20 
17 3.35 (t 5.5) 64.4 16/16’ 20  
18 7.84 (d 10) - 15, 16/16’,19, 20/20’ - 20, 20’ 
19 - 173.0 - -  
20 3.54 (m) 53.6 16/16’ 16/16’, 17 16/16’, 18 
20’ 3.36 (m) 53.6 - - 18 
21 - - - -  
22 - 166.3 - -  
23 3.66 (s) 51.6 22 -  
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Table S2. NMR Data for acurin B in DMSO-d6. 1H NMR spectrum and all 2D spectra were recorded at 
the Varian Unity Inova-500 spectrometer at DTU. Signals were referenced by solvent signals for 
DMSO-d6 at δH = 2.49 ppm and δC = 39.5 ppm. 
1
2
3
4
5
6
7
8
9
10
11
12 13
14
O
22
OO23
15 19
17
NH
18
16
O
20
OH
21  
Atom  1H-chemical shift [ppm]/  
J coupling constants [Hz] 
13C-chemical 
shift [ppm] 
HMBC 
correlations 
1 1.71 (1H, m) 14.3 2, 3, 4, 22 
2 6.87 (1H, m) 139.2 1 
3 - 125.0 - 
4 6.84 (1H, m) 128.5 22 
5 - 136.7 - 
6 6.69 (dd, 15.1, 2.5) 140.0 5, 12 
7 6.57 (1H, m) 137.9 3 
8 7.04 (1H, m) 123.3 - 
9 6.47 (1H, m) 123.7 8, 14 
10 7.83 (1H, m) 135.1 13 
11 - 140.0 - 
12 1.63 (3H, m) 13.2 3, 5 
13 1.85 (3H, s) 10.8 10, 11, 14 
14 - 199.8 - 
15 4.50 (1H, m) 47.3 14, 16/16’, 19 
16 2.35  26.6 14 
16’ 1.92 26.6 14 
17 3.55 (2H, m) 52.9 15, 16/16’, 17 
18 7.89 (1H, m) - - 
19 - 172.2 - 
20 3.36 (2H, m) 63.5 - 
21 - - - 
22 - 166.3 - 
23 3.65 (3H, s) 50.9 22 
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Appendix H
Investigation of the secondary metabolite
potential in Aspergillus aculeatus
This chapter describes a basic bioinformatic study to reveal the secondary metabolite synthases that are
present in A. aculeatus. The genome of A. aculeatus ATCC16872 was recently sequenced by the DOE Joint
Genome Institute, and the automatically annotated genome is available at http://genome.jgi-psf.org/Aspac1
/Aspac1.home.html.
H.1 Identiﬁcation of synthases
For identiﬁcation of synthases, I used a combination of BLAST search using characterized synthases from
A. nidulans and keyword search for speciﬁc domains of the three types of synthases: PKSs, NRPSs, and
terpenoid synthases. The search identiﬁed 24 PKSs, 19 NRPSs, 9 terpenoid synthases, and 5 hybrid synthases
(H.1).
Figure H.1: Distribution of secondary metabolite synthases in A. aculeatus.
For identiﬁcation of functional domains, the 57 putative synthases were analyzed using the Conserved
Domain Database (CDD) [Marchler-Bauer et al., 2011]. The deduced domain organization is shown for all
synthases in Table H.1. It should be noted that some recently discovered and poorly characterized domains
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are not detected by CDD e.g. product template (PT) and thio Hydrolase (TH) domains, why these have to
be annotated manually.
The putative NRPSs were additionally analyzed using the web-based program NRPSpredictor2 [Röttig
et al., 2011] which allows for prediction of the adenylation domain speciﬁcity i.e. which amino acid is selected
and attached to the NRP chain.
Table H.1: Secondary metabolite synthases in A. aculeatus. aPredicted by AUGUSTUS, bPredicted by
FGeneSH, cPredicted amino acid recognized by the adenylation domain (Score: 0-100) by NRPS Predictor2
[Röttig et al., 2011]. TIDS = trans-isoprenyl diphosphate synthase, OHFT = Omega-hydroxypalmitate O-
feruloyl transferase, Dhb = 2,3-dihydroxy-benzoic acid, Hpg = 4-hydoxy-phenyl-glycine, Orn = ornithine,
Aad = 2-amino-adipic-acid.
Type Model ID Length (aa) Domains (CDD/NRPS2)
PKS 48 2429 KS AT DH MT DH KR ACP
PKS 108 2409 KS AT DH MT DH ACP
PKS 26431 2426 KS AT MT DH KR ACP
PKS 28570 2548 KS AT MT DH KR ACP
PKS 29093 2387 KS AT MT DH KR ACP
NR-PKS 31261 2165 KS AT ACP TE
NR-PKS 33832 1793 KS AT ACP/thiolase-like
PKS 42038 2896 KS AT DH MT DH KR ACP DH
PKS 42746 2186 KS AT DH MT KR ACP
PKS 43562 2372 KS AT DH ER KR ACP
PKS 63275-46489 213 KR ACP (ER KR ACP)a
PKS 47290 2422 KS AT DH MT ER KR ACP
PKS 48557 3214 KS AT DH MT ER DH ACP Monoamine oxidase
PKS 50671 2346 KS AT DH ER KR
NR-PKS 54632 2546 KS AT ACP MT TR
PKS 55425 2437 KS AT DH MT ER KR
PKS 63311 3042 PKS - DH ACP DH
PKS 65031 1681 AT ACP KR C
PKS 120020 429 KS
NR-PKS 126899 2143 SAT KS AT ACP TE
PKS 1867870 2470 KS AT DH MT KR ACP
PKS 1870238 2467 KS AT DH MT ER KR ACP
NR-PKS 1874409 1779 KS AT ACP
Continued on Next Page
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Table H.1  Continued
Type Model ID Length (aa) Domains (CDD/NRPS2)
PKS 1882131(*) 563 (2247) DH KR ACP (OHFT MT ER KR ACP)b
PKS 1889732 2165 IPP isomerase - KS AT MT DH - TIDS
PKS 1904397 1750 KS AT DH KR ACP
NRPS 20389 1022 Cys (50)c
NRPS 19967 4728 Ala (90), Dhb (90), ser (90)
NRPS 241 1780 Leu (40), Arg (40)
NRPS 1878108 1734 Val (70), Aad (60)
NRPS 112572 1427 Pro (90)
NRPS 802 1066 Val (50)
NRPS 115976 1998 Cys (60)
NRPS 42025 7330 Hpg (40), Ala (60), Dhb (40), Val (50), Ala (60), Tyr (40)
NRPS 60230 6264 Pro (60), Ser (40), Orn (60), Val (70)
NRPS 43289 1071 Leu (50)
NRPS 29371 1079 Leu (60)
NRPS 122295 1553 Hpg (50)
NRPS 34099 2140 Lys (30), Leu (40)
NRPS 394 1477 Asp (40), Cys (60)
NRPS 64101 2407 Thr (40), Ala (60)
NRPS 64146 5041 Phe (60), Cys (50), Orn (50), Gln (40)
NRPS 1907395 2068 Val (60)
NRPS 1860611 5438 Phe (40), Phe (50), Pro (50), Pro (60), Leu (50)
NRPS 37457 7009 Cys (60), Leu (70), Val (70), Pro (40), Glu (50)
PKS/NRPS 51108 4073 KS AT DH MT KR ACP C A P DH (Glu (50))
PKS/NRPS 43247 3970 KS AT DH KR ACP C A P DH (Val (50))
PKS/NRPS 53248 4018 KS AT DH KR ACP C A P DH (Ser(100))
PKS/NRPS 31401 3937 KS AT MT DH KR ACP C A P DH (Val (100))
Terpene synthase 48138 210 Terpene cyclase
Terpene synthase 57499 269 Terpene cyclase
Terpene synthase 58369 365
Terpene synthase 58711 339 Terpene cyclase
Terpene synthase 60731 443 Terpene cyclase
Terpene synthase 116070 373 Terpene cyclase
Terpene synthase 125390 385 Terpene cyclase
Continued on Next Page
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Table H.1  Continued
Type Model ID Length (aa) Domains (CDD/NRPS2)
Terpene synthase 127866 744 Polyprenyl synthetase
Terpene synthase 1858621 778 Polyprenyl synthetase
H.2 Annotation and assessment of polyketide synthases
The A. aculeatus genome contains 24 putative PKSs, of which only ﬁve appear to be non-reducing (NR) i.e.
they do not contain any reduction domains. A very interesting discovery was the presence of a hybrid IPP
isomerase-PKS-trans-isoprenyl diphosphate synthase (1889732). An IPP isomerase is the enzyme that cat-
alyzes the reversible reaction of isopentenylpyrophosphate (IPP) into dimethylallylpyrophosphate (DMAPP)
in the biosynthesis towards terpenoids. Trans-isoprenyl diphosphate synthases (TIDSs) catalyze head-to-tail
condensation of IPP and DMAPP building blocks to synthesize terpenes. To my knowledge, this conﬁgu-
ration has not been reported before, and although is it not possible to predict the product, is should be
fair to assume that is is a hybrid meroterpenoid (PKS-terpene) which is synthesized in a novel manner than
previosly reported meroterpenoids e.g. austinols.
Although most of the PKS seem to be full-length (containing a full set of domains), three putative
synthases are very short and do not contain a full set of domains: 46489, 120020, and 1882131.
H.2.1 46489 is a non-ordinary or non-functional PKS
CDD analysis suggested that 46489 comprised two domains: KR (partial) and ACP (Figure H.3A). As the
ACP is normally found in the C-terminus of the PKS, I examined the upstream genome sequence for PKS
activities. One gene (63275), located just upstream of 46489, did indeed encode an enoyl reductase (ER)
(Figure H.3B) which is present in highly reducing PKSs. The entire genomic stretch surrounding 46489
(+/- 20 kb) was analyzed using the two gene prediction algorithms FgeneSH (Softberry) and AUGUSTUS
[Stanke et al., 2004], and AUGUSTUS did indeed predict the two genes as one single gene, encoding three
full domains: ER, KR, and ACP (Figure H.3C). However, I was unable to locate any KS or AT domains,
which are essential for ordinary PK synthesis by a type I iterative PKS. Thus this putative PKS must be a
non-ordinary PKS, or a non-functional part of a type I iterative PKS which has been partly lost or partly
gained by an unknown mechanism.
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Figure H.2: Gene prediction for putative PKS 46489. JGI prediction in red, AUGUSTUS prediction in green.
Figure H.3: Annotation of putative PKS 46489. A. CDD search for 46489 identiﬁes KR and ACP domains.
b. CDD search for 63275 identiﬁes ER domain. C. CDD search for combined 63275-46489 (predicted by
AUGUSTUS) identiﬁes ER, KR and ACP domains.
394
H.2.2 120020 may be a type III PKS
The putative PKS 120020 was analysed by CDD, revealing that only a KS domain was present. Analysis
of the genome sequence surrounding the putative PKS gene did not reveal any additional domains, however
several non-PKS-related genes were predicted. This suggested that the PKS did in fact only comprise a KS
domain, which led me to propose that this gene may encode a type III PKS.
In contrast to the multidomain type I and type II PKSs, type III PKSs are selfcontained homodimeric
enzymes that on their own can catalyze a whole set of reactions: recruitment of a starter unit, decarboxylative
condensation of extender units, ring closures, and/or cyclization of the polyketide chain [Austin and Noel,
2009]. All of these reactions take place within the same active site pocket.
Type III PKSs are most common in bacteria but interestingly, Li and co-workers recently identiﬁed and
characterized a type III PKS from A. niger [Li et al., 2011a]. As this type of PKSs is in fact present in
Aspergilli, it is likely that 120020 is a type III PKS.
H.2.3 1882131 is a non-ordinary PKS that contains a novel SAT domain
The 1882131 putative PKS was analyzed by CDD, and only three domains were identiﬁed: DH, KR, and
ACP (Figure H.5A). Analysis of the surrounding genome sequence (+/- 20 kb) an subsequent re-annotation
by FGeneSH and AUGUSTUS revealed that the ORF was in fact longer than initially predicted (Figure
H.5B). However, no KS nor AT domain was identiﬁed. Instead, the predicted gene contained part of a
conserved domain from a omega-hydroxypalmitate O-feruloyl transferase (OHFT) in the N-terminus. A
OHFT catalyzes the transfer of a feruloyl-CoA to a 16-hydroxypalmitate, yielding a 16-feruloyloxypalmitate
(Figure H.6) [Gou et al., 2009, Molina et al., 2009].
Figure H.4: Gene prediction for putative PKS 1882131. JGI prediction in red, AUGUSTUS and FGeneSH
prediction in green.
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Figure H.5: Annotation of putative PKS 1882131. A. CDD search for 1882131 identiﬁes ER, KR and ACP
domains. B. CDD search for 1882131* (predicted by FgeneSH) identiﬁes OHFT, MT, ER, KR and ACP
domains.
Interestingly, there is a non-identiﬁed stretch of >500 amino acids between the predicted OHFT and the
methyl transferase (MT) active site. This stretch could contain novel domains which obviate the need for KS
and AT domains, which are normally present in a functional PKS. Although I cannot speculate concerning the
products of the PKS, I propose that 1882131 is a functional, non-ordinary PKS that employs an alternative
starter unit which is recruited and attached by the alternative transferase domain.
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Figure H.6: Activity of the omega-hydroxypalmitate O-feruloyl transferase (OHFT). OHFT attaches the
feruloyl-CoA to the C16-hydroxy group of 16-hydroxypalmitate to yield 16-feruloyloxypalmitate.
H.3 Phylogeny of the A. aculeatus PKSs
in order to get an overview of the PKSs that are present in A. aculeatus, I aligned the amino acid sequences
using ClustalW and made a phylogenetic tree (Figure H.7) [Larkin et al., 2007]. For reference, I included A.
nidulans wA (AN8209) and A. niger yanA (ASPNI44965). As expected, the reducing PKSs cluster together,
and the non-reducing PKSs cluster together. There are four PKSs that do not cluster with the two large
groups: 65031, 120020, 1999732, and 1904397. The latter clusters with yanA, and further analyses have
veriﬁed that 1904397 is in fact a 6-MSA synthase (Chapter 12). 65031 and 120020 do not seem complete,
which could explain the lack of homology to the remaining PKSs. 1889732 is described in Section H.2 as a
hybrid PKS-terpene synthase, and as this is a novel conﬁguration it could certainly explain why it diﬀers
from the other PKSs.
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Figure H.7: Phylogenetic tree of A. aculeatus PKSs with two references: ASPNI44965 (A. niger 6-MSA
synthase yanA) and AN8209 (A. nidulans YWA1 synthase wA).
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